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Cryptosporidium is the most important waterborne pathogen due to its resistance to chlorine in 
drinking water. The contribution of Cryptosporidium to waterborne diseases in Australia is 
however, unknown. The level of faecal contamination of drinking water catchments with this 
parasite was assessed by longitudinal analysis of faecal samples collected from marsupials, 
sheep, cattle and rabbits (n = 5,774) from eleven drinking water catchments across three states; 
New South Wales (NSW), Queensland (QLD) and Western Australia (WA). Faecal samples 
were screened by quantitative PCR (qPCR) and typed at two loci using Sanger sequencing. 
The overall prevalence of Cryptosporidium in faecal samples was 18.3% (1,054/5,774; 95% 
CI, 17.3-19.3). Of these, 873 samples produced clean Sanger sequencing chromatograms, and 
the remaining 181 samples, which initially produced chromatograms suggesting the presence 
of multiple different sequences, were re-analysed by Next Generation Sequencing (NGS) to 
resolve the presence of Cryptosporidium and the species composition of mixed infections. The 
overall prevalence of mixed infection was 1.7% (98/5,774), and in the remaining 83 samples, 
NGS detected only one species of Cryptosporidium. Of the 17 Cryptosporidium species and 
four genotypes detected (Sanger sequencing combined with NGS), 13 are capable of infecting 
humans; C. parvum, C. hominis, C. ubiquitum, C. cuniculus, C. meleagridis, C. canis, C. felis, 
C. muris, C. suis, C. scrofarum, C. bovis, C. erinacei and C. fayeri. Sewage (influent) samples 
across these states were also collected (n = 730) and screened by qPCR and typed using next 
generation sequencing (NGS). In sewage samples, the overall Cryptosporidium prevalence was 
11.4% (83/730); 14.3% (3/21) in NSW, 10.8% (51/470); in QLD and 12.1% (29/239) in WA, 
and a total of 17 Cryptosporidium species and 6 genotypes were detected by NGS, including 
some of the same zoonotic species detected in animal faecal samples. This study highlights the 
iii 
public health importance of continued identification of the sources/carriers of human 
pathogenic strains for accurate risk assessment and optimal catchment management.
iv 
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Aims and scope of the thesis 
 
Diarrhoea is one of the five most common disease-related causes of death worldwide and 
is responsible for 2.2 million deaths annually, mainly in children younger than five years of 
age (Kosek et al., 2003; Keusch et al., 2016; WHO, 2017). Yet, due to lack of systematic 
surveillance in developing countries, the global burden of water associated diarrhoea and 
gastrointestinal diseases is scant (Ryan et al., 2017). Even in some developed countries such as 
Australia, where routine disease surveillance systems exist, the majority of water related 
gastroenteritis cases that occur in the community remains unnotified and the true burden of 
waterborne diseases is unknown (O'Toole et al., 2015). 
With a worldwide distribution, waterborne parasitic protozoan pathogens contribute to 
almost four billion cases of diarrhoea every year, and therefore are of increasing concern 
(Wright and Gundry, 2009). Of these, Cryptosporidium is considered a major cause of severe 
waterborne diarrhoea worldwide, which can be life-threatening in immunocompromised 
individuals, and therefore represents a major public health concern for water utilities even in 
developed nations including Australia (Ryan et al., 2016). Currently ~ 17 million cases of 
gastroenteritis are reported in Australia per annum (p.a.), which has been estimated to cost over 
1 billion dollars p.a. (Anon, 2006), and as a waterborne pathogen, Cryptosporidium accounts 
for a significant proportion of these cases. 
Cryptosporidium is particularly suited to waterborne transmission as the oocyst stage is 
small in size, highly resistant to chlorine disinfection of drinking water and can survive for 
months in moist, ambient conditions (King and Monis, 2007; Ryan et al., 2017). It has a very 
low infectious dose (10-100 oocysts) and is usually shed in very large quantities in faeces. For 
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example, neonatal calves can excrete up to 30 billion oocysts or more over a 1-2 week period 
(Kuczynska and Shelton, 1999) and even apparently healthy animals can shed high numbers of 
oocysts (>5×106 oocysts per gram) (Chalmers and Giles, 2010). Water sources, mainly surface 
water, can become contaminated through direct defaecation of oocyst-contaminated faeces by 
animals or humans in the water or by surface run off. Therefore, risk assessment and risk 
management of the drinking water supply in relation to Cryptosporidium should be based, 
firstly, on identifying the sources of Cryptosporidium, and whether the species being shed in 
faeces are human-infectious or not. Despite this, the transmission dynamics of human 
pathogenic species and genotypes of Cryptosporidium from animals to humans through 
contamination of water sources is not well understood. 
Currently, 37 Cryptosporidium species are recognized as valid (Jezkova et al., 2016; 
Zahedi et al., 2017; Čondlová et al., 2018; Kváč et al., 2018). Molecular data indicates that at 
least 17 of these are infectious to humans, with the zoonotic C. parvum and the largely 
anthroponotic C. hominis by far the most common species reported in humans worldwide, 
responsible for all waterborne outbreaks typed to date, with the exception of a single outbreak 
in the UK caused by C. cuniculus (Xiao, 2010; Puleston et al., 2014). In Australia, 
cryptosporidiosis is considered as a notifiable infectious disease across all states, with a 
seasonal pattern of disease notification that has remained consistent (Lal et al., 2015). However, 
relatively few genotyping studies have been conducted in Australia, but to date, C. hominis, C. 
parvum, C. meleagridis (from birds and humans), C. fayeri (from marsupials), and C. andersoni 
and C. bovis (from cattle), have been reported in humans in Australia (cf. Ryan and Power, 
2012). However, a review conducted for Water Research Australia (Ryan, 2014), identified 
that a key knowledge gap in assessing microbial risks to surface waters was the lack of 
quantitative prevalence and genotyping data on zoonotic Cryptosporidium species infecting 
animal hosts in Australian drinking water catchments over time and space, and their potential 
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link with water related outbreaks of Cryptosporidium in the human population (Ryan, 2014). 
Therefore, the over-arching aim of this PhD thesis was that sophisticated genetic fingerprinting 
of faecal samples from animals in drinking water catchments and human sewage can be used 
to characterise the diversity of Cryptosporidium species and genotypes contaminating drinking 
water catchments and Waste Water Treatment Plants (WWTPs) to better inform risk 
management. To address this, for the first time in Australia, a comprehensive quantitative 
survey of Cryptosporidium species and genotypes in marsupials, rabbits, cattle and sheep in 11 
catchments and in 25 wastewater treatment plants (WWTPs) across three states, over a three-
year period to gain a more thorough understanding of the zoonotic risk these parasites pose to 
humans. 
Specifically, this project aimed to: 
1. Collect faecal samples from the four most dominant non-rodent animals inhabiting water 
catchments (marsupials, sheep, rabbits and cattle) as well as from WWTP influent across 
three states, with very different climatic conditions; 
2. Use qPCR to screen the faecal samples and WWTP samples for Cryptosporidium;  
3. Enumerate Cryptosporidium oocysts in faecal samples and WWTP samples by qPCR 
with droplet digital PCR (ddPCR) calibrated standards; 
4. Determine the diversity of Cryptosporidium species in animal and WWTP samples using 
both Sanger and next generation sequencing (NGS) at multiple loci; 
 
The Australian Drinking Water Guidelines 2011 (ADWG) provide a framework for good 
management of drinking water supplies based on a preventive risk management approach 
(NHMRC-NRMMC, 2011). Risk management is based on assessing risks and reducing them 
to acceptable levels to assure safety. The ADWG currently do not have numerical targets for 
microbial safety of drinking water, but it is anticipated that this discrepancy will soon be 
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addressed and that a combination of quantitative microbial risk assessment (QMRA) and the 
metric of Disability Adjusted Life Years (DALYs) will be used to define microbial safety 
(O’Toole et al., 2015). The economic benefits to the industry, of effective modelling and 
management of waterborne pathogens, in particular Cryptosporidium, is substantial, as 
currently in Australia, >600 million dollars is expended annually to implement monitoring and 
management policies, and every water quality incident that is avoided through better 
management can save up to $100 million (CRC, 2008). Therefore, data generated from this 
thesis is crucial for more informed and accurate modelling and quantitative microbial risk 
assessments (QMRA), and more targeted control and risk mitigation strategies. 
 
A note on thesis layout, formatting and style 
 
This multidisciplinary PhD thesis incorporates the fields of molecular biology, 
parasitology, and public health, and comprises a number of scientific manuscripts, presented 
as chapters, which have been published in peer reviewed journals. In order to maintain a 
consistent style and to form a coherent and integrated body of work, each chapter commences 
with a preface introducing and linking the published work to the overall aims of the thesis, and 
ends with a summary outlining the main findings of the manuscript as they relate to the thesis. 
Since the chapters contain fully formed scientific manuscripts, the papers naturally contain 
their own abstract, introduction, materials and methods, results, and discussion sections. 
Chapter one provides a thorough review of Cryptosporidium species, particularly 
zoonotic species detected in wildlife and also focuses on a “One Health” approach to 
prophylactic prevention of cryptosporidiosis including improved detection, diagnosis and 
treatment, and the importance of understanding zoonotic transmission. 
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Chapters two, three and four focus on screening faecal samples for Cryptosporidium from 
animals inhabiting water catchment areas across three states and provide improved molecular 
diagnostic, quantitation (enumeration) and characterisation tools for Cryptosporidium using 
digital PCR and and next generation sequencing (NGS). 
Chapter five focuses on screening, quantification and characterisation of 
Cryptosporidium species in influent from wastewater treatment plants (WWTPs) using NGS, 
to more accurately determine the prevalence and composition of Cryptosporidium species in 
WWTPs. 
Chapter six summarises the general findings of this project, discusses potential gaps in 
the field, and future directions. 
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For clarity and consistency, and also to avoid repetition, this chapter consists of an 
amalgamation of two invited review papers which aim to provide a thorough review of zoonotic 
Cryptosporidium species from a one health perspective. 
The two papers are entitled “Cryptosporidium in Humans and Animals - a One Health approach 
to prophylaxis” and “Public health significance of Zoonotic Cryptosporidium species in 
wildlife: Critical insights into better drinking water management”. 
Some of the tables have been updated to include the most recent literature and a section on the 





More than 15% of the world’s population has no access to safe drinking water (Cauchie 
et al., 2014). Waterborne parasitic protozoan diseases with worldwide distribution, result in 
four billion cases of diarrhoea, with 1.6 million deaths annually (www.who.int) and 62.5 
million DALYs worldwide (Wright and Gundry, 2009; WHO, 2009). Yet, despite the latest 
advances made in water treatment measures, protecting drinking water supplies against 
waterborne pathogens remains one of the most challenging concerns for the entire drinking 
water supply chain worldwide (Cotruva et al., 2004; Betancourt and Rose, 2004; Thompson 
and Smith, 2011; Plutzer, 2013; Burnet et al., 2014). In response to this, in 2009, the World 
Health Organization (WHO) developed guidelines for water suppliers on how to implement 
“Water Safety Plans” (WSPs), in the hope of halving the number of people without safe access 
to drinking water by the end of 2015 (WHO, 2009). 
In less developed countries, the lack of basic infrastructure for providing safe drinking 
water is considered a major cause of poor water quality, which contributes to the spread of 
endemic/epidemic waterborne diseases. However, even in industrialized nations, highly 
advanced infrastructures are not yet a protective factor against outbreaks (Cummins et al., 
2010; Smith and Nichols, 2010; Castro-Hermida et al., 2011; Burnet et al., 2014; Smolders et 
al., 2015). This appears to be largely due to a lack of knowledge about the epidemiology and 
transmission dynamics of waterborne pathogens (e.g. from animals ranging within the 
catchments), which leads to poor management practices for drinking water catchments (Castro-
Hermida et al., 2011; Gormley et al., 2011). 
Waterborne parasitic protozoans are responsible for the majority of waterborne outbreaks 
worldwide, with socio-economic impacts even in developed countries (Cotruva et al., 2004; 
Pond, 2005; Baldursson and Karanis, 2011; Cauchie et al., 2014). Of these, Cryptosporidium 
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was the aetiological agent in 60.3% (120) of the waterborne protozoan parasitic outbreaks that 
have been reported worldwide between 2004 and 2010 (Baldursson and Karanis, 2011). For 
the global water industry, therefore, Cryptosporidium represents the major public health 
concern, as its oocyst (the environmentally stable stage) is able to survive and penetrate routine 
wastewater treatment and is resistant to inactivation by commonly used drinking water 
disinfectants (Fayer et al., 2001; Baldursson and Karanis, 2011; Burnet et al., 2014). As a result 
of these waterborne outbreaks of cryptosporidiosis, Cryptosporidium testing in source or 
finished water is now mandatory in many industrialised nations. For example, the U.S. EPA, 
working with the U.S. public water supply industry, developed and implemented the Long-
term Stage 2 Enhanced Surface Water Treatment Rule (LT2ESWTR), known as LT2, to 
control Cryptosporidium in public water supplies (US EPA, 2006). LT2 requires all public 
water suppliers using surface water sources serving populations >10,000 to monitor their 
sources for Cryptosporidium by analysing at least 24 consecutive monthly samples. In the UK, 
the Drinking Water Inspectorate (DWI) requires that water companies carry out risk 
assessments on all their water supply sites to ascertain the level of risk Cryptosporidium poses 
to the final treated water quality. Those at high risk need additional treatment (in the form of 
properly controlled coagulation/flocculation filtration systems or membrane or UV treatment 
systems). The UK regulations also require companies to design and continuously operate 
adequate treatment and disinfection. A proven failure to comply with this is now an offence 
(DWI, 2010). 
Cryptosporidium species are protozoan parasites that infect a broad range of hosts 
including humans, and domestic and wild animals worldwide, causing asymptomatic or mild-
to-severe gastrointestinal disease in their host species (Monis and Thompson, 2003; Hunter et 
al., 2007; Xiao, 2010; Ryan and Power, 2012; Kváč et al., 2014a; Ryan et al., 2014; Lukášová 
et al., 2018). 
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1.2.1 Clinical symptoms 
 
Human cryptosporidiosis is frequently accompanied by abdominal pain, fever, vomiting, 
malabsorption and diarrhoea that may sometimes be profuse and prolonged (Chalmers and 
Davies, 2010; Bouzid et al., 2013). The immune status of the host, both innate and adaptive 
immunity, has a major impact on the severity of the disease and its prognosis. 
Immunocompetent individuals typically experience self-limiting diarrhoea and transient 
gastroenteritis lasting up to two weeks and recover without treatment, suggesting an efficient 
host antiparasite immune response. Immunocompromised individuals, including HIV/AIDS 
patients (not treated with antiretroviral therapy), often suffer from intractable diarrhoea, which 
can be fatal (Current and Garcia, 1991). An effective vaccine for cryptosporidiosis is not yet 
available. 
The Global Enteric Multicenter Study (GEMS) study, which was a three-year matched 
case-control study of moderate-to-severe diarrhoea in over 22,000 infants and children at seven 
sites across Africa and Asia aged 0-59 months, found that Cryptosporidium was second only 
to rotavirus as a major cause of severe diarrhoea (Kotloff et al., 2013; Nasrin et al., 2013). 
More recent matched case–control studies of diarrhoea have confirmed this (Breurec et al., 
2016). Similarly, a birth cohort study conducted by a Global Network for the Study of 
Malnutrition and Enteric Diseases (MAL-ED) has assessed pathogen-specific burdens in 
diarrhoeal and nondiarrhoeal stool specimens from 2,145 children aged 0-24 months, over five 
years at eight community sites in Africa, Asia and South America, and identified 
Cryptosporidium spp. as one of the five highest attributable burdens of diarrhoea in the first 
year of life (Platts-Mills et al., 2015). Globally, cryptosporidiosis is estimated to be responsible 
for the majority of deaths among children under 5 years of age (Lozano et al., 2012; Striepen, 
2013; Shoultz et al., 2016) and Cryptosporidium infection in children is also associated with 
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malnutrition, persistent growth retardation, impaired immune response and cognitive deficits 
(Mølbak et al., 1997; Guerrant et al., 1999). The mechanism by which Cryptosporidium affects 
child growth seems to be associated with inflammatory damage to the small intestine 
(Kirkpatrick et al., 2002). Undernutrition (particularly in children) is both a sequela of and a 
risk factor for cryptosporidiosis, particularly in low-income familes (Macfarlane and Horner-
Bryce, 1987; Sallon et al., 1988; Checkley et al., 1997; Bushen et al., 2007; Mondal et al., 
2009; Quihui-Cota et al., 2015). FAO’s executive summary of the State of Food Insecurity in 
the World (http://www.fao.org/docrep/018/i3458e/i3458e.pdf) indicates there are 842 million 
chronically malnourished persons worldwide, which significantly contributes to impaired 
immunity and thus increased susceptibility to infection with Cryptosporidium, perpetuating the 
cycle of chronic diarrhoea and malnutrition. In developed countries, Cryptosporidium is less 
common and accounts for ~9% of diarrhoeal episodes in children (Fletcher et al., 2012). 
 
1.2.2 Taxonomy and Species in the genus 
 
Until recently, Cryptosporidium was classified as a coccidian parasite. However, it has 
long been speculated that Cryptosporidium represents a ‘missing link’ between the more 
primitive gregarine parasites and coccidians (Ryan et al., 2016). The similarities between 
Cryptosporidium and gregarines have been supported by extensive microscopic, molecular, 
genomic and biochemical data (cf. Ryan et al., 2016), which have served as the basis for the 
formal transfer of Cryptosporidium from subclass Coccidia, class Coccidiomorphea to a new 
subclass, Cryptogregaria, within class Gregarinomorphea (Cavalier-Smith, 2014). The genus 
Cryptosporidium is currently the sole member of Cryptogregaria and is described as 
comprising epicellular parasites of vertebrates possessing a gregarine-like feeder organelle but 
lacking an apicoplast (Cavalier-Smith, 2014). 
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Currently, 37 Cryptosporidium species have been recognized as valid (Table 1.1), and 
more than 17 species have been identified in humans (Table 1.1). Of these, by far the most 
common species reported in humans worldwide are C. parvum and C. hominis (Xiao, 2010; Li 
et al., 2015a; Ryan and Xiao, 2014; Ryan et al., 2015; Holubová et al., 2016; Kváč et al., 2016; 
Zahedi et al., 2017; Čondlová et al., 2018, Kváč et al., 2018) and have been responsible for the 
majority of waterborne outbreaks typed to date with the exception of a waterborne outbreak in 
the UK caused by C. cuniculus from rabbits (Oryctolagus cuniculus) (Chalmers et al., 2009; 
Xiao, 2010; Ryan et al., 2014).
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Table 1.1. Valid Cryptosporidium species confirmed by molecular analysis. 
Species name Author(s) Type host(s) Major host(s) Reports in humans 
C. occultus Kváč et al., 2018 Rattus norvegicus (Brown rat) Rodents (Apodemus 
spp.) 
Ong et al., 2002; and unpublished (Acc. No. 
HQ822146) 
C. apodemi Čondlová et al., 2018 Apodemus agrarius (Striped field 





C. ditrichi Čondlová et al., 2018 Apodemus flavicollis (Yellow-




Unpublished single human infection, reported in 
Sweden (Acc. No. KU892579) 
C. homai Zahedi et al., 2017 Cavia porcellus (Guinea pigs) Rodents (Apodemus 
spp.) 
None reported 
C. ducismarci Traversa et al., 2008; Ježková 
et al., 2016 
Testudo marginata (Marginated 
tortoise), Python regius (Ball 
python), Chamaeleo calyptratus 
(Veiled chameleon), 
Malacochersus tornieri (Pancake 
tortoise), Agrionemys [Testudo] 
horsfieldii (Russian tortoise) 
Tortoises None reported 
C. testudinis Ježková et al., 2016 Agrionemys [Testudo] horsfieldii 
(Russian tortoise), Chelonoidis 
chilensis (Chaco tortoise), Testudo 
graeca Linnaeus (Greek tortoise), 
Testudo hermanni Gmelin 
(Hermann’s tortoise), Geochelone 
elegans (Indian star tortoise), 
Stigmochelys pardalis (Leopard 
tortoise), Testudo marginata 
(Marginated tortoise), Astrochelys 
radiata (Radiated tortoise), 
Psammobates oculifer (Serrated 
tortoise), Python regius (Ball 
python) 
Tortoises None reported 
C. avium Holubová et al., 2016 Cyanoramphus novaezelandiae 
(Red-crowned parakeet), Agapornis 
roseicollis (Rosy-faced lovebird), 
Gallus gallus (Chicken), Amazona 
Birds None reported 
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aestiva (Blue-fronted Amazon 
parrot), Lophochroa leadbeateri 
(Major Mitchell’s cockatoo), 
Nymphicus hollandicus (Cockatiel), 
Melopsittacus undulates 
(Budgerigar) 
C. proliferans Kváč et al., 2016 Equus africanus (African wild ass), 
Equus asinus (Donkey), Sciurus 
carolinensis (Eastern gray squirrel), 
Syncerus caffer (African buffalo), 
Equus caballus (Horse),  
Tachyoryctes splendens (East 
African mole rat) 
Rodents, Equine None reported 
C. rubeyi Li et al., 2015a Spermophilus beecheyi (California 
ground squirrel) 
Squirrels Not reported 
C. scophthalmi Alvarez-Pellitero et al., 2004; 
Unpublished (Acc. No. 
KR340588, KR340589) 
Scophthalmus maximus (Turbot) Turbot None reported 
C. huwi Ryan et al., 2015 Poecilia reticulata (Guppy), 
Paracheirodon innesi (Neon tetra) 





C. erinacei Kváč et al., 2014b Erinaceus europaeus (European 
hedgehog) 
Hedgehogs, horses Kváč et al., 2014a 
C. scrofarum Kváč el al., 2013 Sus scrofa (Pig) Pigs Kváč et al., 2009a, 2009b 
C. viatorum Elwin et al., 2012a Homo sapiens (Human) Humans Elwin et al., 2012a; Insulander et al., 2013 
C. tyzzeri Tyzzer, 1912; Ren et al., 2012 Mus musculus (Mouse) Rodents Rasková et al., 2013 
C. cuniculus Robinson et al., 2010 Oryctolagus cuniculus (European 
rabbit) 
Rabbits Chalmers et al., 2009; Anonymous, 2010; 
Molloy et al., 2010; Chalmers et al., 2011a, 
2012; Koehler et al., 2014 
C. ubiquitum Fayer et al., 2010 Bos taurus (Cattle) Ruminants, rodents, 
primates 
Commonly reported (cf. Fayer et al., 2010; Elwin 
et al., 2012b) 
C. xiaoi Fayer et al., 2010 Ovis aries (Sheep) Sheep and goats Adamu et al., 2014 
C. ryanae Fayer et al., 2008 Bos taurus (Cattle) Cattle None reported 
C. macropodum Power and Ryan, 2008 Macropus giganteus (Eastern Grey 
kangaroo) 
Marsupials None reported 
C. fragile Jirku et al., 2008 Duttaphrynus melanostictus (Toad) Toads None reported 
C. fayeri Ryan et al., 2008 Macropus rufus (Red kangaroo) Marsupials Waldron et al., 2010 
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C. bovis Fayer et al., 2005 Bos taurus (Cattle) Cattle Khan et al., 2010; Ng et al., 2012; Helmy et al., 
2013 
C. suis Ryan et al., 2004 Sus scrofa (Pig) Pigs Xiao et al., 2002a; Leoni et al., 2006; Cama et 
al., 2007; Wang et al., 2013a 
C. galli Pavalasek, 1999; Ryan et al., 
2003 
Spermestidae, Frangillidae, Gallus 
gallus, Tetrao urogallus, Pinicola 
enucleator (Birds) 
Birds None reported 
C. hominis Morgan-Ryan et al., 2002 Homo sapiens (Human) Humans Most common species in humans 
C. molnari Alvez-Pellitero and Sitja-
Bobadilla, 2002 
Sparus aurata (Gilt-head sea 
bream) and Dicentrarchus labrax 
(European seabass) 
Fish None reported 
C. canis Fayer et al., 2001 Canis familiaris (Dog) Dogs Many reports (cf. Lucio-Forster et al., 2010) 
C. andersoni Lindsay et al., 2000 Bos taurus (Cattle) Cattle Leoni et al., 2006; Morse et al., 2007; Waldron et 
al., 2011; Agholi et al., 2013; Jiang et al., 2014; 
Liu et al., 2014a 
C. varanii Pavlasek et al., 1995 Varanus prasinus (Emerald 
Monitor) 
Lizards None reported 
C. baileyi Current et al., 1986 Gallus gallus (Chicken) Birds None reported 
C. parvum Tyzzer, 1912 Bos taurus (Cattle) Ruminants Commonly reported in humans 
C. meleagridis Slavin, 1955 Meleagris gallopavo (Turkey) Birds and humans Commonly reported in humans 
C. serpentis Levin, 1980 Elaphe guttata, E. subocularis, 
Sanzinia madagascarensus 
(Snakes) 
Snakes and lizards None reported 
C. felis Iseki, 1979 Felis catis (Cat) Cats Many reports (cf. Lucio-Forster et al., 2010) 
C. wrairi Vetterling et al., 1971 Cavia porcellus (Guinea pig) Guinea pigs None reported 
C. muris Tyzzer, 1907, 1910 Mus musculus (House mouse) Rodents Many reports - Guyot et al., 2001; Gatei et al., 
2002a; Tiangtip and Jongwutiwes, 2002; Gatei et 
al., 2003; Palmer et al., 2003; Gatei et al., 2006; 
Leoni et al., 2006; Muthusamy et al., 2006; 
Azami et al., 2007; Al-Brikan et al., 2008; Neira 
et al., 2012; Hasajová et al., 2014; Petrincová et 
al., 2015; Spanakos et al., 2015 
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1.2.3 Life cycle 
 
The complex, monoxenous life cycle of Cryptosporidium consists of several 
developmental stages involving both sexual and asexual cycles which are demonstrated in Fig 
1.1. The primary site of infection with C. hominis and C. parvum is the small intestine, with 
the ileum above the caecal junction being favoured in some animals such mice and calves (Xiao 
and Fayer, 2008). 
 




Environmentally-resistant oocysts, representing the infective life cycle stage of the 
parasite, are excreted in the faeces (Xiao and Fayer, 2008). These oocysts are extremely 
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resilient, due to their thick trilaminar walls, are able to survive many months in a watery 
environment and are resistant to disinfectants including chlorine in drinking water (Fayer, 
2004). Once the oocysts are excreted into the environment, they can be ingested by a host 
through the faecal-oral route. Excystation occurs in the gastrointestinal tract; this causes the 
release of four infective sporozoites through a suture opening, which then attaches to the apical 
membrane of the epithelial host cell and undergo successive rounds of asexual and sexual 
reproduction (Xiao and Fayer, 2008) (Fig 1.1). Following the adherence of the anterior end of 
the sporozoite to the luminal surface of an epithelial cell in the microvilli, each sporozoite 
matures into a trophozoite. Trophozoites undergo asexual proliferation by merogony to form 
meronts, marking the beginning of the asexual part of the life cycle (Hijjawi et al., 2010). Type 
I meronts develop six or eight nuclei, each incorporated into a merozoite, which are released 
from the parasitiphorous vacuole once mature. The mature type I merozoites infect other host 
cells and either recycle as type I meronts and merozoites, or develop into a type II meront, 
which produces four merozoites (Hijjawi et al., 2010). Following the release of mature type II 
merozoites, a new host cell is invaded and the sexual phase in the life cycle (gametogeny) is 
initiated. Type II merozoites either enlarge and develop into a uni-nucleate macrogamont or 
undergo cellular fission forming a multi-nucleated microgamont containing 14-16 non-
flagellated microgametes. 
Microgametes are released from ruptured microgamonts; they penetrate host cells 
containing macrogamonts and subsequently fertilise the macrogamont forming a zygote 
(Hijjawi et al., 2010). The zygote undergoes sporogony during which, both thin-walled and 
thick-walled oocysts are formed, each containing four potentially infective sporozoites. Thin 
walled oocysts remain within the host leading to autoinfection and persistent infections, thick 
walled oocysts are shed in the faeces into the environment, for ingestion by a new host. 
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The presence of gamont-like extracellular stages in the life cycle of Cryptosporidium was 
first observed in a study by Hijjawi et al. (2002) and has since been reported by several 
investigators (Hijjawi et al., 2004; Rosales et al., 2005; Karanis et al., 2008; Borowski et al., 
2010; Koh et al., 2013, 2014; Huang et al., 2014; Aldeyarbi and Karanis, 2016). Where these 
gamont stages occur in the life cycle and what stages they develop into is not clearly understood 
(Clode et al., 2015). 
 
1.2.4 Transmission dynamics 
 
Oocysts of Cryptosporidium species from humans and animals are ubiquitous in the 
environment and therefore cryptosporidial infections can be acquired through multiple routes 
(reviewed by Robertson et al., 2014). Transmission of oocysts is by the faecal-oral route, either 
directly or indirectly. For humans, direct transmission can be from person to person primarily 
due to poor hygiene among household members and attendees in day care centres, aged care 
facilities and other institutions, or from animals to persons such as farmworkers and pet owners. 
Most indirect transmission is from contaminated drinking or recreational water. Contaminated 
food can also be a source of transmission, and contamination can occur at every step throughout 
the food preparation process, from farm to table (Nyachuba, 2010; Budu-Amoako et al., 2011). 
Findings from animal models, human case reports and a few epidemiological studies suggest 
that Cryptosporidium may also be transmitted via inhalation of aerosolized droplets or by 
contact with fomites contaminated by coughing (see Sponseller et al., 2014). 
Cryptosporidiosis is a highly prevalent and extremely widespread disease (Ryan et al., 
2014), and several factors contribute to this. Infected individuals shed large numbers of 
oocysts, which are environmentally very robust, resistant to inactivation by commonly used 
drinking water disinfectants including chlorine treatment and are able to survive routine 
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wastewater treatments (Baldursson and Karanis, 2011; Burnet et al., 2014). Cryptosporidium 
oocysts are highly infectious; in human volunteer studies, as few as 10 or less Cryptosporidium 
oocysts can produce disease in healthy adults (Okhuysen et al., 1999; Chappell et al., 2006). A 
quantitative risk assessment has estimated that ingestion of a single oocyst of the C. parvum 
IOWA isolate will result in clinical disease in 2.79% of immunologically normal persons 
(Pouillot et al., 2004). Another contributing factor to the high prevalence and widespread 
distribution of Cryptosporidium is the lack of treatment options. Only one drug, nitazoxanide 
(NTZ, Alinia; Romark Laboratories, Tampa, FL, United States), has been approved by the US 
Food and Drug Administration (FDA). This drug, however, exhibits only moderate clinical 
efficacy in malnourished children and immunocompetent people, and none in 
immunocompromised individuals like people with HIV (Abubakar et al., 2007; Amadi et al., 
2009). 
 
1.2.5 Detection and Diagnosis 
 
The ‘One Health’ approach to tackle zoonotic diseases, defined as ‘One Medicine’ by 
Schwabe (1984), is a worldwide strategy to improve health and well-being through the 
mitigation and prevention of disease risks that originate at the interface between humans, 
animals and their various environments. Cryptosporidium presents many challenges for 
detection and diagnosis. The use of different diagnostic methods and the inconsistent 
application of typing techniques can make direct comparisons difficult or even impossible 
between clinical, veterinary and environmental testing or between different regions and 
countries (Chalmers and Katzer, 2013). Detection of Cryptosporidium in clinical pathology 
laboratories is still based mainly on microscopic detection via stains and/or fluorescent 
antibodies (IFA) and other antigenic detection methods. Although microscopy needs relatively 
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simple instruments and cheap consumables, it is labour intensive, requires a skilled operator 
and lacks sensitivity and specificity (Chalmers and Katzer, 2013). Morphological characters 
for identifying Cryptosporidium are few (Fall et al., 2003; Checkley et al., 2015) and 
differential staining techniques are usually required due to the fact that oocysts are similar in 
size and shape to yeasts, faecal components and other debris (O'Donoghue, 1995; Fall et al., 
2003). Acid fast (AF)-modified Ziehl-Neelsen staining is one of the most common differential 
staining techniques (O'Donoghue, 1995; Chalmers and Katzer, 2013). However, the detection 
limits of conventional microscopy for Cryptosporidium have been reported to be as low as 
10,000 to 50,000 oocysts per gram of human faeces (Weber et al., 1991; 1992), resulting in 
low levels of infection or sporadic shedding possibly going unnoticed when conventional 
methods of detection are used. Sporadic shedding is such that studies have shown that three 
separate faecal samples should be examined for immunocompetent patients and two samples 
for patients with AIDS for confident diagnosis of cryptosporidial infections using acid-fast 
staining (Clavel et al., 1995). IFA stains offer superior sensitivity; in some studies, about 97% 
sensitivity compared with only about 75% sensitivity for acid-fast staining (Chalmers et al., 
2011b). However, IFA is more expensive than acid-fast staining and requires a fluorescence 
microscope and trained staff (Chalmers et al., 2011b). This is particularly problematic in 
resource-poor areas where cryptosporidiosis is a major health problem. A recent study 
proposed the use of phase-contrast microscopy (PCM) as a specific and inexpensive method 
for detection of Cryptosporidium; however, this method still lacks sensitivity (Ignatius et al., 
2016). 
Other antigen detection formats such as enzyme-linked immunosorbent assays (ELISAs), 
enzyme immunoassays (EIAs) and immunochromatographic (dipstick) assay for 
Cryptosporidium are also commercially available and have the advantage of reducing assay 
times and being amenable to automation. However, diagnostic sensitivities are variable (70%-
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100%) (Garcia and Shimizu, 1997; Johnston et al., 2003; Youn et al., 2009; Chalmers et al., 
2011b); some rapid tests have reduced specificity and sensitivity for species other than C. 
parvum or C. hominis (Robinson et al., 2010; Agnamey et al., 2011), and confirmation of 
positive reactions is needed (Youn et al., 2009). Biosensor chips, that detect and quantitate C. 
parvum in real-time via anti-C. parvum IgM binding, have also been developed (Kang et al., 
2008; Campbell and Mutharasan, 2008); however, detection limits are relatively high (100 or 
more oocysts) and they have yet to be fully evaluated on water or faecal samples. Another 
major limitation of both conventional microscopy and antigen detection methods is that they 
cannot identify to species or subtype level, which is essential for understanding transmission 
dynamics and outbreaks, in particular for zoonotic species. 
Polymerase chain reaction (PCR)-based techniques have permitted specific and sensitive 
detection and differentiation of Cryptosporidium spp. for clinical diagnosis and environmental 
monitoring (Chalmers et al., 2011b). Real-time or quantitative PCR (qPCR) assays have been 
developed to quantitate the numbers of Cryptosporidium oocysts present in human and animal 
faecal and water samples (Hadfield et al., 2011; Elwin et al., 2012a; Yang et al., 2013, 2014) 
with 100% specificity and sensitivities as low as 200 oocysts per gram of faeces, which equates 
to 2 oocysts per PCR (Hadfield et al., 2011). Multiplex qPCR assays have also been developed 
for the detection of Cryptosporidium and other common causes of diarrhoea such as Giardia 
duodenalis and Entamoeba histolytica, which have the advantage of identifying mixed 
infections (Taniuchi et al., 2013; Van Lint et al., 2013; Nurminen et al., 2015). 
The most widely used molecular markers for typing of Cryptosporidium isolates are the 
18S ribosomal RNA (18S rRNA) gene and the 60-kDa glycoprotein (gp60) gene. The latter 
locus encodes a precursor protein, that is cleaved to produce mature cell surface glycoproteins 
(gp45/gp40 and gp15) implicated in zoite attachment to, and invasion of enterocytes (Strong 
et al., 2000; Xiao, 2010; Ryan et al., 2014). Most of the genetic heterogeneity in the gp60 gene 
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is the variation in the number of a tri-nucleotide repeat (TCA, TCG or TCT) in the 5′ end (gp40) 
of the coding region, although extensive sequence polymorphism is also present in the rest of 
the gene. The repeats are used to define the subtype families within a species, whereas the 
remaining polymorphic sites are used to identify subtypes within a subtype family (Strong et 
al., 2000; Ryan et al., 2014). Miniaturized fluidic devices, which can detect to species level, 
have also been developed, mainly for the water industry (reviewed by Bridle et al., 2012), but 




New drug targets for Cryptosporidium are urgently needed, as the only FDA-approved 
drug, nitazoxanide, does not provide benefit for malnourished children and 
immunocompromised patients with cryptosporidiosis. However, Cryptosporidium has 
completely lost the plastid-derived apicoplast present in many other apicomplexans, and the 
remnant mitochondrion lacks the citrate cycle and cytochrome-based respiratory chain 
(Abrahamsen et al., 2004). Therefore, many classic drug targets are unavailable in 
Cryptosporidium. Progress in developing anticryptosporidial drugs has also been affected by 
the inability to generate large numbers of Cryptosporidium oocysts in vitro and an inability to 
genetically manipulate the organism (Miyamoto and Eckmann, 2015; Ryan and Hijjawi, 2015). 
The recent development of a hollow-fibre in vitro culture system to generate large numbers of 
oocysts (up to 108 oocysts per day) (Morada et al., 2016) and advances in genetically 
engineering Cryptosporidium (Vinayak et al., 2015), will transform the development of novel 
therapeutics. 
To date, the best studied drug target is the bacterial-derived inosine 5′-monophosphate 
dehydrogenase (IMPDH) gene, as Cryptosporidium does not contain guanine salvage enzymes 
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and is totally dependent on this enzyme to convert adenosine salvaged from the host into 
guanine nucleotides (Striepen et al., 2004; Kirubakaran et al., 2012; Mandapati et al., 2014). 
This, coupled with the parasite’s high metabolic demand for nucleotides due to the complicated 
life cycle of this parasite, make IMPDH an important drug target (Umejiego et al., 2008; 
Maurya et al., 2009; Macpherson et al., 2010; Sharling et al., 2010; Gorla et al., 2012, 2013; 
Johnson et al., 2013; Jefferies et al., 2015; Kim et al., 2015; Li et al., 2015b). 
Other drug targets include long-chain fatty acyl-coenzyme A synthetases (LC-ACS), which are 
essential in fatty acid metabolism (Abrahamsen et al., 2004), and a recent study reported good 
efficacy of the ACS inhibitor triacsin C against cryptosporidial infection in mice (Guo et al., 
2014). A parasite cysteine protease inhibitor was also effective in vitro and in an animal model 
(Ndao et al., 2013). Other studies have focused on repurposing existing drugs to overcome the 
prohibitive costs of de novo drug development (estimated to be between $500 million and $2 
billion per compound successfully brought to market) (Adams and Brantner, 2006). For 
example, several compounds from the Medicines for Malaria Venture (MMV) Open Access 
Malaria Box have exhibited activity against C. parvum (Bessoff et al., 2014) and drugs such as 
the human 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor, 
itavastatin and Auranofin (Ridaura®) initially approved for the treatment of rheumatoid 
arthritis and have been shown to be effective against Cryptosporidium in vitro (Bessoff et al., 





The development of vaccines for cryptosporidiosis, particularly in vulnerable 
populations such as children and malnourished populations, is urgent, but has been hampered 
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by an incomplete understanding of the host immune response to Cryptosporidium (Mead, 2014; 
Ludington and Ward, 2015). Therefore, a better understanding of host-parasite interactions is 
crucial for the development of an effective vaccine (Mead, 2014). Given that adults in highly 
endemic areas are partly immune to reinfection, and human challenge studies have shown that 
previous infection or exposure leads to a higher infectious dose [ID50] (Okhuysen et al., 1998; 
Chappell et al., 1999), development of a successful vaccine should be possible. It is known that 
both innate and adaptive host response are important in the control of Cryptosporidium 
infection (Takeuchi et al., 2008; Petry et al., 2010; McDonald et al., 2013). Yet the nature of 
these responses, particularly in humans, is not completely understood (Borad and Ward, 2010; 
Ludington and Ward, 2015). 
Early mediators of innate immune protection include the thick mucus layer of the small 
intestine, intestinal epithelial cells and chemokines, cytokines and antimicrobial peptides 
secreted into the intestinal lumen and/or underlying submucosa and bloodstream (Ludington 
and Ward, 2015). Important cytokines include γ-interferon (IFN-γ), which is secreted early in 
infection by natural killer (NK) cells, macrophages and dendritic cells, which are thought to 
play a major role in orchestrating both the innate and adaptive immune responses (McDonald 
et al., 2013; Ludington and Ward, 2015). T-helper 1 (Th1) inflammatory response and 
cytokines, such as interleukin 12, 15 and 18, are also important in the resistance and recovery 
to Cryptosporidium infection (Robinson et al., 2001; Dann et al., 2005; McDonald et al., 2006; 
Ehigiator et al., 2007a; Choudhry et al., 2012; Bedi et al., 2015). Treatment of both 
immunocompetent and immunodeficient mice with IL-12 before infection prevented or greatly 
reduced the severity of infection and was attributed to a decrease in IFN-γ reduction (Bedi et 
al., 2015). Data suggest that IL-15 has an important role in activating an NK cell-mediated 
pathway that leads to the elimination of Cryptosporidium from the intestine (Dann et al., 2005). 
IL-18 is produced by epithelial cells in the gut and a number of different immune cells and is 
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upregulated in response to C. parvum infection, and it has been proposed that one of the 
functions of IL-18 is to promote IFN-γ expression by macrophages (McDonald et al., 2006). 
Toll-like receptors expressed by epithelial cells have been shown to be important in modulation 
of the host immune response and subsequent parasite clearance (Chen et al., 2005; Barrier et 
al., 2006; Costa et al., 2011; O’Hara et al., 2011; Lantier et al., 2014; Perez-Cordon et al., 2014; 
Yang et al., 2015a). 
MicroRNA (miRNA) regulation also appears to play an important role in host cell 
protection against Cryptosporidium (Chen et al., 2007; Zhou et al., 2009; Hu et al., 2010; Gong 
et al., 2011; Zhou et al., 2012; Xie et al., 2014). miRNA are small RNA molecules of 23 
nucleotides that result in gene silencing via translational suppression or mRNA degradation 
and are a mechanism to fine-tune cellular responses to the environment, and may be regulators 
of host antimicrobial immune responses (Gong et al., 2011). More than 700 miRNAs have been 
identified in humans and are postulated to control 20%-30% of human genes. miRNA-
mediated post-transcriptional gene regulation may regulate expression of genes critical to 
epithelial antimicrobial defence, and one cellular miRNA (let-7i) has been shown to target 
Toll-like receptor 4 (TLR4) and regulate TLR4-mediated anti-C. parvum defence (Chen et al., 
2007). Functional manipulation of select miRNA expression levels in epithelial cells has been 
shown to alter C. parvum infection burden in vitro (Gong et al., 2011; Zhou et al., 2012). The 
intercellular adhesion molecule-1 (ICAM-1; CD54) is a 90-kDa member of the Ig superfamily 
expressed by several cell types including endothelial and epithelial cells and is thought to 
facilitate adhesion and recognition of lymphocytes at infection sites as ICAM-1 is 
constitutively present on endothelial and epithelial cells, but its expression is increased by pro-
inflammatory cytokines or following microbe infection. Evidence has shown that miR-221- 
mediated translational suppression controls ICAM-1 expression through targeting the ICAM-
1 3′-untranslated region (UTR), in epithelial cells in response to C. parvum infection, as 
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transfection of an miR-221 precursor an invitro model of human biliary cryptosporidiosis 
abolished C. parvum-stimulated ICAM-1 protein expression (Gong et al., 2011). 
Mannose-binding lectin (MBL) is an evolutionarily conserved protein, secreted by 
hepatocytes, that functions in human innate immunity by binding to microbial surfaces and 
promoting opsonophagocytosis. MBL has been shown to be important in the protection against 
cryptosporidiosis, as children and HIV-infected adults with mannose-binding lectin deficiency 
have increased susceptibility to cryptosporidiosis and more severe disease (Kelly et al., 2000; 
Kirkpatrick et al., 2006; Carmolli et al., 2009). The genetic contribution to deficient or low 
serum levels of MBL results from polymorphisms in the MBL2 gene (MBL1 is a pseudogene), 
which create low MBL-producing MBL2 genotypes in ~5% of the world’s population 
(Carmolli et al., 2009). In one study on a cohort of preschool children from Dhaka, Bangladesh, 
polymorphisms in the MBL2 gene (and corresponding haplotypes) and deficient serum levels 
of MBL were associated with increased susceptibility to infection with Cryptosporidium. MBL 
deficiency of <500 ng/mL was associated with single and multiple symptomatic episodes of 
Cryptosporidium infection, with an odds ratio (OR) of 7.6 for children with multiple 
symptomatic infections with Cryptosporidium (Carmolli et al., 2009). The mechanism by 
which MBL controls Cryptosporidium infection and protects children from it is still not clearly 
understood. 
Adaptive immunity creates immunological memory after an initial response to 
Cryptosporidium and leads to an enhanced response to subsequent encounters with 
Cryptosporidium. For example, antibodies to the parasite antigen gp15 were associated with 
protection against reinfection (Moss et al., 1998). The adaptive immune response to 
Cryptosporidium is characterised as a Th1 response (Ehigiator et al., 2007a) and the importance 
of the adaptive immune response during Cryptosporidium infection is highlighted by the 
susceptibility of patients with AIDS to cryptosporidiosis, as well as the resolution of infection 
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observed following CD4+ T lymphocyte cell reconstitution in patients given antiretroviral 
therapy (Borad and Ward, 2010; O’Connor et al., 2011). Low absolute CD4+ T cell counts in 
patients with HIV/AIDS were thought to be responsible for persistent and severe 
cryptosporidiosis; however, research with Simian immunodeficiency virus (SIV)-infected 
macaques reported that persistent cryptosporidiosis was more dependent on SIV load and 
profound viral damage to gut lymphoid tissue and rapid depletion of mucosal CD4+ T cells 
during the acute phase of viral infection, than on declining circulating CD4+ T cell levels 
during chronic SIV infection (Singh et al., 2011). This suggests that depletion of local CD4+ 
T cells may be more predictive of disease severity than absolute CD4+ T cell numbers. The 
importance of other T cells such as CD8+ has not been extensively studied but do appear to 
play a role in the protection of the host against gastric cryptosporidiosis (Kváč et al., 2011; 
Ludington and Ward, 2015). The role of humoral immunity in protection from 
cryptosporidiosis is not well understood, and no clear surrogate marker of protective immunity 
exists (reviewed in Ludington and Ward, 2015, and Checkley et al., 2015). 
The ideal Cryptosporidium vaccine should provide rapid lifelong immunity in all 
vaccinated individuals, be broadly protective against the most common species and subtypes 
of Cryptosporidium, prevent disease transmission, and be readily accessible, stable and cheap 
(Mead, 2014; Ludington and Ward, 2015). Ensuring cross-reaction against the most common 
species infecting humans, however, will be difficult, as more than 20 Cryptosporidium species 
and genotypes can infect humans as discussed above. For example, a recent study showed that 
infection of gnotobiotic pigs with C. hominis resulted in complete protection against 
subsequent infection with C. hominis, but incomplete protection against infection with C. 
parvum (Sheoran et al., 2012); therefore, multiple species will need to be targeted to provide 
sufficient cross-protection. In addition, as children, malnourished, and immunocompromised 
individuals are the most important vaccine targets, and they may not be able to develop a strong 
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and sustained immune-mediated protection in response to vaccination. Indeed, malnutrition 
has been cited as an important factor underlying limited efficacy of vaccines (Savy et al., 2009). 
It is therefore likely that adjuvants such as TLR ligands (Steinhagen et al., 2011), will be 
required to enhance the immune response in target populations (Barrier et al., 2006; Lantier et 
al., 2014). 
Several antigens, aimed at raising immunoglobulin G antibodies, are being developed as 
vaccine candidates (Mead, 2014). Some of the best studied are gp15 (Preidis et al., 2007; 
Egorov et al., 2010; Ajjampur et al., 2011; Allison et al., 2011; Sarkar et al., 2012; Lazarus et 
al., 2015), cp15 (Jenkins and Fayer, 1995; Hong-Xuan et al., 2005; Wang et al., 2010a; Liu et 
al., 2010; Manque et al., 2011; Roche et al., 2013) and cp23 (Ehigiator et al., 2007b; Benitez 
et al., 2009; Liu et al., 2010). The gp15 antigen is derived from the glycoprotein gp60, which 
is cleaved by a parasite serine proteinase into two surface proteins-gp15 and gp40, both of 
which play an essential role in parasite motility and attachment to and invasion of host 
epithelial cells (Boulter-Bitzer et al., 2007), and can stimulate γ-interferon production by 
peripheral blood mononuclear cells of those previously infected (Preidis et al., 2007). The gp15 
antigen is relatively conserved between C. parvum and C. hominis, and studies in Bangladesh 
indicated that there is a significant cross-reactivity between them and that antibodies to gp15 
were associated with shorter duration of illness (Allison et al., 2011). Similarly, in a study in 
Kenya, AIDS patients without diarrhoea had significantly higher serum IgG levels to gp15 than 
those with diarrhoea (Wanyiri et al., 2014). 
cp15 is an immunodominant protein present on the oocyst surface and is associated with 
internal structures and bears no apparent similarity to gp15 (Boulter-Bitzer et al., 2007). 
Immunization of pregnant goats with cp15 vaccines protected offspring (Sagodira et al., 1999). 
The impact of malnutrition, however, on vaccination was demonstrated in recent research on 
intranasal vaccination of nourished and malnourished mice, with the cp15 antigen primed with 
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a live enteric bacterial vector (Roche et al., 2013). The authors reported that malnutrition 
blunted antigen-specific cell-mediated responses to cp15 and that vaccination resulted in only 
transient reduction in stool shedding of Cryptosporidium and was not protective against disease 
(Roche et al., 2013). 
cp23 is an immunodominant protein, geographically conserved among C. parvum 
isolates, is present in both the sporozoite and merozoite stages (Mead, 2014), and antibodies to 
it are frequently detected following Cryptosporidium infection (Priest et al., 2001; Wanyiri et 
al., 2014). Serum antibodies to both gp15 and cp23 are associated with protection from 
diarrhoea in immunocompetent adult human volunteers infected with Cryptosporidium (Moss 
et al., 1998; Chappell et al., 1999; Riggs, 2002; Frost et al., 2005). Thus, a multivalent vaccine, 
incorporating multiple antigens or antigenic epitopes, may enhance protection against 
infection. For example, a divalent cp23 and cp15 vaccine prolonged the prepatent period and 
decreased oocyst shedding in mice vaccinated with the divalent vaccine compared with 
vaccination with cp23 alone (Liu et al., 2010). Similarly, a reverse vaccinology approach based 
on genome mining that included three antigens; the well-characterised cp15, a calcium-
activated apyrase involved in the invasion process of Cryptosporidium and profilin, an agonist 
of the innate immune system through its recognition by Toll-like receptors, induced specific 
and potent humoral and cellular immune responses in mice; however, further studies are 
necessary to verify the protection induced by these antigens (Manque et al., 2011). The 
development of an effective vaccine against Cryptosporidium is still a challenge and a better 
understanding of which immune responses are necessary for protection is essential to the 
development of immune-based interventions. 
 
1.3 Sources of human-infectious Cryptosporidium species 
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Due to the morphological similarity of Cryptosporidium oocysts from different host 
species, initial findings of Cryptosporidium infections in both domestic and wild animals were 
assumed to be due to C. parvum leading to an overestimation of the potential role of animals 
as reservoirs of human disease (Appelbee et al., 2005). However, with the assistance of 
advanced molecular techniques, many of these species in wildlife particularly were identified 
as host-adapted genotypes (Table 1.2). Of the 37 Cryptosporidium species that have been 
recognized as valid, more than 20 species and genotypes have been identified in humans 
including C. hominis, C. parvum, C. meleagridis, C. felis, C. canis, C. cuniculus, C. ubiquitum, 
C. viatorum, C. muris, C. suis, C. fayeri, C. andersoni, C. bovis, C. scrofarum, C. tyzzeri, C. 
erinacei and Cryptosporidium horse, mink, skunk and chipmunk I genotypes, with C. hominis 
and C. parvum most commonly reported (Xiao, 2010; Ryan et al., 2014). These 
Cryptosporidium spp. infect both immunocompetent and immunocompromised persons (Ryan 
et al., 2014; Zahedi et al., 2016a). Of these, C. parvum and C. hominis are by far the most 
common species reported in humans worldwide (Xiao, 2010; Ryan and Xiao, 2014), and are 
responsible for most cryptosporidiosis outbreaks, with C. hominis responsible for more 
outbreaks than C. parvum in most regions (Xiao, 2010). 
 
1.3.1 Cryptosporidium hominis 
 
Although humans are the major host species for C. hominis, there have been isolated 
reports in domestic animals and wildlife hosts including sheep, goats, cattle, a dugong, non-
human primates and kangaroos (Morgan et al., 2000; Smith et al., 2005; Giles et al., 2009; 
Abeywardena et al., 2012; Ye et al., 2012; Connelly et al., 2013; Karim et al., 2014; Koinari et 
al., 2014; Parsons et al., 2015; Gu et al., 2016; Koehler et al., 2016; Schiller et al., 2016; Zahedi 
et al., 2016b) and in fish (Koinari et al., 2013) (Table 1.2). Cryptosporidium hominis/C. 
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parvum-like sequences were identified in red and black-and-white colobus monkeys in Uganda 
(Salyer et al., 2012). However, typing was obtained using a short fragment of the 
Cryptosporidium oocyst wall protein (COWP) gene, which is not reliable for differentiating 
Cryptosporidium species. In Australia, a number of recent studies have also identified C. 
hominis/C. parvum-like isolates at the 18S locus in marsupials including bandicoots, brushtail 
possums, eastern grey kangaroos and brush-tailed rock wallabies (Hill et al., 2008; Ng et al., 
2011; Dowle et al., 2013; Vermeulen et al., 2015). However, despite efforts, the identification 
of C. hominis/C. parvum could not be confirmed at other loci. This might be due to low 
numbers of oocysts and the multi copy nature of the 18S rRNA gene. Another study reported 
a C. hominis-like sequence at the 18S locus in a wild dingo, but was also unable to confirm this 
at other loci (Ng et al., 2011). 
Subtyping of C. hominis at the gp60 locus has identified nine subtype families (Ia to Ik) 
(Ryan et al., 2014). To date, few C. hominis subtypes have been reported in wild mammals but 
include subtype IbA9G2 in flying foxes, IbA10G2 in eastern grey kangaroos, IbA12G3 in 
Rhesus macaques, subtype IbA9G3 and IiA17 in Cynomolgus monkeys and Rhesus monkeys, 
and subtype IfA12G2 in baboons and Mitumba chimpanzees (Feng et al., 2011a; Karim et al., 
2014; Bodager et al., 2015; Parsons et al., 2015; Schiller et al., 2016; Zahedi et al., 2016b). 
 
1.3.2 Cryptosporidium parvum 
 
Cryptosporidium parvum was first described in mice (Tyzzer, 1912) and is primarily a 
parasite of artiodactyls and humans (Xiao, 2010). Cryptosporidium parvum has however been 
frequently reported in wildlife, infecting a broad range of wild species including various 
rodents, bovids, camelids, equids, canids, non-human primates and marine mammals (Table 
1.2) (Morgan et al., 1999a; Matsui et al., 2000; Atwill et al., 2001; Perez and Le Blancq, 2001; 
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Matsubayashi et al., 2004; Ryan et al., 2004; Appelbee et al., 2005; Feng et al., 2007; Meireles 
et al., 2007; Paziewska et al., 2007; Starkey et al., 2007; Ziegler et al., 2007; Gómez-Couso et 
al., 2012; Ye et al., 2012; Abu Samraa et al., 2013; García-Presedo et al., 2013a; Liu et al., 
2013; Reboredo-Fernandez et al., 2014; Montecino-Latorre et al., 2015; Wells et al., 2015; 
Mynářová et al., 2016; Wagnerová et al., 2016). 
Few studies have identified C. parvum in captive wild mammals but red deer, fallow 
deer, addaxes, Arabian oryx, gemsboks, orangutans and sable antelopes are among mammals 
to be infected with C. parvum in captivity (Perez and Le Blancq, 2001; Ryan et al., 2003; 
Hajdusek et al., 2004; Matsubayashi et al., 2004; Abe et al., 2006; Feng et al., 2007; Meireles 
et al., 2007; Bodager et al., 2015; Wang et al., 2015; Zhao et al., 2015a; Mynářová et al., 2016). 
Subtyping of C. parvum at the gp60 locus has identified fourteen subtype families (IIa to 
IIo (Ryan et al., 2014). Few studies which identified C. parvum in wild mammals have 
conducted typing at the gp60 locus, but to date, a variety of C. parvum subtypes including 
IIdA15G1, IIdA18G1, IIdA19G1 from golden takins, lemurs, chipmunks and hamsters, 
IIaA15G2R1, IIaA19G2R1, IIaA19G3R1, IIaA19G4R1, IIaA20G3R1, IIaA20G4R1, 
IIaA20G3R2 and IIaA21G3R1 from deer and eastern grey kangaroos, IIdA17G1, IIdA18G1I, 
IdA19G1 and IIdA24G1 from European hedgehogs, IIaA18G3R1 from water buffalo, 
IIaA16G2R1 and IIaA13G1R1 from Eurasian wild boars, and IIaA13G2R1, IIaA15G2R1, and 
IIaA17G2R1from mustangs and Chincoteague ponies have been reported (Lv et al., 2009; 
García-Presedo et al., 2013a; Bodager et al., 2015; Montecino-Latorre et al., 2015; Wagnerová 
et al., 2015, 2016; Zhao et al., 2015a; Hofmannová et al., 2016; Sangster et al., 2016; Zahedi 




1.3.3 Cryptosporidium cuniculus 
 
Cryptosporidium cuniculus (previously known as rabbit genotype) was first reported in 
rabbits by Inman and Takeuchi (1979), who described the microscopic detection and ultra-
structure of endogenous Cryptosporidium parasites in the ileum of an asymptomatic female 
rabbit. Molecular characterisation of C. cuniculus was first conducted on rabbit faecal samples 
from the Czech Republic (Ryan et al., 2003) and C. cuniculus was formally re-described as a 
species in 2010 (Robinson et al., 2010). Since then, it has been described from rabbits across a 
wide geographic area including Australia, China, the UK, the Czech Republic, Poland, France 
and Nigeria (Ryan et al., 2003; Nolan et al., 2010; Shi et al., 2010; Chalmers et al., 2011a; 
Zhang et al., 2012; Nolan et al., 2013; Koehler et al., 2014; Liu et al., 2014b; Puleston et al., 
2014; Zahedi et al., 2016b). Cryptosporidium cuniculus has a close genetic relationship with 
C. hominis and its zoonotic potential became clear in 2008, when it was responsible for a 
drinking-water associated outbreak of cryptosporidiosis in the UK (Chalmers et al., 2009; 
Robinson et al., 2011; Puleston et al., 2014) and has also been identified in many sporadic 
human cases of cryptosporidiosis (Chalmers et al., 2011c; Robinson et al., 2011; Elwin et al., 
2012b; Koehler et al., 2014). It is also the third most commonly identified Cryptosporidium 
species in patients with diarrhoea in the UK (Chalmers et al., 2011a). Subtyping at the gp60 
locus has identified two distinct subtype families, designated Va and Vb (Chalmers et al., 
2009). Most cases described in humans relate to clade Va and the first waterborne outbreak 
was typed as VaA22 (Robinson et al., 2008; Chalmers et al., 2009). Cryptosporidium cuniculus 
has been reported in rabbits and humans (subtypes VaA9-VaA22 and VbA20-VbA37 - see 
Wang et al., 2012) but has recently been identified in marsupials (subtype VbA26) (and a 
human - subtype VbA25) in Australia (Nolan et al., 2013; Koehler et al., 2014). The widespread 
occurrence of C. cuniculus genotypes in rabbits and the fact that it has been now been identified 
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in marsupials in Australia suggests that C. cuniculus might be a species more ubiquitous than 
previously thought, and might be able to spread to other mammals as well as humans. 
Therefore, there is a need to diligently monitor for C. cuniculus in the vicinity of drinking water 
catchments and in drinking water. 
 
1.3.4 Cryptosporidium ubiquitum 
 
Cryptosporidium ubiquitum (previously cervine genotype, cervid, W4 or genotype 3) 
was first identified by Xiao et al. (2000) in storm water samples in lower New York State 
(stormwater isolate W4, GenBank accession no. AF262328). Subsequently, Perez and Le 
Blancq (2001) identified this genotype in white-tailed deer-derived isolates from lower New 
York State and referred to it as genotype 3. Since then it has been described in a wide variety 
of hosts worldwide including humans and was formally described as a species in 2010 (Fayer 
et al., 2010). Cryptosporidium ubiquitum is of public health concern because of its wide 
geographic distribution and broad host range (Li et al., 2014). In addition to domestic animals 
(in particular sheep) and wildlife, C. ubiquitum has been frequently reported from drinking 
source water, stormwater runoff, stream sediment and wastewater in various geographic 
locations, suggesting potential contamination of water sources with oocysts of C. ubiquitum 
shed by animals inhabiting water catchments (Nolan et al., 2013; Li et al., 2014). 
Cryptosporidium ubiquitum is considered an emerging zoonotic pathogen (Li et al., 2014), as 
it has been identified in many human cases of cryptosporidiosis in the United Kingdom, 
Slovenia, the United States, Canada, Spain, New Zealand, Venezuela and Nigeria (Wong and 
Ong, 2006; Fayer et al., 2010; Chalmers et al., 2011c; Cieloszyk et al., 2012; Elwin et al., 
2012b; Blanco et al., 2015; Qi et al., 2015a). 
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In wildlife, C. ubiquitum has been reported sporadically in rodents, wild ruminants, 
carnivores, marsupials, hedgehog and primates (Table 1.2) (Perez and Le Blancq, 2001; da 
Silva et al., 2003; Feng et al., 2007, 2010; Karanis et al., 2007; Ziegler et al., 2007; Cinque et 
al., 2008; Wang et al., 2008; Fayer et al., 2010; Feng et al., 2011b; Robinson et al., 2011; Abu 
Samraa et al., 2013; Mi et al., 2013; Murakoshi et al., 2013; Li et al., 2014; Ma et al., 2014; 
Perec-Matysiak et al., 2015; Qi et al., 2015a, 2015b; Song et al., 2015; Stenger et al., 2015a; 
Vermeulen et al., 2015; Koehler et al., 2016; Li et al., 2016a). 
Cryptosporidium ubiquitum is genetically distant from C. hominis and C. parvum and 
until recently, gp60 homologs had not been sequenced. However, the gp60 gene of C. 
ubiquitum was identified by whole genome sequencing and six subtype families (XIIa-XIIf) 
within C. ubiquitum have been identified (Li et al., 2014). Application of this new tool to 
human, animal, and environmental (water) isolates has suggested that sheep and rodents are a 
key source of C. ubiquitum transmission to humans, through either direct human contact with 
infected animals or by contamination of drinking source water (Li et al., 2014). For example, 
in the US, all C. ubiquitum specimens from humans characterised belonged to the same subtype 
families found in wild rodents in the US (XIIb, XIIc and XIId) (Li et al., 2014). However, as 
persons in the United States usually have little direct contact with wild rodents, the authors 
concluded that transmission of C. ubiquitum to humans from rodents was likely to come from 
drinking untreated water contaminated by wildlife (Li et al., 2014). 
 
1.3.5 Cryptosporidium muris 
 
Cryptosporidium muris is a gastric parasite and was first identified in the gastric glands 
of mice in 1907 by Tyzzer (1907). Since then, molecular tools have shown that it has a wide 
host range, including various mammals (rodents, canids, felids, suids, giraffida, camelidae, 
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equids, nonhuman primates and marsupials) and birds (Tables 1.1 and 1.2). Cryptosporidium 
muris is considered a zoonotic species as there have been numerous reports of C. muris in 
humans and one report in human sewage (Guyot et al., 2001; Gatei et al., 2002a; Tiangtip and 
Jongwutiwes, 2002; Gatei et al., 2003; Hurkova et al., 2003; Palmer et al., 2003; Gatei et al., 
2006; Leoni et al., 2006; Muthusamy et al., 2006; Azami et al., 2007; Al-Brikan et al., 2008; 
Neira et al., 2012; Hasajová et al., 2014; et al., Petrincová et al., 2015; Spanakos et al., 2015). 
In a recent human infectivity study, C. muris was examined in six healthy adults 
(Chappell et al., 2015). Volunteers were challenged with 105 C. muris oocysts and monitored 
for 6 weeks for infection and/or illness. All six patients became infected with two patients 
experiencing a self-limited diarrhoeal illness. The number of C. muris oocysts shed during the 
study ranged from 6.7 × 106 to 4.1 × 108, and C. muris-infected subjects shed oocysts longer 
than occurred with other species studied in healthy volunteers. Three volunteers shed oocysts 
for 7 months (Chappell et al., 2015). The authors concluded that healthy adults are susceptible 
to C. muris, which can cause mild diarrhoea and result in persistent, asymptomatic infection 
(Chappell et al., 2015), which confirms the zoonotic status of C. muris and highlights the public 
health risks of finding C. muris in wildlife in drinking water catchments. 
 
1.3.6 Cryptosporidium andersoni 
 
Like C. muris, C. andersoni is also a gastric parasite and primarily infects the abomasum 
of cattle and to a lesser extent, sheep and goats (Wang et al., 2012; Ryan et al., 2014). 
Cryptosporidium andersoni produces oocysts that are morphologically similar to, but slightly 
smaller than those of C. muris (7.4-8.8 × 5.8-6.6 μm vs 8.2-9.4 × 6.0-6.8 μm, respectively) and 
was originally mistakenly identified in cattle as C. muris based on its oocyst size. In 2000, it 
was described as a new species based on the location of endogenous stages in the abomasum, 
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its host range, and genetic distinctness at multiple loci (Lindsay et al., 2000). It has only 
occasionally been detected in wild animals (Table 1.2) (Ryan et al., 2004; Lv et al., 2009; Wang 
et al., 2008; Feng et al., 2010; Wang et al., 2015; Zhao et al., 2015a; Gu et al., 2016; Osman et 
al., 2017). Several studies have reported that C. andersoni is the dominant species in source 
and tap water (Nichols et al., 2010; Feng et al., 2011b), suggesting that cattle may be the 
primary source of contamination. Interestingly, in a recent study, it was found at a prevalence 
of 15.6% (19/122) and 0.5% (1/200) in captive and wild giant pandas, respectively in China 
(Wang et al., 2015). It is occasionally detected in humans (Leoni et al., 2006; Morse et al., 
2007; Waldron et al., 2011; Agholi et al., 2013; Jiang et al., 2014; Liu et al., 2014a). Two 
studies in China by the same research group have reported that C. andersoni was the most 
prevalent Cryptosporidium species detected in humans (Jiang et al., 2014; Liu et al., 2014a). 
However, further research is required to better understand the zoonotic importance of C. 
andersoni. 
 
1.3.7 Cryptosporidium canis 
 
Cryptosporidium canis (previously dog genotype I) was first identified as the dog 
genotype by Xiao et al. (1999) and described as a species in 2001 (Fayer et al., 2001), on the 
basis that C. canis oocysts were infectious for calves but not mice and were genetically distinct 
from all other species. Cryptosporidium canis and its sub-genotypes (C. canis dog genotype, 
fox genotype and C. canis coyote genotype) have been reported in dogs, foxes and coyotes 
(Table 1.2) (Xiao et al., 2002a; Zhou et al., 2004; Fayer, 2010; Feng, 2010). It has also been 
reported worldwide in humans (Fayer, 2010; Lucio-Forster et al., 2010; Elwin et al., 2012b; 
Mahmoudi et al., 2015; Parsons et al., 2015). 
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1.3.8 Cryptosporidium erinacei 
 
Little is known about epidemiology and pathogenicity of zoonotic C. erinacei in wildlife. 
Cryptosporidium erinacei (previously known as the hedgehog genotype) was first identified 
morphologically in a captive four-toed hedgehog (Ateletrix albiventris) in 1998 (Graczyk et 
al., 1998). An isolate from a European hedgehog originating from Denmark was typed in 2002 
(Enemark et al., 2002) and shown to be distinct. Subsequent studies have identified C. erinacei 
in hedgehogs, horses and humans (Meredith and Milne, 2009; Dyachenko et al., 2010; 
Laatamna et al., 2013; Kváč et al., 2014a, 2014b; Hofmannová et al., 2016). At the gp60 locus, 
C. erinacei isolates are identified as subtype family XIII (Lv et al., 2009; Dyachenko et al., 
2010; Laatamna et al., 2013; Kváč et al., 2014b; Hofmannová et al., 2016). Previously reported 
C. erinacei subtypes include XIIIaA19R12 (GQ214081), XIIIaA19R13 (KU679366), 
XIIIaA20R10 (KF055453), XIIIaA21R10 (GQ214085), XIIIaA22R9 (KC305644), and 
XIIIaA22R11 (GQ259140) (Kváč et al., 2014b; Hofmannová et al., 2016). 
 
1.3.9 Cryptosporidium fayeri and Cryptosporidium macropodum 
 
The two main species identified in a wide range of marsupials are C. fayeri and C. 
macropodum (previously marsupial genotype I and II) (Table 1.2) (Morgan et al., 1997; Power 
et al., 2004, 2005; Power and Ryan, 2008; Ryan et al., 2008; Nolan et al., 2010; Power, 2010; 
Ng et al., 2011; Yang et al., 2011; Ryan and Power, 2012; Nolan et al., 2013; Vermeulen et al., 
2015; Zahedi et al., 2016b; Šlapeta et al., 2017). Neither of these species is associated with 
diarrhoea in their marsupial hosts (Ryan and Power, 2012). Cryptosporidium macropodum has 
not been reported in humans but cryptosporidiosis caused by C. fayeri has been reported in a 
29-year-old female patient in Australia (Waldron et al., 2010). The woman was 
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immunocompetent but suffered prolonged gastrointestinal illness. The patient resided in a 
national forest on the east coast of New South Wales (NSW), Australia, an area where 
marsupials are abundant. She had frequent contact with partially domesticated marsupials 
(Waldron et al., 2010). Identification of C. fayeri in a human patient is a concern for water 
catchment authorities in the Sydney region. The main water supply for Sydney, Warragamba 
Dam, covers 9,050 km2 and is surrounded by national forest inhabited by diverse and abundant 
marsupials. At the gp60 locus, the subtype family IV has been identified with six subtypes 
(IVa-IVf) (Power et al., 2009). Subtyping of the human-derived isolate of C. fayeri identified 
IVaA9G4T1R1, which has also been identified in eastern grey kangaroos in Warragamba Dam, 
suggesting possible zoonotic transmission (Power, 2010; Waldron et al., 2010). 
In addition to C. fayeri and C. macropodum, there have been several other host-adapted 
genotypes identified in Australian marsupials. Possum genotype I has been described in 
brushtail possums, a host species found in a range of habitats throughout Australia (Hill et al., 
2008) and the novel kangaroo genotype I in western grey kangaroos (Yang et al., 2011). 
Possum genotype I and kangaroo genotype I have not been reported in humans or other animals 
and their zoonotic potential is unknown. 
 
1.3.10 Cryptosporidium meleagridis 
 
Cryptosporidium meleagridis infects the intestinal (small and large intestine and bursa) 
epithelial cells of a wide range of birds (Table 1.3) (Ryan and Xiao, 2014). It was first detected 
in a wild turkey (Meleagris gallopavo) by Tyzzer in 1929, but not named as a valid 
Cryptosporidium species until 1955 (Slavin, 1955). Cryptosporidium meleagridis oocysts have 
been experimentally infected into broiler chickens, ducks, turkeys, calves, pigs, rabbits, rats 
and mice (Darabus and Olariu, 2003; Ryan and Xiao, 2014). It has also been reported as one 
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of the most commonly detected human-infectious Cryptosporidium species in wastewater 
(Feng et al., 2007, 2011a; Li et al., 2012). 
Molecular analysis has revealed that C. meleagridis has relatively low host specificity, 
and many C. meleagridis subtypes at other loci have been found in both birds and humans and 
both anthroponotic and zoonotic transmission routes have been suggested (Cama et al., 2003; 
Elwin et al., 2012b; Silverlås et al., 2012). Cryptosporidium meleagridis has also been 
identified in deer mice, mountain gorillas, minks and marsupials (Feng et al., 2007; Sak et al., 
2014; Vermeulen et al., 2015; Zhang et al., 2016a). It is also the third most prevalent species 
infecting humans (Morgan et al., 2000; Cama et al., 2003; Gatei et al., 2006; Leoni et al., 2006; 
Muthusamy et al., 2006; Berrilli et al., 2012; Elwin et al., 2012b; Neira et al., 2012; Silverlås 
et al., 2012; Kurniawan et al., 2013; Sharma et al., 2013; Adamu et al., 2014; Ghaffari and 
Kalantari, 2014; Rahmouni et al., 2014; Ryan and Xiao, 2014; Stensvold et al., 2014, 2015; 
Wang et al., 2014). In some studies, C. meleagridis prevalence is similar to that of C. parvum 
(Gatei et al., 2002b; Cama et al., 2007). 
Subtyping at the gp60 locus has identified seven subtype families (IIIa-IIIg) and the 
likely occurrence of cross-species transmission of C. meleagridis between birds and humans 
(Wang et al., 2014). Human volunteer studies have shown that healthy adults can be infected 
and become ill after ingesting C. meleagridis oocysts (Chappell et al., 2011). In the study by 
Chappell et al. (2011), five volunteers were challenged with 105 C. meleagridis oocysts and 
monitored for six weeks for faecal oocysts and clinical manifestations. Four volunteers had 
diarrhoea; three had detectable faecal oocysts; and one infected volunteer remained 
asymptomatic. All infections were self-limiting and oocysts were cleared within 12 days of 
challenge (Chappell et al., 2011). 
The ability of C. meleagridis to infect humans and other mammals, and its close 
relationship to C. parvum and C. hominis at multiple loci, has led to the suggestion that 
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mammals actually were the original hosts, and that the species has later adapted to birds (Xiao 
et al., 2002a). Subtyping at the gp60 locus has identified seven subtype families (IIIa to IIIg) 
(Stensvold et al., 2015). Further details on transmission dynamics will be discussed in section 
1.3.12. 
 
1.3.11 Other Cryptosporidium species and genotypes reported in wild mammals 
 
A number of other Cryptosporidium species and genotypes have been identified in 
wildlife (Table 1.2). Most are host-adapted genotypes that are not of public health significance, 
however several have been identified in humans (Table 1.2). Of these, C. viatorum, the 
chipmunk genotype I, mink genotype and skunk genotype are considered emerging human 
pathogens (Xiao et al., 2002b; Jiang et al., 2005; Feltus et al., 2006; Feng et al., 2007; 
ANOFEL, 2010; Insulander et al., 2013; Lebbad et al., 2013; Guo et al., 2015; Song et al., 
2015; Yan et al., 2017). At the gp60 locus, 15 different subtypes have been identified for 
Cryptosporidium chipmunk genotype I but subtypes differ only in the number of tandem 
repeats (TCA/TCG/TCT) and comprise a single subtype family (XIVa). Analysis indicates that 
subtypes from humans and wildlife are genetically similar and zoonotic transmission might 
play a potential role in human infections (Guo et al., 2015). The skunk and mink genotypes 
have also been reported in a few human cases of cryptosporidiosis (Robinson et al., 2008; 
Chalmers et al., 2009; Rengifo-Herrera et al., 2011; Elwin et al., 2012b; Ng-Hublin et al., 
2013a; Ebner et al., 2015). 
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Table 1.2. Cryptosporidium species and genotypes identified by molecular tools in wild terrestrial mammals and their zoonotic importance. 
Cryptosporidium 
species/genotypes 
Wildlife hosts Zoonotic 
importance 
gp60 subtypes reported in 
wildlife 
References 
C. hominis Fallow deer (Dama dama), Dugong (Dugong 
dugon), Chinchillas (Chinchilla lanigera), Baboons 
(Pabio anubis), Chimpanzees (Pan troglodytes 
schweinfurthii), Red colobus (Procolobus 
rufomitratus), Black-and-white colobus (Colobus 
guereza), Rhesus macaque (Macaca mulatta), 
Cynomolgus monkey (Macaca fascicularis), 
Japanese macaque (Macaca fuscata), Crab-eating 
macaque (Macaca fascicularis), Francois' leaf 
monkey (Trachypithecus francoisi), Lemurs (Lemur 
spp.), Gibbon (Hylobatidae spp.), Bandicoots 
(Isoodon obesulus), Bushtail possums (Trichosurus 
vulpecula), Estern grey kangaroos (Macropus 
giganteus), Brush-tailed rock-wallabies (Petrogale 
penicillata), Wild dingo (Canis lupus dingo), 
Squirrel monkey (Saimiri sciureus), European 
hedgehogs (Erinaceus europaeus), Horses (Equus 
caballus), flying fox (Pteropus poliocephalus), 
Eastern grey kangaroos (Macropus giganteus); 
Badger (Meles meles), Striped field mouse 







IaA14R7, IbA9G2, IbA9G3, 
IbA10G2, IbA10G2R2, 
IbA12G3, IdA14, IdA15, 
IdA15G1, IdA19, IdA20, 
IeA11G3T3, IfA12G2, 
IfA16G2, IfA22G2, IiA17, 
IkA7G4, IkA15G1, IkA16, 
IkA16G1, IkA20G1 
Morgan et al., 2002; Ng et al., 
2011; Salyer et al., 2012; Ye et 
al., 2012; Dowle et al., 2013; 
Nolan et al., 2013; Karim et al., 
2014; Ryan et al., 2014; Ye et 
al., 2014; Krawczyk et al., 
2015; Laatamna et al., 2015; 
Liu et al., 2015a; Parsons et al., 
2015; Gu et al., 2016; Jian et 
al., 2016; Koehler et al., 2016; 
Schiller et al., 2016; Zahedi et 
al., 2016b; Danišová et al., 
2017; Deng et al., 2017; Inácio 
et al., 2017; Mateo et al., 2017; 
Baroudi et al., 2018 
C. parvum Alpaca (Vicugna pacos), Swamp deer (Cervus 
duvauceli), Red deer (Cervus elaphus), Roe deer 
(Capreolus capreolus), Fallow deer (Dama dama), 
Addaxes (Addax nasomaculatus), Arabian oryx 
(Oryx leucoryx), Gemsboks (Oryx gazella), Sable 
antelopes (Hippotragus niger), White-tailed deer 
(Odocoileus Virginianus), Grey wolf (Canis lupus), 
Racoon dog (Nyctereutes procyonoides viverrinus), 
European rabbit (Oryctolagus cuniculus), Nutria 
(Myocastor coypus), Prezewalski's wild horse (Equus 
przewalskii), Eastern grey squirrel (Sciurus 
carolinensis), Ground Squirrels (Spermophilus 
beecheyi), Siberian chipmunk (Tamias sibiricus), 













Morgan et al., 1999a; Matsui et 
al., 2000; Atwill et al., 2001; 
Perez and Le Blancq, 2001; 
Ryan et al., 2003, 2004; 
Matsubayashi et al., 2004; 
Ekanayake et al., 2007; Feng et 
al., 2007; Meireles et al., 2007; 
Paziewska et al., 2007; Starkey 
et al., 2007; Ziegler et al., 2007; 
Cinque et al., 2008; Lv et al., 
2009; Feng, 2010; Gómez-
Couso et al., 2012; Ravaszova 
et al., 2012; Ye et al., 2012; 
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Hamsters (Cricetinae), Wood mice (Apodemus 
sylvaticus), White-footed mouse (Peromyscus 
leucopus), Yellow-bellied marmot (Marmota 
flaviventris), Bamboo rats (Rhizomys sinensis), 
Small brown bat (Myotis lucifugus), Campbell 
hamster (Phodopus campbelli), Golden hamster 
(Mesocricetus auratus), Capybara (Hydrochoerus 
hydrochaeris), Racoon dog (Nictereutes 
procyonoides viverrinus), Red fox (Vulpes vulpes), 
Rhesus macaques (Macaca mulatta), Toque 
macaques (Macaca sinica sinica), Grey langurs 
(Semnopithecus priam thersites), Purple-faced 
langurs (Trachypithecus vetulus philbricki), 
Common dolphins (Delphinus delphis), Golden 
takins (Budorcas taxicolor bedfordi), Eastern grey 
kangaroos (Macropus giganteus), Asian house rat 
(Rattus tanezumi), Brown rat (Rattus norvegicus), 
Bamboo rats (Rhizomys sinensis), Water buffalo 
(Bubalus bubalis), Eurasian wild boars (Sus scrofa), 
European hedgehogs (Erinaceus europaeus), Horse 
(Equus caballus), Mustang (Equus caballus), 
Chincoteague ponies (Equus caballus), Donkey 
(Equus asinus), Orangutans (Pongo abelii and Pongo 
pygmaeus), European hedgehogs (Erinaceus 
europaeus), Striped field mouse (Apodemus 
agrarius), Yellow-necked mouse (Apodemus 
flavicollis), Bank vole (Myodes glareolus), Qinghai 
vole (Microtus fuscus), Wild plateau pika (Ochotona 
curzoniae) 
IIdA24G1, IIiA10, 
IIoA13G1, IIpA9 (novel 
subtype) 
Dowle et al., 2013; García-
Presedo et al., 2013a; Nolan et 
al., 2013; Liu et al., 2014; 
Reboredo-Fernandez et al., 
2014; Bodager et al., 2015; Du 
et al., 2015; Krawczyk et al., 
2015; Laatamna et al., 2015; 
Liu et al., 2015b; Montecino-
Latorre et al., 2015; Qi et al., 
2015b; Wagnerová et al., 2015; 
Wang et al., 2015; Wells et al., 
2015; Zhao et al., 2015a, 
2015b; Hofmannová et al., 
2016; Koehler et al., 2016; 
Mynářová et al., 2016; Sangster 
et al., 2016; Zahedi et al., 
2016b, 2016c; Danišová et al., 
2017; Inácio et al., 2017; Mateo 
et al., 2017; Martins et al., 
2018; Zhang et al., 2018 
C. cuniculus European rabbit (Oryctolagus cuniculus), Eastern 




sporadic cases of 
cryptosporidiosis in 
the UK and has been 
identified in a human 
in Australia 
VaA18, VbA18, VbA19, 
VbA21, VaA22, VbA24, 




Xiao et al., 2002a; Ryan et al., 
2003; Nolan et al., 2010; 
Chalmers, 2012; Robinson et 
al., 2010; Elwin et al., 2012b; 
Zhang et al., 2012; Nolan et al., 
2013; Kaupke et al., 2014; 
Koehler et al., 2014; Liu et al., 
2014b; Puleston et al., 2014; 
Koehler et al., 2016; Yang et 
al., 2016a 
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C. ubiquitum Swamp deer (Cervus duvauceli), Deer mouse 
(Peromyscus), Eastern grey squirrels (Sciurus 
carolinensis), Red squirrel (Sciurus vulgaris), 
Eastern chipmunk (Tamias striatus), Lemur 
(Lemuroidea), North American beaver (Castor 
canadensis), Woodchuck (Marmota monax), 
Raccoon (Procyon lotor), White–tailed deer 
(Odocoileus virginianus), Sika deer (Cervus 
Nippon), Roe deer (Capreolus capreolus), Blesbok 
(Damaliscus pygargus phillipsi), Ibex (Capara 
sibirica), Nyala (Niyala anagasii), Coquerel’s sifaca 
(Propithecus coquereli), Large Japanese field mouse 
(Apodemus speciosus), Striped field mouse 
(Apodemus agrarius), Jeju striped field mouse 
(Apodemus chejuensis), Yak (Bos grunniens), 
Hedgehog (Erinaceinae spp.), Wombat (Vombatidae 
spp.), Red fox (Vulpes vulpes), Eastern grey squirrel 




XIIa, XIIb, XIIc, XIId, XIIe, 
XIIf 
Perez and Le Blancq, 2001; da 
Silva et al., 2003; Ryan et al., 
2003; Feng et al., 2007; Karanis 
et al., 2007; Ziegler et al., 2007; 
Cinque et al., 2008; Wang et 
al., 2008; Fayer et al., 2010; 
Feng, 2010, 2012; Robinson et 
al., 2010, 2011; Abu Samraa et 
al., 2013; Nolan et al., 2013; 
Murakoshi et al., 2013; Li et al., 
2014; Ma et al., 2014; Perec-
Matysiak et al., 2015; Qi et al., 
2015a, 2015b; Song et al., 
2015; Stenger et al., 2015b; 
Koehler et al., 2016; Li et al., 
2016a, 2016b; Mateo et al., 
2017; Prediger et al., 2017; 
Zhang et al., 2018 
C. muris Wild rats (Rattus sp.), Mice (Mus sp.), Greater 
bilblies (Macroties lagotis), Girrafes house mice 
(Mus musculus), Eastern grey squirrel (Sciurus 
carolinensis), Golden hamster (Mesocricetus 
auratus), Rock hyrax (Procavia capensis), Large 
footed mouse-eared bat (Myotis adversus), Japanese 
field mouse (Apodemus argenteus), Bilbies 
(Macrotis lagotis), Bank voles (Clethrionomys 
glareolus), Campbell hamster (Phodopus campbelli), 
Siberian hamster (Phodopus sungorus), Golden 
hamster (Mesocricetus auratus), Mountain goats 
(Oreamnos americanus), Cynomolgus monkeys 
(Macaca fascicularis), East African mole rat 
(Tachyoryctes splendens), Ringed seal (Pusa 
hispida), Donkey (Giraffa camelopardalis), Ringed 
seal (Phoca hispida), Large Japanese field mouse 
(Apodemus speciosus), Cynomolgus monkey 
(Macaca fascicularis), Slow loris (Nycticebus 
coucang), Ostriches (Struthio camelus), Mountain 
gorillas (Gorilla beringei beringei), Asian house rat 
Numerous reports in 
humans 
- Morgan et al., 1999a; Dubey et 
al., 2002; Xiao et al., 2002a, 
2004a; Warren et al., 2003; 
Nakai et al., 2004; Hikosaka 
and Nakai, 2005; Santin et al., 
2005; Azami et al., 2007; Al-
Brikan et al., 2008; Kváč et al., 
2008; Lupo et al., 2008; Lv et 
al., 2009; Kodádková et al., 
2010; Feng, 2010; Yang et al., 
2011, 2013; Murakoshi et al., 
2013; Ng-Hublin et al., 2013b; 
Karim et al., 2014, Qi et al., 
2014; Sak et al., 2014; Du et 
al., 2015; Laatamna et al., 
2015; Petrincová et al., 2015; 
Song et al., 2015; Wagnerová et 
al., 2015; Zhao et al., 2015b; 
Mynářová et al., 2016; Wait et 
al., 2017 
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(Rattus tanezumi), Brown rat (Rattus norvegicus), 
House mouse (Mus musculus), horse (Equus 
caballus), Striped field mouse (Apodemus agrarius), 
Jeju striped field mouse (Apodemus chejuensis), 
Orangutans (Pongo abelii and Pongo pygmaeus), 
Tasmanian devil (Sarcophilus harrisii) 
C. andersoni Bacterian camel (Camelus bactrianus), Dromedary 
camel (Camelus dromedarius), European wisent 
(Bison bonasus), Marmots Campbell hamster 
(Phodopus campbelli), Golden hamster 
(Mesocricetus auratus), Golden takins (Budorcas 
taxicolor bedfordi), Giant panda (Ailuropoda 
melanoleuca), Rhesus macaque (Macaca mulatta), 
American mink (Mustela vison), horse (Equus 
caballus), Yak (Bos grunniens) 
Minor - Matsubayashi et al., 2005; 
Wang et al., 2008; Lv et al., 
2009; Stuart et al., 2013; Du et 
al., 2015; Liu et al., 2015c; 
Wang et al., 2015; Zhao et al., 
2015a; Gu et al., 2016; Li et al., 
2016b; Deng et al., 2017 
 
C. felis Rhesus macaques (Macaca mulatta); Pallas’s cat 
(Felis Manul), Red fox (Vulpes vulpes) 
Numerous reports in 
humans 
- Lucio-Forster et al., 2010; Ye et 
al., 2012; Beser et al., 2015; 
Ebner et al., 2015; Li et al., 
2015c; Mateo et al., 2017 
C. canis dog genotype Unidentified fox, Coyote (Canis latrans); American 
minks (Mustela vison) 
Numerous reports in 
humans 
- Xiao et al., 2002a; Ryan et al., 
2004; Zhou et al., 2004; Trout 
et al., 2006; Ziegler et al., 2007; 
Elwin et al., 2012b; 
Koompapong et al., 2014; Yang 
et al., 2018 
C. canis fox genotype Fox (Vulpes vulpes), Arctic foxes (Vulpes lagopus), 
raccoon dogs (Nyctereutes procyonoides), Minks 
(Mustela vison), Red fox (Vulpes vulpes), Mongoose 
(Herpestes ichneumon), Qinghai vole (Microtus 
fuscus) 
No reports in 
humans to date 
- Zhou et al., 2004; Swaffer et 
al., 2014; Zhang et al., 2016a, 
2016b; Mateo et al., 2017; 
Yang et al., 2018; Zhang et al., 
2018 
C. canis coyote 
genotype 
Coyote (Canis latrans) No reports in 
humans to date 
- Xiao et al., 2002a; Zhou et al., 
2004 






Meredith and Milne, 2009; 
Dyachenko et al., 2010; 
Laatamna et al., 2013; Nolan et 
al., 2013; Kváč et al., 2014a, 
2014b; Hofmannová et al., 
2016 
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C. fayeri Southern brown bandicoot (Isodon obesulus), 
Western-barred bandicoot (Permeles bougainville), 
Koala (Phascolarctos cincerus), Red kangaroo 
(Macropus rufus), Eastern grey kangaroo (Macropus 
giganteus), Yellow footed rock wallaby (Petrogale 
xanthopus), Western grey kangaroo (Macropus 
fuliginosus), Tasmanian devil (Sarcophilus harrisii), 
Wombat (Vombatidae spp.), Short-beaked echidna 
(Tachyglossus aculeatus) 





Power et al., 2005; Ryan et al., 
2008; Yang et al., 2008, 2011; 
Power, 2010; Waldron et al., 
2010; Feng et al., 2011b; Nolan 
et al., 2013; Swaffer et al., 
2014;Vermeulen et al., 2015; 
Koehler et al., 2016; Šlapeta et 
al., 2017; Wait et al., 2017; 
Zahedi et al., 2018 
Opossum genotype I (C. 
fayeri) 
Opossum (Didelphimorphia) No reports in 
humans to date 
XIaA4G1T1 Feng et al., 2011b 
Opossum genotype II Virginia opossum (Didelphis virginiae) No reports in 
humans to date 
- Xiao et al., 2002b; Oates et al., 
2012 
C. meleagridis Mountain gorillas (Gorilla beringei beringei), Brush-
tailed rock wallabies (Petrogale penicillata), Deer 
mouse (Peromyscus sp.), Minks (Mustela vison), Fox 
(Vulpes vulpes) 
Major IIIbA, IIIgA (closest match to 
IIIeA19G2R1) 
Morgan et al., 2000; Cama et 
al., 2003; Gatei et al., 2006; 
Leoni et al., 2006; Muthusamy 
et al., 2006; Feng et al., 2007; 
Elwin et al., 2012b; Silverlås et 
al., 2012; Kurniawan et al., 
2013; Adamu et al., 2014; 
Ghaffari and Kalantari, 2014; 
Rahmouni et al., 2014; Ryan 
and Xiao, 2014; Sak et al., 
2014; Wang et al., 2014; 
Stensvold et al., 2015; 
Vermeulen et al., 2015; Zhang 
et al., 2016a; Yang et al., 2018 
C. tyzerri Mice (Mus musculus), Brown rats (Rattus 
norvegicus), Large-footed bat (Myotus adversus), 
Yellow-necked mouse (Apodemus flavicollis), Bank 
vole (Myodes glareolus), Common vole (Microtus 
arvalis), Red panda (Ailurus fulgens), Leopard 
(Panthera pardus), Takin (Budorcas taxicolor), 
Prairie bison (Bison bison), Lesser panda (Ailurus 
fulgens), Black leopards (Pantera pardus), Bobcats 
(Lynx rufus), Horse (Equus caballus) 
Occasionally 
reported in humans 
IXaA5R2, IXaA6R1, 
IXaA6R2, IXaA6R3, IXbA6, 
IXbA6R2, IXbA22R9 
 
Morgan et al., 1999a, Xiao et 
al., 2002a; Bajer et al., 2003; 
Alves et al., 2005; Foo et al., 
2007; Karanis et al., 2007; 
Ziegler et al., 2007; Lv et al., 
2009; Feng et al., 2011b; 
Carver et al., 2012; Kváč et al., 
2012; Ren et al., 2012; Rasková 
et al., 2013; Silva et al., 2013; 
Swaffer et al., 2014; 
Wagnerová et al., 2015 
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C. macropodum Red kangaroo (Macropus rufus), Eastern grey 
kangaroo (Macropus giganteus), Swamp wallaby 
(Wallabia bicolor), Western grey kangaroos 
(Macropus fuliginosus) 
No reports in 
humans to date 
- Power et al., 2004, 2005; Power 
and Ryan, 2008; Power, 2010; 
Yang et al., 2011; Nolan et al., 
2013; Koehler et al., 2016; 
Zahedi et al., 2016b 
C. macropodum-like Wallaby (Macropus spp.) No reports in 
humans to date 
- Koehler et al., 2016 
C. bovis Yaks, foxes, Gorillas (single report), Roe deer 
(Capreolus capreolus), Yak (Bos grunniens) 
Occasionally 
reported in humans 
- Robinson et al., 2011; Helmy et 
al., 2013; García-Presedo et al., 
2013b; Sak et al., 2013; Qin et 
al., 2014; Qi et al., 2015b; Li et 
al., 2016b 
C. ryanae Roe deer (Capreolus capreolus), Water buffaloes 
(Bubalus bubalis), Yak (Bos grunniens) 
No reports in 
humans to date 
- Feng et al., 2012; García-
Presedo et al., 2013b; Li et al., 
2016b 
C. ryanae-like Deer (Cervidae spp.) 
 
No reports in 
humans to date 
- Koehler et al., 2016 
C. wrairi Guinea pig (Cavia porcellus), California ground 
squirrels (Spermophilus beecheyi) 
No reports in 
humans to date 
VIIaA13T1, VIIaA17T1,  
VIIaA16T1 
Atwill et al., 2004; Feng et al., 
2007, 2011b, Paziewska et al., 
2007; Lv et al., 2009 
C. scrofarum Asian house rat (Rattus tanezumi), Brown rat (Rattus 
norvegicus), Eurasian wild boars (Sus scrofa), 
Eurasian wild boars (Sus scrofa), Striped field mouse 
(Apodemus agrarius), Yellow-necked mouse 
(Apodemus flavicollis), Common shrew (Sorex 
araneus) 
Occasionally 
reported in humans 
- Castro-Hermida et al., 2011; 
García-Presedo et al 2013a; 
Němejc et al., 2013; Ng-Hublin 
et al., 2013b, Bodager et al., 
2015; Parsons et al., 2015; 
Rodriguez-Rivera et al., 2016; 
Danišová et al., 2017; Li et al., 
2017 
C. suis Chimpanzees (Pan troglodytes schweinfurthii), 
Eurasian wild boars (Sus scrofa), Rodents, Yellow-
necked mouse (Apodemus flavicollis) 
Occasionally 
reported in humans 
- Paziewska et al., 2007; Castro-
Hermida et al., 2011; Němejc et 
al., 2012, 2013; García-Presedo 
et al., 2013a; Bodager et al., 
2015; Parsons et al., 2015; 
Rodriguez-Rivera et al., 2016; 
Danišová et al., 2017 
C. occultus Asian house rat (Rattus tanezumi), Yak (Bos 
grunniens), Brown rat (Rattus norvegicus) 
No reports in 
humans to date 
- Ong et al., 2002; Ng-Hublin et 
al., 2013b; Li et al., 2016b; 
Kváč et al., 2018 
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C. rubeyi California ground squirrel (Otospermophilus. 
beecheyi), Belding’s ground squirrel (Urocitellus. 
beldingi), Golden Mantled ground squirrel 
(Callospermophilus. lateralis) 
No reports in 
humans to date 
- Pereira et al., 2010; Li et al., 
2015a 
C. viatorum Australian swamp rat (Rattus lutreolus) reported in humans XVbA2G1 Koehler et al., 2018 
C. occultus Brown rat (Rattus norvegicus) No reports in 
humans to date 
- Kváč et al., 2018 
Bear genotype  Black bear (Ursus americanus) No reports in 
humans to date 
- Xiao et al., 2000 
Bat genotype I Chinese rufous horseshoe bat (Rhinolophus sinicus), 
Stoliczka's trident bat (Aselliscus stoliczkanus) 
No reports in 
humans to date 
- Wang et al., 2013b 
Bat genotype II Chinese rufous horseshoe bat (Rhinolophus sinicus), 
Fulvus roundleaf bat (Hipposideros fulvus), 
Leschenault's rousette (Rousettus leschenaultii) 
No reports in 
humans to date 
- Wang et al., 2013b 
Bat genotype III Big brow bat (Eptesicus fuscus) No reports in 
humans to date 
- Kváč et al., 2015 
Bat genotype IV Western barbastelle (Barbastella barbastellus) No reports in 
humans to date 
- Kváč et al., 2015 
Bat genotype V Lesser short-nosed fruit bat (Cynopterus brachyotis) No reports in 
humans to date 
- Murakoshi et al., 2016 
Bat genotype VI Cave nectar bat (Eonycteris spelaean) No reports in 
humans to date 
- Murakoshi et al., 2016 
Bat genotype VII Philippine forest horseshoe bat (Rhinolophus inops) No reports in 
humans to date 
- Murakoshi et al., 2016 
Bat genotype VIII flying fox (Pteropus poliocephalus) No reports in 
humans to date 
- Schiller et al., 2016 
Bat genotypeIX flying fox (Pteropus poliocephalus) No reports in 
humans to date 
- Schiller et al., 2016 
Bat genotype X flying fox (Pteropus poliocephalus) No reports in 
humans to date 
- Schiller et al., 2016 
Bat genotype XI flying fox (Pteropus poliocephalus) No reports in 
humans to date 
- Schiller et al., 2016 
Beaver genotype North American beaver (Castor canadensis) No reports in 
humans to date 
- Feng et al., 2007 
Brushtail possum I Brushtail possum (Trichasuris vulpecula) No reports in 
humans to date 
- Hill et al., 2008; Barbosa et al., 
2017 
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Chipmunk genotype I Chipmunk sp. (Tamias sp.), Eastern grey squirrel 
(Sciurus carolinensis), Deer mice (Peromyscus 
maniculatus), Striped field mouse (Apodemus 






Jiang et al., 2005; Feltus et al., 
2006; Feng et al., 2007; 
ANOFEL, 2010; Insulander et 
al., 2013; Lebbad et al., 2013; 
Guo et al., 2015; Song et al., 
2015; Prediger et al., 2017 
Chipmunk genotype II Eastern chipmunk (Ramias striatus) No reports in 
humans to date 
- Feng et al., 2007; Stenger et al., 
2015b 
Chipmunk genotype III Siberian chipmunk (Tamias sibiricus) No reports in 
humans to date 
- Lv et al., 2009 
Deer genotype White–tailed deer (Odocoileus virginianus), Sika 
deer (Cervus nippon), Roe deer (Capreolus 
capreolus), Red deer (Cervus elaphus), Hokkaido 
sika deer (Cervus nippon yesoensis) 
No reports in 
humans to date 
- Xiao et al. 2002b; Feng et al. 
2007; Jellison et al. 2009; 
Robinson et al., 2011; Santin 
and Fayer 2015;  
Wells et al. 2015; Kato et al., 
2016; Koehler et al., 2016 
Deer mouse genotype I Deer mouse (Peromyscus) No reports in 
humans to date 
- Xiao et al., 2002b; Feng et al., 
2007, 2011b 
Deer mouse genotype II Deer mouse (Peromyscus) No reports in 
humans to date 
- Xiao et al., 2002b; Feng et al., 
2007 
Deer mouse genotype 
III 
Deer mouse (Peromyscus) No reports in 
humans to date 
- Feng et al., 2007; Stenger et al., 
2015b 
Deer mouse genotype 
IV 
Deer mouse (Peromyscus) No reports in 
humans to date 
- Feng et al., 2007 
Ferret genotype Ferret (Mustelidae), Siberian chipmunk (Tamias 
sibiricus), River otters (Lontra canadensis), Black-
footed ferret (Mustela nigripes), Red squirrel 
(Sciurus vulgaris), Chipmunk sp (Tamias sp.), 
Eurasian red squirrel (Sciurus vulgaris) 
No reports in 





Xiao et al., 2002a; Abe and 
Iseki, 2003; Gaydos et al., 
2007; Kváč et al., 2008; Lv et 
al., 2009; Feng et al., 2011b; Li 
et al., 2016a; Prediger et al., 
2017 
Giant panda genotype Giant panda (Ailuropoda melanoleuca) No reports in 
humans to date 
- Liu et al., 2013 
Squirrel genotypes I-III Golden-mantled ground squirrels 
(Callospermophilus lateralis), Belding's ground 
squirrels (Urocitellus beldingi), California ground 
squirrels (Otospermophilus beecheyi), Blacktailed 
prairie dog (Cynomys ludovicianus) 
No reports in 
humans to date 
- Atwill et al., 2004; Pereira et 
al., 2010; Stenger et al., 2015b 
Hamster genotype Siberian hamster (Phodopus sungorus) No reports in 
humans to date 
- Lv et al., 2009 
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Horse genotype Przewalski’s wild horse (Equus przewalski), Four-
toed hedgehog (Atelerix albiventris) 
Identified in humans 




Ryan et al., 2003; Robinson et 
al., 2008; Xiao et al., 2009; Abe 
and Matsubara, 2015; 
Wagnerová etal., 2015 
Kangaroo genotype I Eastern grey kangaroo (Macropus giganteus) No reports in 
humans to date 
- Yang et al., 2011; Koehler et 
al., 2016 
Mink genotype River otter (Lontra canadensis), American minks 
(Mustela vison), Stoat (Mustela ermine), Raccoon 
dog (Nyctereutes procyonoides) 




Feng et al., 2007, Wang et al., 
2008; Feng et al., 2011b; Ng-
Hublin et al., 2013b; Stuart et 
al., 2013; Ebner et al., 2015; 
Zhang et al., 2016a; Yang et al., 
2018 
Monkey genotype Rhesus macaques (Macaca mulatta), Long-tailed 
macaques (Macaca fascicularis) 
No reports in 
humans to date 
- Xiao et al., 1999a; Sricharern et 
al., 2016 
Mouse genotype II House mouse (Mus musculus) No reports in 
humans to date 
- Foo et al., 2007; Silva et al., 
2013 
Mouse genotype III House mouse (Mus musculus) No reports in 
humans to date 
- Silva et al., 2013 
Muskrat genotype I Muskrat (Ondatra zibethicus), Boreal red-backed 
vole (Myodes rutilus), Bank vole (Myodes glareolus) 
No reports in 
humans to date 
- Xiao et al., 2002a; Zhou et al., 
2004; Feng et al., 2007; 
Danišová et al., 2017 
Muskrat genotype II Muskrat (Ondatra zibethicus), Red fox (Vulpus 
vulpus), Deer mouse (Peromyscus maniculatus), 
Meadow vole (Microtus pennsylvanicus), Striped 
field mouse (Apodemus agrarius) 
No reports in 
humans to date 
- Ziegler et al., 2007; Robinson et 
al., 2011; Danišová et al., 2017 
Naruko genotype Large Japanese field mouse (Apodemus speciosus) No reports in 
humans to date 
- Murakoshi et al., 2013 
Pika genotype Wild plateau pika (Ochotona curzoniae) No reports in 
humans to date 
- Zhang et al., 2018 
Qinghai 
vole genotype 
Qinghai vole (Microtus fuscus) No reports in 
humans to date 
- Zhang et al., 2018 
Rat genotype I Brown rat (Rattus norvegicus) No reports in 
humans to date 
- Ng-Hublin et al., 2013b 
Rat genotype II Asian house rat (Rattus tanezum),Wild black rat 
(Rattus rattus), Brown rat (Rattus norvegicus) 
No reports in 
humans to date 
- Lv et al., 2009; Ng-Hublin et 
al., 2013b; Silva et al., 2013 
Rat genotype III Asian house rat (Rattus tanezumi), Wild black rat 
(Rattus rattus) 
No reports in 
humans to date 
- Lv et al., 2009; Paparini et al., 
2012; Ng-Hublin et al., 2013b; 
Silva et al., 2013 
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Rat genotype IV Tanezumi rat (Rattus tanezumi), Asian house rat 
(Rattus tanezumi), Brown rat (Rattus norvegicus) 
No reports in 
humans to date 
- Ng-Hublin et al., 2013b 
Seal genotypes I and II Ringed seals (Phoca hispida), Harbor seals (Phoca 
vituline), Hooded seal (Cystophora cristata) 
No reports in 
humans to date 
- Santín et al., 2005; Bass et al., 
2012 
Seal genotype III Harp seal (Pagophilus groenlandicus) No reports in 
humans to date 
- Bass et al., 2012 
Seal genotype IV 
(similar to skunk 
genotype) 
Southern elephant seal (Mirounga leonina) No reports in 
humans to date 
- Rengifo-Herrera et al. 2011, 
2013 
Seal genotype V 
(Weddell seal genotype) 
Weddel seal (Leptonychotes weddellii) 
 
No reports in 
humans to date 
- Rengifo-Herrera et al., 2013  
Skunk/ skunk-like 
genotype 
Striped skunk (Mephitis mephitis), Raccoon 
(Procyon lotor), Eastern grey squirrel (Sciurus 
carolinensis), River otter (Lontra canadensis), 
Raccoon (Procyon lotor), Southern elephant seal 
(Mirounga leonina), Skunk (Mephitis mephitis), 
American red (Tamiasciurus hudsonicus), Fox 
squirrel (Sciurus niger) 




Xiao et al., 2002b; Zhou et al., 
2004; Feng et al., 2007; Ziegler 
et al., 2007; Robinson et al., 
2008; Chalmers et al., 2009; 
Feng et al., 2011b; Rengifo-
Herrera et al., 2011; Elwin et 
al., 2012b; Stenger et al., 
2015b; Leśniańska et al., 2016; 





No reports in 
humans to date 
- Wait et al., 2017; Yan et al., 
2017 
Vole genotype Meadow vole (Microtus pennsylvanicus) No reports in 
humans to date 
- Feng et al., 2007 
Wildbeast genotype Black wildbeast (Connochaetos) No reports in 
humans to date 
- Alves et al., 2005 
Novel genotype (closely 
related to bear 
genotype) 
Striped field mouse (Apodemus agrarius), Jeju 
striped field mouse (Apodemus chejuensis) 
No reports in 
humans to date 
- Song et al., 2015 
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1.3.12 Cryptosporidium in birds 
 
The mobility of migratory birds, together with their distribution and ability to form large 
colonies, makes them potentially suitable to spread pathogens. Due to their easy access to 
drinking water catchments and other water sources, wild birds are believed to be a potential 
risk to drinking water safety. The epidemiology of avian cryptosporidiosis, in particular 
zoonotic Cryptosporidium species infecting birds is therefore of public health importance. 
Currently four avian Cryptosporidium spp. are recognised; C. meleagridis (discussed in section 
1.3.10), C. baileyi, C. galli and C. avium (Table 1.3) (Ryan and Xiao, 2014; Holubová et al., 
2016). Of these four species, only C. meleagridis is considered of zoonotic importance. In 
addition to C. meleagridis, other zoonotic species/genotypes of Cryptosporidium reported in 
birds include C. hominis, C. parvum, C. muris, C. canis, C. ubiquitum and C. andersoni, and 
the Cryptosporidium ferret genotype (Zylan et al., 2008; Jellison et al., 2009; Ryan, 2010; 
Gomes et al., 2012; Reboredo-Fernandez et al., 2015; Koehler et al., 2016; Li et al., 2016a; 
Helmy et al., 2017; Osman et al., 2017, Azmanis et al., 2018). In addition, eighteen genotypes; 
avian genotypes I-IV and VI to IX, the black duck genotype, the Eurasian woodcock genotype, 
finch genotypes I-III and goose genotypes I-V have been reported (Table 1.3). To date, there 
is no evidence of human cryptosporidiosis caused by these genotypes. 
Cryptosporidium baileyi is generally associated with the respiratory form of 
cryptosporidiosis in birds and has been predominantly reported in broiler chickens. Compared 
to C. meleagridis, C. baileyi is capable of infecting a larger spectrum of avian hosts (Table 
1.3), targeting various sites of infection mostly associated with the digestive and respiratory 
tracts (Ryan and Xiao, 2014; Máca and Pavlásek, 2016; Nakagun et al., 2017; Xiang et al., 
2017). Experimental cross-transmission of C. baileyi to other birds has been successful, 
however there has been no reports of cross-transmission between birds and other vertebrates 
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(Lindsay and Blagburn, 1990; Cardozo et al., 2005), except for a single unsubstantiated report 
of human infection with C. baileyi, which did not include any molecular analysis (Ditrich et 
al., 1991). Therefore, C. baileyi is not considered to be of public health significance. 
Unlike other avian species, C. galli is a gastric species with endogenous developmental 
stages occurring in the glandular epithelial cells of the proventriculus (Pavlásek, 1999; 2001; 
Ryan et al., 2003; Ng et al., 2006; Ryan and Xiao, 2014; Máca and Pavlásek, 2016; Osman et 
al., 2017). It predominantly infects birds of the family Spermestidae, Fringilidiae and domestic 
chickens (Gallus gallus), and seems to be more prevalent among songbirds (Table 1.3). 
Successful experimental cross-transmission of C. galli to other chickens has been reported, 
however the full extent of its host range is still unknown (Ryan, 2010). It has not been reported 
in humans. 
The most recently described avian species is C. avium (formerly avian genotype V) 
which infects the ileum, caecum, kidney, ureter, and cloaca of avian hosts (Holubová et al., 
2016). First reported in cockatiels (Nymphicus hollandicus) in Japan (Abe and Makino, 2010) 
and subsequently in many other bird hosts (Table 1.3), there is no evidence that C. avium infects 
humans. There is a single report of C. avium from green iguanas (Iguana inguana) (Kik et al., 
2011). 
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Table 1.3. Cryptosporidium species and genotypes in avian hosts confirmed by molecular analysis (Modified from Ryan and Xiao, 2014). 
Species name Major host(s) Site of infection References 
C. avium (Previously 
avian genotype V) 
Red-crowned parakeet (Cyanoramphus novaezelandiae), 
Rosy-faced lovebird (Agapornis roseicollis), Chickens (Gallus 
gallus), Blue-fronted Amazon (Amazona aestiva), Major 
Mitchell’s cockatoo (Lophochroa leadbeateri), Cockatiel 
(Nymphicus hollandicus), Budgerigar (Melopsittacus 
undulates); Fischer’s lovebird (Agapornis fischeri).  
- Abe and Makino, 2010; Qi et al., 2011; Zhang et 
al., 2015; Holubová et al., 2016; Li et al., 2016a 
C. baileyi Turkey (Meleagris gallopavo), Chicken (Gallus gallus), 
Brown squail (Synoicus australis), Cocktails (Nymphicus 
hollandicus), Whooping crane (Grus vipio), Grey-bellied 
bulbul (Pycnonotus spp.), Black vulture (Coragyps atratus), 
Saffron finch (Sicalis flaveola), Mixed-bred falcons (Falco 
rusticolus Falco cherrug), Ruddy Shelduck (Tadorna 
Paroaria ferruginea), Red-billed leiothrixes (Leiothrix lutea), 
Pekin ducks (Anas platyrhynchos), Buffy-fronted seedeater 
(Sporophila frontalis), Java sparrows (Padda oryzivora), 
Mynas (Acridotheres tristis), Zebra  finches (Taeniopygia 
guttata), Crested Lark (Galerida cristana), Gouldian finch 
(Chloebia gouldiae), Black-billed magpie (Pica pica), 
Ostriches (Struthio camelus), Quails (Coturnixcoturnix 
japonica), Red grouse (Lagopus lagopus scotica), Red-
crowned crane (Grus japonenis), Snowy owl (Bubo 
scandiacus), Ring-necked pheasants (Phasianus colchicus), 
scaled quail (Callipepla squamata), Atlantic canary (Serinus 
canaria), Budgerigar (Melopsittacus undulates), Crested myna 
(Acridotheres cristatellus), Rock dove (Columba livia), Swan 
goose (Anser cygnoides) 
Cloaca, bursa, trachea Morgan et al., 2001; Abe and Iseki, 2004; Kimura 
et al., 2004; Ng et al., 2006; Huber et al., 2007; 
Nakamura et al., 2009; Abe and Makino, 2010; 
Wang et al., 2010; Qi et al., 2011; Wang et al., 
2012; Baroudi, et al., 2013; Baines et al., 2014; 
Hamidinejat et al., 2014; Wang et al., 2014; Li et 
al., 2015c, 2016a; Máca and Pavlásek, 2015, 
2016; da Cunha et al., 2017; Helmy et al., 2017; 
Nakagun et al., 2017; Xiang et al., 2017 
C. galli Chicken (Gallus gallus), Finches (Spermestidae and 
Fringillidae), Capercaille (Tetrao urogallu), Pine grosbeak 
(Pinicola enuncleator), Turqoise parrots (Neophema 
pulchella), Cuban flamingo (Phoenicopterus ruber ruber), 
Rhinoceros hornbill (Buceros rhinoceros), Red-cowled 
cardinal (Paroaria dominicana), Zebra finches (Taeniopygia 
guttata), Chocolate parson finches (Peophila cincta), Chesnut 
finches (Lonchura castaneothorax), Painted firetail finches 
(Ebmlema picta), Canaries (Serinus sp.), Glosters (Serinus 
canaria), Green-winged saltatros (Saltator similis), Slate-
Preventriculus Ryan et al., 2003; Ng et al., 2006; Antunes et al., 
2008; Nakamura et al., 2009; da Silva et al., 2010; 
Qi et al., 2011; Nakamura et al., 2014; Chelladurai 
et al., 2016; Li et al., 2016a; Máca and Pavlásek, 
2016; Osman et al., 2017 
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collard seedeater (Sporophila schistaceca), Great-billed seed 
finch (Oryzoborus maximiliani), Ultramarine grosbeak 
(Cyanocompsa brissonii), Bohemian waxwing (Bombycilla 
garrulous), Silver-eared Mesia (Leiothrix argentauris), 
Cockatiel (Nymphicus hollandicus), Chopi blackbird 
(Gnorimopsar chopi), Green-winged saltator (Saltator 
similis), Rufous-collared sparrow (Zonotrichia capensis), 
Rosella (Platycercus eximus), Ring-necked pheasants 
(Phasianus colchicus), American red-winged blackbirds 
(Agelaius phoeniceus), Chinese hwamei (Garrulax canorus) 
C. meleagridis Turkey (Meleagris gallopavo), Indian ring-necked parrot 
(Psittacula kameri), Red-legged partridge (Alectoris rufa), 
Cocktails (Nymphicus hollandicus), Bohemian waxwing 
(Bombycilla garrulous), Rufous turtle dove (Streptopelia 
orientalis), Fan-tailed pigeon (Columba livia), Chicken 
(Gallus gallus), Quails (Coturnixcoturnix japonica), Pekin 
ducks (Anas platyrhynchos), Domestic Pigeons (Columba 
livia domestica), European turtle dove (Streptopelia turtur), 
Red-legged partridge (Alectoris rufa), Ring-necked pheasants 
(Phasianus colchicus) 
Intestine Morgan et al., 2000; Glaberman et al., 2001; Abe 
and Iseki, 2004; Abe and Makino 2010; Wang et 
al., 2010b; Qi et al., 2011; Berrilli et al., 2012; 
Wang et al., 2012; Baroudi, et al., 2013; Wang et 
al., 2014; Koompapong et al., 2014; Máca and 
Pavlásek, 2015; Reboredo-Fernandez et al., 2015; 
Máca and Pavlásek, 2016; Zahedi et al., 2018 
Avian genotype I Red factor canary (Serinus canaria), Canary (S. canaria), 
Indian peafowl (Pavo cristatus) 
- Ng et al., 2006; Nakamura et al., 2009 
Avian genotype II Eclectus (Eclectus roratus), Galah (Eolophus roseicapilla), 
Cockatiel (Nymphicus hollandicus), Major Mitchel Cockatoo 
(Cavcatua lead beater), Ostriches (Struthio camelus), White-
eyed parakeet (Aratinga leucophthalma) 
- Meireles et al., 2006; Ng et al., 2006; Nakamura et 
al., 2009; Seva-Ada et al., 2011; Nguyen et al., 
2013 
Avian genotype III Galah (Eolophus roseicapilla), Cockatiel (Nymphicus 
hollandicus), Java sparrow (Padda oryzivora), Son conure 
(Aratinga solstitialis), Peach-faced lovebirds (Agapornis 
roseicollis), Seagull (Laridae sp), Blue-fronted amazon 
(Amazona aestival), Cockatiel (Nymphicus hollandicus), 
Rufous-collared sparrow (Zonotrichia capensis), Lovebird 
(Agapornis species), Toco toucan (Ramphastus toco), White-
throated toucan (Ramphastus Tucanus), Saffron toucanet 
(Pteroglossus bailloni) 
- Ng et al., 2006; Nakamura et al., 2009; Makino et 
al., 2010; Gomes et al., 2012; Koompapong et al., 
2014; Nakamura et al., 2014; Ravich et al., 2014; 
Li et al., 2015c; Cano et al., 2016; Silva Novaes et 
al., 2018 
Avian genotype IV Japanese white-eye (Zosterops japonica) - Abe and Makino, 2010; Qi et al., 2011 
Avian genotype VI American red-winged blackbirds 
(Agelaius phoeniceus) 
- Chelladurai et al., 2016 
Avian genotype VII Turkey (Meleagris gallopavo), Chicken (Gallus gallus) - Helmy et al., 2017 
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Avian genotype VIII Turkey (Meleagris gallopavo), Chicken (Gallus gallus) - Helmy et al., 2017 
Avian genotype IX Turkey (Meleagris gallopavo), Chicken (Gallus gallus) - Helmy et al., 2017 
Duck genotype Black duck (Anus rubripes), Canada geese (Branta 
Canadensis), Mandarin duck (Aix galericulata) 
- Jellsison et al., 2004; Zhou et al., 2004; Cano et 
al., 2016; da Cunha et al., 2017 
Eurasian woodcock 
genotype 
Eurasian woodcock (Scolopax rusticola) - Ryan et al., 2003; Ng et al., 2006 
Finch genotype I Gouldian finch (Erythrura gouldiae) - Morgan et al., 2001 
Finch genotype II Red-winged pytilia (Pytilia phoenicoptera) - Morgan et al., 2001 
Finch genotype III Red-winged pytilia (Pytilia phoenicoptera) - Morgan et al., 2001 
Goose genotype I Canada geese (Branta canadensis) - Xiao et al., 2002b; Jellison et al., 2004; Zhou et 
al., 2004 
Goose genotype II Canada geese (Branta canadensis) - Jellison et al., 2004; Zhou et al., 2004 
Goose genotype III Canada geese (Branta canadensis) - Jellison et al., 2004 
Goose genotype IV Canada geese (Branta canadensis) - Jellison et al., 2004; Cano et al., 2016 
Goose genotype V Canada geese (Branta canadensis) - Jellison et al., 2004 
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1.3.13 Cryptosporidium in fish 
 
Cryptosporidium has been described in both fresh and marine water piscine species with 
parasitic stages located either on the stomach or intestinal surface, or deep within the 
epithelium (Table 1.4). The first account of Cryptosporidium in a piscine host was C. nasorum, 
identified in a Naso tang, a tropical fish species (Hoover et al., 1981). However, currently only 
three species are recognized; C. molnari, C. scophthalmi and C. huwi (previously known as 
piscine genotype I) (Alvarez-Pellitero and Sitja-Bobadilla, 2002; Alvarez-Pellitero et al., 2004; 
Palenzuela et al., 2010; Ryan et al., 2015), none of which have been reported in humans. In 
fish hosts, Cryptosporidium fish species and genotypes are typically located either in the 
stomach or intestine and the parasite can cause clinical manifestations, such as emaciation, 
decrease in growth rate, anorexia, whitish faeces, abdominal swelling, and ascites (Alvarez-
Pellitero et al., 2004; Ryan et al., 2015). Most studies on Cryptosporidium in fish have been 
reported in farmed or aquarium fish (Table 1.4) and little data are currently available regarding 
the molecular identification of Cryptosporidium species and genotypes in wild fish populations 
and, in particular, in edible fish (Palenzuela et al., 2010; Reid et al., 2010; Barugahare et al., 
2011; Gibson-Keuh et al., 2011; Koinari et al., 2013; Certad et al., 2015). 
In addition to the three recognised species of Cryptosporidium in piscine hosts, numerous 
Cryptosporidium species and genotypes have been reported in fish including; piscine 
genotypes 2 to 8, unnamed novel genotypes (n = 6), rat genotype III, C. parvum, C. hominis, 
C. xiaoi and C. scrofarum (Table 1.4). Of these, only C. parvum, C. hominis and C. scrofarum 
are of public health interest. Cryptosporidium scrofarum was identified in a whiting (Reid et 
al., 2010); C. parvum was found in School whiting, Nile tilapias, a Silver barb, Arctic char and 
European whitefish and C. hominis was reported in Mackerel scad (Reid et al., 2010; Gibson-
Kueh et al., 2011; Koinari et al., 2013; Certad et al., 2015). In one of the most recent studies, 
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C. parvum was identified in freshwater fish from Lake Geneva (Lac Leman) by both histology 
and molecular analysis (Certad et al., 2015). In that study, the overall prevalence of 
Cryptosporidium was 36.6% (15/41); the prevalence of C. parvum and C. molnari was 86.7% 
(13/15) and 6.7% (1/15), respectively, while 6.7% (1/15) were mixed C. parvum and C. molnari 
infections (Certad et al., 2015). Histological analysis identified C. parvum developmental 
stages in the stomach and intestine suggesting that C. parvum was infecting the fish, rather than 
being passively carried, which has important public health implications. 
Subtyping of Cryptosporidium isolates in fish has identified C. parvum subtype 
IIaA18G3R1 in School whiting from Australia (Reid et al., 2010), three C. parvum subtypes 
(IIaA14G2R1, IIaA15G2R1 and IIaA19G4R1) in Nile tilapia, silver barb and mackerel scad 
and a C. hominis subtype (IdA15G1) in mackerel scad in Papua New Guinea (Koinari et al., 
2013), and C. parvum subtypes IIaA15G2R1, IIaA16G2R1 and IIaA17G2R1 in Arctic char 
and European whitefish from France (Certad et al., 2015). All of these C. parvum subtypes are 
zoonotic and are commonly found in cattle and humans (Xiao, 2010). The identification of the 
C. hominis subtype probably reflects human sewage contamination of the water. Clearly further 
studies in this area are required to better understand the transmission dynamics of 
Cryptosporidium in fish. 
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Table 1.4. Cryptosporidium species reported in fish using molecular tools (Modified from Ryan et al., 2014). 
Species Host Site of Infection Reference 
C. huwi (previously piscine genotype 1) Guppy (Poecilia reticulata) Stomach Ryan et al., 2004; Ryan et al., 2015 
C. molnari Gilthead sea bream (Sparus aurata), European sea 
bass (Dicentrarchus labrax), Murray cod 
(Maccullochella peelii peelii) 
Stomach (and intestine) Palenzuela et al., 2010; Barugahare et al., 
2011; Certad et al., 2015 
C. scophthalmi Turbot (Scophthalmus maximus) Intestine Alvarez-Pellitero et al., 2004; Unpublished 
(Acc. No. KR340588, KR340589) 
Piscine genotype 2 Angelfish (Pterophyllum scalare) Stomach Murphy et al., 2009 
Piscine genotype 3 Mullet (Mugil cephalus) Intestine Reid et al., 2010 
Piscine genotype 4 Golden algae eater (Crossocheilus aymonieri), 
Kupang damsel (Chrysiptera hemicyanes), Oscar 
fish (Astronatus ocellatis), Neon tetra 
(Paracheirodon innesi) 
Intestine Reid et al., 2010; Morine et al., 2012 
Piscine genotype 5 Angelfish (Pterophyllum scalare), Butter bream 
(Monodactylidae), Golden algae eater 
(Crossocheilus aymonieri) 
- Zanguee et al., 2010 
Piscine genotype 6, piscine genotype 6-
like 
Guppy (Poecilia reticulata), Gourami 
(Trichogaster trichopterus) 
- Zanguee et al., 2010; Morine et al., 2012 
Piscine genotype 7 Red eye tetra (Moenkhausia sanctaefilomenae) - Morine et al., 2012 
Piscine genotype 8 Oblong silver biddy (Gerres oblongus) - Koinari et al., 2013 
Rat genotype III, C. hominis, C. parvum, 
C. xiaoi and C. scrofarum 
Whiting (Sillago vittata), Barramundi (Lates 
calcarifer), Arctic char (Salvelinus alpinus), Nile 
tilapias (Oreochromis niloticus), Silver barb 
(Puntius gonionotus), Mackerel scad (Decapterus 
macarellus), European whitefish (Coregonus 
lavaretus), School whiting (Sillago vittata) 
- Reid et al., 2010; Gibson-Kueh et al., 2011; 
Koinari et al., 2013; Certad et al., 2015 
Novel un-named genotypes (n=5) Orange clownfish (Amphiprion percula), Azure 
damsel (Chrysiptera hemicyanea), Blue tang 
(Paracanthurus hepatus), Platyfish (Xiphophorus 
maculatus), Oscar (Astronotus ocellatus), 
Goldfish (Carassius auratus) 
- Yang et al., 2015b 
Novel genotype Male Koi carp (Cyprinus carpio)  Yang et al., 2016b 
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1.3.14 Cryptosporidium in amphibians and reptiles 
 
Little is known about Cryptosporidium species infecting amphibians. Of the three orders 
of amphibians; Anura, Caudata and Gymnophonia, Cryptosporidium has been only reported in 
Anura which includes frogs and toads and only one species, C. fragile is recognised (Table 1.5) 
(Jirků et al., 2008). In transmission experiments, C. fragile was not infective in one fish species 
(Poecilia reticulate), four amphibian species (Bufo bufo, Rana temporaria, Litoria caerulea 
and Xenopus laevis), one species of reptile (Pantherophis guttatus) and SCID mice (Jirků et 
al., 2008). This species has not been reported in humans. 
Cryptosporidium infections are ubiquitous in reptiles and have been reported in more 
than 57 reptilian species (O'Donoghue, 1995; Ryan and Xiao, 2014). Unlike in other animals 
in which Cryptosporidium infection is usually self-limiting in immunocompetent individuals, 
cryptosporidiosis in reptiles is frequently chronic and sometimes lethal in some snakes. Both 
intestinal and gastric cryptosporidiosis have been described in snakes and lizards. To date, four 
species are recognised; C. serpentis, C. varanii (previously C. saurophilum), C. testudinis 
(previousely tortoise genotype I) and C. ducismarci (previously tortoise genotype II) (Levine, 
1980; Pavlásek et al., 1995; Koudela and Modry, 1998; Pavlásek and Ryan, 2008; Traversa, 
2010; Jezkova et al., 2016); none of which have been reported in humans, but C. serpentis has 
been identified in cattle (Azami et al., 2007; Chen and Qiu, 2012). 
Cryptosporidium parvum, C. muris, C. andersoni and Cryptosporidium tyzzeri are also 
commonly reported in reptiles, particularly snakes but this is thought to be due to mechanical 
transmission due to predation of infected rodents and is not thought to present a substantial 
zoonotic risk (Morgan et al., 1999b; Xiao et al., 2004b; Pedraza-Diaz et al., 2009; Díaz et al., 
2013; da Silva et al., 2014; Yimming et al., 2016; Osman et al., 2017). In addition, various 
host-adapted genotypes have been identified including tortoise genotype III and snake 
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genotypes I and II (cf. Ryan and Xiao, 2014), which have not been reported in humans (Table 
1.5) (Xiao et al., 2004b; Pedraza-Diaz et al., 2009; Traversa, 2010; Richter et al., 2011; Seva-
Ada et al., 2011; Rinaldi et al., 2012; da Silva et al., 2014; Abe and Matsubara, 2015; Jezkova 
et al., 2016).
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Table 1.5. Amphibian and reptile Cryptosporidium species and genotypes and their hosts confirmed by molecular analyses (modified from Ryan 
et al., 2014). 
Species/genotype Amphibian/Reptile Host species Site of infection Reference 
C. ducismarci (previously Tortoise 
genotype II) 
Marginated tortoise (Testudo marginata), Ball python 
(Python regius), Veiled chameleon (Chamaeleo 
calyptratus), Pancake tortoise (Malacochersus tornieri), 
Russian tortoise (Agrionemys [Testudo] horsfieldii), 
Intestine Alves et al., 2005; Traversa et al., 2008; 
Pedraza-Díaz et al., 2009; Griffin et al., 
2010; Traversa, 2010; Richter et al., 2012; 
Jezkova et al., 2016 
C. fragile Black-spined toads (Duttaphrynus melanostictus) Stomach Jirků et al., 2008 
C. serpentis Amazon tree boa (Corallus hortulanus), Black rat snake 
(Elaphe obsoleta obsolete), Bornmueller's viper (Vipera 
bornmuelleri), Bull snake (Pituophis melanoleucus 
melanoleucus), California kingsnake (Lampropeltis getulus 
californiae), Cornsnake (Elaphe guttata guttata), Common 
death adder (Acanthophis antarticus), Desert monitor 
(Varanus griseus), Eastern / Mainland Tiger snake 
(Notechis scutatus), Frilled lizard (Chlamydosaurus kingui), 
Giant madagascar or Oustalet’s chameleon (Chamaeleo 
oustaleti), Leopard gecko (Eublepharis macularius), 
Mexican black kingsnake (Lampropeltis getulus nigritus), 
Milk snake (Lampropeltis triangulum), Mountain viper 
(Vipera wagneri), Python (Python molurus), Savannah 
monitor (Varanus exanthematicus), Skink (Mabuya 
perrotetii), Taipan (Oxyuranus scutellatus), Red-tailed boa 
(Boa constrictor constrictor), Rainbow boa (Epicrates 
cenchria cenchria), Common frog eye gecko 
(Teratoscincus scincus), Eastern kingsnake (Lampropeltis 
getula) 
Stomach Kimbell et al., 1999; Morgan et al., 1999b; 
Hajdusek et al., 2004; Xiao et al., 2004b; 
Pedraza-Díaz et al., 2009; Richter et al., 
2011; Seva-Ada et al., 2011; Rinaldi et al., 
2012; Diaz et al., 2013; da Silva et al., 
2014; Abe and Matsubara, 2015; Yimming 
et al., 2016 
C. testudinis (previousely Tortoise 
genotype I) 
Russian tortoise (Agrionemys [Testudo] horsfieldii), chaco 
tortoise (Chelonoidis chilensis), Greek tortoise (Testudo 
graeca Linnaeus), Hermann’s tortoise (Testudo hermanni 
Gmelin), Indian star tortoise (Geochelone elegans), Leopard 
tortoise (Stigmochelys pardalis), Marginated tortoise 
(Testudo marginata), Radiated tortoise (Astrochelys 
radiata), Serrated tortoise (Psammobates oculifer), Ball 
python (Python regius) 
Stomach Xiao et al., 2002b, 2004b, Alves et al., 
2005; Pedraza-Díaz et al., 2009; Griffin et 
al., 2010; Richter et al., 2012; Jezkova et 
al., 2016 
C. varanii African fat-tailed gecko (Hemitheconyx caudicinctus), 
Leopard gecko (Eublepharis macularius), Boa constrictor 
(Boa constrictor), Cornsnake (Elaphe guttata guttata), 
Intestine and 
Cloaca 
Koudela and Modry, 1998; Morgan et al., 
1999b; Hajdusek et al., 2004; Xiao et al., 
2004b; Plutzer and Karanis, 2007; 
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Desert monitor (Varanus griseus), Gecko (Gekkoninae sp.), 
Green iguana (Iguana iguana), Lampropeltis sp; Louisiana 
pine snake (Pituophis ruthveni), Plated lizard 
(Gerrhosaurus sp.), Schneider’s Skink (Eumeces 
schneideri), Taipan (Oxyuranus scutellatus), Baron’s green 
racer (Philodryas baroni), Yellow anaconda (Eunectes 
notaeus), Cornsnake (Elaphe guttata guttata), Mato Grosso 
lancehead (Bothrops matogrossensis), Veiled chameleon 
(Chamaeleo calyptratus), Chinese wonder gecko 
(Teratoscincus roborowskii) 
Pedraza-Díaz et al., 2009; Richter et al., 
2011; da Silva et al., 2014; Abe and 
Matsubara, 2015 
Lizard genotype/C. serpentis-like Leopard gecko (Eublepharis macularius), Corn snake 
(Pantherophis guttatus), Chinese wonder gecko 
(Teratoscincus scincus) 
- Xiao et al., 2004b; Richter et al., 2011, 
Abe and Matsubara, 2015 
Snake genotype I New Guinea Viper boa (Candoia asper), Japanese grass 
snakes (Rhabdophis tigris) 
- Xiao et al., 2002b; Kuroki et al., 2008 
Snake genotype II Boa constrictor (Boa constrictor ortoni) - Xiao et al., 2004b 
Tortoise genotype III leopard tortoise (Stigmochelys pardalis) - Jezkova et al., 2016 
66 
1.4 The role of urbanisation in the transmission of zoonotic Cryptosporidium species 
from wildlife 
 
The risk of waterborne outbreaks of cryptosporidiosis depends on a complex interplay of 
factors, associated with both the environment and the biology and ecology of host and parasite. 
Cryptosporidium detection in an animal faecal sample does not necessarily mean active 
infection in the host, nor does this guarantee that the parasite prevalence and the host-
population dynamics are conducive to an outbreak. For these reasons, the epidemiological 
potential of detection of Cryptosporidium in wildlife cannot be easily and fully extrapolated. 
An increased epidemiological risk, however, can be identified when there is an overlap between 
humans and the distribution and dispersal of animal hosts. This is largely due to human 
encroachment into wildlife populated areas, which, by extension, also includes conversion of 
natural environments to drinking water catchments. Similarly, urban environments may also 
represent attractive new habitats for animals harbouring zoonotic Cryptosporidium spp. Thus, 
it is clear that wildlife-associated Cryptosporidium is an increasing concern for 
cryptosporidiosis in humans. 
During the last 100 years in many countries of the world, there have been dramatic 
changes in natural/rural landscapes due to urbanisation (Mackenstedt et al., 2015). Although 
urbanisation is one of the leading causes of species extinction (McKinney, 2006), for adaptable 
species, urban and periurban areas can be very attractive due to increased food and water 
resources (waste food, pet food, garden produce, water tanks etc.) (Mackenstedt et al., 2015). 
In these environments, wildlife species may reach far higher population densities than in more 
natural or rural landscapes (Bradley and Altizer, 2007), potentially increasing the faecal-oral 
transmission of oocysts between wildlife and humans and contamination of drinking water 
catchments. 
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Shifting boundaries between wildlife and humans have been responsible for the 
emergence of species like C. ubiquitum and chipmunk genotype I in human populations. For 
example, squirrels host C. ubiquitum, chipmunk genotype I, the skunk genotype and other 
Cryptosporidium genotypes associated with human disease (Feng et al., 2007; Ziegler et al., 
2007; Kváč et al., 2008; Stenger et al., 2015b), and because they frequently share habitats with 
humans they may be a significant reservoir of human infection. Squirrels can reach relatively 
high densities in suitable habitats, resulting in high rates of environmental loading of 
Cryptosporidium oocysts (Atwill et al., 2001). For example, California ground squirrels can 
reach densities as high as 92 adults hectare-1 (Owings et al., 1977; Boellstorff and Owings, 
1995), which when combined with shedding of up to 2 - 105 oocysts animal-1 day-1 results in 
rates of environmental loading equivalent to 1 - 107 oocysts hectare-1 day-1 (Atwill et al., 2004). 
Further analysis of squirrel populations however has suggested that most tree squirrels host 
zoonotic species and genotypes while ground squirrels host species and genotypes that are 
tribe-specific and unlikely to cause human disease, despite overlapping ranges (Stenger et al., 
2015b). This highlights the importance of extensive molecular epidemiological studies of 
wildlife to better understand the public health risks. 
While urban-environment-induced increases in wildlife population densities are 
conducive to elevated rates of Cryptosporidium transmission, the host specificity of some 
wildlife species and genotypes may limit the potential for spillover of wildlife genotypes to 
sympatric populations of humans. For example, in Australia, the common brushtail possum is 
one of the most abundant native marsupials in urban environments, having successfully adapted 
to utilise anthropogenic resources (Hill et al., 2008). A higher Cryptosporidium prevalence in 
urban compared to woodland possum populations (11.3 versus 5.6%) has been reported, but 
the majority of possums sampled shed low numbers of host adapted (possum genotype) oocysts 
(1 to 102) (Hill et al., 2008). However, the finding a C. fayeri clinical infection in a human, 
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which had previously been thought to be a host-adapted species (Waldron et al., 2010), 
highlights our lack of knowledge about the human infectious potential of many species and 
genotypes of Cryptosporidium infecting wildlife. 
 
1.5 Cryptosporidium in Australian humans 
 
In Australia, the National Notifiable Diseases Surveillance System (NNDSS) was 
established in 1990 under the auspices of the Communicable Diseases Network Australia and 
in 2001, cryptosporidiosis was listed as a national notifiable disease (Blumer et al., 2003). 
Analysis of national notification rates revealed increased total notification rates in 2002, 2005, 
2006, 2009, 2012, 2013, 2015, 2016 and 2017 with the highest number of cases reported in 
2016 (5420) (Table 1.6), suggesting that outbreaks may have occurred. The pattern of 
cryptosporidiosis in Western Australia (WA) is somewhat different with increased notification 
rates in 2003, 2007, 2011 and 2017 (Table 1.6). 
Cryptosporidiosis outbreaks in Australia have predominantly been attributed to 
contaminated recreational waters (see Ng-Hublin et al., 2018) and genotyping studies have 
demonstrated that  and  are the dominant species infecting humans but C. 
meleagridis, C. fayeri, C. andersoni, C. bovis, C. cuniculus, a novel Cryptosporidium species 
most closely related to C. wrairi and the Cryptosporidium mink genotype have been reported 
(Robertson et al., 2002; Chalmers et al., 2005; Jex et al., 2007; Ng et al., 2008; Alagappan et 
al., 2008; Jex et al., 2008; O’Brien et al., 2008; Waldron et al., 2009a, 2009b; Waldron et al., 
2010; Power et al., 2011; Waldron et al., 2011a, 2011b; Ng et al., 2012; Jex et al., 2012; Koehler 
et al., 2013; Ng-Hublin et al., 2013; Sari et al., 2013 unpublished - KF279538; Yang et al., 
2013; Koehler et al., 2014b).
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Table 1.6. Number of cryptosporidiosis notifications received from State and Territory health 
authorities from 2001-2018. ACT = Australian Capital Territory, NSW= New South Wales, 
NT= Northern Territory, Qld = Queensland, SA = South Australia, Tas = Tasmania, Vic = 
Victoria and WA = Western Australia. 
Year ACT NSW NT Qld SA Tas Vic WA Total 
2001 10 195 258 415 65 78 440 164 1625 
2002 36 306 217 2023 125 47 284 226 3264 
2003 8 203 96 162 80 26 208 437 1220 
2004 6 353 111 674 82 18 306 125 1675 
2005 27 848 83 1366 168 22 513 183 3210 
2006 79 778 71 699 202 28 1097 252 3206 
2007 9 545 111 431 449 37 622 608 2812 
2008 11 485 102 695 60 36 451 163 2003 
2009 106 1463 151 1458 106 67 1038 235 4624 
2010 12 349 97 301 48 100 434 141 1482 
2011 13 360 94 465 128 42 260 449 1811 
2012 19 684 235 1371 162 42 461 168 3142 
2013 39 1109 89 769 135 74 1265 372 3852 
2014 30 420 87 668 224 33 636 310 2408 
2015 26 1052 123 1314 419 19 855 255 4063 
2016 48 1203 280 2368 433 32 811 245 5420 
2017 83 1252 90 1287 351 44 1183 400 4690 
2018 19 441 75 771 137 14 497 69 2023 
 
1.6 Risk management 
 
A key part of a One Health approach to Cryptosporidium prophylaxis is a better 
understanding of environmental, epidemiological and aetiological factors associated with 
cryptosporidial infections to enable more targeted risk management. The far-reaching One 
Health strategy aims at integrating multidisciplinary knowledge and evidence, and at 
coordinating the interventions, to create a global synergism catering for all aspects of health 
care for humans, animals and the environment (the One Health Triad). 
It has been shown that an important host risk factor includes HIV status. 
Cryptosporidium is an important pathogen regardless of HIV prevalence (Kotloff et al., 2013); 
however, HIV-positive children are between 3 and 18 times more likely to have 
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Cryptosporidium than those who were HIV negative (Tumwine et al., 2005; Mbae et al., 2013; 
Tellevik et al., 2015). With the widespread availability of antiretroviral therapy, particularly in 
industrialized countries, the incidence of cryptosporidiosis has decreased among people living 
with AIDS (Kaplan et al., 2000). However, the increasing number of transplant recipients and 
those receiving immunosuppressive drugs may contribute significantly to the burden in the 
future (Bonatti et al., 2012; Desoubeaux et al., 2012). Malnutrition is also a risk factor for both 
diarrhoea and prolonged diarrhoea caused by Cryptosporidium, with significantly higher rates 
of infection in malnourished children after controlling for HIV status (Amadi et al., 2001; 
Haque et al., 2009; Moore et al., 2010; Mondal et al., 2012). An unknown number of 
individuals experience asymptomatic Cryptosporidium infection (Houpt et al., 2005). This 
clinically silent infection may remain undetected and untreated, and therefore may contribute 
not only to parasite transmission but also to malnutrition and the associated clinical sequelae. 
Breastfeeding may provide some protection, as a recent study of Bangladeshi infants reported 
that protection from Cryptosporidium infection was associated with high anti-Cryptosporidium 
IgA in breastmilk (Korpe et al., 2013). 
Under an environmental perspective, the prophylaxis of waterborne cryptosporidiosis 
must consider optimal management (or design) of source, recycled and recreational waters. 
Protection of source water and swimming pools is a key element of Cryptosporidium 
prevention as contamination of drinking water and swimming pools is a major mode of 
transmission (Baldursson and Karanis, 2011; Widerström et al., 2014; Jacob et al., 2015; Ryan 
et al., 2017) and is often achieved by restricting the access to catchments and water bodies, 
while swimming pools are designed and monitored according to construction standards and 
guidelines. Infection prevention and management, however, can only be achieved through a 
deep understanding of the routes of transmission, sources of contamination (human and 
animal), disease prevalence in the population and the risk factors in the final host. 
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The link between Cryptosporidium in drinking water and sporadic infections is well 
documented (Baldursson et al., 2011; Widerström et al., 2014; Jacob et al., 2015); however, 
the association between drinking water contamination and endemic cryptosporidiosis is not 
well established. For example, some studies report drinking unsafe water as a risk factor for 
endemic cryptosporidial infection (Leach et al., 2000; Goh et al., 2004) while others report no 
association (Khalakdina et al., 2003; Roy et al., 2004; Sarkar et al., 2013). Seasonal patterns 
are also thought to be associated with an increased transmission risk (Checkley et al., 1998; 
Muchiri et al., 2009), such as when recreational waters are more heavily utilised. 
Management of Cryptosporidium public health risks specifically for the drinking water 
industry requires the implementation of a holistic approach including research, monitoring 
Cryptosporidium oocysts in animals and source water, and catchment management (e.g., access 
protection, vegetation cover, etc.). High-precipitation events favour the transfer and survival 
of oocysts in surface waters and/or groundwater (Bridgman et al., 1995; Jagai et al., 2009). 
This may result in contamination of source water and increased risk of cryptosporidiosis 
depending on the source of contamination (Jagai et al., 2009). Indeed, the average odds of 
identifying Cryptosporidium oocysts in fresh surface waters is 2.61 (95% CI, 1.63-4.21; 
I2=16%) times higher during and after extreme weather events (Young et al., 2015). Shifts in 
precipitation patterns (intensity and location) is one of the climate change predictions for the 
future (Pachauri, 2008), and this will clearly impact both waterborne and foodborne 
transmissions of Cryptosporidium, and therefore, future human exposures may differ 
significantly from current patterns as the climate changes (Schijven et al., 2013). 
Hydrodynamic modelling has been shown to represent a valid and cost-effective support, for 
decision-making and understanding of events (Hoyer et al., 2015). Quantitative microbial risk 
assessment (QMRA) is another widely used tool to estimate health impacts from exposure to 
Cryptosporidium and other pathogens (Young et al., 2015) and has been applied to climate 
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which had previously been thought to be a host-adapted species (Waldron et al., 2010), 
highlights our lack of knowledge about the human infectious potential of many species and 
genotypes of Cryptosporidium infecting wildlife. 
 
1.5 Cryptosporidium in Australian humans 
 
In Australia, the National Notifiable Diseases Surveillance System (NNDSS) was 
established in 1990 under the auspices of the Communicable Diseases Network Australia and 
in 2001, cryptosporidiosis was listed as a national notifiable disease (Blumer et al., 2003). 
Analysis of national notification rates revealed increased total notification rates in 2002, 2005, 
2006, 2009, 2012, 2013, 2015, 2016 and 2017 with the highest number of cases reported in 
2016 (5420) (Table 1.6), suggesting that outbreaks may have occurred. The pattern of 
cryptosporidiosis in Western Australia (WA) is somewhat different with increased notification 
rates in 2003, 2007, 2011 and 2017 (Table 1.6). 
Cryptosporidiosis outbreaks in Australia have predominantly been attributed to 
contaminated recreational waters (see Ng-Hublin et al., 2018) and genotyping studies have 
demonstrated that  and C. parvum are the dominant species infecting humans but C. 
meleagridis, C. fayeri, C. andersoni, C. bovis, C. cuniculus, a novel Cryptosporidium species 
most closely related to C. wrairi and the Cryptosporidium mink genotype have been reported 
(Robertson et al., 2002; Chalmers et al., 2005; Jex et al., 2007; Ng et al., 2008; Alagappan et 
al., 2008; Jex et al., 2008; O’Brien et al., 2008; Waldron et al., 2009a, 2009b; Waldron et al., 
2010; Power et al., 2011; Waldron et al., 2011a, 2011b; Ng et al., 2012; Jex et al., 2012; Koehler 
et al., 2013; Ng-Hublin et al., 2013; Sari et al., 2013 unpublished - KF279538; Yang et al., 
2013; Koehler et al., 2014b).
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non-zoonotic species in water samples (Li et al., 2015d). Another study of a drinking water 
supply in Australia, found no C. hominis in any water sample tested, but Cryptosporidium 
genotypes associated with native and non-native wildlife made up 70% of all isolates typed 
(Swaffer et al., 2014). Similarly, Ruecker et al. (2012) reported that non-zoonotic wildlife 
species and genotypes of Cryptosporidium accounted for 64.3% of Cryptosporidium identified 
in environmental water samples in Canada and that only 7.2% of human infectious species 
were detected. A low prevalence of C. hominis and C. parvum was also reported by Nolan et 
al. (2013) in Melbourne catchments, who detected C. hominis and C. parvum in only 0.6% of 
samples, despite screening >2,000 animal faecal samples. However, the human-infectious 
potential of many wildlife-adapted Cryptosporidium is currently unknown and the UK 
outbreak caused by C. cuniculus should act as a caution against assuming these unusual species 
and genotypes are not significant (Chalmers et al., 2009; Robinson et al., 2011). 
Accurate, quantitative identification of Cryptosporidium in wildlife excreta is an 
essential starting point for estimating catchment loads (Davies et al., 2003). Quantitative PCR 
(qPCR) (real-time PCR) therefore represents an invaluable tool that enables rapid, high-
throughput and cost-effective detection and quantitation of Cryptosporidium oocysts and is 
increasingly being used to monitor oocyst shedding by animals in catchments (Yang et al., 
2014a). Due to the intrinsic constraints of qPCR, standards of known concentration are required 
to generate calibration curves used to estimate the concentration of pathogens in a sample 
(Hindson et al., 2013; Rački et al., 2014). Therefore, the quantification of the target molecules 
in the unknown sample is only as good as that of the standards used. Droplet digital PCR 
(ddPCR) (Hindson et al., 2013) is the third-generation implementation of conventional PCR 
that facilitates the quantitation of nucleic acid targets without the need for calibration curves 
(Vogelstein and Kinzler, 1999). A recent study compared ddPCR with qPCR for the 
quantitative detection of Cryptosporidium DNA in animal and human faecal samples (Yang et 
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al., 2014b) and revealed that ddPCR appeared to be less sensitive to inhibitors than qPCR and 
that inaccurate calibration of qPCR standards resulted in qPCR overestimating the numbers of 
oocysts present (Yang et al., 2014b). This has important implications for catchment risk 
management. However, qPCR is cheaper and provides better throughput and therefore using 
ddPCR to precisely quantify qPCR standards would be one way to combine the advantages of 
the two technologies and provide more accurate assessment of Cryptosporidium catchments 
loads from wildlife faecal samples. 
Besides quantitative considerations, measuring the infectivity is also important for 
adjusting the risk profile of oocysts from wildlife in source waters (Swaffer et al., 2014). For 
example, a recent study has shown that the infectivity fraction of oocysts within source water 
samples in South Australian catchments was low (~3.1%), which provided a much more 
accurate water quality risk assessment (Swaffer et al., 2014). This low infectivity fraction is 
consistent with source water infectivity reported by Di Giovanni et al. (1999) of 4.9% and 
Lalancette et al. (2010) of 0%. The ability to routinely measure oocyst infectivity has been 
hampered by a number of issues including the distribution and low numbers of oocysts, costs 
and reproducibility (Di Giovanni and LeChevallier, 2005; Swaffer et al., 2014). However, 
recent improvements in cell culture immunofluorescence assays have led to the development 
of a single format assay that provides information on method performance (recovery rate), 
oocyst number, oocyst infectivity and genotype of infectious oocysts, overcoming many of 
these obstacles (King et al., 2015). This assay should therefore enable a more comprehensive 
understanding of Cryptosporidium risk for different water sources, assisting in the selection of 
appropriate risk mitigation measures (King et al., 2015). It is, however important to remember 
that the detection of non-viable oocysts in the 10-20 L of the water column that is usually 
sampled, does not mean that other oocysts in the water body are also non-viable. 
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Factors that affect the viability of Cryptosporidium oocyst load in faecal samples from 
wildlife in the catchment and water (runoffs, water column and sediments), include solar 
inactivation, desiccation, temperature and residence time in catchments and these dynamics 
should be factored into risk assessments (Hijen et al., 2006; King and Monis, 2007; Monis et 
al., 2014). Transport, including hydrodynamically-driven accumulation, settlemement, 
dispersion, dilution etc. can also affect oocyst concentrations in the water, either positively or 
negatively. Peak flow periods (when the maximum area of catchment is contributing to stream 
flow), are a major driver behind the transport of oocysts to surface water. Therefore, monitoring 
the distribution of Cryptosporidium during elevated flow conditions caused by rainfall run-off 
is important given the demonstrated positive and significant correlation between 
Cryptosporidium concentration with flow and turbidity (Swaffer et al., 2014). Measuring the 
infectivity of different wildlife derived Cryptosporidium species under different climatic 
conditions is therefore crucial for accurate risk assessment of public health implications, 
particularly as more extreme precipitation events is predicted globally (IPCC, 2013 - 
www.ipcc.ch) (Ryan et al., 2014). 
There are still many research gaps in our understanding of the public health significance 
of wildlife in drinking water catchments, and taxonomic and molecular epidemiological studies 
on Cryptosporidium spp. in wildlife, especially those in watersheds are still scarce. Whole 
genome studies in Cryptosporidium species will assist with the development of gp60 and other 
typing tools to better access the zoonotic potential and transmission dynamics of 
Cryptosporidium in wildlife. Morphological and biological data, including pathogenicity and 
oocyst shedding rates, are not yet available for some common zoonotic Cryptosporidium 
species and genotypes in wildlife. There is also a need to confirm if molecular detection of 
zoonotic Cryptosporidium species in wildlife is commonly associated with actual infections or 
mechanical transmission (Ryan et al., 2014). Cryptosporidium cuniculus is the only species 
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besides C. hominis and C. parvum, known to be associated with a waterborne outbreak of 
human cryptosporidiosis, yet little is known about the prevalence and oocyst shedding rates of 
C. cuniculus in rabbits. 
The evolution of methods to enumerate and genotype oocysts, and determine oocyst 
infectivity provides much-needed tools to refine the human health risk from wildlife in 
catchments and future studies will provide water quality managers with much more accurate 
and informed data for modelling and quantitative microbial risk assessments (QMRA) of 
wildlife in various catchments.
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This chapter consists of a published paper in PLos One, entitled “Zoonotic Cryptosporidium 
species in animals inhabiting Sydney water catchments”. The text of this manuscript is the 
same as the published version of the paper found in the Appendices (see Appendix 3) except 
for modifications, such as in-thesis referencing. This chapter develops, optimises and validates 
a pilot methodology to conduct a comprehensive quantitative survey of species and genotypes 
of Cryptosporidium in animal faecal samples. More specifically it aims to: (1) use qPCR to 
screen a subset of faecal samples (n = 952) collected from animals inhabiting within the 
WaterNSW area of operation for the presence of Cryptosporidium spp.; (2) enumerate 
Cryptosporidium oocysts in faecal samples by qPCR with droplet digital PCR (ddPCR) 
calibrated standards; (3) identify species and subtypes of Cryptosporidium at multiple loci. 
 
2.2 Statement of contribution 
 
As lead author on this manuscript, AZ conducted the majority of the laboratory work (with the 
exception of the independent confirmation by the Australian Water Quality Centre (AWQC) 
staff members; PM, SA and BK, and enumeration of Cryptosporidium oocysts by microscopy 
by Australian Laboratory Services (Scoresby, Vic), validated and analysed the data, and wrote 
the first and final drafts of this manuscript. FJ provided assistance in PCR set ups and AP 
helped with data analysis. YR and CO were involved in data validation and manuscript draft 
preparation. IR assisted with statistical analysis. AB organised sample collection and helped 
with funding acquisition and methodology. UR supervised the project and was directly 
involved in project administration, conceptualisation, funding acquisition, methodology, data 
154 
validation, review and editing the manuscript. All authors critically reviewed and approved the 





Cryptosporidium is one of the most common zoonotic waterborne parasitic diseases worldwide 
and represents a major public health concern of water utilities in developed nations. As animals 
in catchments can shed human-infectious Cryptosporidium oocysts, determining the potential 
role of animals in dissemination of zoonotic Cryptosporidium to drinking water sources is 
crucial. In the present study, a total of 952 animal faecal samples from four dominant species 
(kangaroos, rabbits, cattle and sheep) inhabiting Sydney’s drinking water catchments were 
screened for the presence of Cryptosporidium using a quantitative PCR (qPCR) and positives 
sequenced at multiple loci. Cryptosporidium species were detected in 3.6% (21/576) of 
kangaroos, 7.0% (10/142) of cattle, 2.3% (3/128) of sheep and 13.2% (14/106) of rabbit 
samples screened. Sequence analysis of a region of the 18S rRNA locus identified C. 
macropodum and C. hominis in 4 and 17 isolates from kangaroos respectively, C. hominis and 
C. parvum in 6 and 4 isolates respectively each from cattle, C. ubiquitum in 3 isolates from 
sheep and C. cuniculus in 14 isolates from rabbits. All the Cryptosporidium species identified 
were zoonotic species with the exception of C. macropodum. Subtyping using the 5′ half of 
gp60 identified C. hominis IbA10G2 (n = 12) and IdA15G1 (n = 2) in kangaroo faecal samples; 
C. hominis IbA10G2 (n = 4) and C. parvum IIaA18G3R1 (n = 4) in cattle faecal samples, C. 
ubiquitum subtype XIIa (n = 1) in sheep and C. cuniculus VbA23 (n = 9) in rabbits. Additional 
analysis of a subset of samples using primers targeting conserved regions of the MIC1 gene 
and the 3′ end of gp60 suggests that the C. hominis detected in these animals represent 
substantial variants that failed to amplify as expected. The significance of this finding requires 
further investigation but might be reflective of the ability of this C. hominis variant to infect 
animals. The finding of zoonotic Cryptosporidium species in these animals may have important 
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Cryptosporidium is one of the most prevalent waterborne parasitic infections (Baldursson 
and Karanis, 2011) and represents a public health concern of water utilities in developed 
countries, including Australia. Currently, 37 Cryptosporidium species have been recognised 
based on biological and molecular characteristics including two recently described species; C. 
proliferans and C. avium (Ryan and Hijjawi, 2015; Li et al., 2015; Kváč et al., 2016; Holubová 
et al., 2016; Zahedi et al., 2017a; Čondlová et al., 2018; Kváč et al., 2018.). Of these, C. parvum 
and C. hominis have been responsible for all waterborne outbreaks typed to date, with the 
exception of a single outbreak in the UK caused by C. cuniculus (Xiao, 2010; Chalmers et al., 
2009; Puleston et al., 2014). 
In Australia, marsupials, rabbits, sheep and cattle are the dominant animals inhabiting 
drinking water catchments and can contribute large volumes of manure to water sources (Ryan 
and Power, 2012). Therefore, it is important to understand the potential contribution from these 
animals in terms of Cryptosporidium oocyst loads into surface water. A number of genotyping 
studies have been conducted on animals in Australian water catchments to date and have 
reported a range of species including C. parvum, C. hominis, C. cuniculus, C. ubiquitum, C. 
bovis, C. ryanae, C. canis, C. macropodum, C. fayeri, C. xiaoi, C. scrofarum, and C. andersoni 
(Power et al., 2004; Cinque et al., 2008; McCarthy et al., 2008; Nolan et al., 2010, 2013; Ng et 
al., 2011a, 2011b; Yang et al., 2011; Abeywardena et al., 2013a, 2013b; Koehler et al., 2014a; 
Yang et al., 2014a; Abeywardena et al., 2015). To date, in humans in Australia, C. hominis, C. 
parvum, C. meleagridis, C. fayeri, C. andersoni, C. bovis, C. cuniculus, a novel 
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Cryptosporidium species most closely related to C. wrairi and the Cryptosporidium mink 
genotype have been reported (Robertson et al., 2002; Chalmers et al., 2005; Jex et al., 2007; 
Ng et al., 2008; Alagappan et al., 2008; Jex et al., 2008; O’Brien et al., 2008; Waldron et al., 
2009a, 2009b; Waldron et al., 2010; Power et al., 2011; Waldron et al., 2011a, 2011b; Ng et 
al., 2012; Jex et al., 2012; Koehler et al., 2013; Ng-Hublin et al., 2013; Sari et al., 2013 
unpublished - KF279538; Yang et al., 2013; Koehler et al., 2014b). The aim of the present 
study was to use molecular tools to identify the Cryptosporidium sp. infecting the kangaroos, 
rabbits, cattle and sheep population inhabiting Sydney’s drinking water catchments and so 
better understand the potential health risks they pose. 
 
2.5 Materials and Methods 
 
2.5.1 Sample collection and processing 
 
Animal faecal samples were collected by WaterNSW staff from watersheds within the 
WaterNSW area of operations. Sampling was carried out either on land owned by WaterNSW 
or on private land owned by farmers who gave permission to WaterNSW staff to conduct this 
study on their property. To minimize cross-contamination and avoid resampling the same 
animals, animals were observed defaecating and then samples were collected randomly from 
freshly deposited faeces from the ground, using a scrapper to expose and scoop from the center 
of the scat pile. Samples were collected on a monthly interval over an 18 months period (July, 
2013 to February, 2015) into individual 75 ml faecal collection pots, and stored at 4°C until 
required (no animal was sacrificed). As faecal samples were collected from the ground and not 
per rectum, animal ethics approval was not required. Instead, an animal cadaver/tissue 
notification covering all the samples collected was supplied to the Murdoch University Animal 
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Ethics Committee. The animal sources of the faecal samples were confirmed by watching the 
host defaecate prior to collection and also with the aid of a scat and tracking manual published 
for Australian animals (Triggs, 2004). Faecal samples were collected from two previously 
identified hotspot zones from eastern grey kangaroos (Macropus giganteus) (n = 576), cattle 
(n = 142), sheep (n = 128) and rabbits (n = 106). This study did not involve collecting samples 
from endangered or protected animal species. Samples were shipped to Murdoch University 
and stored at 4°C until required. 
 
2.5.2 Enumeration of Cryptosporidium oocysts in faecal samples 
 
Enumeration of Cryptosporidium oocysts by microscopy was conducted in duplicate for 
a subset of samples (n = 8) by Australian Laboratory Services (Scoresby, Victoria). To quantify 
recovery efficiency, each individual faecal composite or homogenate was seeded with 
ColorSeed (Biotechnology Frontiers Ltd. [BTF], Sydney, Australia). Cryptosporidium oocysts 
were purified from faecal samples using immunomagnetic separation (IMS) employing the 
Dynal GC Combo kit (Dynal, Oslo, Norway) as described by Cox et al. (2005). Oocysts were 
stained with Easystain and 4',6'-diamidino-2-phenylindole (DAPI; 0.8 μg.ml-1) (Biotechnology 
Frontiers Ltd. [BTF], Sydney, Australia) and examined with an Axioskop epifluorescence 
microscope (Zeiss, Germany) using filter set 09 (blue light excitation) for Easystain (BTF), 
filter set 02 (UV light excitation) for DAPI staining, and filter set 15 (green light excitation) 
for ColorSeed (BTF). The identification criteria described in U.S. EPA method 1623 (US EPA, 
2012) were used for Easystain-labeled and DAPI-stained objects. 
 
2.5.3 DNA isolation 
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Genomic DNA was extracted from 250mg of each faecal sample using a Power Soil 
DNA Kit (MO BIO, Carlsbad, California). A negative control (no faecal sample) was used in 
each extraction group. 
 
2.5.4 PCR amplification of the 18S rRNA gene 
 
All samples were screened for the presence of Cryptosporidium at the 18S rRNA locus 
using a quantitative PCR (qPCR) previously described (King et al., 2005; Yang et al., 2014b). 
qPCR standards were Cryptosporidium oocysts (purified and haemocytometer counted), 
diluted to a concentration of 10,000 oocysts/μl. DNA was extracted from this stock using a 
Powersoil DNA extraction kit (MO BIO, Carlsbad, California, USA). The 10,000 oocyst/μl 
DNA stock was then serially diluted to create oocyst DNA concentrations equivalent to 1,000, 
100, 10, 1 oocysts/μl DNA respectively to be used for standard curve generation using Rotor-
Gene 6.0.14 software. Absolute numbers of Cryptosporidium oocysts in these standards were 
determined using droplet digital PCR (ddPCR) at the 18S locus using the same primer set and 
these ddPCR calibrated standards were used for qPCR as previously described (Yang et al., 
2014b). Each 10 μl PCR mixture contained 1x KAPA Taq buffer (KAPA Biosystems), 3.75 
mM MgCl2, 400 μM of each dNTP, 0.5 μM 18SiF primer, 0.5 μM 18SiR primer, 0.2 μM probe 
and 1U/reaction Kapa DNA polymerase (KAPA Biosystems). The PCR cycling conditions 
consisted of one pre-melt cycle at 95°C for 6 min and then 50 cycles of 94°C for 20 sec and 
60°C for 90 sec. 
Samples that were positive by qPCR were amplified at the 18S locus using primers which 
produced a 611 bp product (Table 2.1) as previously described (Silva et al., 2013) with minor 
modifications; the annealing temperature used in the present study was 57°C for 30 sec and the 
number of cycles was increased from 39 to 47 cycles for both primary and secondary reactions. 
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PCR contamination controls were used including negative controls and separation of 
preparation and amplification areas. A spike analysis (addition of 0.5 μl of positive control 
DNA into each sample) at the 18S locus by qPCR, was conducted on randomly selected 
negative samples from each group of DNA extractions to determine if negative results were 
due to PCR inhibition, by comparing the Ct of the spike and the positive control (both with 
same amount of DNA). 
 
Table 2.1. List of primers used in this study to amplify 18S, lectin (Clec), gp60, lib13, MIC1 
gene loci. 
Gene Forward Primer Reverse Primer Reference 






















gp60 5′ ATAGTCTCGCTGTATTC 3′ 5′ GCAGAGGAACCA 
GCATC 3′ 
Peng et al., 2003; Zhou et 
al., 2003 
















gp60 5′ ATAGTCTCCGCTGTATTC   
3′ 
5′ GGA AGG AAC GAT 
GTA TCT 3′ 
Alves et al., 2003; Webber 
et al., 2014 
5′ GGAAGGGTTGTATTTATT 
AGATAAAG 3′ 
5′ GCA GAG GAA CCA 
GCATC 3′ 
 





















2.5.5 PCR amplification of the lectin (Clec) gene 
 
Samples that were typed as C. parvum, C. hominis and C. cuniculus at the 18S locus were 
also typed using sequence analysis at a unique Cryptosporidium specific gene (Clec) that codes 
for a novel mucin-like glycoprotein that contains a C-type lectin domain (Morgan et al., 1997; 
Bhalchandra et al., 2013). Hemi-nested primers were designed for this study using MacVector 
12.6 (http://www.macvector.com). The external primers Lectin F1 5′ 
TCAACTAACGAAGGAGGGGA 3′ and Lectin R1 5′ GTGGTGTAGAATCGTGGCCT 3′ 
produced a fragment size of 668 bp for C. hominis and 656 bp for C. parvum. The secondary 
reaction consisted of primers, Lectin F2 5′ CCAACATACCATCCTTTGG 3′ and Lectin R1 5′ 
GTGGTGTAGAATCGTGGCCT 3′ (Table 2.1), which produced a fragment of 518 bp for C. 
hominis, 506 bp for C. parvum and 498 bp for C. cuniculus. The cycling conditions for the 
primary amplification was 94°C for 3 min, followed by 94°C for 30 sec, 58°C for 30 sec, 72°C 
for 1 min for 40 cycles, plus 5 min at 72°C for the final extension. The same cycling conditions 
were used for the secondary PCR, with the exception that the number of cycles was increased 
to 47 cycles. The 25 μl PCR mixture consisted of 1 μl of DNA, 1x Go Taq PCR buffer (KAPA 
Biosystems), 200 μM of each dNTP (Promega, Australia), 2mM MgCl2, 0.4 μM of each primer, 
0.5 units of Kapa DNA polymerase (KAPA Biosystems). The specificity of this locus for 
Cryptosporidium has been previously confirmed (Yang et al., 2013). Enumeration of 
Cryptosporidium oocysts by qPCR was conducted using a specific C. hominis and C. parvum 
assay targeting the Clec gene as previously described (Yang et al., 2013). 
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2.5.6 PCR amplification of the gp60 gene 
 
Samples that were typed as C. hominis, C. parvum, C. cuniculus and C. ubiquitum at the 
18S locus were subtyped at the 60 kDa glycoprotein (gp60) locus using nested PCR as 
previously described (Table 2.1) (Strong et al., 2000; Peng et al., 2003; Zhou et al., 2003; Li et 
al., 2014). 
 
2.5.7 Sequence analysis and phylogenetic analysis 
 
The amplified DNA from secondary PCR products were separated by gel electrophoresis 
and purified for sequencing using an in-house filter tip method (Yang et al., 2013). Purified 
PCR products from all three loci, were sequenced independently using an ABI Prism™ Dye 
Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, California) according to 
the manufacturer’s instructions at 57°C, 58°C and 54°C annealing temperatures for the 18S 
rRNA, lectin and gp60 loci, respectively. Sanger sequencing chromatogram files were 
imported into Geneious Pro 8.1.6 (Kearse et al., 2012), edited, analysed and aligned with 
reference sequences from GenBank using ClustalW (http://www.clustalw.genome.jp). 
Distance (Neighbor Joining, NJ), Parsimony and Maximum Likelihood (ML) trees were 
constructed using MEGA version 7 (Tamura et al., 2011). 
 
2.5.8 Independent confirmation by the Australian Water Quality Centre (AWQC) 
 
A total of eight blinded faecal samples consisting of seven C. hominis positives and one 
Cryptosporidium negative were sent to the Australian Water Quality Centre (AWQC) for 
independent analysis. DNA was extracted using a QIAamp DNA Mini extraction kit (Qiagen, 
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Australia). Samples were screened using primers targeting the 18S rRNA locus (Xiao et al., 
2000 as modified by Webber at al., 2014), the gp60 locus using producing an approx. 871 bp 
secondary product (Alves et al., 2003 as modified by Webber at al., 2014) and an approx. 400 
bp primary product (Zhou et al., 2003) as well as the lib13 (Hadfield et al., 2011) and MIC1 
gene loci (Webber at al., 2014) as previously described (Table 2.1). PCRs were conducted on 
a RotorGene 6000 HRM (Qiagen) or LightCycler 96 (Roche) and amplification of the correct 
product was determined by DNA melting curve analysis (Webber et al., 2014). Amplicons with 
atypical DNA melting profiles were further characterised by capillary electrophoresis using a 
DNA 1000 chip on a Bioanalyzer 2100 (Agilent) as per the manufacturer’s instructions. The 
amplicons from all positive PCRs were purified using a Qiagen PCR purification kit according 
to the manufacturer’s instructions and submitted to the Australian Genome Research Facility 
for DNA sequencing using BigDye3 chemistry on an Applied Biosystems AB3730xl capillary 
DNA sequencer. Sequences were analyzed using Geneious Pro 6.1.8 (Biomatters). 
 
2.5.9 PCR amplification of open reading frames flanking gp60 and MIC1 
 
Open reading frames flanking both ends of gp60 and MIC1 in the C. parvum genome 
were used in BLAST searches (http://blast.ncbi.nlm.nih.gov/) to obtain homologous C. hominis 
sequences. Alignments of the C. parvum and C. hominis open reading frame pairs were 
constructed using Geneious Pro 6.1.8 (Biomatters). Conserved primers were designed for each 
alignment using the default settings and a target amplicon size of approximately 400 bp. The 
resulting primers (Table 2.2) were subjected to BLAST searches to verify specificity.
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Table 2.2. List of primers designed to amplify regions flanking the 5′ and 3′ ends of MIC1 and 
gp60 gene loci. 
Gene Flanking open 
reading frame 
Forward Primer Reverse Primer Product size (C. 
parvum and C. 
hominis) 















































Each 25 μl qPCR reaction contained 0.5x GoTaq PCR Buffer (Promega), 1.5 mM MgCl2, 
0.2 mM dNTP, 3.3 μM SYTO 9, 100 ng GP32, 0.5 μM forward primer, 0.5 μM reverse primer, 
1 unit Promega GoTaq HS, and 2 μl of DNA extract. The qPCR was performed on a Light 
Cycler96 (Roche), and cycling conditions consisted of one pre-melt cycle at 95°C for 6 min 
and then 40 cycles of 94°C for 45 sec, 60°C for 45 sec and 72°C for 60 sec. High-resolution 
DNA melting curve analysis was conducted from 65°C to 97°C using an acquisition rate of 25 
reads /°C. Blastocystis hominis DNA was used as a negative control and nuclease free water 
was used as a no template control. Positive controls included C. parvum Iowa 2a (BTF, Sydney, 
Australia) and C. hominis IbA10G2 (kindly provided by Ika Sari). Amplicons were sized by 
capillary electrophoresis using a DNA 1000 chip on a Bioanalyzer 2100 (Agilent) as per the 
manufacturer’s instructions. 
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2.5.10 Statistical Analysis 
 
The prevalence of Cryptosporidium in faecal samples collected from each host species 
was expressed as the percentage of samples positive by qPCR, with 95% confidence intervals 
calculated assuming a binomial distribution, using the software Quantitative Parasitology 3.0 
(Rózsa et al., 2000). Linear coefficients of determination (R2) and Spearman’s rank correlation 
coefficient (Spearman’s rho) were used for the analysis of agreement (correlation) between 
oocyst numbers per gram of faeces determined by qPCR calibrated with ddPCR standards and 
enumeration of Cryptosporidium oocysts by microscopy (IMS) using SPSS 21.0 for Windows 




2.6.1 Prevalence of Cryptosporidium in faecal samples collected from various hosts 
 
The overall PCR prevalence of Cryptosporidium species in 952 faecal samples collected 
from four different host species was 5% (48/952) (Table 2.3). Cryptosporidium species were 
detected in 3.6% (21/576) of the kangaroo faecal samples, 7.0% (10/142) of cattle faeces, 2.3% 
(3/128) of sheep faeces and 13.2% (14/106) of rabbit faecal samples based on qPCR and 
sequence analysis of the 18S rRNA locus (Table 2.3).
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Table 2.3. Prevalence of Cryptosporidium species in faecal samples collected from four 
different host species in Sydney water catchments*. 95% confidence intervals are given in 
parenthesis. 






Species and subtype 
Eastern grey 
kangaroo 
576 21 3.6 (95% CI, 2.3-5.5) C. hominis (n = 17)** 
IbA10G2 (n = 12) 
IdA15G1 (n = 2) 
C. macropodum (n =4 ) 
Cattle 142 10 7 (95% CI, 3.4-12.6) C. hominis ( n= 6)**  
IbA10G2 (n = 4) 
C. parvum (n = 4)  
IIaA18G3R1 (n = 4) 
Sheep 128 3 2.3 (95% CI, 0.5-6.7) C. ubiquitum (n = 3)** 
XIIa (n = 1) 
Rabbit 106 14 13.2 (95% CI, 7.4-21.2) C. cuniculus (n = 14)** 
VbA 23 (n = 9) 
Total 952 48 5 (95% CI, 3.7-6.6)  
* Based on PCR amplification and sequencing at the 18S rRNA gene, with subtyping based on 
DNA sequence analysis of a 400 bp amplicon from the 5′ end of gp60.  
** Not all positive samples were successfully typed. 
 
2.6.2 Cryptosporidium species detected in various hosts 
 
Sequencing of secondary PCR amplicons at the 18S rRNA locus identified four of the 21 
positive isolates from kangaroo faecal samples as C. macropodum, while the other 17 isolates 
were identified as C. hominis (100% similarity for 550bp) (Table 2.4). Of the ten positives 
detected in cattle faecal samples, six were C. hominis and four were C. parvum (Table 2.4). 
The three sheep positive samples were identified as C. ubiquitum and all fourteen positives 
detected in rabbit faecal samples were C. cuniculus (Table 2.4). 
Sequence analysis at the lectin (Clec) locus was consistent with 18S gene results. Eleven 
of 17 C. hominis isolates from kangaroos were successfully amplified and confirmed as C. 
hominis sequences. Eight of the 14 positives from rabbits successfully amplified at this locus 
and were identified as C. cuniculus. Four of six C. hominis and all four C. parvum isolates from 
cattle were also confirmed at this locus. 
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Table 2.4. Species and subtypes of Cryptosporidium identified at 18S and gp60 loci in this 
study. 
Host species Southing Easting qPCR 
(18S) 
18S locus gp60 locus 
Eastern grey kangaroo 1 -34.18861 150.2918 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 2 -34.203794 150.284394 detected C. macropodum - 
Eastern grey kangaroo 3 -34.20207 150.2742 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 4 -34.193631 150.273387 detected C. macropodum - 
Eastern grey kangaroo 5 -34.188607 150.291818 detected C. macropodum - 
Eastern grey kangaroo 6 -34.20458 150.2881 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 7 -34.61547 150.59756 detected C. hominis no amplification 
Eastern grey kangaroo 8 -34.23796 150.2598 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 9 N/A N/A detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 10 N/A N/A detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 11 N/A N/A detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 12 N/A N/A detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 13 -34.61686 150.68794 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 14 -34.63269 150.619 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 15 -34.63269 150.61897 detected C. hominis no amplification 
Eastern grey kangaroo 16 -34.61422 150.59331 detected C. hominis C. hominis IbA15G1 
Eastern grey kangaroo 17 -34.61415 150.59376 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 18 -34.61686 150.68794 detected C. hominis no amplification 
Eastern grey kangaroo 19 -31.60846 150.60819 detected C. macropodum - 
Eastern grey kangaroo 20 -34.61472 150.68475 detected C. hominis C. hominis IbA10G2 
Eastern grey kangaroo 21 -34.61472 150.68475 detected C. hominis C. hominis IbA15G1 
Cattle 1 -34.61278 150.585 detected C. hominis no amplification 
Cattle 2 -34.60429 150.60170 detected C. hominis C. hominis IbA10G2 
Cattle 3 -34.61283 150.58514 detected C. hominis no amplification 
Cattle 4 -34.60429 150.60170 detected C. parvum C. parvum IIaA18G3R1 
Cattle 5 -34.60642 150.60126 detected C. parvum C. parvum IIaA18G3R1 
Cattle 6 -34.61373 150.5876 detected C. parvum C. parvum IIaA18G3R1 
Cattle 7 -34.61373 150.5876 detected C. hominis C. hominis IbA10G2 
Cattle 8 -34.6195 150.5242 detected C. hominis C. hominis IbA10G2 
Cattle 9 -34.60429 150.60170 detected C. hominis C. hominis IbA10G2 
Cattle 10 -34.63269 150.619 detected C. parvum C. parvum IIaA18G3R1 
Sheep 1 -34.61556 150.68353 detected C. ubiquitum no amplification 
Sheep 2 -34.61556 150.68353 detected C. ubiquitum no amplification 
Sheep 3 -34.61743 150.68674 detected C. ubiquitum C. ubiquitum XIIa 
Rabbit 1 -34.61954 150.62169 detected C. cuniculus no amplification 
Rabbit 2 -34.61959 150.62172 detected C. cuniculus C. cuniculus VbA23 
Rabbit 3 -34.61937 150.62178 detected C. cuniculus C. cuniculus VbA23 
Rabbit 4 -34.61479 150.68492 detected C. cuniculus C. cuniculus VbA23 
Rabbit 5 -34.61954 150.62169 detected C. cuniculus no amplification 
Rabbit 6 -34.6195 150.52415 detected C. cuniculus no amplification 
Rabbit 7 -34.61937 150.62178 detected C. cuniculus C. cuniculus VbA23 
Rabbit 8 -34.61283 150.58514 detected C. cuniculus C. cuniculus VbA23 
Rabbit 9 -34.61556 150.68353 detected C. cuniculus C. cuniculus VbA23 
Rabbit 10 -34.61278 150.585 detected C. cuniculus no amplification 
Rabbit 11 -34.61479 150.68492 detected C. cuniculus C. cuniculus VbA23 
Rabbit 12 -34.60429 150.60170 detected C. cuniculus C. cuniculus VbA23 
Rabbit 13 -34.18951 150.2885 detected C. cuniculus no amplification 
Rabbit 14 -34.6327 150.619 detected C. cuniculus C. cuniculus VbA23 
 
Sequences at the gp60 locus were obtained for 14 kangaroo and four cattle isolates that 
were typed as C. hominis at the 18S rRNA locus. These samples failed to amplify at the gp60 
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locus using the primers of Strong et al. (2000) or Alves et al. (2003), which amplify an approx. 
832 bp fragment, but were successfully amplified using the nested primers by Zhou et al. 
(2003), which amplify a 400 bp product. In approx. 50% of samples, the primary reaction did 
not produce a visible band by gel electrophoresis but a band of the correct size was visible for 
the secondary PCR, which was then confirmed by sequencing. 
The C. hominis subtypes IbA10G2 and IdA15G1 were identified in 12 and 2 kangaroo 
samples respectively and the IbA10G2 subtype was also identified in four cattle samples (Table 
2.4 and Fig 2.1A). The four C. parvum isolates from cattle were identified as subtype 
IIaA18G3R1 and the C. cuniculus isolates were subtyped as VbA23 (n = 9) (Table 2.4 and Fig 
2.1B and 2.1D). Of the three C. ubiquitum positive isolates at 18S locus, only one isolate was 
successfully subtyped and identified as C. ubiquitum subtype XIIa (Table 2.4 and Fig 2.1C). 
Nucleotide sequences reported in this paper are available in the GenBank database under 
accession numbers; KX375346, KX375347, KX375348, KX375349, KX375350, KX375351, 
KX375352, KX375353, KX375354 and KX375355. 
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Fig 2.1. Phylogenetic relationships of Cryptosporidium subtypes inferred from Neighbor 
Joining (NJ) analysis of Kimura's distances calculated from pair-wise comparisons of gp60 
sequences. (A) Relationships among C. hominis subtypes. (B) Relationships among C. parvum 
subtypes. (C) Relationships between C. ubiquitum subtypes. (D) Relationships between C. 
cuniculus subtypes. Percentage support (>50%) from 1000 pseudoreplicates from NJ analyses 
is indicated at the left of the supported node. 
 
2.6.3 Independent confirmation by the Australian Water Quality Centre (AWQC) 
 
Blind independent analysis conducted by AWQC using the 18S rRNA nested PCR of 
Xiao et al. (2000) identified C. hominis in six samples, corresponding with the six positive 
samples from kangaroos, and failed to detect Cryptosporidium in the other two samples, one 
of which corresponded with the negative sample. Amplification of a region of gp60 using the 
protocol described by Alves et al. (2003) failed to produce an amplicon for either the primary 
or secondary reactions. Amplification of gp60 using the protocol described by Zhou et al. 
(2003), failed to amplify the correct-sized product for the primary PCR but produced amplicons 
C. hominis IbA10G2 - E.G.Kangaroo 17
C. hominis IbA10G2 - E.G.Kangaroo 20
C. hominis IbA10G2 - E.G.Kangaroo 14
C. hominis IbA10G2 - E.G.Kangaroo 13
C. hominis IbA10G2 - E.G.Kangaroo 12
C. hominis IbA10G2 - E.G.Kangaroo 11
C. hominis IbA10G2 - E.G.Kangaroo 10
C. hominis IbA10G2 - E.G.Kangaroo 9
C. hominis IbA10G2 - Cattle 9
C. hominis IbA10G2 - E.G.Kangaroo 8
C. hominis IbA10G2 - Cattle 8
C. hominis IbA10G2 - AY262031
C. hominis IbA10G2 - E.G.Kangaroo 1
C. hominis IbA10G2 - Cattle 2
C. hominis IbA10G2 - E.G.Kangaroo 3
C. hominis IbA10G2 - Cattle 7
C. hominis IbA10G2 - E.G.Kangaroo 6
C. hominis IfA19G1R5 - AF440638
C. hominis IeA11G3T3 - AY738184
C. hominis IiA17 - HM234173
C. hominis IjA14 - JF681174
C. hominis IhA14G1 - FJ971716
C. hominis IaA23R4 - AF164502
C. hominis IgA24 - EF208067
C. hominis IdA15G1 - GU214351
C. hominis IdA15G1 - E.G.Kangaroo 21










C. ubiquitum XIIa - JX412915
C. ubiquitum XIIa - Sheep 3
C. ubiquitum XIIa - JX412921
C. ubiquitum XIId - JX412922
C. ubiquitum XIIb - JX412926
C. ubiquitum XIIc - JX412925
C. ubiquitum XIIe - KC204983







C. parvum IIaA18G3R1 - Cattle 5
C. parvum IIaA18G3R1 - Cattle 6
C. parvum IIaA18G3R1 - Cattle 4
C. parvum IIaA18G3R1 - FJ861295
C. parvum IIaA18G3R1 - Cattle 10
C. parvum IIgA9 - AY873780
C. parvum IIlA18 - AM937006
C. parvum IIkA14 - AB237137
C. parvum IIbA14 - AF402285
C. parvum IIoA16G1 - JN867335
C. parvum IIdA18G1 - AY738194
C. parvum IInA8 - FJ897787
C. parvum IIfA6 - AY738188
C. parvum IIiA10 - AY873782
C. parvum IIeA12G1 - AY382675
C. parvum IIcA5G3a - AF164491














C. cuniculus VbA23 - Rabbit 11
C. cuniculus VbA23 - Rabbit 12
C. cuniculus VbA23 - Rabbit 9
C. cuniculus VbA23 - Rabbit 8
C. cuniculus VbA23 - Rabbit 7
C. cuniculus VbA23 - Rabbit 4
C. cuniculus VbA23 - Rabbit 3
C. cuniculus VbA23 - Rabbit 2
C. cuniculus VbA23 - Rabbit 14
C. cuniculus VbA26 - KU531705
C. cuniculus VbA29 - FJ262734





of the correct size for the secondary PCR for the six positive samples, which when sequenced 
were confirmed as C. hominis subtype IbA10G2. Amplification at the lib13 locus was also 
successful for the six positive samples, which were confirmed as C. hominis. Amplification at 
the MIC1 locus failed to produce any amplicons. The gp60 and MIC1 amplification failures 
were further investigated using PCR assays designed to target open reading frames (ORFs) 
flanking these two loci. All four primer sets produced strong amplification of the correctly 
sized fragments for the C. parvum and C. hominis control DNA. The cgd6-1070 ORF (located 
downstream of gp60 in C. parvum), and cgd6-810 ORF (upstream of MIC1), both amplified 
from four of the six samples previously identified as C. hominis. In the case of the other 2 
ORFs, weak amplification was observed for one sample for cgd6-1090 (upstream of gp60) and 
for two samples for cgd6-770 (downstream of MIC1). While only single bands were observed 
for the C. parvum and C. hominis controls, most of the faecal sample extracts produced multiple 
bands. 
 
2.6.4 Enumeration of Cryptosporidium oocysts in faecal samples 
 
Oocyst numbers per gram of faeces for all PCR positive samples were determined using 
qPCR at the Clec locus for 18 C. hominis and 4 C. parvum positives and for a subset of samples 
(n = 8) using microscopy (Table 2.5). For the 8 samples for which both microscopy and qPCR 
data were available, there was poor correlation between the two methods (R2 ≈ 0.0095 and ρ 
(rho) = 0.2026) (Table 2.5). Based on qPCR, the highest numbers of oocysts was detected in 
eastern grey kangaroo isolate 12 (16,890 oocysts/g-1), which was identified as C. hominis 




Table 2.5. Cryptosporidium oocyst numbers in positive samples per gram of faeces (g-1) 
determined using microscopy and qPCR. Note: microscopy data was only available for 12 
samples. 









Eastern grey kangaroo 1 C. hominis 210 54 11,337 
Eastern grey kangaroo 3 C. hominis 11,076 78 5,458 
Eastern grey kangaroo 6 C. hominis <2 61 9,528 
Eastern grey kangaroo 8 C. hominis <2 45 262 
Eastern grey kangaroo 9 C. hominis <2 74 648 
Eastern grey kangaroo 10 C. hominis <2 51 8,735 
Eastern grey kangaroo 11 C. hominis <2 67 131 
Eastern grey kangaroo 12 C. hominis <2 60 16,890 
Eastern grey kangaroo 13 C. hominis - - 26 
Eastern grey kangaroo 14 C. hominis - - 5,458 
Eastern grey kangaroo 16 C. hominis - - 7,570 
Eastern grey kangaroo 17 C. hominis - - 9,626 
Eastern grey kangaroo 20 C. hominis - - 8,735 
Eastern grey kangaroo 21 C. hominis - - 173 
Cattle 2 C. hominis - - 144 
Cattle 4 C. parvum - - 936 
Cattle 5 C. parvum - - 1,819 
Cattle 6 C. parvum - - 2,197 
Cattle 7 C. hominis - - 4,205 
Cattle 8 C. hominis - - 10,827 
Cattle 9 C. hominis - - 15,804 




The present study described the prevalence and molecular characterisation of 
Cryptosporidium species in faecal samples collected from kangaroo, cattle, sheep and rabbit 
faecal samples from Sydney’s drinking water catchments. The overall prevalence of 
Cryptosporidium species in the faecal samples collected from four animal hosts was 5% and 
was 3.6% in kangaroos, 7% in cattle, 2.3% in sheep and 13.2% in rabbits. Overall, the 
prevalence of infection with Cryptosporidium was generally lower than that reported 
previously in Sydney catchments; 25.8% (Cox et al., 2005), 6.7% (Power et al., 2005) and 8.5% 
(Ng et al., 2011b) and Western Australian catchments; 6.7% (McCarthy et al., 2008). In the 
study by Ng et al. (2011b), the prevalence in eastern grey kangaroos was much higher (16.9%- 
27/160) than the 3.6% prevalence in kangaroo faecal samples in the present study. The overall 
prevalence of Cryptosporidium species in faecal samples collected from different species in 
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the present study was similar to the 2.8% (56/2,009) prevalence identified in faecal samples 
from animals in Melbourne water catchments (Nolan et al., 2013). The lower prevalence in the 
present study and the Melbourne study may be a consequence of testing a greater numbers of 
samples, seasonal and/or yearly variation in prevalence and/or proximity to agricultural land. 
Based on sequence analysis using the 18S rRNA locus, a total of five Cryptosporidium 
species were identified; C. macropodum (n = 4), C. hominis (n = 23), C. parvum (n = 4), C. 
ubiquitum (n = 3) and C. cuniculus (n = 14). The prospect of livestock and wildlife being 
reservoirs for C. hominis has human-health implications, so to verify this finding, a subset of 
faecal samples was subjected to blinded independent analysis. This additional testing initially 
identified C. hominis following sequence analysis of a large fragment of the 18S rRNA gene 
amplified using the Xiao et al. (2000) nested PCR. It is noteworthy that the Xiao outer 18S 
PCR produced a clear amplification signal (threshold cycles between 24 and 29 for positive 
samples), suggesting the presence of reasonable numbers of oocysts with no evidence of PCR 
inhibition for this relatively large amplicon (approx. 1.2 kilobases). The lib13 Taqman assay 
also identified C. hominis in these same samples. However, amplification of gp60 using the 
Alves et al. (2003) nested PCR failed to amplify any Cryptosporidium, either as a nested PCR 
or by direct amplification using the inner primer set. Application of the Zhou et al. (2003) outer 
gp60 primers (which are equivalent to the pairing of the Alves outer forward and inner reverse 
primers) also appeared to be unsuccessful (only four samples produced a band close to the 
expected size), but the Zhou gp60 inner PCR amplified the correctly sized amplicon, which 
was confirmed to be C. hominis IbA10G2. 
The failure to amplify gp60 using the Alves et al. (2003) and Strong et al. (2000) assays 
was unexpected, especially considering the high degree of conservation for the primer binding 
sites across the C. parvum and C. hominis gp60 subtypes and the successful amplification of 
the large 18S rRNA gene fragment, which demonstrates that the DNA quantity and quality was 
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sufficient for amplification within the first round of PCR. The lack of amplification at other 
loci is unlikely to be due to PCR inhibition, as spike analysis indicated no inhibition. To 
investigate this further, a published PCR assay targeting the MIC1 locus from both C. parvum 
and C. hominis (Webber et al., 2014) was also tested and failed to amplify the expected 
fragment from these samples. The MIC1 gene encodes a thrombospondin-like domain-
containing protein, which is secreted in sporozoites prior to host cell attachment and localized 
to the apical complex after microneme discharge (Putignani et al., 2008). As secreted proteins 
often play a critical role in determining virulence and host specificity in host-pathogen 
relationships, it has been hypothesised that MIC1 may play a role in the differences in host 
range observed between C. parvum and C. hominis (Webber et al., 2014). Previous analysis of 
the CryptoDB has identified that both the gp60 and MIC1 loci are on chromosome 6 and in 
close proximity (≈60 kb) (Webber et al., 2014), and it has previously been reported that these 
two genes are genetically linked (Cacciò et al., 2001). Given that three different gp60 reverse 
primers appear to have failed, as well as failure of at least one of the MIC1 primers, it would 
require the occurrence of multiple individual single nucleotide polymorphisms for the results 
to be accounted for by point mutations. Alternatively, a truncation or rearrangement on 
chromosome 6 affecting the 3' end of gp60 and MIC1 could affect these PCR assays. To test 
for any deletions affecting these loci, PCR assays were developed targeting flanking ORFs. 
The PCR assays targeting two ORFs in the region between MIC1 and gp60 (based on the C. 
parvum chromosome 6 map) were positive for some of the samples tested, suggesting that a 
wholesale deletion is not the cause for the failure to amplify MIC1 or the entire gp60. The other 
two PCR assays produced equivocal results in the samples, although they yielded strong 
amplification in the positive controls. The variable sample results may have been due to a 
combination of the low amount of Cryptosporidium DNA present and non-specific 
amplification from other DNA in the sample extracts. The latter is likely, considering that the 
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positive controls produced a single amplicon, whereas most of the sample extracts yielded 
multiple fragments of different sizes. 
Sequencing of chromosome six or the entire genome of this variant C. hominis is required 
to determine the underlying cause for the failure to amplify MIC1 or the larger gp60 region. 
Considering the role of gp60 in host cell adhesion and the hypothesised role of MIC1 in 
infection, it is possible that changes or loss of key genes involved in host specificity could 
explain the success of this particular variant of C. hominis in infecting hosts other than humans. 
If the function of these genes has been altered to better support infection in non-human hosts, 
then the infectivity of this variant in humans needs to be re-evaluated. 
Of the detected species, all but C. macropodum have been reported to cause infection in 
humans at varying frequencies (Xiao, 2010; Ryan and Power, 2012). Cryptosporidium hominis 
and C. parvum are responsible for the majority of human infections worldwide (Xiao, 2010; 
Zahedi et al., 2016). In the present study, the prevalence of the variant C. hominis in kangaroo 
and cattle faecal samples was 2.9% (95% CI, 1.7%-4.7%) and 4.2% (95% CI, 1.6%-9%) 
respectively, and the prevalence of C. parvum in cattle faecal samples was 2.8% (95% CI, 
0.8%-7.1%). Both of these parasites have been linked to numerous waterborne outbreaks 
around the world (Xiao, 2010; Baldursson and Karanis, 2011) and although this prevalence is 
relatively low, both these host species represent a risk of waterborne transmission to humans. 
A number of previous studies have identified C. hominis/C. parvum-like isolates at the 18S 
rRNA locus in marsupials including bandicoots (Isoodon obesulus), brushtail possums 
(Trichosurus vulpecula), eastern grey kangaroos (Macropus giganteus) and brush-tailed rock-
wallabies (Petrogale penicillata) (Hill et al., 2008; Dowle et al., 2013; Vermeulen et al., 2015). 
However, in those studies, despite efforts, the identification of C. hominis/C. parvum could not 
be confirmed at other loci. This may be due to low numbers of oocysts and the multi-copy 
nature of the 18S rRNA gene, which provides better sensitivity at this locus. Alternatively, 
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failure to confirm identity in these other studies could be due the presence of variants with 
substantial differences in the diagnostic loci used, causing those PCR assays to fail. Such is the 
case in the present study, which for the first time has identified a novel C. hominis in kangaroo 
faecal samples based on analysis of multiple loci (18S rRNA, Clec, MIC1, lib13 and gp60). 
Cryptosporidium cuniculus, the most prevalent species detected here (13.2%), has been 
previously identified in rabbits, humans and a kangaroo in Australia (Nolan et al., 2010, 2013; 
Sari et al., 2013 unpublished - KF279538; Koehler et al., 2014a). It was implicated in a 
waterborne outbreak of cryptosporidiosis in humans in England in 2008 (Chalmers et al., 2009; 
Puleston et al., 2014) and has been linked to a number of sporadic human cases across the UK 
(Chalmers et al., 2011; Elwin et al., 2012), Nigeria (Molloy et al., 2010) and France (ANOFEL, 
2010). Cryptosporidium ubiquitum was detected in three sheep samples and is a common 
human pathogen (Xiao, 2010), but has not been identified in Australia in the limited typing of 
Australian human Cryptosporidium isolates that has been conducted to date (Ryan and Power, 
2012), however it has been identified in surface waters in Australia (Monis et al., unpublished). 
Subtyping at the gp60 locus identified the C. hominis subtype IbA10G2 in twelve 
kangaroo and four cattle faecal samples. This is a dominant subtype responsible for C. hominis 
associated outbreaks of cryptosporidiosis in the United States, Europe and Australia (Xiao, 
2010; Ng et al., 2010, 2015; Segura et al., 2015). Cryptosporidium hominis has previously been 
reported in cattle in New Zealand (Abeywardena et al., 2012), Scotland (Smith et al., 2005), 
India (Feng et al., 2007) and Korea (Park et al., 2006). Subtyping at the gp60 locus identified 
IbA10G2 (Smith et al., 2005; Abeywardena et al., 2012), and IdA15G1 (Feng et al., 2007). It 
has been suggested that the IbA10G2 infects cattle naturally in particular circumstances and 
thus could act as a zoonotic infection source in some instances (Smith et al., 2005). 
Interestingly, the studies that detected IbA10G2 in cattle, used PCR-based assays that only 
sequenced the 5' end of gp60, similar to the assay used in this study, so it is possible that these 
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reports also represent detection of a variant C. hominis gp60. This is the first report of the same 
subtype of C. hominis in kangaroos and cattle in the same catchment. In two kangaroo samples, 
the C. hominis IdA15G1 subtype was identified. This is also a common C. hominis subtype 
identified in humans worldwide (O'Brien et al., 2008; Sharma et al., 2013; Feng et al., 2014; 
Guo et al., 2015; Segura et al., 2015). The source and human health significance of the novel 
C. hominis detected in kangaroo and cattle samples in the present study is currently unknown. 
Environmental pollution from human and domestic animal faeces such as contamination of 
watersheds due to anthropogenic and agricultural activities conducted in the catchment area, in 
particular livestock farming, could be a potential source for wildlife infections with C. hominis. 
However, further studies are required to better understand the involvement of humans and 
livestock in the epidemiology of zoonotic Cryptosporidium species in wildlife. 
The C. parvum subtype IIaA18G3R1 was identified in four cattle samples. IIaA18G3R1 
is also a common subtype in both humans and cattle worldwide and has been reported widely 
in both calves and humans in Australia (Ryan and Power, 2012). Subtyping of the single C. 
ubiquitum isolate from sheep identified XIIa. To date six subtype families (XIIa to XIIf) have 
been identified in C. ubiquitum (Li et al., 2014). Of these, XIIa, XIIb, XIIc, and XIId have been 
found in humans and therefore XIIa is a potentially zoonotic subtype (Li et al., 2014). The C. 
cuniculus subtype identified in the present study was VbA23. Two distinct gp60 subtype 
families, designated Va and Vb have been identified in C. cuniculus (Chalmers et al., 2009). 
Most cases described in humans relate to clade Va and the first waterborne outbreak was typed 
as VaA22 (Robinson et al., 2008; Chalmers et al., 2009). Previous studies in Australia have 
identified subtype VbA26 from an eastern grey kangaroo (Koehler et al., 2014b), subtypes 
VbA23R3 and VbA26R4 (Nolan et al., 2010, 2013), VbA22R4, VbA24R3 and VbA25R4 
(Nolan et al., 2013) in rabbits and subtype VbA25 (Koehler et al., 2014b) and VbA27 (Sari et 
al., 2013 unpublished-KF279538) in a human patient. 
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Accurate quantification of Cryptosporidium oocysts in animal faecal deposits on land is 
important for estimating catchment Cryptosporidium loads. In the present study, oocyst 
concentration (numbers per gram of faeces-g-1) was also determined for 18 C. hominis and four 
C. parvum positives using qPCR and for a subset of samples (n = 8) by microscopy. qPCR 
quantitation was conducted at the Clec locus rather than the 18S rRNA locus as the former is 
unique to Cryptosporidium and therefore more specific than the available 18S rRNA qPCR 
assays. There was poor correlation between qPCR and microscopy for the eight samples for 
which data from both methods were available, with qPCR detecting higher numbers of oocysts 
than microscopy with the exception of one sample (eastern grey kangaroo 3). Increased 
sensitivity of qPCR and the estimation of much higher numbers of oocysts in faecal samples 
by qPCR versus microscopy has been previously reported (Operario et al., 2015). A major 
limitation of qPCR is that the quantitative data generated are only as accurate as the standards 
used. A study which compared droplet digital PCR (ddPCR) (which provides absolute 
quantitation without the need for calibration curves) with qPCR, reported that qPCR 
overestimated the oocysts counts compared to ddPCR (Yang et al., 2014b). In the present study, 
the discrepancy between qPCR and microscopy could be due to a number of different factors; 
(1) IMS for microscopy and direct DNA extraction from faeces were conducted on different 
subsamples of each faecal sample and therefore the numbers of oocysts present in the 
subsamples may differ, (2) microscopy counts intact oocysts whereas qPCR will detect not 
only oocysts but also sporozoites that have been released from oocysts, other lifecycle stages 
and any free DNA, therefore qPCR may produce higher counts than microscopy. In the present 
study, the mean oocysts g-1 for kangaroos and cattle that were positive for C. hominis was 6,041 
(range 26-16,890) and for cattle that were positive for C. parvum was 1,535 (range 936-2,197) 
as determined by qPCR. By microscopy, oocysts counts were available for kangaroo samples 
only and the mean was 5,643 (range <0.5-11,076). A previous study in WaterNSW catchments, 
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reported mean Cryptosporidium oocysts g-1 of 40 (range 1-5,988) for adult cattle, 25 for 
juvenile cattle (range <1-17,467), 23 for adult sheep (range <1-152,474), 49 for juvenile sheep 
(range <1-641) and 54 for adult kangaroos (range <1-39,423) (Davies et al., 2003). The age of 
the kangaroos and cattle sampled in the present study are unknown, but qPCR quantitation 
suggests that these were actual infections and not mechanical transmission. However, future 
studies should include oocyst purification via IMS prior to qPCR for more accurate 
quantitation. In addition, homogenisation of samples is important when comparing microscopy 
and qPCR i.e faecal slurries should be made, mixed well and aliquots of that mixture used for 
both microscopy and qPCR to ensure better consistency between techniques. 
It is important to note that of the numbers of oocysts detected in animal faeces in 
catchments, only a fraction of oocysts may be infectious. For example, a recent study has shown 
that the infectivity fraction of oocysts within source water samples in South Australian 
catchments was low (~3.1%) (Swaffer et al., 2014). While it would be expected that oocysts in 
faecal samples would have much higher infectivity than oocysts in source water, reports 
suggest that only 50% of oocysts in fresh faeces are infectious, and that temperature and 
desiccation can rapidly inactivate oocysts in faeces while solar inactivation, predation and 
temperature will all impact oocyst survival in water (King and Monis, 2007). 
The identification of mostly zoonotic Cryptosporidium species in animals inhabiting 
Sydney catchments indicates that there is a need to diligently monitor Cryptosporidium in 
source waters. Such monitoring is also critical, given the resistance of Cryptosporidium oocysts 
to chlorine (Yoder and Beach, 2010). Further studies are essential to confirm the nature of the 
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2.10 Chapter summary 
 
For the purpose of this thesis, it is hypothesised that animals inhabiting drinking water 
catchments can potentially contribute a large volume of manure, and therefore 
Cryptosporidium oocysts to drinking water sources. This indicates the need for continued 
monitoring of animals in catchment areas to identify sources and carriers of zoonotic 
Cryptosporidium species in animal populations. Currently, in the case of Cryptosporidium, 
standard monitoring data are based on fluorescence microscopy, which does not include species 
and subtype identification. This results in inaccurate risk assessments that either under or 
overestimate the public health risk. This chapter successfully explored and characterised 
Cryptosporidium species in 952 faecal samples collected from both livestock and wildlife in 
Sydney’s largest watersheds. All three of the aims outlined within this chapter’s preface 
(Section 2.1) were satisfied; the prevalence of Cryptosporidium in faecal samples collected 
from various hosts was determined by qPCR at the 18S locus, samples positive for 
Cryptosporidium were characterised at three loci including 18S, gp60 and clec, and the results 
were independently confirmed by the Australian Water Quality Centre (AWQC). Oocyst 
numbers per gram of faeces for all PCR positive samples were also determined using qPCR 
and for a subset of samples (n = 8) using microscopy. Of the five Cryptosporidium species 
identified in this study, four species are of public health significance; C. hominis (detected in 
both cattle and kangaroos) was the most prevalent species detected in total of 952 faecal 
samples, followed by C. cuniculus (from rabbits), C. parvum (from cattle), C. macropodum 
(from kangaroos), C. ubiquitum (from sheep). One of the major outcomes of this chapter was 
successful subtyping of C. hominis IbA10G2 in twelve kangaroo and four cattle, and C. hominis 
IdA15G1 in two kangaroo faecal samples at the gp60 locus. Subtype IbA10G2 is a dominant 
subtype responsible for C. hominis associated outbreaks of cryptosporidiosis worldwide and 
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has also been previously reported in a range of animals, including cattle. However, this is the 
first report of this subtype of C. hominis in kangaroos. Other Cryptosporidium gp60 subtypes 
identified in this chapter are also of public health significance (C. hominis IdA15G1, C. parvum 
IIaA18G3R1, C. cuniculus VbA23, and C. ubiquitum XIIa). The presence of zoonotic 
Cryptosporidium species in both livestock and wildlife inhabiting drinking water catchments 
may have implications for management of drinking water sources. Therefore, continued 
identification of the sources/carriers of human pathogenic strains would be useful to more 
accurately assess risk. Although the approach taken in this chapter provides a wealth of 
information on the species of Cryptosporidium present in faecal samples, it was unable to 
further investigate intra-isolate diversity of low-abundance intra-isolate variants of 
Cryptosporidium at the gp60 locus which is crucial to better understand the epidemiology and 
transmission dynamics of cryptosporidiosis. In order to address this knowledge gap, in Chapter 
three compared Sanger and Next Generation Sequencing of gp60 amplicons from a subset of 
samples from this chapter and additional samples from China were compared to examine the 
extent of within-host genetic diversity of Cryptosporidium gp60 subtypes from different 
geographic areas.
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The finding of zoonotic Cryptosporidium species in both livestock and wildlife inhabiting 
Sydney’s drinking water catchments indicates a need to investigate the nature of the C. hominis, 
C. parvum and C. cuniculus variants identified in these animals to better estimate the potential 
risk for humans. Therefore, in this chapter the molecular findings described in Chapter Two 
are expanded upon by further investigating the composition of Cryptosporidium gp60 subtypes 
in samples positive for zoonotic Cryptosporidium species. It consists of a published paper in 
the International Journal for Parasitology, entitled “Next Generation Sequencing uncovers 
within-host differences in the genetic diversity of Cryptosporidium gp60 subtypes”. The text 
of this manuscript is the same as the published version of the paper found in the Appendices 
(see Appendix 4) except for modifications, such as in-thesis referencing. This chapter 
particularly aims to use high throughput NGS to better identify levels of intra-isolate diversity 
of zoonotic Cryptosporidium species compared to conventional Sanger sequencing, in three 
different Cryptosporidium species (C. hominis, C. parvum and C. cuniculus) sourced from two 
distinct geographic regions (Australia and China). 
 
3.2 Statement of contribution 
 
As first author, AZ developed the concept and, conducted all the labwork and data analysis, 
and prepared the original and final draft of the manuscript. FJ provided assistance in labwork 
and AG helped with sample preparation for Next Generation Sequencing and data analysis. AP 
and CO contributed to manuscript preparation. AB provided logistic support for sample 
collection in Australia and revised the manuscript. IR assisted with statistical analysis, and 
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The extent of within-host genetic diversity of parasites has implications for our understanding 
of the epidemiology, disease severity and evolution of parasite virulence. As with many other 
species, our understanding of the within-host diversity of the enteric parasite Cryptosporidium 
is changing. The present study compared Sanger and Next Generation Sequencing (NGS) of 
glycoprotein 60 (gp60) amplicons from Cryptosporidium hominis (n = 11), Cryptosporidium 
parvum (n = 22) and Cryptosporidium cuniculus (n = 8) DNA samples from Australia and 
China. Sanger sequencing identified only one gp60 subtype in each DNA sample: one C. 
hominis subtype (IbA10G2) (n = 11), four C. parvum subtypes belonging to IIa (n = 3) and IId 
(n = 19) and one C. cuniculus subtype (VbA23) (n = 8). NGS identified the same subtypes 
initially identified by Sanger sequencing, but also identified additional gp60 subtypes in C. 
parvum and C. cuniculus but not in C. hominis, DNA samples. The number of C. parvum and 
C. cuniculus subtypes identified by NGS within individual DNA samples ranged from two to 
four, and both C. parvum IIa and IId subtype families were identified within the one host in 
two samples. The finding of the present study has important implications for Cryptosporidium 




Humans and animals often become co-infected with different species and genotypes of 
the same parasite genus, resulting in within-host parasite interactions (Holmes and Price, 1986; 
Read and Taylor, 2001; Choisy and de Roode, 2010; Seppälä and Jokela, 2016). Importantly, 
the presence of co-infecting parasite species genotypes within a host can potentially modify 
parasite fitness by allowing them to adapt to different selection pressures and can drive the 
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evolution of parasite virulence and alter host susceptibility to other parasites, infection 
duration, disease severity, transmission risks, clinical symptoms and consequently treatment 
and prevention strategies (Vaumourin et al., 2015; Grinberg and Widmer, 2016; Seppälä and 
Jokela, 2016). Therefore, within-host parasite interactions have important repercussions for 
human or animal health. For instance, parasite co-infections within a single host can result in 
gene exchange via recombination. This can drive parasite evolution by making the parasites 
more resistant to drugs. Interactions among co-infecting parasite species, genotypes and 
subtypes of the same parasite genus can also modify co-evolutionary dynamics between the 
host and parasites. In addition, parasite interactions can help with maintaining genetic variation 
in parasite traits such as infectivity and virulence which are crucial components of pathogen 
fitness and are important to better understand disease dynamics and the changing epidemiology 
of parasitic diseases (Seppälä et al., 2012; Vaumourin et al., 2015; Seppälä and Jokela, 2016). 
Cryptosporidium spp. are ubiquitous enteric parasites that infect a broad range of hosts 
including humans and animals (Xiao, 2010). They are a major contributor to moderate-to-
severe diarrhoeal disease in developing countries and are second only to rotavirus as a cause 
of moderate-to-severe diarrhoea in children younger than 2 years (Kotloff et al., 2013). Of the 
37 species currently recognised, Cryptosporidium parvum and Cryptosporidium hominis 
account for the majority of human infections and typed outbreaks (Xiao, 2010; Ryan et al., 
2017; Zahedi et al., 2017a; Čondlová et al., 2018; Kváč et al., 2018), with the exception of 
Cryptosporidium cuniculus which was responsible for a waterborne outbreak in the UK 
(Puleston et al., 2014). The parasite is transmitted via the faecal-oral route through human to 
human, animal to human and animal to animal contact, and via contaminated water; therefore, 
hosts are exposed to multiple sources of potentially genetically diverse oocysts (Xiao, 2010; 
Grinberg and Widmer, 2016). Once ingested, sporozoites excyst from the oocyst, invade the 
host cells and undergo subsequent rounds of asexual and sexual reproduction. 
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Currently, the only available drug for human infections (nitazoxanide - Romark 
Laboratories, Florida, USA), has variable efficacy (Abubakar et al., 2007; Amadi et al., 2009) 
and an effective vaccine has yet to be developed (Mead, 2014; Ryan et al., 2016). Halofuginone 
lactate (Halocur; Intervet, New Zealand) is commercially available against cryptosporidiosis 
in dairy calves, with variable efficacy (Trotz-Williams et al., 2011; Almawly et al., 2013). 
Therefore, Cryptosporidium control currently relies mainly on improved sanitation and 
understanding its transmission dynamics. 
Analysis of the extent of within-host genetic diversity in Cryptosporidium has been 
hampered due to the difficulties in culturing this parasite, with clonal lineages derived from 
individual sporozoites unavailable (Grinberg and Widmer, 2016). Of the multilocus sequencing 
typing strategies employed to examine within-host genetic diversity, sequence analysis of the 
glycoprotein 60 (gp60) gene is the most common (Xiao, 2010), as it is the most polymorphic 
locus in the genome (Abrahamsen et al., 2004). Despite the importance of within-host genetic 
diversity for our understanding of cryptosporidiosis epidemiology, relatively little is known 
(Cama et al., 2006; Jeníková et al., 2011; Waldron and Power, 2011; Ramo et al., 2014, 2016; 
Shrestha et al., 2014). Most studies have relied on conventional PCR and Sanger-based 
genotyping methods, and automated fragment analysis, however a major limitation of these 
approaches is their inability to resolve complex DNA mixtures and detect low-abundance intra-
isolate variants (Paparini et al., 2015; Grinberg and Widmer, 2016). 
Next Generation Sequencing (NGS) of amplicons offers the advantage of massive 
parallelization of sequencing reactions to more effectively identify low-abundance genotypes 
in mixed infections. To date, only one study has examined the extent of intra-isolate diversity 
of Cryptosporidium at the gp60 locus using NGS (Grinberg et al., 2013). In that study, NGS 
analysis of two C. parvum samples from one geographic location (New Zealand) revealed 
much higher levels of intra-isolate diversity compared with Sanger sequencing. In the present 
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study, we examined intra-host genetic diversity of a much larger number of Cryptosporidium 
samples (n = 41) from three different species (C. hominis, C. parvum and C. cuniculus) and 
from two distinct geographic regions (Australia and China), using both NGS and conventional 
Sanger sequencing at the gp60 locus to better understand the epidemiology of this important 
parasite. Animal faecal samples in Australia were collected from watersheds within the 
WaterNSW (New South Wales) area of operations and included two dairy farms and faecal 
samples collected from the surrounding bushland. Faecal samples from China were collected 
from a cattle breeding centre and two dairy farms, all located in Henan province. 
 
3.5 Materials and methods 
 
3.5.1 Sample collection and processing 
 
A total of 41 DNA samples positive for Cryptosporidium, belonging to three 
Cryptosporidium spp. (as determined by Sanger sequencing - see Section 3.5.3), were analysed 
in the present study; C. parvum (n = 22) from cattle (Bos taurus), C. hominis (n = 11) from 
eastern grey kangaroos (Macropus giganteus), and C. cuniculus (n = 8) from rabbits 
(Oryctolagus cuniculus). 
 
3.5.2 DNA isolation 
 
Upon collection, faecal samples were stored at 4°C until analysed. Following five cycles 
of freeze–thaw, genomic DNA was extracted from 250 mg of each faecal sample using a Power 
Soil DNA Kit (MO BIO, Carlsbad, California, USA). Extraction blanks (no faecal sample) 
were used in each extraction group. Purified DNA was stored at -20°C prior to PCR. DNA 
201 
extraction and post-DNA extraction procedures were performed in separate dedicated 
laboratories. 
 
3.5.3 Sanger sequencing 
 
All samples were initially identified to species level at the 18S locus using nested PCR 
amplification and Sanger sequencing of a fragment of the 18S locus as previously described 
(Silva et al., 2013). Samples were then subtyped at the gp60 locus using a nested PCR to 
amplify an approximately 400 bp product using the primers AL3531 (5′ 
ATAGTCTCCGCTGTATTC 3′) and AL3533 (5′ GAGATATATCTTGGTGCG 3′) for the 
primary PCR, and AL3532 (5′ TCCGCTGTATTCTCAGCC 3′) and LX0029 (5′ 
CGAACCACATTACAAATGAAGT 3′) for the secondary PCR (Sulaiman et al., 2005). Each 
25 μl PCR mixture contained 1 μl of genomic DNA, 1x KAPA Taq  buffer (KAPA Biosystems, 
South Africa), 3.75 mM MgCl2, 400 μM of each dNTP, 0.4 μM of forward and reverse primers 
and 1 U of Kapa Taq DNA polymerase (KAPA Biosystems, South Africa). The PCR cycling 
conditions were modified and consisted of an initial denaturation at 94°C for 3 min and then 
40 cycles of 94°C for 45 sec, 54°C for 45 sec and 72°C for 1 min, followed by a final extension 
step at 72°C for 7 min. PCR contamination controls were used including negative controls. 
PCR setup and DNA handling procedures were performed in separate and dedicated exclusion 
hoods; PCR and post-PCR procedures were performed in separate dedicated laboratories. 
Gel electrophoresis was used to separate the amplified DNA fragments from the 
secondary PCR products at the gp60 locus, which were subsequently purified for sequencing 
using an in-house filter tip method as previously described (Yang et al., 2013). Purified PCR 
products were sequenced independently in both directions using an ABI PrismTM Dye 
Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, California, USA) 
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according to the manufacturer’s instructions and with a 54°C annealing temperature. Sanger 
sequencing chromatogram files were imported into Geneious Pro 8.1.6 (Kearse et al., 2012), 
and the nucleotide sequences of each gene were analysed and aligned with reference sequences 
from GenBank using Clustal W (www.clustalw.genome.jp). 
 
3.5.4 Next Generation Sequencing (NGS) 
 
Partial Cryptosporidium gp60 gene sequences were amplified for NGS on the MiSeq 
(Illumina) platform using the same assay described for Sanger sequencing (Sulaiman et al., 
2005), with the exception that secondary PCR primers were modified to contain MiSeq adapter 
sequences on the 5′ end, as per standard protocols for the MiSeq platform (Illumina 
Demonstrated Protocol: Metagenomic Sequencing Library Preparation). PCRs were performed 
in 25 μl volumes containing PCR buffer (KAPA Biosystems), 2 mM MgCl2, 0.01 mg of BSA 
(Fisher Biotech, Australia), 1 mM dNTPs (Fisher Biotech), 0.4 μM of each primer and 0.5 U 
of KAPA Taq DNA Polymerase (KAPA Biosystems, South Africa). Primary PCRs used 2 μl 
of DNA as a template and secondary reactions contained 1-2 μl of the primary product as a 
template. All PCRs contained no-template controls and extraction reagent blank controls. All 
PCRs were performed with an initial denaturation at 95°C for 5 min, followed by 35 cycles of 
95°C for 30 sec, 50°C for 30 sec and 72°C for1 min, and a final extension period at 72°C for 5 
min. 
From the resulting Cryptosporidium gp60 amplicons, sequencing libraries for the MiSeq 
sequencing platform were produced according to Illumina recommended protocols (Illumina 
Demonstrated Protocol: Metagenomic Sequencing Library Preparation), with the following 
amendments. Briefly, purified, uniquely indexed libraries from individual DNA samples were 
pooled for sequencing in equimolar quantities based on the fluorescent intensity of amplicon 
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libraries after electrophoresis through a 2% agarose gel stained with GelRed (Fisher Biotech) 
and visualised under UV light. Sequencing was performed on an Illumina MiSeq using 500-
cycle V2 chemistry (250 paired-end reads) following the manufacturer’s recommendations. 
 
3.5.5 Bioinformatics analysis 
 
Sequences were processed to retain only reads with perfect AL3532 and LX0029 primer 
sequences (no mismatches allowed). Primer sequences and distal bases were removed in 
Geneious Pro 8.1.6 (Kearse et al., 2012) and remaining reads were quality filtered using 
USEARCH v9.1.13 (Edgar, 2010), retaining only sequences with a <1% expected error rate 
(96.4% of sequences retained). Singletons, doubletons, and sequences with replicate copies 
less than 0.01% of the total number of unique sequences per sample (14.8% of quality filtered 
sequences) were discarded due to their high probability of being generated by sequencing 
and/or PCR error. Chimeric sequences (<0.08%) were identified and removed using 
USEARCH v9.1.13 (Edgar, 2010). 
All remaining high-quality sequences were compared, using BLAST (Altschul et al., 
1990), with an in-house reference database containing 131 Cryptosporidium gp60 sequences 
from all characterised C. parvum, C. hominis and C. cuniculus subtypes available in GenBank 
(Supplementary Table 3-S1 - Digital appendix 1). For C. hominis and C. parvum, gp60 
subtypes were only assigned if NGS reads matched identically (100% pairwise identify and 
query coverage) to only one gp60 subtype reference sequence. For C. cuniculus, all available 
reference GenBank sequences were 1-3 bp shorter at the 5′ end compared with the NGS reads 
obtained in the present study. To accommodate this incongruity between query and reference 
sequences, C. cuniculus subtypes were assigned only if NGS reads matched to only one C. 
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3.6.1 Sanger sequencing 
 
Sanger sequencing identified one subtype per amplicon with only one C. hominis subtype 
(IbA10G2) identified in all 11 C. hominis DNA samples from eastern grey kangaroos. Four C. 
parvum subtypes were identified in ruminant-derived DNA samples from Australia and China: 
IIaA16G2R1 (n = 3), IIdA15G1 (n = 2), IIdA18G3R1 (n = 2), IIdA19G1 (n = 15); and only 
one C. cuniculus subtype (VbA23) was identified in all eight DNA samples positive for C. 
cuniculus from rabbits (Table 3.1). Both IIa and IId C. parvum subtype families were identified 
in Australian samples positive for C. parvum, but only the IId C. parvum subtype family was 




From the 41 DNA samples, a total of 566,719 high quality NGS reads were obtained after 
initial quality filtering procedures. For the 11 C. hominis DNA samples, there was 100% 
agreement between Sanger and NGS sequencing with C. hominis IbA10G2, the only subtype 
identified in assigned reads (Table 3.1). For the 22 C. parvum samples, however, although the 
subtype identified by Sanger was also the main subtype identified by NGS, multiple additional 
subtypes, ranging from 0.4% to 31% of the total assigned reads, were identified. A total of 11 
C. parvum subtypes were identified by NGS; IIaA14G2R1 (n = 3), IIaA15G2R1 (n = 3), 
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IIaA16G2R1 (n = 3), IIaA16G3R1 (n = 2), IIdA14G1 (n = 2), IIdA15G1 (n = 2), IIdA17G1 (n 
= 7), IIdA18G1 (n = 15), IIdA18G3R1 (n = 2), IIdA19G1 (n = 15), IIdA20G1 (n = 12). The 
number of C. parvum subtypes identified by NGS within individual samples ranged from two 
to four, with both IIa and IId subtype families identified within the one host in two samples 
(i.e. AUSC9 and AUSC20) (Table 3.1). 
For C. cuniculus, as with C. parvum, the subtype identified by Sanger was also identified 
by NGS, with multiple additional subtypes ranging from 0.4% to 6.7% of the total assigned 
reads identified. A total of three C. cuniculus subtypes were identified by NGS: VbA22 (n = 
8); VbA23 (n = 8); VbA25 (n = 8); with all three subtypes identified within individual DNA 
samples. 
The extremely high level of stringency used in identifying the C. parvum, C. hominis, 
and C. cuniculus subtypes resulted in a high number of unassigned reads that failed to match 
known reference sequences with 100% pairwise identity and 100% query cover (or 99% for C. 
cuniculus) (Table 3.1). 
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Table 3.1. Comparison of glycoprotein 60 (gp60) subtypes identified in Cryptosporidium spp. from Australia and China using Sanger and Next 
Generation Sequencing (NGS). Genotypes in bold are the main subtypes identified by NGS, based on fraction of assigned reads. EGK, Eastern 





Sanger gp60 subtype Number of NGS 
sequences 
Number and (%) of NGS 
sequences assigned 
NGS gp60 subtypes 
EGK 1 EGK Australia C. hominis IbA10G2 15,609 7,896 (50.6) C. hominis IbA10G2 
EGK 2 EGK Australia C. hominis IbA10G2 13,335 6,651(49.9) C. hominis IbA10G2 
EGK 3 EGK Australia C. hominis IbA10G2 7,845 4,019 (54.2) C. hominis IbA10G2 
EGK 4 EGK Australia C. hominis IbA10G2 1,963 845 43.0 C. hominis IbA10G2 
EGK 5 EGK Australia C. hominis IbA10G2 1,840 858 (46.6) C. hominis IbA10G2 
EGK 6 EGK Australia C. hominis IbA10G2 1,869 781 (41.8) C. hominis IbA10G2 
EGK 8 EGK Australia C. hominis IbA10G2 2,024 900 (44.5) C. hominis IbA10G2 
EGK 9 EGK Australia C. hominis IbA10G2 2,473 1,156 (46.7) C. hominis IbA10G2 
EGK 10 EGK Australia C. hominis IbA10G2 12,760 6,291 (51.0) C. hominis IbA10G2 
EGK 11 EGK Australia C. hominis IbA10G2 12,824 6,536 (51.5) C. hominis IbA10G2 
EGK 12 EGK Australia C. hominis IbA10G2 12,927 6,663 (48.4) C. hominis IbA10G2 
AUSC 9 Cattle Australia C. parvum IIdA18G3R1 10,524 4,871 (46.2) C. parvum IIdA18G3R1 
 228 (2.1) C. parvum IIaA16G3R1 
AUSC 20 Cattle Australia C. parvum IIdA18G3R1 17,161 8,223 (47.9) C. parvum IIdA18G3R1 
 399 (2.3) C. parvum IIaA16G3R1 
AUSC 21 Cattle Australia C. parvum IIaA16G2R1 24,600 2,670 (10.8) C. parvum IIaA16G2R1 
 531 (2.1) C. parvum IIaA15G2R1 
 102 (0.4) C. parvum IIaA14G2R1 
AUSC 22 Cattle Australia C. parvum IIaA16G2R1 21,155 2,313 (10.9) C. parvum IIaA16G2R1 
 512 (2.4) C. parvum IIaA15G2R1 
 91 (0.4) C. parvum IIaA14G2R1 
AUSC 24 Cattle Australia C. parvum IIaA16G2R1 21,838 2,458 (11.2) C. parvum IIaA16G2R1 
 485 (2.2) C. parvum IIaA15G2R1 
 95 (0.4) C. parvum IIaA14G2R1 
AUSC 25 Rabbit Australia C. cuniculus VbA23 14,597 4,941 (33.8) C. cuniculus VbA23 
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 437 (2.9) C. cuniculus VbA25 
 61 (0.4) C. cuniculus VbA22 
AUSC 26 Rabbit Australia C. cuniculus VbA23 9,177 3,654 (39.8) C. cuniculus VbA23 
 349 (3.8) C. cuniculus VbA25 
 50 (0.5) C. cuniculus VbA22 
AUSC 27 Rabbit Australia C. cuniculus VbA23 7,340 2,984 (40.6) C. cuniculus VbA23 
 492 (6.7) C. cuniculus VbA25 
 58 (0.7) C. cuniculus VbA22 
AUSC 28 Rabbit Australia C. cuniculus VbA23 11,031 4,226 (38.3) C. cuniculus VbA23 
 487 (4.41) C. cuniculus VbA25 
 79 (0.7) C. cuniculus VbA22 
AUSC 29 Rabbit Australia C. cuniculus VbA23 10,548 3,863 (36.6) C. cuniculus VbA23 
 401 (3.8) C. cuniculus VbA25 
 71 (0.6) C. cuniculus VbA22 
AUSC 30 Rabbit Australia C. cuniculus VbA23 12,066 4,794 (39.7) C. cuniculus VbA23 
 387 (3.2) C. cuniculus VbA25 
 80 (0.6) C. cuniculus VbA22 
AUSC 31 Rabbit Australia C. cuniculus VbA23 9,006 3,609 (40) C. cuniculus VbA23 
 312 (3.4) C. cuniculus VbA25 
 81 (0.8) C. cuniculus VbA22 
AUSC 32 Rabbit Australia C. cuniculus VbA23 14,987 5,743 (38.3) C. cuniculus VbA23 
 581 (3.8) C. cuniculus VbA25 
 156 (1) C. cuniculus VbA22 
ChS 1 Sheep China C. parvum IIdA15G1 15,851 7,577 (47.8) C. parvum IIdA15G1 
 932 (5.8) C. parvum IIdA14G1 
ChG 3 Goat China C. parvum IIdA15G1 23,637 7,346 (31) C. parvum IIdA14G1 
 6,681 (28.2) C. parvum IIdA15G1 
ChC 6 Cattle China C. parvum IIdA19G1 22,857 11,169 (48.8) C. parvum IIdA19G1 
 2,430 (10.7) C. parvum IIdA18G1 
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 359 (1.5) C. parvum IIdA17G1 
 171 (0.7) C. parvum IIdA20G1 
ChC 7 Cattle China C. parvum IIdA19G1 17,491 8,103 (46.3) C. parvum IIdA19G1 
 1,736 (1) C. parvum IIdA18G1 
 271 (1.5) C. parvum IIdA17G1 
 130 (0.7) C. parvum IIdA20G1 
ChC  8 Cattle China C. parvum IIdA19G1 22,137 10,857 (49) C. parvum IIdA19G1 
 2,766 (12.4) C. parvum IIdA18G1 
 582 (2.6) C. parvum IIdA17G1 
 253 (1.1) C. parvum IIdA20G1 
ChC 9 Cattle China C. parvum IIdA19G1 13,843 6,891 (49.7) C. parvum IIdA19G1 
 1,477 (10.6) C. parvum IIdA18G1 
 280 (2) C. parvum IIdA17G1 
 113 (0.8) C. parvum IIdA20G1 
ChC 10 Cattle China C. parvum IIdA19G1 9,854 3,859 (39.1) C. parvum IIdA19G1 
 632 (6.4) C. parvum IIdA18G1 
ChC 11 Cattle China C. parvum IIdA19G1 16,988 8,543 (50.2) C. parvum IIdA19G1 
 2,150 (12.6) C. parvum IIdA18G1 
 128 (0.7) C. parvum IIdA20G1 
ChC 12 Cattle China C. parvum IIdA19G1 15,253 7,856 (51.5) C. parvum IIdA19G1 
 1,902 (12.4) C. parvum IIdA18G1 
 118 (0.7) C. parvum IIdA20G1 
ChC 13 Cattle China C. parvum IIdA19G1 19,493 8,945 (45.8) C. parvum IIdA19G1 
 2,289 (11.7) C. parvum IIdA18G1 
 591 (3) C. parvum IIdA17G1 
 176 (0.9) C. parvum IIdA20G1 
ChC 14 Cattle China C. parvum IIdA19G1 11,222 5,873 (52.3) C. parvum IIdA19G1 
 1,238 (11) C. parvum IIdA18G1 
 80 (0.7) C. parvum IIdA20G1 
ChC 15 Cattle China C. parvum IIdA19G1 16,251 8,125 (49.9) C. parvum IIdA19G1 
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 1,975 (12.1) C. parvum IIdA18G1 
 126 (0.7) C. parvum IIdA20G1 
ChC 17 Cattle China C. parvum IIdA19G1 21,536 11,598 (53.8) C. parvum IIdA19G1 
 2,464 (11.4) C. parvum IIdA18G1 
 204 (0.9) C. parvum IIdA20G1 
ChC 18 Cattle China C. parvum IIdA19G1 13,933 6,801 (48.8) C. parvum IIdA19G1 
 1,404 (10) C. parvum IIdA18G1 
ChC 20 Cattle China C. parvum IIdA19G1 17,406 7,152 (41.1) C. parvum IIdA19G1 
 1,294 (7.4) C. parvum IIdA18G1 
ChC 24 Cattle China C. parvum IIdA19G1 15,193 8,117 (51.3) C. parvum IIdA19G1 
 1,885 (12.4) C. parvum IIdA18G1 
 347 (2.2) C. parvum IIdA17G1 
 125 (0.8) C. parvum IIdA20G1 
ChC 25 Cattle China C. parvum IIdA19G1 24,275 11,985 (49.3) C. parvum IIdA19G1 
 2,694 (11.1) C. parvum IIdA18G1 
 598 (2.4) C. parvum IIdA17G1 





In the present study, the extent of within-host diversity of gp60 subtypes in three 
Cryptosporidium spp. (C. hominis, C. parvum and C. cuniculus) from two geographic locations 
(Australia and China) was analysed using Sanger and NGS. Sanger sequencing identified only 
one gp60 subtype in each DNA sample (positive for Cryptosporidium); NGS identified the 
same subtype, but also identified additional within-host subtypes for samples positive for C. 
parvum and C. cuniculus, but not for C. hominis. The direct Sanger sequencing of PCR 
amplicons employed in the present study is not necessarily the best-suited method for 
uncovering within-host diversity. Other tools such as sequencing clones and Single Strand 
Conformational Polymorphism (SSCP) can also be employed to identify minor sequence 
variants or to determine whether products of a PCR are homogeneous or heterogeneous. All 
the Australian samples were sourced from water catchments in Sydney (New South Wales), 
and Sanger-based typing of these samples have been previously discussed (Chapter 2). Typing 
of the samples from China (collected from dairy cattle farms) has also been previously reported 
(Wang et al., 2011; 2014). 
Two C. parvum subtype families (IIa and IId) were identified by both Sanger and NGS 
in ruminant-derived DNA samples from both Australia and China, with four and 11 subtypes 
identified, respectively. The IIa and IId subtypes are found in both humans and ruminants and 
are responsible for zoonotic cryptosporidiosis (Xiao, 2010). One C. cuniculus subtype family 
(Vb) was identified by both Sanger and NGS, with one and three subtypes identified in 
individual samples, respectively. Two gp60 subtype families (Va and Vb) have been previously 
identified in C. cuniculus, with most human cases of cryptosporidiosis caused by the Va 
subtype family, including the first waterborne outbreak of cryptosporidiosis with C. cuniculus 
in the UK which was typed as VaA22 (Puleston et al., 2014). Both Sanger and NGS identified 
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only one C. hominis subtype (IbA10G2) in all 11 DNA samples from kangaroos. This is a 
dominant subtype responsible for the majority of C. hominis-associated outbreaks worldwide 
(Xiao, 2010) and the identification of this subtype in kangaroos has previously been 
independently confirmed (Zahedi et al., 2016). 
The finding of multiple gp60 subtypes (2-4) in individual hosts in the present study is 
consistent with the study by Grinberg et al. (2013) which identified 10 unique subtypes within 
a single C. parvum sample through NGS techniques. However, in that study, the number of 
identified subtypes for a single sample using NGS is much greater than that observed in our 
study. However, in the study by Grinberg et al. (2013), two of the four least abundant subtypes 
were only observed once (singletons) out of a total of 1,589 sequence types and the remaining 
two subtypes fell outside the percentage cut-off used in this present study. Therefore, it is likely 
that a more stringent analysis would have resulted in a reduced number of subtypes being 
identified. 
There are several limitations of the present study including the possibility that assignment 
of multiple subtypes may have been due to NGS sequence artefacts. Error rates for Illumina 
Miseq sequencing have been estimated at an average of 0.9 errors per 100 bases (Loman et al., 
2012; Salipante et al., 2014), which is considerably less than for other benchtop sequencers, 
such as the Ion Torrent (~1.5 errors per 100 bases) (Loman et al., 2012; Salipante et al., 2014). 
To accommodate for this potential source of error, we employed a very high stringency for 
assignment to subtype: 100% pairwise identity and 100% query cover (or 99% for C. 
cuniculus). This resulted in a large number of unassigned reads (Table 3.1). However, at the 
high stringency level used to assign subtypes, no sequences were equivocally assigned to 
multiple subtypes, which lends confidence to the data. 
It is possible that PCR polymerase slippage artefacts contributed to the number of 
subtypes detected. However, it does not account for all the diversity. For example, co-
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occurrence of C. parvum IIa and IId in two samples cannot be explained by PCR slippage, as 
this would have required the occurrence of slippage by multiple trinucleotides in the TCA 
repeat region repeatedly across samples, which is unlikely, given the stability of imperfect 
repeat regions (Bacon et al., 2000; Klintschar and Wiegand, 2003). In addition, if PCR 
polymerase slippage was the main cause of subtype diversity identified, then it would be 
expected that subtype diversity would also have been seen in C. hominis, which was not the 
case. 
It is possible that the lower PCR annealing temperature required to amplify gp60 
sequences for NGS (50°C) compared with Sanger (54°C) resulted in non-target sequences 
being amplified and sequenced alongside Cryptosporidium gp60 sequences, which would 
contribute greatly to the number of unassigned sequences in this analysis. 
Another limitation of the present study is that both Sanger and NGS were conducted 
using nested and not single round PCR. Nested PCR approaches have an inherent risk of 
contamination and have previously been shown to exhibit strong amplification biases (Park 
and Crowley, 2010). By involving two sequential rounds of amplification, nested PCR may not 
accurately represent the extent of genetic diversity initially present in the sample, because it 
introduces a bottleneck in the genetic variation between the first and second round. However, 
attempts to produce amplicons from single round PCRs were unsuccessful for most of the 
samples and therefore a nested PCR approach was necessary. This is a well-recognised but 
inherent problem of Cryptosporidium epidemiological analysis, as frequently 
Cryptosporidium-positive faecal samples contain very low numbers of oocysts and high levels 
of PCR inhibitors, which necessitates a nested PCR approach (Paparini et al., 2015). However, 
while nested PCR bias may reduce the number of variants detected, in the present study, 
multiple subtypes were successfully identified in individual samples. 
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While multiple gp60 subtypes were identified within C. parvum and C. cuniculus, only 
one subtype was identified in DNA samples positive for C. hominis, which may reflect their 
local population structures. Little information is available for C. cuniculus, but available data 
for C. parvum and C. hominis indicates a flexible reproductive strategy with panmictic (where 
genetic exchange occurs at random with limited or no sub-structuring), clonal and epidemic 
population structures (Mallon et al., 2003; Morrison et al., 2008; Tanriverdi et al., 2008; 
Widmer and Sullivan, 2010; Drumo et al., 2012; De Waele et al., 2013; Widmer et al., 2015; 
Ramo et al., 2015, 2016). The relative contribution of each type of population structure appears 
to vary between regions and hosts, and may reflect the prevailing ecological transmission 
dynamics (Mallon et al., 2003; Tanriverdi et al., 2008; Widmer and Sullivan, 2010; Herges et 
al., 2012; Widmer et al., 2015). The finding of only one C. hominis subtype by both Sanger 
and NGS in the kangaroo-derived DNA samples may reflect a clonal population structure 
operating locally in kangaroo populations from the main Sydney drinking water catchment. 
Analysis of the population structure, however, requires analysis of multiple loci which was not 
conducted in the present study. 
Importantly, the identification of only one C. hominis subtype by both Sanger and NGS 
in the kangaroo-derived DNA samples suggests a single, recent introduction of C. hominis into 
kangaroos, which may spill over to infect other hosts in catchments, providing a reservoir for 
human infection. However, further research is required on a much larger number of samples 
belonging to different subtypes. In addition, inferences regarding the population structure are 
complicated by the fact that the rate of mutation of the gp60 gene remains unknown, multi-
locus analysis is required and Cryptosporidium within-host genetic diversity may occur both 
within and between the oocysts (Grinberg et al., 2013; Grinberg and Widmer, 2016). 
The extent of within-host genetic diversity at the gp60 locus, as demonstrated by the 
present study, may have implications for Cryptosporidium vaccine and drug development. For 
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example, vaccine research for Cryptosporidium has focused on proteins involved in attachment 
to, and invasion of, host cells (Mead, 2014; Ludington and Ward, 2015). Therefore, 
immunisation with predominant antigens could result in vaccine failures in some regions where 
heterogeneous parasite populations dominate (Grinberg and Widmer, 2016). As with malaria, 
undetected low-level drug-resistant co-infecting species and genotypes of Cryptosporidium 
within the same host could also impact anti-Cryptosporidium drug discovery studies and result 
in unexplained chemotherapy failure (Tyagi et al., 2013; Grinberg and Widmer, 2016). These 
findings also have implications for our understanding of the epidemiology and transmission 
dynamics of Cryptosporidium, as previous studies have relied on Sanger sequencing, which 
may not reflect the extent of within-host diversity and result in incorrect assumptions regarding 
transmission of the parasite. More extensive studies employing NGS approaches on a wider 
range of samples are important to determine the extent of Cryptosporidium within-host genetic 




The authors wish to acknowledge the assistance of Frances Brigg and the Western Australia 
State Agriculture Biotechnology Centre for Sanger sequencing. This work was supported by 
an Australian Research Council Linkage Grant (Grant number LP130100035). 
215 
3.9 References 
Abrahamsen, M.S., Templeton, T.J., Enomoto, S., Abrahante, J.E., Zhu, G., Lancto, C.A., 
Deng, M., Liu, C., Widmer, G., Tzipori, S., Buck, G.A., Xu, P., Bankier, A.T., Dear, P.H., 
Konfortov, B.A., Spriggs, H.F., Iyer, L., Anantharaman, V., Aravind, L., Kapur, V., 2004. 
Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science. 
304, 441-445. 
Abubakar, I., Aliyu, S.H., Arumugam, C., Usman, N.K., Hunter P.R., 2007. Treatment of 
cryptosporidiosis in immunocompromised individuals: systematic review and meta-
analysis. Br. J. Clin. Pharmacol. 63, 387-393. 
Almawly, J., Prattley, D., French, N.P., Lopez-Villalobos, N., Hedgespeth, B., Grinberg, A., 
2013. Utility of halofuginone lactate for the prevention of natural cryptosporidiosis of 
calves, in the presence of co-infection with rotavirus and Salmonella typhimurium. Vet. 
Parasitol. 197, 59-67. 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., 1990. Basic local alignment 
search tool. J. Mol. Biol. 215, 403-410. 
Amadi, B., Mwiya, M., Sianongo, S., Payne, L., Watuka, A., Katubulushi, M., Kelly, P., 2009. 
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in 
HIV positive Zambian children: a randomised controlled trial. BMC Infect. Dis. 9, 195. 
Bacon, A.L., Farrington, S.M., Dunlop, M.G., 2000. Sequence interruptions confer differential 
stability at microsatellite alleles in mismatch repair-deficient cells. Hum. Mol. Gen. 9, 
2707-2713. 
Cama, V., Gilman, R.H., Vivar, A., Ticona, E., Ortega, Y., Bern, C., Xiao, L., 2006. Mixed 
Cryptosporidium infections and HIV. Emerg. Infect. Dis. 12, 1025-1028. 
216 
Choisy, M., de Roode, J.C., 2010. Mixed infections and the evolution of virulence: effects of 
resource competition, parasite plasticity, and impaired host immunity. Am. Nat. 175, 
E105-E118. 
De Waele, V., Van den Broeck, F., Huyse, T., McGrath, G., Higgins, I., Speybroeck, N., 
Berzano, M., Raleigh, P., Mulcahy, G.M., Murphy, T.M., 2013. Panmictic Structure of 
the Cryptosporidium parvum population in Irish calves: influence of prevalence and host 
movement. Appl. Environ. Microbiol. 79, 2534-2541. 
Drumo, R., Widmer, G., Morrison, L.J., Tait, A., Grelloni, V., D’Avino, N., Pozio, E., Cacciò, 
S.M., 2012. Evidence of host-associated populations of Cryptosporidium parvum in Italy. 
Appl. Environ. Microbiol. 78, 3523-3529. 
Edgar, R.C., 2010. Search and clustring orders of magnitude faster that BLAST. 
Bioinformatics. 26, 2460-2461. 
Grinberg, A., Biggs, P.J., Dukkipati, V.S., George, T.T., 2013. Extensive intra-host genetic 
diversity uncovered in Cryptosporidium parvum using Next Generation Sequencing. 
Infect. Genet. Evol. 15, 18-24. 
Grinberg, A., Widmer, G., 2016. Cryptosporidium within-host genetic diversity: systematic 
bibliographical search and narrative overview. Int. J. Parasitol. 46, 465-471. 
Herges, G.R., Widmer, G., Clark, M.E., Khan, E., Giddings, C.W., Brewer, M., Mcevoy, J.M., 
2012. Evidence that Cryptosporidium parvum populations are panmictic and 
unstructured in the upper Midwest of the United States. Appl. Environ. Microbiol. 78, 
8096-8101. 
Holmes, J.C., Price, P.W., 1986. Communities of parasites. In: Kikkawa, J., Anderson, D.J., 
(Eds.), Community Ecology: Pattern and Process. Blackwell Scientific Publications, 
London, pp. 187-213. 
217 
Jeníková, M., Němejc, K., Sak, B., Květoňová, D., Kváč, M., 2011. New view on the age-
specificity of pig Cryptosporidium by species-specific primers for distinguishing 
Cryptosporidium suis and Cryptosporidium pig genotype II. Vet. Parasitol. 176, 120-125. 
Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., Buxton, S., 
Cooper, A., Markowitz, S., Duran, C., Thierer, T., Ashton, B., Meintjes, P., Drummond, 
A., 2012. Geneious Basic: An integrated and extendable desktop software platform for 
the organization and analysis of sequence data. Bioinformatics. 28, 1647-1649. 
Kváč, M., Vlnatá, G., Ježková, J., Horčičková, M., Konečný, R., Hlásková, L., McEvoy, J., 
Sak, B., 2018. Cryptosporidium occultus sp. n. (Apicomplexa: Cryptosporidiidae) in rats. 
Eur. J. Protistol. 63, 96-104. 
Klintschar, M., Wiegand, P., 2003. Polymerase slippage in relation to the uniformity of 
tetrameric repeat stretches. Forensic Sci. Internat. 135, 163-166. 
Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., Nasrin, D., Farag, T.H., Panchalingam, S., Wu, 
Y., Sow, S.O., Sur, D., Breiman, R.F., Faruque, A.S., Zaidi, A.K., Saha, D., Alonso, P.L., 
Tamboura, B., Sanogo, D., Onwuchekwa, U., Manna, B., Ramamurthy, T., Kanungo, S., 
Ochieng, J.B., Omore, R., Oundo, J.O., Hossain, A., Das, S.K., Ahmed, S., Qureshi, S., 
Quadri, F., Adegbola, R.A., Antonio, M., Hossain, M.J., Akinsola, A., Mandomando, I., 
Nhampossa, T., Acacio, S., Biswas, K., O’Reilly, C.E., Mintz, E.D., Berkeley, L.Y., 
Muhsen, K., Sommerfelt, H., Robins-Browne, R.M., Levine, M.M., 2013. Burden and 
aetiology of diarrhoeal disease in infants and young children in developing countries (the 
Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 
382, 209-222. 
Loman, N.J., Misra, R.V., Dallman, T.J., Constantinidou, C., Gharbia, S.E., Wain, J., Pallen, 
M.J., 2012. Performance comparison of benchtop high-throughput sequencing platforms. 
Nat. Biotechnol. 30, 434-439. 
218 
Ludington, J.G., Ward, H.D., 2015. Systemic and mucosal immune responses to -vaccine 
development. Curr. Trop. Med. Rep. 2, 171-180. 
Mallon, M., MacLeod, A., Wastling, J., Smith, H., Reilly, B., Tait, A., 2003. Multilocus 
genotyping of Cryptosporidium parvum Type 2: population genetics and sub-structuring. 
Infect. Genet. Evol. 3, 207-218. 
Mead, J.R., 2014., Prospects for immunotherapy and vaccines against Cryptosporidium. Hum. 
Vaccin. Immunother. 10, 1505-1513. 
Morrison, L.J., Mallon, M.E., Smith, H.V., MacLeod, A., Xiao, L., Tait, A., 2008. The 
population structure of the Cryptosporidium parvum population in Scotland: a complex 
picture. Infect. Genet. Evol. 8, 121-129. 
Paparini, A., Gofton, A., Yang, R., White, N., Bunce, M., Ryan, U.M., 2015. Comparison of 
Sanger and next generation sequencing performance for genotyping Cryptosporidium 
isolates at the 18S rRNA and actin loci. Exp. Parasitol. 151-152, 21-27. 
Park, J.W., Crowley, D.E., 2010. Nested PCR bias: a case study of Pseudomonas spp. in soil 
microcosms. J. Environ. Monit. 12, 985-988. 
Puleston, R.L., Mallaghan, C.M., Modha, D.E., Hunter, P.R., Nguyen-Van-Tam, J.S., Regan, 
C.M., Nichols, G.L., Chalmers, R.M., 2014. The first recorded outbreak of 
cryptosporidiosis due to Cryptosporidium cuniculus (formerly rabbit genotype), 
following a water quality incident. J. Water. Health. 12, 41-50. 
Ramo, A., Quílez, J., Del, Cacho, E., Sánchez-Acedo, C., 2014. Optimization of a fragment 
size analysis tool for identification of Cryptosporidium species and gp60 alleles infecting 
domestic ruminants. Vet. Parasitol. 205, 466-471. 
Ramo, A., Quílez, J., Vergara-Castiblanco, C., Monteagudo, L., Del Cacho, E., Clavel, A., 
2015. Multilocus typing and population structure of Cryptosporidium from children in 
Zaragoza, Spain. Infect. Genet. Evol. 31, 190-197. 
219 
Ramo, A., Quílez, J., Monteagudo, L., Del Cacho, E., Sánchez-Acedo, C., 2016. Intra-Species 
Diversity and Panmictic Structure of Cryptosporidium parvum Populations in Cattle 
Farms in Northern Spain. PLoS One. 11, e0148811. 
Read, A.F., Taylor, L.H., 2001. The ecology of genetically diverse infections. Science. 292, 
1099-1102. 
Ryan, U., Zahedi, A., Paparini, A., 2016. Cryptosporidium in humans and animals - a one health 
approach to prophylaxis. Parasite Immunol. 38, 535-547. 
Ryan, U., Lawler, S., Reid, S., 2017. Limiting swimming pool outbreaks of cryptosporidiosis - 
the roles of regulations, staff, patrons and research. J. Water Health. 15, 1-16. 
Salipante, S.J., Kawashima, T., Rosenthal, C., Hoogestraat, D.R., Cummings, L.A., Sengupta, 
D.J., Harkins, T.T., Cookson, B.T., Hoffman, N.G., 2014. Performance comparison of 
Illumina and Ion Torrent next-generation sequencing platforms for 16S rRNA-based 
bacterial community profiling. Appl. Environ. Microbiol. 80, 7583-7591. 
Seppälä, O., Karvonen, A., Rellstab, C., Louhi, K.R., Jokela, J., 2012. Reciprocal interaction 
matrix reveals complex genetic and dose-dependent specificity among coinfecting 
parasites. Am. Nat. 180, 306-315. 
Seppälä, O., Jokela, J., 2016. Do coinfections maintain genetic variation in parasites? Trends 
Parasitol. 32, 930-938. 
Shrestha, R.D., Grinberg, A., Dukkipati, V.S., Pleydell, E.J., Prattley, D.J., French, N.P., 2014. 
Infections with multiple Cryptosporidium species and new genetic variants in young 
dairy calves on a farm located within a drinking water catchment area in New Zealand. 
Vet. Parasitol. 202, 287-291. 
Silva, S.O.S., Richtzenhain, L.J., Barros, I.N., Gomes, A.M., Silva, A.V., Kozerski, N.D., de 
Araújo Ceranto, J.B., Keid , L.B., Soares, R.M., 2013. A new set of primers directed to 
18S rRNA gene for molecular identification of Cryptosporidium spp. and their 
220 
performance in the detection and differentiation of oocysts shed by synanthropic rodents. 
Exp. Parasitol. 135, 551-557. 
Sulaiman, I.M., Hira, P.R., Zhou, L., Al-Ali, F.M., Al-Shelahi, F.A., Shweiki, H.M., Iqbal, J., 
Khalid, N., Xiao, L., 2005. Unique endemicity of cryptosporidiosis in children in Kuwait. 
J. Clin. Microbiol. 43, 2805-2809. 
Tanriverdi, S., Grinberg, A., Chalmers, R.M., Hunter, P.R., Petrovic, Z., Akiyoshi, D.E., 
London, E., Zhang, L., Tzipori, S., Tumwine, J.K., Widmer, G., 2008. Inferences about 
the global population structures of Cryptosporidium parvum and Cryptosporidium 
hominis. Appl. Environ. Microbiol. 74, 7227-7234. 
Trotz-Williams, L.A., Jarvie, B.D., Peregrine, A.S, Duffield, T.F., Leslie, K.E., 2011. Efficacy 
of halofuginone lactate in the prevention of cryptosporidiosis in dairy calves. Vet. Rec. 
168, 509. 
Tyagi, R.K., Das, M.K., Singh, S.S., Sharma, Y.D., 2013. Discordance in drug resistance 
associated mutation patterns in marker genes of Plasmodium falciparum and 
Plasmodium knowlesi during coinfections. J. Antimicrob. Chemother. 68, 1081-1088. 
Vaumourin, E., Vourc'h, G., Gasqui, P., Vayssier-Taussat, M., 2015. The importance of 
multiparasitism: examining the consequences of co-infections for human and animal 
health. Parasit. Vectors. 8, 545. 
Waldron, L.S., Power, M.L., 2011. Fluorescence analysis detects gp60 subtype diversity in 
Cryptosporidium infections. Infect Genet Evol. 11, 1388-1395. 
Wang, R., Wang, H., Sun, Y., Zhang, L., Jian, F., Qi, M., Ning, C., Xiao., 2011. Characteristics 
of Cryptosporidium transmission in preweaned dairy cattle in Henan, China. J. Clin. 
Microbial. 49, 1077-1082. 
Wang, R., Zhang, L., Axén, C., Bjorkman, C., Jian, F., Amer, S., Liu, A., Feng, Y., Li, G., Lv, 
C., Zhao, Z., Qi, M., Dong, H., Wang, H., Sun, Y., Ning, C., Xiao, L., 2014. 
221 
Cryptosporidium parvum IId family: clonal population and dispersal from Western Asia 
to other geographical regions. Sci. Rep. 4, 4208. 
Widmer, G., Sullivan, S., 2010. Genomics and population biology of Cryptosporidium species. 
Parasite Immunol. 34, 61-71. 
Widmer, G., Ras, R., Chalmers, R.M., Elwin, K., Desoky, E., Badawy, A., 2015. Population 
structure of natural and propagated isolates of Cryptosporidium parvum, C. hominis and 
C. meleagridis. Environ. Microbiol. 17, 984-993. 
Xiao, L., 2010. Molecular epidemiology of cryptosporidiosis: an update. Exp. Parasitol. 124, 
80-89. 
Yang, R., Murphy, C., Song, Y., Ng-Hublin, J., Estcourt, A., Hijjawi, N., Chalmers, R., 
Hadfield, S., Bath, A., Gordon C., Ryan, U., 2013. Specific and quantitative detection 
and identification of Cryptosporidium hominis and C. parvum in clinical and 
environmental samples. Exp. Parasitol. 135, 142-147. 
Zahedi, A., Monis, P., Aucote, S., King, B., Paparini, A., Jian, F., Yang, R., Oskam, C., Ball, 
A., Robertson, I., Ryan, U., 2016. Zoonotic Cryptosporidium species in animals 




Co-infection with different species and genotypes of Cryptosporidium can have 
important repercussions on disease dynamics and the changing epidemiology of 
cryptosporidiosis. One of the most common tools used in tracking transmission of zoonotic 
Cryptosporidium species is Sanger sequencing of the glycoprotein 60 (gp60) (the most 
hypervariable locus in the genome). Despite this, little is known about the extent of within host 
genetic diversity of Cryptosporidium. In this chapter, the intra-host genetic diversity of 
Cryptosporidium using Sanger sequencing and NGS of gp60 amplicons from the main species 
infecting humans including C. hominis, C. parvum and C. cuniculus isolates from Australia 
and China were compared. Sanger sequencing identified only one gp60 subtype in each isolate, 
whereas NGS identified the same subtypes initially identified by Sanger sequencing but also 
identified additional gp60 subtypes. These findings have important implications for 
Cryptosporidium transmission tracking as well as vaccine and drug studies. Building on 
methodology validated in the last two chapters, in the following chapter the screening, 
enumeration and characterisation of Cryptosporidium species and genotypes in faecal samples 
collected from animals in water catchment areas across three states in Australia using both 
Sanger sequencing and NGS are described. 
223 
Chapter Four - Cryptosporidium species and subtypes in animals inhabiting drinking 
water catchments in three states across Australia 
 
Alireza Zahedia, Paul Monisb, Alexander W. Goftona, Charlotte L. Oskama, Andrew Ballc, 
Andrew Bathd, Michael Bartkowe, Ian Robertsona,f, Una Ryana. 
 
aSchool of Veterinary and Life Sciences, Murdoch University, Perth, Australia 
bAustralian Water Quality Centre, South Australian Water Corporation, Adelaide, Australia 
cWaterNSW, Sydney, Australia 
dWater Corporation, Perth, Australia 
eSeqwater, Ipswich, Queensland, Australia 
fChina-Australia Joint Research and Training Center for Veterinary Epidemiology, College of 




This chapter builds upon the methodological advances described in chapters two and three, and 
consists of a manuscript published in Water Research, entitled “Cryptosporidium species and 
subtypes in animals inhabiting drinking water catchments in three states across Australia” (see 
Appendix 5). In Chapter two, the species of Cryptosporidium detected in a subset of faecal 
samples collected from animals inhabiting watersheds within the WaterNSW area of 
operations, and the presence of zoonotic Cryptosporidium species in both livestock and wildlife 
inhabiting drinking water catchments are described. These findings highlighted the potential 
role these animals may play in the dissemination of zoonotic Cryptosporidium species to 
drinking water sources and the associated human health risks and therefore, necessitated 
continued monitoring and identification of the sources/carriers of human infectious 
Cryptosporidium spp. in water catchments. In the present chapter, a more comprehensive 
longitudinal analysis of Cryptosporidium spp. in faecal samples from cattle, marsupials, sheep, 
rabbits, birds and wildlife (n = 5,574) across various drinking water catchments in three states 
in Australia (NSW, QLD and WA) over a three-year period, was conducted using a 
combination of Sanger sequencing and NGS.  
 
4.2 Statement of contribution 
 
As first author in this paper, AZ developed the concept, collected the samples (except samples 
from QLD and NSW which were collected by Seqwater and WaterNSW staff members, 
respectively), conducted all the labwork, analysed the data, interpreted the findings and wrote 
the first and final draft of the manuscript. PM, AG and CO contributed to data analysis and 
manuscript preparation. AB, AB and MB provided logistic support to the project, organised 
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samples collection from other states (QLD and NSW) and reviewed and edited the manuscript. 
IR assisted with statistical analysis and sample collection methodology and design. UR 
managed and supervised the project, was directly involved in project administration, 
conceptualisation, funding acquisition, methodology, data analysis and validation, manuscript 
writing and critically revised drafts of the manuscript. All authors reviewed and approved the 





As part of long-term monitoring of Cryptosporidium in water catchments serving Western 
Australia, New South Wales (Sydney) and Queensland, Australia, we characterised 
Cryptosporidium in a total of 5,774 faecal samples from 17 known host species and 7 unknown 
bird samples, in 11 water catchment areas over a period of 30 months (July 2013 to December 
2015). All samples were initially screened for Cryptosporidium spp. at the 18S rRNA locus 
using a quantitative PCR (qPCR). Positives samples were then typed by sequence analysis of 
an 825 bp fragment of the 18S gene and subtyped at the glycoprotein 60 (gp60) locus (832 bp). 
The overall prevalence of Cryptosporidium across the various hosts sampled was 18.3% 
(1,054/5,774; 95% CI, 17.3-19.3). Of these, 873 samples produced clean Sanger sequencing 
chromatograms, and the remaining 181 samples, which initially produced chromatograms 
suggesting the presence of multiple different sequences, were re-analysed by Next- Generation 
Sequencing (NGS) to resolve the presence of Cryptosporidium and the species composition of 
potential mixed infections. The overall prevalence of confirmed mixed infection was 1.7% 
(98/5,774), and in the remaining 83 samples, NGS only detected one species of 
Cryptosporidium. Of the 17 Cryptosporidium species and four genotypes detected (Sanger 
sequencing combined with NGS), 13 are capable of infecting humans; C. parvum, C. hominis, 
C. ubiquitum, C. cuniculus, C. meleagridis, C. canis, C. felis, C. muris, C. suis, C. scrofarum, 
C. bovis, C. erinacei and C. fayeri. Oocyst numbers per gram of faeces (g-1) were also 
determined using qPCR, with medians varying from 6,021 - 61,064 across the three states. The 
significant findings were the detection of C. hominis in cattle and kangaroo faeces and the high 
prevalence of C. parvum in cattle. In addition, two novel C. fayeri subtypes (IVaA11G3T1 and 
IVgA10G1T1R1) and one novel C. meleagridis subtype (IIIeA18G2R1) were identified. This 
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is also the first report of C. erinacei in Australia. Future work to monitor the prevalence of 




Globally, it is estimated that there are between 1.7- 4.6 billion episodes of diarrhoea every 
year with 2.2 million associated deaths (Keusch et al., 2016; WHO, 2017). The transmission 
of many gastrointestinal diseases is closely linked to water, yet the true disease burden 
attributable to water-associated pathogens is currently unknown, largely due to lack of adequate 
detection and surveillance systems (Ryan et al., 2017). This is particularly the case in countries 
such as Australia, that have a relatively low level of endemic diarrhoeal disease, which means 
that even specially designed high-quality epidemiological trials have a limited ability to detect 
cases of diarrhoea attributable to drinking water (Sinclair et al., 2015). Routine disease 
surveillance systems are even less sensitive and detect only a small fraction of the pathogen 
infections that occur in the community (O'Toole et al., 2015). For example, a national survey 
of gastroenteritis in Australia in 2002, suggested a ratio of about 500 community cases to one 
notified case (Hall et al., 2006). 
Cryptosporidium is one of the most prevalent waterborne parasitic infections. From the 
start of the last century to 2016, there were a total of 905 reported waterborne outbreaks caused 
by protozoan parasites and of these Cryptosporidium accounted for almost 60% (524 
outbreaks) (Karanis et al., 2007; Baldursson and Karanis, 2011; Efstratiou et al., 2017). The 
largest Cryptosporidium outbreak occurred in Milwaukee in 1993, which affected 403,000 
individuals via contaminated drinking water (MacKenzie et al., 1995), with an estimated 
illness-associated cost of US$ 96.2 M and 100 deaths (Corso et al., 2003). Rates of waterborne 
parasitic protozoan outbreaks have been increasing due to increased and improved surveillance. 
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Between 2010-2016, 381 outbreaks were reported, nearly half of which (49% -188 outbreaks), 
were reported in Australia and New Zealand (Efstratiou et al., 2017). However, the true level 
of waterborne disease in Australia is unknown. 
Currently, 37 Cryptosporidium species are recognised (Jezkova et al., 2016; Zahedi et 
al., 2017; Čondlová et al., 2018; Kváč et al., 2018), of which 17 have been reported in humans 
worldwide. In Australia, seven Cryptosporidium species (C. hominis, C. parvum, C. 
meleagridis, C. cuniculus, C. fayeri, C. andersoni and C. bovis) have been reported in humans 
(Koehler at al., 2014a, 2014b; Zahedi et al., 2016a). However, C. hominis and C. parvum have 
been responsible for the majority of human infections throughout the world (Xiao, 2010; Ryan 
and Power, 2012) and for all waterborne outbreaks typed to date, with the exception of a single 
outbreak in the UK caused by C. cuniculus (Xiao, 2010; Puleston et al., 2014; Efstratiou et al., 
2017). 
The 2011 Australian Drinking Water Guidelines 2011 (ADWG) contains mostly 
qualitative information on treatment requirements (https://www.nhmrc.gov.au/guidelines-
publications/eh52), but will soon move to a health-based target of 10-6 disability adjusted life 
years (DALYs) per person per year for Cryptosporidium (O’Toole et al., 2015). This allows 
for up to approximately 6% of diarrhoeal disease caused by Cryptosporidium to be associated 
with consumption of drinking water (O’Toole et al., 2015). To meet this target, data about the 
prevalence of human-infectious Cryptosporidium species in source waters and catchments is 
important for quantitative microbial risk assessment (QMRA) processes. However, relatively 
few large-scale longitudinal studies have been undertaken in Australia (e.g. Ryan et al., 2005; 
Ng et al., 2011a; Nolan et al., 2013; Koehler et al., 2016; Zahedi et al., 2016b) and no studies 
have compared catchments in different states in Australia. The aim of the present study 
therefore was to use molecular tools to more accurately determine the prevalence, species and 
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oocyst load of Cryptosporidium in Australian water catchments across three states; New South 
Wales (NSW), Queensland (QLD) and Western Australia (WA). 
 
4.5 Materials and methods 
 
4.5.1 Catchment and sample collection in each state 
 
To comply with the ADWG, water utilities employ a risk-based multiple barrier approach 
with water source/catchment management and protection, being the first barrier, and other 
barriers at the treatment, storage, and distribution stages of water supply systems. Some 
drinking water catchments have a relatively low density of development, and little significant 
anthropogenic activity; however, this is not always the case. With the exception of rodents, 
which are seldom infected with human-infectious Cryptosporidium species (Feng et al., 2007; 
Foo et al., 2007), the predominant animals in Australian catchments are marsupials (mainly 
kangaroos), rabbits, sheep and cattle (Ryan and Power, 2012). However, the importance of 
these host species varies between states and individual catchments. The most abundant hosts 
were selected on a per catchment basis after consultation with water utility staff from each 
state. The population size of livestock examined in individual catchments was known and 
appropriate sample sizes were estimated using Epitools 
(http://epitools.ausvet.com.au/content.php?page=home). Unfortunately, the size of wildlife 
populations in these catchments is unknown, which precluded sample size analysis. 
Greater Sydney’s drinking water catchments cover 16,000 km2 of land and are managed 
by WaterNSW. About 30% of catchment land is national park and bushland, but over 60% of 
the catchments are privately owned. Two catchments were chosen in NSW (Catchment A and 
Catchment B), for which cattle and sheep grazing is the largest single land use, but horse studs, 
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piggeries, dairies and poultry production are also present. Eastern grey kangaroos (Macropus 
giganteus) and rabbits (Oryctolagus cuniculus) are the dominant non-domestic species 
inhabiting these catchments. More than one-quarter of catchment B (2,600 km2) has been 
protected from most human activities for over 70 years. 
Seqwater is one of Australia’s largest water businesses with the most geographically 
spread and diverse asset base of any capital city water authority. South-east QLD’s catchments 
cover more than 12,000 km2 of land but only 650 km2 hectares of this land is owned by 
Seqwater. Three catchment areas were analysed; Catchment A covers an area of 67 km2 and 
supplies a large portion of the Sunshine Coast’s drinking water. Catchment B is located in the 
Gold Coast hinterland in South-east QLD and supplies bulk raw water to local irrigators and 
Seqwater. Catchment C is situated between Brisbane and the Sunshine Coast. Cattle and sheep 
are the main livestock present in these catchments. 
Water Corporation (WC) in Western Australia, is one of the world’s largest water utilities 
servicing an area of over 2.5 million km2. Six catchments were analysed; Catchment A is used 
for agriculture and urban development; catchment B is located in the South of WA; catchment 
C supplies approximately 20 percent of Perth’s fresh water; catchment D is located in the 
southwest of WA; catchment E located ~70 km from metropolitan Perth; and catchment F is 
located approximately 100 km south of Perth. 
 
4.5.2 Sample collection and processing 
 
In NSW, animal faecal samples were collected by WaterNSW staff within the 
WaterNSW area of operations. Samples were collected at monthly intervals over a 30-month 
period (July, 2013 to December, 2015). A total of 1,521 faecal samples were collected from 
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Eastern grey kangaroos (Macropus giganteus) (n = 835), beef cattle (n = 243), sheep (n = 217), 
rabbits (n = 217), horses (n = 5) and pigs (n = 4) (Table 4.1). 
In QLD, animal faecal samples were collected by Seqwater staff over a 14-month period 
(September, 2014 to November, 2015). A total of 653 faecal samples were collected from cattle 
(n = 568, of which 216 were dairy cattle and 352 were beef cattle), sheep (n = 9), horses (n = 
38), birds (n = 9), pigs (n = 4), rabbits (n = 5), flying foxes (Pteropus sp.) (n = 9), feral red deer 
(Cervus elaphus) (n = 6), wild dogs (n = 3), a single goat, and a single wallaby (species 
unknown) (Table 4.1). 
In WA, a total of 3,600 faecal samples were collected from beef cattle (n = 300), sheep 
(n = 150), Western grey kangaroos (Macropus fuliginosus) (n = 2,393), rabbits (n = 450), birds 
(n = 7) and feral pigs (n = 300) (Table 4.1). 
The animal sources of the faecal samples were determined by visually sighting the 
animals defaecating and with the aid of a scat and tracking manual published for Australian 
animals (Triggs, 2004). All faecal samples were collected off the ground into individual 75 ml 
faecal collection pots and stored at 4°C until required, with samples collected in NSW and 
QLD transported at 4°C to Murdoch University for analysis. 
 
4.5.3 DNA isolation and qPCR 
 
Genomic DNA (gDNA) was extracted from 250mg of each faecal sample using a Power 
Soil DNA Kit (MO BIO, Carlsbad, California, USA). An extraction reagent blank (no faecal 
sample) was used in each extraction group. Purified gDNA was stored at -20°C prior to 
molecular analyses. All samples were screened for the presence of Cryptosporidium at the 18S 
rRNA locus using a quantitative PCR (qPCR) as previously described (King et al., 2005; Yang 
et al., 2014) using a Ct threshold of <35 cycles. At the 18S locus, C. macropodum, a marsupial 
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adapted species of Cryptosporidium, was used as a positive control for PCR amplifications of 
non-marsupial-derived samples. For samples collected from marsupials (kangaroos), C. 
parvum was used as a positive control. 
Quantitation was conducted using standards consisting of recombinant plasmids 
containing partial fragments of the Cryptosporidium 18S rRNA, calibrated by droplet digital 
PCR (ddPCR) as described by Yang et al. (2014). Target copy numbers detected were 
converted to numbers of oocysts based on the fact that the 18S gene in Cryptosporidium has 
five copies (Le Blancq et al., 1997), and there are four haploid sporozoites per oocyst. 
Therefore, every 20 copies of 18S detected by qPCR were equivalent to one oocyst.
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Table 4.1. Prevalence of Cryptosporidium in different hosts and catchments across three states of Australia; NSW, QLD and WA, as determined 
by Sanger sequencing. 
Catchment Cattle 
No +/total no 
(% prevalence 
+ 95% CI) 
Sheep 
No +/total no 
(% prevalence 
+ 95% CI) 
Kangaroos 
No +/total no 
(% prevalence 
+ 95% CI) 
Rabbits 
No +/total no 
(% prevalence 
+ 95% CI) 
Horses 
No +/total no 
(% prevalence 
+ 95% CI) 
Birds 
No +/total no 
(% prevalence 
+ 95% CI) 
Pigs  
No +/total no 
(% prevalence 






QLD         












   Catchment B 56/194 (28.9%- 
22.6-35.8) 
NC NC NC 0/16 (0%- 0-26) 2/4 (50%- 6.8-
93.2) 
N/C NC 
   Catchment C 25/195 (12.8-
8.5-18.3) 


















NSW         








NC NC NC NC 
Catchment B NC NC 37/574 (6.4%- 
4.6-8.8) 
NC 0/5 (0%- 0-52.2) NC 0/4 (0%- 0-
60.2) 
NC 








0/5 (0%- 0-52.2) NC 0/4 (0%- 0-
60.2) 
NC 
WA         




NC 5/7 (71.4%- 29-
96.3) 
NC NC 
   Catchment B NC NC 56/600 (9.3%- 
7.1-11.9) 
NC NC NC NC NC 




NC NC NC NC 






NC NC NC NC NC 




NC NC NC NC 
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   Catchment F NC NC 96/300 (32%- 
26.8-37.6) 
NC NC NC 48/300 (16%- 
12-20.6) 
NC 
































         
NC = Not Collected. 
* Goat sample 
** Samples collected opportunistically from wildlife (7/9 flying fox, 0/1 wallaby, 2/6 feral deer, 2/3 wild dog) 
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4.5.4 PCR amplification at the 18S and gp60 loci by nested PCR 
 
Samples that were positive by qPCR were amplified at the 18S locus using nested primers 
which produced an approximately 825 bp product as previously described (Xiao et al., 1999b). 
PCR contamination controls were used, including negative controls to detect contamination 
and separate laboratory areas were used for DNA and PCR mastermix preparation and post-
PCR handling. 
Samples that were typed as C. hominis, C. parvum, C. cuniculus, C. meleagridis, C. 
ubiquitum and C. fayeri by Sanger sequencing at the 18S locus were subtyped at the 60 kDa 
glycoprotein (gp60) locus using nested PCRs as previously described (Strong et al., 2000; 
Glaberman et al., 2001; Peng et al., 2003; Zhou et al., 2003; Power et al., 2009; Li et al., 2014). 
At the gp60 locus, for samples which were initially identified as C. hominis and C. parvum at 
the 18S locus, C. cuniculus was used as a positive control. For samples which were previously 
identified as C. cuniculus at the 18S locus, C. parvum was used as a positive control. 
 
4.5.5 Sanger sequence analysis 
 
The amplified DNA from secondary PCRs were separated by gel electrophoresis and 
purified for sequencing using an in-house filter tip method (Yang et al., 2013). Purified PCR 
products from both loci were sequenced independently on an ABI Prism™ Dye Terminator 
Cycle Sequencing kit (Applied Biosystems, Foster City, California) according to the 
manufacturer’s instructions, at 57°C annealing temperature for the 18S rRNA and a range of 
different annealing temperatures for different species at gp60 (56°C for C. fayeri, 58°C for C. 
meleagridis and 54°C for the remaining species). Sanger sequences were assigned taxonomy 
by aligning chromatograms to curated reference sequences from GenBank using 99% sequence 
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identity. Alignments were produced with Clustal W (http://www.clustalw.genome.jp), utilised 
as a plugin within Geneious Pro 8.1.6 (Kearse et al., 2012) and phylogenetic analysis was 
conducted using MEGA6 (after selection of the best nucleotide substitution models) (Tamura 
et al., 2013) (data not shown). 
 
4.5.6 Next Generation Sequencing (NGS) 
 
Samples that produced mixed chromatograms by Sanger sequencing (n = 251) were 
analysed by NGS on the MiSeq (Illumina) platform at the 18S locus using the 18S iF/iR primers 
(Morgan et al., 1997) as previously described (Paparini et al., 2015). These primers were 
selected over the longer Xiao et al. (1999) primers used for Sanger sequencing, due to length 
limitation imposed by the 250 bp paired-end sequencing technology utilised. Briefly, PCR 
primers were modified to contain MiSeq adapter sequences on the 5′ end, as per standard 
protocols for the MiSeq platform (Illumina Demonstrated Protocol: Metagenomic Sequencing 
Library Preparation). All PCR amplicons were double purified using the Agencourt AMPure 
XP Bead PCR purification protocol (Beckman Coulter Genomics, USA) and pooled in 
approximate equimolar ratios. To minimize laboratory and cross-contamination all DNA 
handling and PCR-setup procedures were performed within dedicated and physically separated 
PCR containment hoods that are UV-sterilized between each use. Post-PCR procedures were 
all performed in a physically separate dedicated laboratory. 
Sequencing was performed on an Illumina MiSeq using 500-cycle V2 chemistry (250 
paired-end reads) following the manufacturer’s recommendations. Two no-template controls 
and two DNA extraction reagent blank controls were included in the library preparation, and 
distributed between samples in the PCR plate layout. All no-template and DNA extraction 
reagent blank controls produced no detectable amplification of Cryptosporidium DNA after 
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initial amplicon-generation PCRs or indexing PCRs. This indicated that level of cross 
contamination between samples, or from the laboratory environment, was below the detection 
limit of the library preparation procedure and for this reason were not sequenced. 
 
4.5.7 Statistical Analysis 
 
The prevalence of Cryptosporidium in each host species was expressed as the percentage 
of samples positive by qPCR, which were also confirmed by Sanger and/or NGS analysis of 
the 18S rRNA locus, with 95% confidence intervals calculated assuming a binomial 
distribution, using the software Quantitative Parasitology 3.0 (Rózsa et al., 2000). DNA 
extraction efficiency was estimated for each extraction, based on the number of the gene 
copies/oocysts equivalents measured by ddPCR. Chi-square and non-parametric analyses were 
performed using IBM SPSS 21.0 (statistical package for the social sciences) for Windows 
(SPSS inc. Chicago, USA) to determine if there were any associations between the prevalence 
and concentration of Cryptosporidium oocysts at different sampling times and across states. 
 
4.5.8 Bioinformatics analysis 
 
Paired-end reads (73.42% of basecalls >Q30) were merged and quality filtered with 
USEARCH v10 (Edgar, 2010), retaining reads with >50 bp merged overlap, <0.1% expected 
error, no mismatches in the primer sequences, a minimum length of 200 bp, and a minimum of 
100 identical replicate copies. Primer sequences and any distal bases were also removed from 
all reads. Reads were then denoised and chimera filtered with the UNOISE3 algorithm (Edgar, 
2016), to generate 107 zero-radius operational taxonomic units (ZOTUs), that represent unique 
biologically correct sequences (Edgar, 2016). Remaining high quality Cryptosporidium spp. 
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18S ZOTU sequences were assigned to taxonomic groups by comparing ZOTUs to a curated 
custom in-house database using BLAST 2.6.0 (Altschul et al., 1990). The reference database 
contained 63 reliable 18S reference sequences from 63 Cryptosporidium species and genotypes 
extracted from GenBank (Benson et al., 2005). Taxonomy was only assigned if there was a 
single unambiguous best BLAST hit with >99% pairwise identity over >98% of the query 
sequence length. This high stringency threshold was based on the minimum pairwise 
percentage dissimilarity between any two Cryptosporidium species/genotypes in the database 
to unsure unambiguous taxonomic classifications. Of the 107 ZOTUs generated, 41 ZOTUs 
were not Cryptosporidium 18S sequences when compared to GenBank using BLAST. Where 
possible genus-level taxonomy was assigned when queries hit reference sequences with >99% 
identity over >98% of the reads, and assigned to no other taxa at the same level. Although non-
Cryptosporidium ZOTUs were abundant (38.3% of total ZOTUs), they represented a very 




4.6.1 Overall prevalence of Cryptosporidium as determined by Sanger sequencing and 
NGS 
 
The overall PCR prevalence of Cryptosporidium species in the 5,774 faecal samples 
collected systematically from seven main host species and opportunistically from 10 host 
species, in addition to seven unknown bird samples, was 18.3% (1,054/5,774; 95% CI, 17.3-
19.3), based on PCR positive samples that were confirmed by Sanger or NGS sequencing. 
The overall prevalence in each state based on qPCR positive samples that have been 
confirmed by Sanger sequencing or NGS was 25.9% (169/653; 95% CI, 22.6-29.4) in QLD, 
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17.5% (632/3,600; 95% CI, 16.3-18.8) in WA and 16.6% (253/1,521; 95% CI, 14.8-18.6) in 
NSW. For ease of analysis and reporting, the prevalence and species detected by Sanger and 
NGS are discussed separately. 
 
4.6.2 Prevalence of Cryptosporidium as determined by Sanger sequencing in various 
hosts and catchments 
 
Of the 873 samples which produced clean Sanger chromatograms, the highest prevalence 
was detected in birds (68.7%), followed by 21.5% in cattle, 16.2% in pigs, 14.3% in rabbit 
samples, 13.5% in kangaroos and 8% in sheep. No Cryptosporidium was detected in the 43 
horse faecal samples screened (Table 4.1). A high prevalence was also detected in the small 
numbers of wildlife sampled (Table 4.1). The overall prevalence of Cryptosporidium in each 
state was 22.8%; 95% CI, 19.7-26.2 (149/653) in QLD, 14.9%; 95% CI, 13.7-16.1 (535/3,600) 
in WA, and 12.4%; 95% CI, 10.8-14.2 (189/1,521) in NSW. 
The prevalence of Cryptosporidium in cattle was not significantly different across the 
three states; 18.5% in NSW, 21.7% in WA and 22.7% in QLD (29.6% in dairy cattle and 18.5% 
in beef cattle). The prevalence of Cryptosporidium was highest in sheep from WA (11.3%), 
compared to 11.1% in QLD and 5.5% in NSW. Kangaroos were only sampled in NSW (8.6%) 
and WA (15.2%). Cryptosporidium was not detected in the small numbers of rabbits sampled 
in QLD (n = 5), but was more prevalent in rabbits in NSW (27.6%) than WA (8%). 




4.6.3 Oocyst load 
 
Oocyst numbers per gram of faeces (g-1) were also determined using qPCR (Table 4.2; 
mean, median and range for samples identified as Cryptosporidium species by Sanger 
sequencing and NGS). The highest median concentration of Cryptosporidium oocysts was 
identified in cattle; (31,072 oocysts/g-1), followed by rabbits (27,919 oocysts/g-1), while the 
lowest median concentration of oocysts was observed among samples collected 
opportunistically from wildlife in QLD (9,063 oocysts/g-1). Overall, there was no significant 
difference between the median Cryptosporidium oocysts per gram of faeces in samples 
collected from sheep, kangaroos, pigs and birds, which ranged from 10,032 to 26,756 
oocysts/g-1 (Table 4.2). 
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Table 4.2. Numbers of Cryptosporidium oocysts in positive samples per gram of faeces (g-1) (mean, median with range in parenthesis (determined 
by qPCR) per host species per catchment across three states of Australia; NSW, QLD and WA. 
Catchment Cattle Sheep Kangaroos Rabbits Horses Birds Pigs Other 
QLD         










Catchment B 53,508, 42,803 
(1,920-182,664) 
NC NC NC NC 6,201, 6,201 
(2,622-9,780) 
NC NC 
Catchment C 44,914, 33,581 
(680-228,548) 
NC NC ND ND 7,376, 7,376 
(4,720-10,032) 
NC 8,832, 9,063 
(622-19,047) 











NSW         








NC NC NC NC 
Catchment B NC NC 11,615, 10,265 
(131-41,088) 
NC ND NC ND NC 








ND NC ND NC 
WA         




NC 38,841, 44,812 
(5,270-78,433) 
NC NC 
Catchment B NC NC 19,978, 17,738 
(440-63,002) 
NC NC NC NC NC 




NC NC NC NC 






NC NC NC NC NC 




NC NC NC NC 
Catchment F NC NC 23,482, 18,085 
(714-275,402) 
NC NC NC 22,861, 22,062 
(873-88,026) 
NC 




























NA = Not Available. 
NC = Not Collected. 
ND = Not Detected. 
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4.6.4 Cryptosporidium species detected in various hosts at the 18S locus by Sanger 
sequencing 
 
Clean 18S Sanger sequences were obtained from 873 positives. Of these, a total of 14 
species and two genotypes were detected; C. macropodum (n = 260), C. fayeri (n = 150), C. 
parvum (n = 106), C. cuniculus (n = 96), C. bovis (n = 60), C. hominis (n = 42), C. ryanae (n 
= 41), C. ubiquitum (n = 36), C. scrofarum (n = 35), C. suis (n = 15), C. muris (n = 15), C. galli 
(n = 8), C. meleagridis (n = 3), C. canis (n = 2), Cryptosporidium rat genotype I (n = 3) and C. 
molnari-like genotype (n = 1) (Table 4.3). 
In cattle, of the 239 positives, a total of seven species and one genotype were detected; 
C. parvum (n = 106), C. bovis (n = 60), C. ryanae (n = 41), C. hominis (n = 16), C. muris (n = 
8), C. ubiquitum (n = 4), C. galli (n = 1) and rat genotype I (n = 3), with C. ubiquitum, C. galli 
and rat genotype I only detected in beef cattle. All the sheep were infected with C. ubiquitum 
(30/30) and all the rabbits were infected with C. cuniculus (96/96). In kangaroos, C. hominis 
(26/436), C. macropodum (260/436) and C. fayeri (150/436) were detected. In pigs, C. suis 
(15/50) and C. scrofarum (35/50) were detected. Three species were detected in the 11 positives 
from birds, a C. molnari-like genotype in a single shag, C. galli (n = 7) and C. meleagridis (n 
= 3). In wildlife, of the 11 positives typed, C. ubiquitum was identified in feral deer (n = 2), C. 
muris in flying foxes (n = 7) and C. canis from wild dogs (n = 2) (Table 4.3). 
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Table 4.3. Cryptosporidium species detected by Sanger sequencing in different hosts and catchments across three states of Australia; NSW, QLD 
and WA. 














+ 95 CI) 
C. ubiquitum 
No +/total no 
(% proportion 

































+ 95 CI) 
QLD           













ND ND ND ND 8/129a 
(6.2%- 2.7-
11.9) 
   Sheep ND ND ND 1/1 (100%- 2.5-
100) 
ND ND ND ND ND ND 
   Horses ND ND ND ND ND ND ND ND ND ND 
   Birds ND ND ND ND ND ND ND ND ND 6/6b (100%- 
54.1-100) 
   Pigs ND ND ND ND ND ND 2/2 (100%- 
15.8-100) 
ND ND ND 
   Wildlife ND ND ND 2/11c (18.2%- 
2.3-51.8) 
ND ND ND ND ND 9/11d 
(81.8%- 
48.2-97.7)  














ND 2/2 (100%- 
15.8-100) 
ND ND 23/146 
(15.7%- 
10.3-22.7) 
NSW           







N/D 1/45 (2.2%- 
0.1-11.8) 
ND ND ND ND 1/45e 
(2.2%- 0.1-
11.8) 
   Sheep N/D ND ND 12/12 (100%- 
73.5-100) 
ND ND ND ND ND ND 




































WA           











ND ND ND ND 3/65g 
(4.6%- 1-
12.9) 
   Sheep ND ND ND 17/17 (100%- 
80.5-100) 
ND ND ND ND ND ND 
   
Kangaroos 















ND ND ND 
Birds ND ND ND ND ND ND ND ND ND 5/5h (100%-
47.8-100) 




























           
ND = Not Detected 
aCryptosporidium muris (n = 8) 
bCryptosporidium molnari (n = 1, Shag), Cryptosporidium galli (n = 5; 2 from an ibis, 1 from a goose, 1 from a boiler chicken, 1 from a swallow) 
cCryptosporidium ubiquitum from feral deer (n = 2) 
dCryptosporidium muris from flying fox (n = 7), Cryptosporidium canis from wild dog (n = 2) 
eCryptosporidium galli 
fCryptosporidium fayeri 
gCryptosporidium rat genotype I (n = 3) 
hCryptosporidium galli (n = 2), Cryptosporidium meleagridis (n = 3) 
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4.6.5 Cryptosporidium gp60 subtypes detected in various hosts by Sanger sequencing 
 
Of the 89 C. parvum cattle isolates subtyped at the gp60 locus, a total of seven subtypes 
were identified; IIaA15G2R1 (n = 5), IIaA16G2R1 (n = 5), IIaA17G2R1 (n = 27), IIaA18G3R1 
(n = 40), IIaA19G2R1 (n = 1), IIaA19G3R1 (n = 11), and a variant of the IIaA13G1 subtype 
in five cattle, which exhibited one single nucleotide polymorphism from the only other 
previous record of this subtype (JX471005). Two C. hominis subtypes were identified; 
IbA10G2 (of which 11 were identified in cattle and 23 in kangaroos) and IdA15G1 (two in 
kangaroos and three in cattle). All the C. ubiquitum typed (n = 28) belonged to subtype family 
XIIa and all the C. meleagridis (n = 3) were identified as a novel subtype; IIIeA18G2R1. Six 
C. cuniculus subtypes were identified; VbA18 (n = 12), VbA23 (n = 46), VbA25 (n = 16), 
VbA26 (n = 8), VbA28 (n = 2) and VbA29 (n = 5). Three C. fayeri subtypes were identified; 
IVfA12G1T1 (n = 23) and two novel subtypes; IVaA11G3T1 (n = 16) and IVgA10G1T1R1 (n 
= 81) (Table 4.4). The novel subtypes (IIaA13G1, IIIeA18G2R1, IVaA11G3T1 and 
IVgA10G1T1R1) identified in the present study have been submitted to GenBank under 
accession numbers MG516789, MG516778, MG516791 and MG516790. All other nucleotide 
sequences reported in this paper are available in the GenBank database under accession 
numbers MG516739 to MG516774 (18S) and MG516775 to MG516798 (gp60).
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Table 4.4. gp60 subtypes detected in different hosts and catchments across three states of Australia; NSW, QLD and WA.  
QLD NSW WA 
 




ND ND ND ND ND ND ND ND ND ND ND 5 ND ND ND ND ND 5 5 
C. parvum 
IIaA15G2R1 
ND ND ND ND ND ND ND ND ND ND ND 5 ND ND ND ND ND 5 5 
C. parvum 
IIaA16G2R1 
ND ND ND ND ND ND 5 ND ND ND 5 ND ND ND ND ND ND ND 5 
C. parvum 
IIaA17G2R1 
13 ND ND ND ND 13 ND ND ND ND ND 14 ND ND ND ND ND 14 27 
C. parvum 
IIaA18G3R1 
24 ND ND ND ND 24 9 ND ND ND 9 7 ND ND ND ND ND 7 40 
C. parvum 
IIaA19G2R1 
ND ND ND ND ND ND 1 ND ND ND 1 ND ND ND ND ND ND ND 1 
C. parvum 
IIaA19G3R1 
8 ND ND ND ND 8 3 ND ND ND 3 ND ND ND ND ND ND ND 11 
C. hominis 
IbA10G2 
7 ND ND ND ND 7 4 ND 23 ND 27 ND ND ND ND ND ND ND 34 
C. hominis 
IdA15G1 




4 1 ND ND 2* 7 ND 10 ND ND 10 ND 11 ND ND ND ND 11 28 
C. cuniculus 
VbA18 
ND ND ND ND ND ND ND ND ND ND ND ND ND ND 12 ND ND 12 12 
C. cuniculus 
VbA23 
ND ND ND ND ND ND ND ND ND 37 37 ND ND ND 9 ND ND 9 46 
C. cuniculus 
VbA25 
ND ND ND ND ND ND ND ND ND 16 16 ND ND ND ND ND ND ND 16 
C. cuniculus 
VbA26 
ND ND ND ND ND ND ND ND ND ND ND ND ND ND 8 ND ND 8 8 
C. cuniculus 
VbA28 
ND ND ND ND ND ND ND ND ND 2 2 ND ND ND ND ND ND ND 2 
C. cuniculus 
VbA29 
ND ND ND ND ND ND ND ND ND 5 5 ND ND ND ND ND ND ND 5 
C. meleagridis 
IIIeA18G2R1 




ND ND ND ND ND ND ND ND ND 2 2 ND ND 79 ND ND ND 79 81 
C. fayeri 
IVaA11G3T1 




ND ND ND ND ND ND ND ND ND ND ND ND ND 23 ND ND ND 23 23 
ND = Not Detected 
*Feral deer 
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4.6.6 Prevalence and species of Cryptosporidium identified by NGS 
 
A total of 251 samples produced mixed Sanger chromatograms and were re-analysed by 
NGS. However, of these, only 181 were assigned to Cryptosporidium species and the 
remaining 70 samples were discarded due to unassigned reads or failure to pass quality 
filtering. Of these 181 samples, which produced mixed chromatograms by Sanger, 83 samples 
did not exhibit mixed infections via NGS, i.e. only one species/genotype was detected 
(Supplementary Table 4-S1 - Digital appendix 2). This suggests that some of the mixed 
chromatograms identified by Sanger, were due to co-amplification of Cryptosporidium with 
non-specific contaminants. Therefore, for the scope of the present study, the prevalence of 
mixed infections is reported based on only those samples which were assigned to multiple 
Cryptosporidium species by NGS (n = 98).  
Therefore, the overall prevalence of mixed infections was 1.7% (98/5,774; 95% CI, 1.4-
2.1) (Table 4.5 and Supplementary Table 4-S1 - Digital appendix 2). These mixed infections 
were detected in faecal samples collected from cattle, kangaroos, rabbits, wild pigs and two 
feral deer. Apart from 10% overall prevalence among samples collected opportunistically from 
wildlife, the highest prevalence of mixed infections was detected in kangaroos (2.8%), 
followed by 1.7% in cattle, 0.9% in rabbits and 0.3% in pigs (Table 4.5). Overall, a total of 15 
species and four genotypes of Cryptosporidium were detected by NGS; C. bovis, C. cuniculus, 
C. fayeri, C. felis, C. galli, C. hominis, C. macropodum, C. meleagridis, C. muris, C. parvum, 
C. rayane, C. scrofarum, C. suis, C. erinacei, C. ubiquitum, kangaroo genotype I, rat genotype 
I, rat genotype II and rat genotype III (Table 4.6). The number of species identified in individual 
hosts ranged from one to six species. However, C. parvum, C. hominis, C. cuniculus, C. muris, 
C. fayeri, C. macropodum, C. suis, C. galli, kangaroo genotype I and rat genotype III were the 
most abundant species identified in samples with mixed infections and therefore, were 
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considered for prevalence and statistical analysis in this study. A total of 39 cattle samples, of 
which 32 were from beef cattle (11 from QLD, 19 from NSW and two from WA), and seven 
from dairy cattle from QLD), produced mixed chromatograms by Sanger sequencing. NGS 
analysis identified mixed infections and the four most abundant species and one most abundant 
Cryptosporidium genotype in individual samples were; C. parvum (n = 16), C. hominis (n = 3), 
C. muris (n = 14), C. galli (n = 5) and rat genotype III (n = 1). In kangaroos, C. parvum (n = 
52), C. hominis (n = 48), C. macropodum (n = 17), C. fayeri (n = 5), C. galli (n = 3) and 
kangaroo genotype I (n = 1) were identified. Re-analysis of all seven faecal samples from wild 
pigs, all seven rabbit samples and two faecal samples collected from feral deer by NGS, 
identified C. suis, C. cuniculus and C. muris as the most abundant species, respectively (Table 
4.6). 
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Table 4.5. Prevalence of mixed infection with different species of Cryptosporidium identified by NGS in samples which produced mixed 
chromatograms by Sanger-sequencing across three states of Australia; NSW, QLD and WA. 
Catchment Cattle 
No +/total no 
(% prevalence 
+ 95 CI) 
Sheep 
No +/total no 
(% prevalence 
+ 95 CI) 
Kangaroos 
No +/total no 
(% prevalence 
+ 95 CI) 
Rabbits 
No +/total no 
(% prevalence 
+ 95 CI) 
Horses 
No +/total no 
(% prevalence 
+ 95 CI) 
Birds 
No +/total no 
(% prevalence 
+ 95 CI) 
Pigs  
No +/total no 
(% prevalence 
+ 95 CI) 
Other 




QLD         
   Catchment A 5/179 (2.8%- 
0.9-6.4) 
0/9 (0%- 0-33.6) NC NC 0/15 (0%- 0-
21.8) 




   Catchment B 2/194 (1%- 0.1-
3.7) 
NC NC NC 0/16 (0%- 0-26) 0/4 (0%- 0-60.2) N/C NC 
   Catchment C 5/195 (2.6- 0.8-
5.9) 


















NSW         








NC NC NC NC 
Catchment B NC NC 6/574 (1%- 0.4-
2.3) 
NC 0/5 (0%- 0-52.2) NC 0/4 (0%- 0-
60.2) 
NC 










NC 0/4 (0%- 0-
60.2) 
NC 
WA         




NC 0/7 (0%- 0-41) NC NC 
   Catchment B NC NC 12/600 (2%- 1-
3.5) 
NC NC NC NC NC 




NC NC NC NC 






NC NC NC NC NC 




NC NC NC NC 
   Catchment F NC NC 5/300 (1.7%- 
0.5-3.8) 

































Table 4.6. Most abundant Cryptosporidium species detected by NGS in different hosts and catchments across three states of Australia; NSW, QLD 
and WA. 














+ 95 CI) 
C. ubiquitum 




































+ 95 CI) 
QLD           
   Cattle 8/18 (44.4%- 
21.5-69.2) 
ND ND ND ND ND ND ND ND 10/18a 
(55.6%- 
30.8-78.5) 
   Sheep ND ND ND ND ND ND ND ND ND ND 
   Horses ND ND ND ND ND ND ND ND ND ND 
   Birds ND ND ND ND ND ND ND ND ND ND 
   Pigs ND ND ND ND ND ND ND ND ND ND 
   Wildlife ND ND ND ND ND ND ND ND ND 2/2b (100%- 
15.8-100)  
   Total 8/18 
(44.4%- 
21.5-69.2) 
ND ND ND ND ND ND ND ND 12/20 (60%- 
36.1-80.9) 
NSW           





ND N/D ND ND ND ND ND 10/19c 
(52.6%- 
28.9-75.6) 
   Sheep N/D ND ND ND ND ND ND ND ND ND 










   Rabbits N/D ND ND ND ND ND ND ND ND ND 











WA           
   Cattle 2/2 (100%- 
15.8-100) 
ND ND ND ND ND ND ND ND ND 
   Sheep ND ND ND ND ND ND ND ND ND ND 
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   Rabbits ND ND ND ND ND ND ND 7/7 (100%- 
59-100) 
ND ND 
   Pigs ND ND ND ND ND 7/7 (100%- 
59-100) 
ND ND ND ND 
Birds ND ND ND ND ND ND ND ND ND ND 






ND ND ND 7/7 (100%- 
59-100) 







           
ND = Not Detected 
aCryptosporidium muris (n = 4), Cryptosporidium galli (n = 5), rat genotype III (n = 1) 
bCryptosporidium muris (n = 2, feral deer) 
cCryptosporidium muris (n = 10) 
dCryptosporidium galli 




Relatively few large-scale studies of Cryptosporidium species in animals inhabiting 
drinking water catchments have been conducted. The present study is the largest single 
published study conducted to date globally and analysed Cryptosporidium species and subtypes 
in 5,774 animal faecal samples from catchments across three states of Australia; NSW, QLD 
and WA. As such, it provides a unique perspective on the epidemiology of Cryptosporidium in 
animals inhabiting water catchments across Australia. In the present study, the overall 
prevalence of Cryptosporidium was 18.3% (1,054/5,774; 95% CI, 17.3-19.3), with a 
prevalence of 25.9% (169/653, 95% CI; 22.6-29.4) in QLD, 17.6% (632/3,600, 95% CI; 16.3-
18.8) in WA and 16.6% (253/1,521, 95% CI; 14.8-18.6) in NSW. Previous studies in Australia 
have reported Cryptosporidium in animal faecal samples from catchments across Australia at 
varying prevalence; 5-25.8% in NSW (Power et al., 2004, 2005; Cox et al., 2005; Ryan et al., 
2005; Ng et al., 2011b; Zahedi et al., 2016b), 1.6-2.8% in Victoria (Cinque et al., 2008; Nolan 
et al., 2013; Koehler et al., 2014a, 2016) and 6.7-16% in WA (McCarthy et al., 2008; Ferguson, 
2010). All of these, with the exception of one study (Cox et al., 2005), have conducted genetic 
characterisation. The largest study was conducted in Melbourne drinking water catchments and 
screened 4,256 wildlife faecal samples between 2011-2015 (Koehler et al., 2016) and overall 
between 2009-2015, analysed 6,265 samples (Nolan et al., 2013; Koehler et al., 2016) and 
reported a prevalence of 2.8% (56/2,009) and 1.6% (69/4,256), respectively (Nolan et al., 2013; 
Koehler et al., 2016). The reason for the much lower prevalence of Cryptosporidium in 
Melbourne catchments is unclear, but it has been suggested that the low prevalence could be 
due to animal culls (resulting in lower density of animals), changing water levels of the 
reservoirs and the end of a nine-year drought (Koehler et al., 2016). 
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Several studies have examined the transport of oocysts from the site of deposition in 
catchments into surface waters used for producing drinking water (Davies et al., 2004; Atwill 
et al., 2006b; Ferguson et al., 2007; Curriero et al., 2011; Khaldi et al., 2011). However, in 
Australia, little published information is available on the prevalence of Cryptosporidium in 
source water. Analysis of Cryptosporidium monitoring data across Australia in source water 
over a period of 11-18 years by Water Research Australia (WaterRA), revealed that detection 
of total (i.e. presumptive) Cryptosporidium ranged from ~ 20% of samples from South 
Australia and WA, to ~ 15% in Melbourne and Canberra, and 2-7% in NSW (Deere et al., 
2014), suggesting that significant numbers of oocysts in faecal samples deposited in catchments 
are transported into source waters due to rainfall run-off. Another study in South Australia, 
reported a significant increase in oocyst concentrations after a rainfall event (Swaffer et al., 
2014). Transport of oocysts into drinking water will be affected by climate change, as it is 
expected to result in less winter rainfall but more extreme precipitation events during summer 
(Sterk et al., 2016). Initial modelling of the impact of climate change on runoff of 
Cryptosporidium from land to surface water suggests a complex relationship that will require 
site-specific analysis (Sterk et al., 2016), and highlights the importance of continued 
monitoring of Cryptosporidium in catchments. 
In the present study, the prevalence of mixed infection assigned to Cryptosporidium spp. 
in faecal samples collected from animals inhabiting 11 catchments across three states in 
Australia was 1.7% (98/5,774; 95% CI, 1.4-2.1). This is the first study to apply NGS in a large-
scale study to determine the prevalence of Cryptosporidium species in animal faecal samples 
with mixed Cryptosporidium infections, with up to six species identified in a single host. 
Interestingly C. parvum was not detected by Sanger sequencing in kangaroos, yet C. parvum 
and C. hominis were among the most abundant species detected in co-infections in cattle and 
kangaroos by NGS (Table 4.6 and Supplementary Table 4-S1 - Digital appendix 2). This has 
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important implications for catchment management, as animals may be shedding human-
infectious species intermittently or in lesser abundance than a dominant species, but if analysed 
by Sanger sequencing, these species may not be detected. In the present study, NGS was used 
only on samples that produced mixed chromatograms via Sanger sequencing due to cost 
constraints. Future studies should apply NGS to type all Cryptosporidium positives from 
catchments. 
Because NGS technologies are highly sensitive, allowing for the detection of low 
abundance sequences in complex DNA mixtures, the presence of cross-contamination between 
samples, or contamination from the laboratory environment has an increased potential to 
influence the taxonomic composition of samples. In addition, sequences that occur in very low 
abundances are likely to be caused by sequencing error, as errors are introduced randomly and 
are not reproduced, and are likely to be unique. Therefore, there is an intrinsic distrust of 
sequences or taxa that are present in low abundances in samples, such as some of the mixed 
Cryptosporidium infections detected in the present study. 
However, no amplified Cryptosporidium DNA was detected in no-template or extraction 
reagent blank PCR controls after both initial amplicon-generation PCR or the indexing PCR, 
indicating that any cross contamination, or contamination from the laboratory, was below the 
detectable limit for the library preparation process. In addition, sequences with less than 100 
identical replicate copies were excluded from the dataset in an attempt to mitigate sequencing 
error. Many taxa in the present study, such as C. erinacei, C. ubiquitum, C. scrofarum, C. 
ryanae, C. meleagridis, and C. bovis are only present in low abundances, and therefore their 
presence cannot be attributed to cross contamination from highly infected samples. 
Analysis of the oocyst load per gram of faeces (g-1) revealed that the highest median 
concentration of Cryptosporidium oocysts was shed by cattle; 31,072 oocyst/g-1, followed by 
rabbits (27,919 oocyst/g-1), sheep (26,756 oocyst/g-1), pigs (21,164 oocyst/g-1), kangaroos 
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(16,018 oocyst/g-1) and birds (10,032 oocyst/g-1). These values are much higher than a previous 
study, which examined a range of animal faeces in Sydney catchments and reported that the 
range of oocyst shedding concentration for cattle was <1-17,467 g-1, with medians of 0.5-23 
oocysts g-1 for adult and juvenile cattle respectively, for sheep, a range of 1-152,474 g-1 with 
medians of 148 and 275 g-1 for adults and juveniles respectively, <1-770 g-1 for pigs with a 
median of 0.5 g-1 and 1-39,423 g-1 for kangaroos with a median of 0.5 g-1 (Davies et al., 2003). 
Studies in the US reported that feedlot cattle shed 7.7 × 104 to 2.3 × 105 and 1.3 to 3.6 oocysts 
g-1 respectively (Hoar et al., 2000; Atwill et al., 2006a). This translates to 1.7 × 105 and 1.4-2.8 
× 104 oocysts/animal per day (Hoar et al., 2000; Atwill et al., 2006a). A limitation of these 
studies, is that oocyst shedding is intermittent (Xiao and Herd, 1994) and recovery rates from 
faecal samples and across animal types can be highly variable. For example, recovery rates 
ranging from 14-70% for adult cattle faeces, 0-83% for calf faeces, 4-48% for sheep faeces, 
40-73% for kangaroo faeces, and 3-24% for pig faeces have been reported (Davies et al., 2003). 
A more recent study based on qPCR, reported a range of 63 - 7.9 × 106 and a median of 3.2 × 
104 g-1 for oocysts in sheep faeces across three states (WA, NSW and South Australia) (Yang et 
al., 2014). Other studies have reported that neonatal calves can excrete up to 30 billion oocysts 
or more over a 1-2 week period (Kuczynska and Shelton, 1999) and that even apparently 
healthy animals can shed high numbers of oocysts (>5 × 106 oocysts g-1) (Chalmers and Giles, 
2010). This coupled with the very low infectious dose (10-100 oocysts) of Cryptosporidium 
(DuPont et al., 1995), has resulted in very significant numbers of oocysts entering drinking 
water supplies resulting in outbreaks e.g. the waterborne outbreak of cryptosporidiosis in 
humans in England in 2008 caused by C. cuniculus (Puleston et al., 2014). 
In the present study, oocyst numbers (g-1) were determined directly by qPCR using 
droplet digital PCR (ddPCR) calibrated standards, which obviates the need for recovery rate 
calculations and has the advantage of providing more accurate quantitation (Yang et al., 2014). 
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Unfortunately, as the population size of animal hosts are unknown in all the catchments, it is 
not possible to calculate catchment loading of oocysts. This is clearly a knowledge gap that 
needs to be addressed. 
In the present study, a total of 17 Cryptosporidium species and four genotypes were 
detected (Sanger sequencing combined with NGS). Of these, 13 are infectious to humans; C. 
parvum, C. hominis and C. meleagridis are the most common species in humans in Australia 
(Ryan and Power, 2012), C. ubiquitum and C. cuniculus are considered emerging human 
pathogens (Puleston et al., 2014; Koehler et al., 2014a; Li et al., 2015), there have been 
numerous reports of C. canis, C. felis, C. muris, C. suis, C. erinacei and C. scrofarum in humans 
(cf. Ryan et al., 2017), two reports of C. bovis (Khan et al., 2010; Ng et al., 2012) and one 
report of C. fayeri in humans (Waldron et al., 2010). This is the first report of C. erinacei in 
Australia. It was detected in cattle and kangaroo faecal samples by NGS only, where it 
accounted for 2-32% of reads (Supplementary Table 4-S1 - Digital appendix 2). As with the 
prevalence of oocysts in source water, very little is known about the species of 
Cryptosporidium in source water in Australia, but a study in South Australia identified C. 
parvum, C. muris, C. ubiquitum, C. ryanae, C. bovis, C. cuniculus (subtypes Va and Vb), C. 
fayeri, C. canis, rat genotype and mouse genotype II (Swaffer et al., 2014; King et al., 2015). 
Little is known however about the prevalence of Cryptosporidium species in source water in 
other states and future studies in this area are needed. 
In cattle, the prevalence of Cryptosporidium was high (22.3%-26.3%) across three states 
and C. parvum was the dominant species ranging from 39.1%-50.7% of samples positive for 
Cryptosporidium in cattle in each state, followed by C. bovis (17.6%-28.1%), C. muris (8.1%-
15.6%) C. hominis (4.7-14.1%), C. ubiquitum (2.7%) and C. ryanae (1.6%-19.7%). 
Cryptosporidium andersoni was not detected. Most of the cattle sampled were adult cattle and 
therefore the high prevalence of C. parvum is surprising, as other studies have suggested that 
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C. parvum dominates in pre-weaned calves but that C. bovis, C. ryanae and C. andersoni 
dominate in older cattle (Santín et al., 2008). This highlights the importance of site-specific 
analysis for accurate QMRA analysis. The C. parvum gp60 subtypes identified (IIaA15G2R1, 
IIaA16G2R1, IIaA17G2R1, IIaA18G3R1, IIaA19G2R1, IIaA19G3R1 and IIaA13G1) are 
commonly identified subtypes in humans and animals worldwide (Xiao, 2010; Feng et al., 
2013), with the exception of subtype IIaA13G1, which has previously only been detected in a 
single human patient from WA (Ng-Hublin et al., 2013). 
Cryptosporidium hominis was detected in cattle faecal samples across all three states at 
a prevalence ranging from 4.5-14.1%. Although C. hominis predominately infects humans, it 
has been previously reported in cattle in Australia (Zahedi et al., 2016b), China (Chen and 
Huang, 2012; Zhang et al., 2018), Kenya (Kang'ethe et al., 2012), Korea (Park et al., 2006), 
Malawi (Banda et al., 2009), New Zealand (Abeywardena et al., 2012), and Scotland (Smith et 
al., 2005). However, there is no molecular evidence confirming transmission of C. hominis 
between cattle and humans, and therefore more studies should be conducted to fully elucidate 
the transmission dynamics of C. hominis in cattle. In the present study, two C. hominis subtypes 
were detected in cattle; IbA10G2 and IdA15G1. Subtype IbA10G2 is a dominant subtype 
responsible for C. hominis-associated outbreaks of cryptosporidiosis worldwide (Xiao, 2010). 
Subtype IdA15G1 was identified in three cattle isolates from WA and has been detected in 
humans from Victoria with a history of gastrointestinal disorders (Koehler et al., 2013). It is 
also the dominant subtype infecting Aboriginal people in WA (Ng-Hublin et al., 2017). 
Cryptosporidium macropodum, which is currently considered non-zoonotic, was the 
dominant species in kangaroos (49.2% of samples positive for Cryptosporidium in kangaroos), 
followed by C. fayeri (27.5%). Three C. fayeri gp60 subtypes were identified; IVfA12G1T1 
and two novel subtypes; IVaA11G3T1 and IVgA10G1T1R1. The former subtype has 
previously been reported in kangaroos (Power et al., 2009), but this is the first report of 
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IVaA11G3T1 and IVgA10G1T1R1 in marsupials. The subtype identified in the first human 
patient infected with C. fayeri was IVaA9G4T1R1 (Waldron et al., 2010) and has previously 
been identified in eastern grey kangaroos from NSW catchments (Power et al., 2009). 
In addition to C. macropodum and C. fayeri, C. hominis, C. parvum, C. galli and 
kangaroo genotype I were also detected in kangaroos from NSW and WA in 13.2%, 9.2%, 
0.5% and 0.2% of positives, respectively. Unfortunately, no faecal samples from kangaroos 
were collected from QLD catchments and given the identification of C. hominis in kangaroos 
from NSW, future studies in catchment areas of QLD should include kangaroos. In NSW 
catchments, a previous study reported an overall prevalence of 5% for Cryptosporidium from 
952 animal faecal samples and 3.6% (21/576) in kangaroos (Zahedi et al., 2016b). The present 
study includes these samples and extends the analysis to include a total of 1,521 samples from 
NSW with an overall prevalence of 16.6% (95% CI, 14.8-18.6) and a prevalence of 14% (95% 
CI, 11.7-16.6) in kangaroos in NSW. The prevalence of Cryptosporidium species in Eastern 
grey kangaroo faecal samples in Sydney catchments has been analysed in several studies. The 
first genetic study (2000-2002), reported a prevalence of 6.7% (239/3,557) (Power et al., 2005) 
and identified only C. macropodum and C. fayeri in the populations (Power et al., 2004). The 
second major study (2006-2008), identified a prevalence of 16.9% (27/160) and identified C. 
macropodum (n = 2), C. parvum (n = 6), C. hominis (n = 18) and a C. parvum-like isolate (n = 
1) (Ng et al., 2011b). However, the finding of C. hominis and C. parvum in the kangaroo faecal 
samples in that study could not be confirmed at additional loci, presumably due to the low 
levels of oocysts in the samples. In the present study, C. hominis was identified by Sanger 
analysis and NGS in 5.2% (43/835; 3.8-6.9) of kangaroos screened in NSW and in the previous 
related study by Zahedi et al. (2016b), the median numbers of C. hominis/g-1 was 4,831 with a 
range of 26-16,890 g-1 (Zahedi et al., 2016b), indicating that significant numbers of oocysts 
were present in some samples. Another recent study also analysed these kangaroo-derived C. 
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hominis isolates using both Sanger and NGS (Zahedi et al., 2017). In that study, unlike C. 
parvum isolates, in which additional within-host gp60 subtype diversity was identified by NGS, 
only one C. hominis subtype was identified by both Sanger and NGS in the kangaroo-derived 
DNA samples, suggesting a single, recent introduction of C. hominis into kangaroos (Zahedi 
et al., 2017). The C. hominis in the kangaroos may have come from spill-back from humans in 
the catchments, which may have also have spilled-over to infect cattle in the catchments. The 
lack of identification of C. hominis in kangaroos in NSW catchments prior to 2011 tends to 
support this. However, only a small fraction of samples were typed in those studies and it is 
not possible to determine if even the same kangaroo populations were analysed in the previous 
studies and therefore it is impossible to draw any real inferences. Collection site coordinates of 
C. hominis positive kangaroo and cattle samples in NSW indicated that there was a 
geographical overlap between areas from which six cattle and nine kangaroo C. hominis 
positives (including both subtypes IbA10G2 and IdA15G1) were collected (S-34.61278, 
E150.58498). Cryptosporidium galli (a common bird parasite) and kangaroo genotype I, 
previously only reported in western grey kangaroos in WA (Yang et al., 2011) were also 
detected in kangaroos, but neither are considered zoonotic. 
Despite being the third most common Cryptosporidium species detected in humans in 
Australia (Ryan and Power, 2012), C. meleagridis was only detected in three bird isolates from 
WA, however very low numbers of faecal samples were collected from birds from WA (n = 7) 
and QLD (n = 9) and no samples were collected from NSW. The C. meleagridis gp60 subtype 
detected was IIIeA18G2R1, which has not been previously reported. 
Cryptosporidium cuniculus was not detected in the five samples that were collected from 
QLD, but was detected at an overall prevalence of 27.6% (60/217) in rabbits in NSW and 9.6% 
(43/450; 95% CI, 7-12.7%) in rabbits in WA. This species has been previously identified in 
rabbits, humans and a kangaroo in Australia (Nolan et al., 2010, 2013; Sari et al., 2013 
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unpublished - KF279538; Koehler et al., 2014a). It has also been linked to a number of sporadic 
human cases across the UK (Chalmers et al., 2011; Elwin et al., 2012), Nigeria (Molloy et al., 
2010) and France (ANOFEL, 2010) and was implicated in a waterborne outbreak of 
cryptosporidiosis in humans in England in 2008 (Chalmers et al., 2009; Puleston et al., 2014). 
Two distinct gp60 subtype families, designated Va and Vb have been identified in C. cuniculus 
(Chalmers et al., 2009). In the present study, all six subtypes belonged to the Vb subtype family 
(VbA18, VbA23, VbA25, VbA26, VbA28 and VbA29). Most cases described in humans relate 
to Va and the first waterborne outbreak was typed as VaA22 (Robinson et al., 2008; Chalmers 
et al., 2009), but a VbA25 variant and VbA27 have been reported in human patients in Australia 
(Sari et al., 2013 unpublished - KF279538; Koehler at al., 2014b). 
Cryptosporidium ubiquitum was the only species detected in sheep by Sanger sequencing 
(5.5%, 11.1% and 11.3% prevalence across NSW, QLD and WA respectively). It was also 
detected 33.3% of feral deer faecal samples in QLD. Cryptosporidium ubiquitum has not been 
identified in Australia in the limited typing of Australian human Cryptosporidium isolates that 
has been conducted to date (Ryan and Power, 2012), however it has been identified in surface 
waters in Australia (Monis et al., unpublished). Subtyping identified all C. ubiquitum positives 
as subtype XIIa, which has been found in humans and therefore XIIa is a potentially zoonotic 
subtype (Li et al., 2014). 
In North America, both wildlife and domestic animals contribute to contamination of 
Cryptosporidium spp. in drinking water catchments, with prevalence ranging from 6 to 20.5% 
(Feng et al., 2007; Starkey et al., 2007; Ziegler et al., 2007a, 2007b; Jellison et al., 2009; Szonyi 
et al., 2010). In those studies, the majority of Cryptosporidium spp. detected in wildlife species 
were host adapted (Feng et al., 2007; Ziegler et al., 2007a; Jellison et al., 2009), while some 
species such as C. hominis-like, C. parvum, C. ubiquitum and C. meleagridis occasionally 
detected in some hosts such as eastern gray squirrels, eastern chipmunks, beavers, woodchucks, 
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raccoons, red-backed voles, deer, geese, and deer mice (Feng et al., 2007; Ziegler et al., 2007a; 
Jellison et al., 2009). In the present study, the majority of samples collected from non-domestic 
species were from kangaroos and rabbits and the most significant difference between the 
findings of the present study and studies conducted in North America, is the identification of 
C. hominis and C. parvum in wildlife (kangaroo) populations. In North American catchments, 
C. parvum, C. bovis, C. ryanae and C. andersoni are the most commonly reported 
Cryptosporidium in cattle faeces (Starkey et al., 2007; Sznoyi et al., 2010). With the exception 
of C. andersoni, these species were also detected in cattle faeces in the present study, along 
with C. hominis. Further studies are required to understand the source and human health 
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Risk assessment and risk management of the drinking water supply in relation to 
Cryptosporidium is based, firstly, on identifying the sources of these pathogens, and secondly,  
whether they are human-infectious or not. Management priorities can then focus on these sites, 
especially those that input oocysts that may be infectious to humans. However, current methods 
to screen for protozoans generally rely on fluorescence microscopy (EPA method 1623), which 
is time-consuming and does not identify species. In this chapter advanced molecular tools were 
employed to conduct for the first time in Australia, a comprehensive quantitative survey of 
species and genotypes of Cryptosporidium in the dominant animals inhabiting water catchment 
areas across NSW, QLD and WA. This involved analysing a total of 5,774 animal faecal 
samples including 1,521 samples from two drinking water catchments in NSW, 653 samples 
from three catchments in QLD, and 3,600 samples from six catchments in WA. The overall 
prevalence of Cryptosporidium was higher than previously reported from Australia and the 
majority of species detected are of public health significance. The significant findings were the 
detection of C. hominis in cattle and kangaroos, and the high prevalence of C. parvum in cattle. 
In addition, two novel C. fayeri subtypes and one novel C. meleagridis subtype were identified, 
and C. erinacei was reported for the first time in Australia. Conclusive molecular evidence 
linking contamination of water supplies by animals in catchments with outbreaks of 
cryptosporidiosis in human populations is scant. However, several studies have strongly linked 
outbreaks of cryptosporidiosis with sheep and cattle grazing near the implicated reservoir, 
catchment or river. This intensifies during extreme ecological events such as rainstorms and 
snowmelt, which usually lead to run-off from the environment and can increase the pollution 
of surface water with animal excreta. Therefore, Cryptosporidium from animals may end up in 
public water supplies at levels that could pose a risk to human health and cause a public health 
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problem. This magnifies the importance of the identification and quantification of zoonotic 
Cryptosporidium species in animals contaminating catchment areas in the present study for 
optimal catchment management. Data from this study, will lead to a better understanding of 
epidemiology and transmission dynamics of Cryptosporidium species across catchments 
investigated in the present project. However, further studies are required to document loads of 
Cryptosporidium oocysts transported to raw water, oocyst viability and the effectiveness of 
treatment processes to inactivate or remove oocysts, so that more robust risk assessments can 
be undertaken. 
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This chapter consists of a manuscript entitled “Profiling the diversity of Cryptosporidium 
species and genotypes in wastewater treatment plants in Australia using Next Generation 
Sequencing”, which has been published in Science of the Total Environment for publication 
(see Appendix 6). In Chapter four, zoonotic Cryptosporidium species in animal faecal samples 
collected from drinking water catchments across three states in Australia were identified and 
analysed. In this Chapter, the methodology and molecular data described in Chapter four is 
built upon, however it focuses on the screening, quantification and characterisation of 
Cryptosporidium species in wastewater treatment plant (WWTP) influent samples. For the first 
time, NGS was utilised on a large scale, to more accurately determine the prevalence and 
composition of Cryptosporidium species in WWTPs (aims 1-4 of the present thesis). 
 
5.2 Statement of contribution 
 
As first author in this paper, AZ processed all the samples, conducted all the labwork, analysed 
the data, interpreted the findings and wrote the first and final draft of the manuscript. AG and 
TG assisted with preparation of samples for NGS and data analysis. PM and CO contributed 
to data analysis and manuscript preparation. AB, AB and AW provided logistic support to the 
project, organised samples collection from other states (NSW, QLD and WA) and reviewed 
and edited the manuscript. IR validated statistical analysis. UR managed and supervised the 
project, was directly involved in project administration, conceptualisation, funding acquisition, 
methodology, data analysis and validation, and critically revised the manuscript. All authors 





Wastewater recycling is an increasingly popular option in worldwide to reduce pressure on 
water supplies due to population growth and climate change. Cryptosporidium spp. are among 
the most common parasites found in wastewater and understanding the prevalence of human-
infectious species is essential for accurate quantitative microbial risk assessment (QMRA) and 
cost-effective management of wastewater. The present study conducted next generation 
sequencing (NGS) to determine the prevalence and diversity of Cryptosporidium species in 
730 raw influent samples from 25 Australian wastewater treatment plants (WWTPs) across 
three states: New South Wales (NSW), Queensland (QLD) and Western Australia (WA), 
between 2014 and 2015. All samples were screened for the presence of Cryptosporidium at the 
18S rRNA (18S) locus using quantitative PCR (qPCR), oocyst numbers were determined 
directly from the qPCR data using DNA standards calibrated by droplet digital PCR, and 
positives were characterized using NGS of 18S amplicons. Positives were also screened using 
C. parvum and C. hominis specific qPCRs. The overall Cryptosporidium prevalence was 11.4% 
(83/730): 14.3% (3/21) in NSW; 10.8% (51/470) in QLD; and 12.1% (29/239) in WA. A total 
of 17 Cryptosporidium species and six genotypes were detected by NGS. In NSW, C. hominis 
and Cryptosporidium rat genotype III were the most prevalent species (9.5% each). In QLD, 
C. galli, C. muris and C. parvum were the three most prevalent species (7.7%, 5.7%, and 4.5%, 
respectively), while in WA, C. meleagridis was the most prevalent species (6.3%). The oocyst 
load/Litre ranged from 70 to 18,055 oocysts/L (overall mean of 3,426 oocysts/L: 
4,746 oocysts/L in NSW; 3,578 oocysts/L in QLD; and 3,292 oocysts/L in WA). NGS-based 
profiling demonstrated that Cryptosporidium is prevalent in the raw influent across Australia 
and revealed a large diversity of Cryptosporidium species and genotypes, which indicates the 




Australia is the driest of the world's inhabited continents, with the lowest percentage of 
rainfall as run-off and the lowest amount of water in rivers (Anonymous, 2004). Drinking water 
resources are under considerable strain as a result of major shifts in long-term climate change, 
and climate predictions for all Australian States and Territories suggest increasing 
temperatures, a decline in average rainfall, but increasing severity and frequency of storm 
events (Garnaut Review, 2008). Consequently, there is increasing pressure for more efficient 
use of water resources, both in urban and rural environments (Toze, 2006a). Recycling 
wastewater will help address these challenges and is a prominent option among the various 
alternative sources of water in both developing and developed countries (Miller, 2006; Mekala 
and Davidson, 2016). However, infection with pathogenic microorganisms is a major risk 
factor (Rodriguez-Manzano et al., 2012) and therefore water destined for reuse must be fit for 
purpose (Toze, 2006b). 
The waterborne parasite Cryptosporidium represents an important public health concern 
for water utilities, as it is a major cause of diarrhoea and there is neither a vaccine nor an 
effective treatment (Ryan et al., 2016; Zahedi et al., 2016a). Cryptosporidium is particularly 
suited to waterborne transmission as the oocyst stage is highly resistant to chlorine disinfection 
and can penetrate and survive routine water and wastewater treatment systems (King and 
Monis, 2007; King et al., 2017; Ryan et al., 2017a). The parasite has been responsible for 
numerous large-scale waterborne outbreaks worldwide (Efstratiou et al., 2017) and is highly 
prevalent in wastewater (Amorós et al., 2016; Ma et al., 2016). 
Cryptosporidium species are currently monitored in wastewater using standard detection 
methodologies (i.e. fluorescence microscopy using EPA method 1623 - USEPA, 2012), 
however, this method cannot discriminate between different Cryptosporidium species. Of the 
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37 recognised Cryptosporidium species, C. hominis and C. parvum are the dominant species 
that infect humans (Ryan et al., 2016; Zahedi et al., 2017a; Čondlová et al., 2018; Kváč et al., 
2018). As not all species of Cryptosporidium are infectious to humans (Ryan et al., 2016), 
understanding the diversity of Cryptosporidium in wastewater is crucial for more accurate 
quantitative microbial risk assessment (QMRA), for proper management of wastewater and its 
recycling. Due to the complex composition, abundance, and distribution patterns of 
Cryptosporidium species present in wastewater samples, molecular techniques such as 
conventional PCR and Sanger sequencing-based genotyping methods are unable to resolve 
complex DNA mixtures due to mixed sequencing chromatograms and are also unable to detect 
low abundance species or variants of Cryptosporidium (which typically appear as a “bumpy 
baseline” in Sanger chromatograms) (Murray et al., 2015; Paparini et al., 2015; Grinberg and 
Widmer, 2016). 
Next-generation sequencing (NGS) technologies have allowed the comprehensive 
characterization and deep coverage of microbial community structure and diversity in 
environmental samples such as soil, water, the atmosphere and other environments (Cruaud et 
al., 2014). NGS is also more sensitive for the detection of less abundant species within 
microbial communities (Salipante et al., 2013). Recently, NGS approaches have been described 
that examine the composition and diversity of microbial communities (Shanks et al., 2013; Ma 
et al., 2015; Newton et al., 2015; Xu et al., 2017), adenovirus (Ogorzaly et al., 2015), norovirus 
(Prevost et al., 2015), astrovirus (Brinkman et al., 2013) and protists (Maritz et al., 2017) in 
sewage. However, to the best of the authors' knowledge, to date no large scale longitudinal 
studies have been undertaken to investigate the composition and diversity of Cryptosporidium 
species in wastewater using high-throughput amplicon NGS. As the costs of NGS continue to 
decrease and the bioinformatics analysis of data continues to improve, NGS screening of 
wastewater samples has become more feasible (Muir et al., 2016). 
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Therefore, the aim of the present study was to use NGS, for the first time on a large scale, 
to more accurately determine the prevalence and composition of Cryptosporidium species in 
Australian WWTPs across three states: New South Wales (NSW), Queensland (QLD) and 
Western Australia (WA). 
 
5.5 Materials and methods 
 
5.5.1 Study sites and sample collection 
 
In NSW, WWTP samples (250 mL raw influent) were collected on a monthly interval 
over five months (April 2015 to August 2015). A total of 21 WWTP samples were collected 
from four wastewater plants within the WaterNSW area of operations (greater Sydney) (Table 
5.1). In QLD, a total of 470 WWTP samples (250 mL raw influent) were collected on 
fortnightly intervals from WWTP sites (n = 19) across south east Queensland (Table 5.1) over 
a year (January 2014 to January 2015). In WA, a total of 239 WWTP samples (250 mL raw 
influent) were collected from two treatment plants on weekly intervals from December 2014 
to December 2015 (Table 5.1). All raw influent WWTP samples were collected into individual 
250 mL collection pots and stored at 4 °C until required and samples collected in NSW and 
QLD were shipped to Murdoch University for analysis.
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Table 5.1. Wastewater treatment plants (WWTPs) included in the present study. 
 Type of plant Rural/urban 
plant 












around the plant 
QLD         
Plant A Trickle filter Rural Domestic/some 
commercial 
9,000 Not received NA Yes Yes (Cattle in neighbouring 
properties) 
Plant B Lagoon Rural Domestic/some 
commercial 
500 Not received NA Yes Yes (Cattle in neighbouring 
field/ wildlife, 
kangaroo/koalas) 




1,000 Not received NA Yes Yes (Bats) 
Plant D Activated sludge Rural Principally 
domestic 





Plant E Activated sludge Urban Principally 
domestic 
45,000 Significant 





Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
Plant F Activated sludge Rural Principally 
domestic 
1,000 Small portion is 
trade waste 
Restaurant waste Yes WWTP in rural area with 
cattle grazing adjacent but 
no linkage to plant inflow. 
Plant G Activated sludge Rural Principally 
domestic 




Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
Plant H Activated sludge Rural Principally 
domestic 
12,500 Insignificant 





sending waste to 
WWTP 
Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
Plant I Activated sludge Rural Principally 
domestic 
2,400 Insignificant 
portion is trade 
waste 
Industrial waste Yes WWTP in rural area with 
cattle grazing adjacent but 
no linkage to plant inflow. 
Plant J Activated sludge Urban Principally 
domestic 
118,000 Significant 
portion is trade 
waste 
Restaurant waste Yes No 
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Plant K Activated sludge Urban Principally 
domestic 
60,000 Small portion is 
trade waste 
Seafood waste Yes No 
Plant L Activated sludge Rural Principally 
domestic 
126,000 Significant 





Plant M Activated sludge Rural Decommissioned 
(August 2014) 
NA NA NA Yes N/A 
Plant N Activated sludge Rural Principally 
domestic 




Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 




300 Small portion is 
trade waste 
Restaurant waste Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
Plant P Activated sludge Rural Principally 
domestic 
43,000 Significant 






Plant Q Activated sludge Rural Principally 
domestic 
47,000 Small portion is 
trade waste 
Restaurant waste Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
Plant R Activated sludge Urban Principally 
domestic 
5,000 Small portion is 
trade waste 
Restaurant waste Yes No 
Plant S Activated sludge Rural Principally 
domestic 
26,000 Small portion is 
trade waste 
Restaurant waste Yes WWTP adjoined to scrub 
area with possible animal 
activity, i.e. kangaroos etc. 
but no linkage to plant 
inflow. 
NSW         
Plant A Oxidation ditch 
(Pasveer), sludge 
lagoons 
Urban Domestic and 
industrial 





Yes Yes (Native wildlife 





Plant B IDEA tank, 
oxidation ditch 
(Pasveer) (not in 
operation), sludge 
drying / lagoons 
Urban Domestic and 
industrial 







Yes Yes (Native wildlife 
(wombats, kangaroos and 
birds )) 
Plant C IDEA tank, 
sludge drying/ 
lagoons 
Urban Domestic and 
industrial 







Yes Yes (Native wildlife 
(wombats, kangaroos and 
birds )) 




Urban Domestic and 
industrial 







Yes Yes (Native wildlife 
(wombats, kangaroos and 
birds )) 
WA         
Plant A Activated sludge Urban Principally 
domestic (but also 
receives industrial 
waste through the 
sewer network) 
75,000 Received Septage and 
grease trap 
waste, abattoir 
and farm waste 
(through third 
party tankers) 
Yes Limited (foxes, feral cats, 
birds and snakes 
Plant B Pond system Urban Domestic 5,000 Not received NA Yes Cattle, kangaroos and birds 
(turtles snakes and birds live 
in the ponds) 
         
NA = Not Available. 
IDEA = Intermittently Decanted Extended Aeration. 
IDAL = Intermittently Decanted Aerated Lagoons. 
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5.5.2 Sample proceeding and DNA isolation 
 
All 250 mL WWTP samples were transferred to 50 mL centrifuge tubes, and evenly 
weighed tubes (n = 5) were prepared from the same samples. These samples were centrifuged 
at 10,000 ×g for 20 min and pellets from the same samples were mixed together again. DNA 
was extracted from aseptically separated 250 mg aliquots of each sample (pellet), using a Power 
Soil DNA Kit (MO BIO, Carlsbad, California, USA) (Walden et al., 2017). An extraction blank 
(no WWTP sample) and a positive extraction control (a Cryptosporidium positive faecal 
sample from a kangaroo), was included in each extraction batch, as a process control for 
extraction efficiency. Purified DNA was stored at −20 °C prior to molecular analyses. 
 
5.5.3 qPCR and oocyst enumeration 
 
All WWTP sample extracts were screened for the presence of Cryptosporidium at the 
18S rRNA (18S) locus using a quantitative PCR (qPCR) as previously described (King et al., 
2005; Yang et al., 2014). A spike analysis of the 18S qPCR assay (addition of 0.5 μL of positive 
control DNA into test samples) was conducted on randomly selected negative samples from 
each group of DNA extractions, to determine if negative results were due to PCR inhibition by 
comparing the cycle threshold (Ct) values of the spike and the positive control (both with same 
concentration of DNA). In addition, Cryptosporidium oocyst concentrations in each sample 
(oocyst numbers per litre) were determined directly from the qPCR data using DNA standards 
calibrated by droplet digital PCR (ddPCR) (QX100™ droplet digital PCR system, Bio-Rad), 
which has the advantage of providing more accurate quantitation (Yang et al., 2014). Briefly, 
target copy numbers of the 18S gene detected in individual samples were converted to estimates 
of oocyst numbers based on the fact that the 18S gene in Cryptosporidium has five copies per 
haploid sporozoite (Le Blancq et al., 1997; Abrahamsen et al., 2004), and there are four haploid 
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sporozoites per oocyst. Therefore, every 20 copies of 18S detected by qPCR were equivalent 
to one oocyst. To estimate oocyst density per litre, oocyst numbers detected per 250 mg aliquots 
of each sample (pellet) were extrapolated to the corresponding total pellet weight extracted 
from each 250 mL wastewater sample, and then multiplied by four. 
 
5.5.4 Next Generation Sequencing (NGS) 
 
Samples that were positive by qPCR were analysed by NGS on the MiSeq (Illumina) 
platform at the 18S locus using the 18S iF/iR primers (Morgan et al., 1997) that were modified 
to contain MiSeq adapter sequences on the 5′ and 3′ end as previously described (Paparini et 
al., 2015). The library was prepared as per standard protocols for the MiSeq platform (Illumina 
Demonstrated Protocol: 16S Metagenomic Sequencing Library Preparation) with the following 
modifications: all PCR amplicons (uniquely indexed per sample) were double purified using 
the Agencourt AMPure XP Bead PCR purification protocol (Beckman Coulter Genomics, 
USA) and pooled in approximate equimolar ratios (based on gel electrophoresis). Sequencing 
was performed on an Illumina MiSeq using 500-cycle V2 chemistry (250 bp paired-end reads) 
following the manufacturer's recommendations. Two no-template controls and two DNA 
extraction reagent blank controls were included in the library preparation and distributed 
between samples in the PCR plate layout. All no-template and extraction reagent blank controls 
produced no detectable amplification of Cryptosporidium DNA throughout the library 
preparation. This indicated that level of cross contamination between samples, or from the 
laboratory environment, was below the detection limit of the library preparation procedure and 
for this reason were not sequenced. We have also previously sequenced extraction blanks and 
no-template controls from other NGS studies in our laboratory, and after quality filtering, <10 
reads were detected in those samples. 
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5.5.5 Species-specific PCR for detection and enumeration of C. hominis and C. parvum 
 
All WWTP samples positive for Cryptosporidium spp. by qPCR at the 18S locus were 
also screened and enumerated independently using primers and species-specific minor groove 
binder (MGB) probes to a unique Cryptosporidium specific gene (Clec) that codes for a novel 
mucin-like glycoprotein that contains a C-type lectin domain to confirm the presence/absence 
of C. hominis and C. parvum as described by Yang et al. (2013). 
 
5.5.6 Statistical analysis 
 
The overall prevalence of Cryptosporidium in samples collected from each WWTP was 
expressed as the percentage of samples positive by combined qPCR and NGS, with 95% 
confidence intervals calculated assuming a binomial distribution, using the software 
Quantitative Parasitology 3.0 (Rózsa et al., 2000). DNA extraction efficiency was estimated 
for each extraction, based on the number of the gene copies/oocyst equivalents measured by 
ddPCR. Odds ratios (OR) and their 95% confidence intervals were used to measure the strength 
of association of season (risk factor) with the occurrence of the Cryptosporidium species in 
WWTP samples. Chi-square and non-parametric analyses were performed using IBM SPSS 
21.0 (statistical package for the social sciences) for Windows (SPSS Inc. Chicago, USA) to 
determine if there were any associations between the prevalence and concentration of 
Cryptosporidium oocysts at different sampling seasons and across states. 
 
5.5.7 Bioinformatics analysis 
 
Illumina MiSeq sequencing resulted in 1,068,270,250 bp paired-end reads with 78% of 
the basecalls >Q30. Paired-end reads were merged and quality filtered with USEARCH v9.2 
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(Edgar, 2010), retaining reads with >50 bp merged overlap, <0.1% expected error, no 
mismatches in the primer sequences, a minimum length of 200 bp, and a minimum of 100 
identical replicate copies as previously described (Zahedi et al., 2017b). Primer sequences and 
any distal bases were also removed from all reads. Reads were then denoised and chimera 
filtered with the UNOISE3 algorithm (Edgar, 2016) to generate 169 zero-radius operational 
taxonomic units (ZOTUs) that represent unique biologically correct sequences (Edgar, 2016). 
Cryptosporidium 18S ZOTU sequences were assigned taxonomy by comparing ZOTUs to a 
curated custom database containing 63 reliable 18S reference sequences from 35 
Cryptosporidium species and 28 genotypes extracted from GenBank using the Basic Local 
Alignment Search Tool (BLAST) (Altschul et al., 1990). Taxonomy was only assigned if there 
was a single unambiguous BLAST hit with >99% pairwise identity over >98% of the query 
ZOTU sequence. Of the 169 ZOTUs generated, 62 did not match any known Cryptosporidium 
species or genotypes. These non-specific ZOTUs were compared to GenBank using BLAST, 
and where possible, taxonomy was assigned when queries hit reference sequences with >99% 
identity over >98% of the query reads and matched to no other taxa at the same level. Many of 
these non-specific ZOTUs were assigned to uncultured eukaryotes or benign waterborne fungi, 
algae and dinoflagellates (Supplementary Table 5-S1 - Digital appendix 3). Although abundant 
at the ZOTU level, these non-specific sequences represented a very small proportion of the 




5.6.1 Overall prevalence of Cryptosporidium in WWTP samples 
 
In the present study, a total of 730 WWTP samples from 25 WWTPs across three states 
in Australia (NSW, QLD and WA) were screened using qPCR, and the composition of 
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Cryptosporidium species in positive samples was determined by NGS. Results were tabulated 
as the prevalence of the most abundant single species (determined by NGS), detected per 
sample (Table 5.2) and the prevalence of all Cryptosporidium species detected across all 
samples regardless of their abundance (Table 5.3). Overall, Cryptosporidium was detected in 
11.4% (83/730; 95% CI, 9.2–13.9) of WWTP samples collected across three states. (Table 5.4 
and Supplementary Table 5-S1 - Digital appendix 3). This comprises a prevalence of 14.3% 
(3/21; 95% CI, 3–36.3) in NSW, 10.8% (51/470; 95% CI, 8.2–14) in QLD and 12.1% (29/239; 
95% CI, 8.3–17) in WA. However, there was no significant difference between the prevalence 
in different states (p > 0.05). In general, across the three states, samples collected in summer 
were 1.9 times more likely to have Cryptosporidium than samples collected during winter 
months (Odds ratio = 1.9; 95% CI, 1.2–3.4), but there was no statistical difference between 
samples collected in spring, winter and autumn (p > 0.05). For NSW, samples were only 
collected for autumn and winter. 
In QLD, the prevalence of Cryptosporidium peaked at 17.5% (18/103; 95% CI, 10.7–
26.2) during summer months (averaged over two partial summers; 2014 and 2015), when the 
samples were 2.3 times more likely to have Cryptosporidium than samples collected during 
winter months (averaged over winter 2014 and 2015) (Odds ratio = 2.3; 95% CI, 1.2–5.2). 
There was no significant difference between the prevalence in spring, autumn and winter 
(p > 0.05). Unlike QLD, WA had the highest prevalence of Cryptosporidium in WWTP 
samples collected during spring (16.8%; 95% CI, 8.3–28.5), while there was no significant 
difference between the prevalence in summer, autumn and winter (p > 0.05). Although the 
prevalence of different species peaked at different times (Supplementary Table5-S1 - Digital 
appendix 3), in WA (Plant A), there was a winter peak in both C. parvum and rate genotype 1 
and a spring peak for C. felis, and in plant B, there was a summer peak for C. suis 
(Supplementary Table5-S1 - Digital appendix 3). 
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Table 5.2. Prevalence of the most abundant Cryptosporidium species detected by NGS of individual wastewater treatment plant (WWTP) samples across 
three states of Australia; NSW, QLD and WA (based on a single species that was the most abundant species detected in each sample). 
























+ 95% CI) 
C. meleagridis 
No +/total no 
(% proportion 
+ 95% CI) 
C. galli 
 No +/total 
no (% 
proportion 















+ 95% CI) 
C. macropodum 
No +/total no 






+ 95% CI) 
QLD             
Plant A ND ND ND 1/25 (4%, 
0.1-20.4) 
ND ND 1/25 (4%, 
0.1-20.4) 
ND ND ND ND ND 
Plant B ND ND ND ND ND ND ND ND ND ND ND 2a/20 
(10%, 1.2-
31.7) 






ND ND ND ND 
Plant D 1/41 (2.4%, 
0.1-12.9) 
ND ND ND ND ND ND ND 1/41 
(2.4%, 0.1-
12.9) 
ND ND ND 






ND 7/41 (17%, 
7.2-32.1) 
ND ND ND ND ND 











ND ND ND 
Plant G 2/41 (4.9%, 
0.6-16.5) 
ND ND 1/41 
(2.4%, 0.1-
12.9) 
ND ND 2/41 
(4.9%, 0.6-
16.5) 
ND ND ND ND ND 
Plant H 1/41 (2.4%- 
0.1-12.9) 






ND ND ND ND ND 
Plant I ND ND ND ND ND ND 1/41 
(2.4%, 0.1-
12.9) 
ND ND ND ND ND 
Plant J ND ND 1/41 
(2.4%, 0.1-
12.9) 




Plant K ND ND ND ND ND ND 5/41 
(12.2%, 
4.1-26.2) 
ND ND ND ND ND 
Plant L ND ND ND ND ND ND ND ND ND ND ND ND 
Plant M ND ND ND 1/7 
(14.3%, 
0.4-57.9) 
ND ND ND ND ND ND ND ND 
Plant N ND ND ND ND ND ND ND ND 1/4 (25%, 
0.6-80.6) 
ND ND ND 
Plant O ND ND ND ND ND ND 1/4 (25%, 
0.6-80.6) 
ND ND ND ND ND 
Plant P ND ND ND ND ND ND 1/4 (25%, 
0.6-80.6) 
ND ND ND ND ND 
Plant Q ND ND ND ND ND ND 1/4 (25%, 
0.6-80.6) 
ND ND ND ND ND 
Plant R ND ND ND ND ND ND ND ND ND ND ND ND 
Plant S ND ND ND ND ND ND ND ND ND ND ND ND 
























NSW             
Plant A ND ND ND ND ND ND ND ND ND ND ND ND 
Plant B 1/5 (20%, 
0.5-71.6) 
ND ND ND ND ND ND ND ND ND ND ND 
Plant C ND 1/5 (20%, 
0.5-71.6) 
ND ND ND ND ND ND ND ND ND ND 
Plant D ND 1/6 
(16.7%, 
0.4-64.1) 
ND ND ND ND ND ND ND ND ND ND 





ND ND ND ND ND ND ND ND ND ND 
WA             
Plant A 3/146 (2.1%, 
0.4-5.9) 
ND ND ND ND 7/146 (4.8%, 
1.9-9.6) 
ND ND 5/146 
(3.4%, 1.1-
7.8) 
ND ND 6b/146 
(4.1%, 1.5-
8.7) 
Plant B ND ND ND ND ND 6/93 (6.5%, 2.4-
13.5) 









   Total 3/146 
(2.1%, 0.4-
5.9) 
ND ND ND ND 13/239 (5.4%, 
2.9-9.1) 











ND = Not Detected. 
arat genotype I (n = 1), rat genotype II (n = 1). 
brat genotype I (n = 2), rat genotype II (n = 2), rat genotype III (n = 1), kangaroo genotype I (n = 1). 
ckangaroo genotype I (n = 3). 
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Table 5.3. Prevalence of all Cryptosporidium species/genotypes detected by NGS in wastewater treatment plant (WWTP) samples across three 
states of Australia; NSW, QLD and WA (regardless of abundance). 
Cryptosporidium spp. No +/total no (% proportion+ 95% CI) 
NSW QLD WA 
C. hominis 2/21 (9.5%; 95% CI, 1.2-30.4) 2/470 (0.4%; 95% CI, 0.1-1.5) ND 
C. parvum 1/21 (4.8%; 95% CI, 0.1-23.8) 21/470 (4.5%; 95% CI, 2.8-6.7) 3/239 (1.3%; 95% CI, 0.3-3.6) 
C. avium  ND 2/470 (0.4%; 95% CI, 0.1-1.5) ND 
C. bovis ND 5/470 (1.1%; 95% CI, 0.3-2.5) ND 
C. canis ND 1/470 (0.2%; 95% CI, 0-1.2) ND 
C. cuniculus ND 1/470 (0.2%; 95% CI, 0-1.2) ND 
C. erinacei 1/21 (4.8%; 95% CI, 0.1-23.8) 14/470 (3.0%; 95% CI, 1.6-4.9) 3/239 (1.3%; 95% CI, 0.3-3.6) 
C. fayeri ND 1/470 (0.2%; 95% CI, 0-1.2) ND 
C. felis ND 4/470 (0.8%; 95% CI, 0.2-2.2) 5/239 (2.1%; 95% CI, 0.7-4.8) 
C. galli 1/21 (4.8%; 95% CI, 0.1-23.8) 36/470 (7.7%; 95% CI, 5.4-10.4) ND 
C. macropodum ND 3/470 (0.6%; 95% CI, 0.1-1.9) 1/239 (0.4%; 95% CI, 0-2.3) 
C. meleagridis ND ND 14/239 (5.9%; 95% CI, 3.2-9.6) 
C. muris 1/21 (4.8%; 95% CI, 0.1-23.8) 27/470 (5.7%; 95% CI, 3.8-8.2) 1/239 (0.4%; 95% CI, 0-2.3) 
C. ryanae ND 3/470 (0.6%; 95% CI, 0.1-1.9) ND 
C. scrofarum ND 3/470 (0.6%; 95% CI, 0.1-1.9) 2/239 (0.8%; 95% CI, 0.1-3) 
C. suis 1/21 (4.8%; 95% CI, 0.1-23.8) 11/470 (2.3%; 95% CI, 1.2-4.1) 1/239 (0.4%; 95% CI, 0-2.3) 
C. ubiquitum ND 2/470 (0.4%; 95% CI, 0.1-1.5) ND 
bat genotype VI ND 1/470 (0.2%; 95% CI, 0-1.2) ND 
kangaroo genotype I ND 1/470 (0.2%; 95% CI, 0-1.2) 4/239 (1.7%; 95% CI, 0.5-4.2) 
rat genotype I ND 9/470 (1.9%; 95% CI, 09.1-3.6) 2/239 (0.8 %; 95% CI, 0.1-3) 
rat genotype II ND 5/470 (1.1%; 95% CI, 0.3-2.5) 2/239 (0.8%; 95% CI, 0.1-3) 
rat genotype III 2/21 (9.5%; 95% CI, 1.2- 30.4) 4/470 (0.8%; 95% CI, 0.2-2.2) 2/239 (0.8%; 95% CI, 0.1-3) 
rat genotype IV ND 2/470 (0.4%; 95% CI, 0.1-1.5) ND 
ND = Not Detected. 
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Table 5.4. Seasonal prevalence, the mean and median Cryptosporidium oocyst concentration in positive samples per litre (mean, median with 
range in parenthesis (determined by qPCR) per season across three states of Australia; NSW, QLD and WA). 
 Summer Autumn Winter Spring Overall 
 
State 
































No +/total no 
(% proportion 



































































































NC = Not Collected. 
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5.6.2 Prevalence of all Cryptosporidium species/genotypes as determined by NGS 
(regardless of abundance) 
 
A total of 17 Cryptosporidium species and six genotypes were detected by NGS (Table 
5.3, and Supplementary Table 5-S1 - Digital appendix 3). Cryptosporidium hominis and rat 
genotype III were the most prevalent species detected in wastewater samples collected from 
NSW (9.5% each, 2/21; 95% CI, 1.2–30.4). In addition to C. hominis and rat genotype III, C. 
parvum was detected in one NSW sample only (4.8%, 1/21; 95% CI; 0.1–23.8) and C. erinacei, 
C. galli, C. muris and C. suis were also detected in the same sample in low abundance (Table 
5.3 and Supplementary Table 5-S1 - Digital appendix 3). In QLD, of the 51 WWTP samples 
positive for Cryptosporidium, NGS detected more than one Cryptosporidium species/genotype 
in 42 samples, ranging from two to eight species in individual samples, whereas in nine 
samples, only one Cryptosporidium species/genotype was identified. In general, the prevalence 
of different Cryptosporidium species/genotypes detected by NGS in WWTP samples across 
QLD ranged from 0.2% to 7.7% (Table 5.3). Cryptosporidium galli (7.7%), C. muris (5.7%) 
and C. parvum (4.5%) were the three most prevalent (and abundant) species detected in WWTP 
samples from QLD, followed by C. erinacei (3.0%), C. suis (2.3%) and rat genotype I (1.9%) 
(Table 5.3), and were significantly more prevalent than all other species detected in samples 
from QLD (p < 0.05) (Table 5.3). Unlike QLD, the majority of samples positive for 
Cryptosporidium in WA (22/29) contained only one species/genotype of Cryptosporidium 
(75.9%; 95% CI, 56.5–89.7), and only seven samples were identified with mixed 
Cryptosporidium species present (24.1%; 95% CI, 10.3–43.5). Cryptosporidium meleagridis 
was detected in 5.9% (15/239; 95% CI, 3.2–9.6) of wastewater samples collected from WA, 
and was significantly more prevalent than any other species detected (p < 0.05). However, there 
was no significant difference between the prevalence of other Cryptosporidium species 
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detected in WA samples (p > 0.05). Cryptosporidium C. parvum (1.3%), C. erinacei (1.3%), 
C. scrofarum (0.8%) and C. muris (0.4%) were detected at a low prevalence only in samples 
with mixed Cryptosporidium species/genotypes in WA (Table 5.3 and Supplementary Table 5-
S1 - Digital appendix 3). 
 
5.6.3 Abundance and diversity of all Cryptosporidium reads determined by NGS 
 
Overall, the highest number of reads (sequences) across the 83 WWTP samples positive 
for Cryptosporidium was assigned to C. galli (22.8% of all sequences analysed). This was 
followed by C. meleagridis (15.7%), C. muris (11.9%), C. felis (8.7%), C. parvum (6.8%), 
kangaroo genotype I (JF316651) (4.9%), C. macropodum (4.5%), rat genotype I (3.9%), rat 
genotype II (2.9%), C. hominis (2.5%), C. erinacei (2.5%), rat genotype III (2.1%), C. suis 
(1.7%), C. bovis (0.8%), C. scrofarum (0.5%), C. canis (0.4%), C. fayeri (0.3%), C. cuniculus 
(0.2%), C. avium (0.2%), C. ubiquitum (0.1%), C. ryanae (0.1%), rat genotype IV (0.1%) and 
bat genotype VI (0.1%) (Supplementary Table 5-S1 - Digital appendix 3 and Fig 5.1). There 
were also a small proportion of NGS sequences (6.1%), across 11 samples, that were not 
assigned to any Cryptosporidium species or genotypes (Supplementary Table 5-S1 - Digital 
appendix 3 and Fig 5.1). In general, at the individual sample level across the three states, the 
number of species identified in individual wastewater samples ranged from one to eight 
species. 
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Fig 5.1. Percent composition of 18S sequences from Cryptosporidium species detected in 
wastewater treatment plant samples from NSW, QLD and WA. 
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5.6.4 Additional confirmation of presence/absence and enumeration of C. hominis and 
C. parvum in WWTP samples using a species-specific qPCR 
 
Of 83 WWTP samples positive for Cryptosporidium spp. NGS detected C. parvum and 
C. hominis in 25 and four samples, respectively, including two samples that contained both 
species (QLD-E76 and QLD-G115) (Table 5.3, Table 5.5 and Supplementary Table 5-S1 - 
Digital appendix 3). A C. parvum species-specific qPCR assay confirmed the presence of C. 
parvum in 20/25 samples, but failed to amplify the remaining five samples, which were 
previously identified by NGS to contain C. parvum sequences in low abundance, ranging from 
113 to 535 reads (Table 5.5). The occurrence of C. hominis in 3/4 WWTP samples was also 
confirmed a C. hominis-specific qPCR, with no C. hominis amplification in a single sample 
which was previously confirmed by NGS to contain C. hominis in low abundance (QLD-E76) 
(Table 5.5 and Supplementary Table 5-S1 - Digital appendix 3). The concentration of C. 
hominis and C. parvum oocysts per litre in these samples ranged from 386 to 3294 and from 
14 to 6314, respectively (Table 5.5). The absence of C. hominis and C. parvum in the remaining 
samples (n = 56) was confirmed by the C. hominis and C. parvum species-specific qPCR assays 
(Table 5.5). 
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Table 5.5. C. hominis and C. parvum detected by NGS and species specific qPCR in individual 
wastewater treatment plant (WWTP) samples positive for Cryptosporidium spp. across three states 
of Australia; NSW, QLD and WA. 
   NGS C. hominis and C. parvum species 
oocysts numbers determined by 
specific qPCR (MGB probes) 
State Plant Sample No of reads assigned 
to C. hominis 
No of reads assigned 
to C. parvum 
C. hominis C. parvum 
QLD 
 
Plant A QLD-A7 0 0 ND ND QLD-A24 0 0 ND ND 
Plant B 
QLD-B2 0 0 ND ND 
QLD-B3 0 109 ND 61 
Plant C 
QLD-C2 0 779 ND 470 
QLD-C3 0 246 ND 117 
QLD-C19 0 910 ND 482 
QLD-C25 0 133 ND 50* 
Plant D QLD-D104 0 1,181 ND 448 
QLD-D140 0 0 ND ND 
Plant E 
QLD-E18 0 562 ND 82* 
QLD-E34 0 0 ND ND 
QLD-E76 109 918 76* 361 
QLD-E195 0 0 ND ND 
QLD-E222 0 0 ND ND 
QLD-E258 0 0 ND ND 
QLD-E303 0 0 ND ND 
QLD-E357 0 0 ND ND 
QLD-E375 0 265 ND 47 
QLD-E393 0 0 ND ND 
Plant F 
QLD-F1 0 0 ND ND 
QLD-F33 0 140 ND 2,834 
QLD-F84 0 126 ND 51 
QLD-F130 0 189 ND 32 
QLD-F157 0 0 ND ND 
QLD-F319 0 0 ND ND 
QLD-F382 0 140 ND 38* 
Plant G 
QLD-G53 0 113 ND 292* 
QLD-G115 2,382 4,336 386 812 
QLD-G304 0 20,571 ND 954 
QLD-G331 0 0 ND ND 
QLD-G340 0 0 ND ND 
Plant H 
QLD-H8 0 18,529 ND 6,314 
QLD-H179 0 1,638 ND 922 
QLD-H197 0 4,674 ND 1,528 
QLD-H386 0 0 ND ND 
Plant I QLD-I41 0 1,873 ND 476 
Plant J 
QLD-J15 0 0 ND ND 
QLD-J47 0 0 ND ND 
QLD-J354 0 0 ND ND 
QLD-J363 0 0 ND ND 
Plant K 
QLD-K71 0 0 ND ND 
QLD-K119 0 0 ND ND 
QLD-K281 0 0 ND ND 
QLD-K380 0 0 ND ND 
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QLD-K389 0 0 ND ND 
Plant M QLD-M60 0 0 ND ND 
Plant N QLD-N35 0 0 ND ND 
Plant O QLD-O54 0 991 ND 14 
Plant P QLD-P63 0 0 ND ND 
Plant Q QLD-Q11 0 0 ND ND 
NSW 
Plant B NSW-B2 0 20,347 ND 1,380 
Plant C NSW-C20 9,227 0 2,998 ND 
Plant D NSW-D21 3,082 0 3,294 ND 
WA 
Plant A 
WA-A5 0 0 ND ND 
WA-A8 0 0 ND ND 
WA-A13 0 0 ND ND 
WA-A16 0 0 ND ND 
WA-A24 0 0 ND ND 
WA-A37 0 0 ND ND 
WA-A40 0 0 ND ND 
WA-A55 0 0 ND ND 
WA-A65 0 884 ND 92 
WA-A66 0 2,563 ND 214 
WA-A68 0 535 ND 51* 
WA-A78 0 0 ND ND 
WA-A79 0 0 ND ND 
WA-A80 0 0 ND ND 
WA-A81 0 0 ND ND 
WA-A82 0 0 ND ND 
WA-A88 0 0 ND ND 
WA-A91 0 0 ND ND 
Plant B 
WA-B2 0 0 ND ND 
WA-B4 0 0 ND ND 
WA-B12 0 0 ND ND 
WA-B13 0 0 ND ND 
WA-B14 0 0 ND ND 
WA-B19 0 0 ND ND 
WA-B28 0 0 ND ND 
WA-B30 0 0 ND ND 
WA-B41 0 0 ND ND 
WA-B42 0 0 ND ND 
WA-B45 0 0 ND ND 
ND = Not Detected. 
*For these samples, the C. hominis and C. parvum species-specific qPCR assay failed and and 
oocyst/L is reported based on 18S qPCR and the percentage of NGS reads attributed to C. hominis 
and C. parvum. 
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5.6.5 Enumeration of Cryptosporidium oocysts in wastewater samples using qPCR 
 
Cryptosporidium oocyst concentration per litre was estimated using qPCR standards 
calibrated by ddPCR at the 18S locus (Table 5.4). Overall, the oocyst load per litre in samples 
collected across the three states ranged from 70 to 18,055 oocysts/L and the mean was 
3,426 oocysts/L (Table 5.4). The mean Cryptosporidium oocyst concentration in samples 
collected from WWTPs in NSW was the highest among the states (4,746 oocysts/L). However, 
due to the low number of samples collected from NSW (n = 21), compared to 470 from QLD 
and 239 from WA, statistical analysis of oocyst load was only conducted for QLD and WA to 
avoid potential bias in the analysis. 
The mean number of oocysts per litre in samples collected from the two WWTPs in WA 
over four seasons was 3,292 oocysts/L (ranging from 327 to 16,812), while the mean 
Cryptosporidium oocyst concentration in these samples peaked during spring 2015 at 
6,326 oocysts/L (ranging from 2,267 to 16,812). This corresponded with a peak of prevalence 
at this time (spring 2015) (16.8%; 95% CI, 8.3–28.5) (Table 5.4). 
Compared to WA, the overall mean Cryptosporidium oocyst concentration in WWTP 
samples from QLD was relatively higher (3,578 oocysts/L, ranging from 70 to 18,055). 
Seasonal mean concentrations (averaged over the two same seasons in 2014 and 2015) were 
1,953 oocysts/L in spring, 2,323 oocysts/L in winter, 2,583 oocysts/L in autumn and 
5,966 oocysts/L in summer. This also corresponded with a peak prevalence of 17.5% (95% CI, 





The present study has demonstrated the utility of NGS in detecting mixtures of 
Cryptosporidium species and genotypes in sewage and has shown that they are frequently 
present but variable and diverse in space, time and composition. The overall prevalence of 
Cryptosporidium in WWTP samples across Australia was 11.4% (83/730). Previous studies 
have reported prevalence ranging from 6.4% to 100% (Xiao et al., 2001; Ward et al., 2002; 
Zhou et al., 2003; Hanninen et al., 2005; Cantusio Neto et al., 2006; Hashimoto et al., 2006; 
Hirata and Hashimoto, 2006; Ottoson et al., 2006; Robertson et al., 2006; Castro-Hermida et 
al., 2008; Feng et al., 2009; Dungeni and Momba, 2010; Liu et al., 2011; Ajonina et al., 2012; 
Ben Ayed et al., 2012; Li et al., 2012; Gallas-Lindemann et al., 2013, Gallas-Lindemann et al., 
2016; Hachich et al., 2013; Spanakos et al., 2015; Amorós et al., 2016; Hatam-Nahavandi et 
al., 2016; Ulloa-Stanojlović et al., 2016; ; Huang et al., 2017; Imre et al., 2017; Ramo et al., 
2017; Santos and Daniel, 2017). However, to the best of the authors' knowledge, in Australia 
little published information is available on the prevalence and composition of Cryptosporidium 
species in wastewater (King et al., 2015, King et al., 2017). 
In the present study, a total of 17 Cryptosporidium species and six genotypes were 
detected by NGS. This is higher than the diversity reported in previous studies due to the ability 
of NGS to detect mixtures of sequences in low abundance. Wastewater treatment networks 
however, rarely contain only domestic wastewater; they often also contain wastewater from 
industrial sources and can be influenced by environmental water sources, such as stormwater 
or groundwater (Pandey et al., 2014). In addition, wild animals may directly contribute to 
contamination of sewage, such as rodents in the sewer networks or birds present at wastewater 
treatment plants. Therefore, the presence of a variety of Cryptosporidium species from 
livestock, wildlife and birds in sewage samples may be attributed to other sources such as 
stormwater or industrial waste from animal processing. 
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In the present study, of 83 WWTP samples positive for Cryptosporidium spp., NGS 
detected C. hominis and C. parvum in only 27 samples (32.5%; 95% CI, 22.6–43.7), of which 
two samples contained both species. A C. hominis and C. parvum species-specific qPCR 
provided further support for the lack of C. hominis and C. parvum in the majority of samples, 
although it failed to detect C. hominis and C. parvum in one and five samples, respectively, 
which were mainly samples with low numbers of C. parvum/C. hominis reads (109–535 reads) 
by NGS. The qPCR assay has been tested extensively on human faecal samples and has been 
shown to have an analytical sensitivity of 1 oocyst/μL of DNA extract (Yang et al., 2013). This 
is the first time we have applied the qPCR to WWTP samples and no inhibition was observed. 
In NSW, the dominant species detected were C. hominis and rat genotype III, whereas in 
QLD, C. galli, C. muris and C. parvum were the three most prevalent species, while in WA, C. 
meleagridis was the most prevalent species. Of these, C. parvum and C. hominis are the most 
common species reported in humans in Australia, accounting for >95% of human infections, 
with C. meleagridis the third most common species reported and usually accounting for 1–2% 
of notifications (Ryan and Power, 2012; Ng-Hublin et al., 2017). There have been numerous 
reports of C. muris in humans in other countries (cf. Ryan et al., 2017b). Other 
Cryptosporidium species with zoonotic potential, which were detected at a low prevalence in 
WWTP samples in the present study included C. bovis, C. canis, C. cuniculus, C. erinacei, C. 
felis, C. scrofarum, C. suis and C. ubiquitum. Nevertheless, caution is required when 
extrapolating any molecular data from WWTP samples to determine host sources of 
wastewater contamination by Cryptosporidium, as there are many potential input sources other 
than humans into wastewater networks. Unlike faecal material, there is no direct relationship 
between Cryptosporidium oocysts from wastewater samples and any potential host species, 
and an understanding of existing host-parasite interactions, parasite epidemiology and sources 
of faecal inputs into the wastewater network is required (Castro-Hermida et al., 2008). 
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A number of studies across the world have reported C. hominis (the predominant species 
in humans) among the most prevalent species detected in wastewater; Australia (King et al., 
2015), Brazil and Peru (Ulloa-Stanojlović et al., 2016), China (Feng et al., 2009; Li et al., 2012; 
Huang et al., 2017), Japan (Hashimoto et al., 2006; Hirata and Hashimoto, 2006), Switzerland 
and Germany (Ward et al., 2002), the USA (Xiao et al., 2001; Zhou et al., 2003) and Tunisia 
(Ben Ayed et al., 2012). In addition to anthroponotic sources of C. hominis, several studies in 
Australia have previously identified C. hominis in Australian cattle and wildlife including 
bandicoots (Isoodon obesulus), brushtail possums (Trichosurus vulpecula), eastern grey 
kangaroos (Macropus giganteus) and brush-tailed rock-wallabies (Petrogale penicillata) (Hill 
et al., 2008; Ng et al., 2011; Dowle et al., 2013; Vermeulen et al., 2015; Zahedi et al., 2016b; 
Zahedi et al., 2018). To date there is no conclusive molecular or epidemiological evidence 
linking contamination of wastewater by animals with the occurrence of C. hominis in raw 
wastewater or in human populations in Australia and further research is required in this area. 
In the present study, C. hominis was detected in NSW in plants C and D which received mainly 
septic tank waste and accounted for 93.0% and 77.3% of all Cryptosporidium species detected 
in plants C and D respectively, suggesting humans were the source. In NSW, C. hominis was 
detected in plants E and G. Plant E received a significant portion of trade waste and the C. 
hominis detected accounted for only 4.4% of all Cryptosporidium species identified, while 
plant G received mostly human waste and the C. hominis detected accounted for 26.6% all 
Cryptosporidium species identified. 
In Europe, several studies have reported that C. parvum is the dominant species in 
wastewater (Hanninen et al., 2005; Spanakos et al., 2015; Imre et al., 2017; Ramo et al., 2017), 
while some studies in China, Iran, Tunisia and the USA have reported that livestock associated 
species such as C. andersoni and C. xiaoi dominate (Xiao et al., 2001; Liu et al., 2011; Ben 
Ayed et al., 2012; Hatam-Nahavandi et al., 2016). In the present study, C. andersoni and C. 
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xiaoi were not detected in WWTPs across three states in Australia, however C. parvum was 
the third most prevalent species identified in QLD samples and was detected in a single sample 
and three samples from NSW and WA, respectively. Cryptosporidium parvum has been 
identified widely in both calves and humans in Australia (Ryan and Power, 2012) with reported 
prevalences for C. parvum in humans in Australia ranging from ~24% in Victoria (Jex et al., 
2007; Koehler et al., 2013) to 17–19.8% in WA (Morgan et al., 1998; Ng et al., 2010) and 
46.8% in NSW (Waldron et al., 2009). There are no published reports on the prevalence of C. 
parvum in the human population in QLD, which is a knowledge gap that needs to be addressed 
Considering that most WWTPs in Australia are well fenced-off and protected, with 
minimal animal access, the predominance of C. parvum in wastewater in QLD may indicate 
that human sewage was the source of C. parvum or that it came from a combination of 
anthroponotic contributions and industry waste from abattoirs. In many of the QLD plants, a 
significant proportion was “trade waste” some of which may have come from abattoirs, 
however it was not possible to obtain further information on the sources of the trade waste. In 
WA, C. parvum was detected in plant A, which received both human and abattoir waste. In 
NSW, the single WWTP (Plant B) that was positive for C. parvum received waste 
predominately from septic tanks, suggesting an anthroponotic source. It is also important to 
remember that previous studies that reported Australian prevalence data for Cryptosporidium 
were from clinical samples, which in many cases were dominated by samples from the major 
metropolitan areas. Based on the population sizes for at least some of the WWTPs in the present 
study, most of the “urban sites” are more likely to be regional centres, so may have a different 
pattern of Cryptosporidium prevalence and species composition compared with major urban 
centres. 
Cryptosporidium meleagridis is a common parasite of humans in Australia (Ryan and 
Power, 2012) and also infects a wide range of birds (Zahedi et al., 2016a), with many 
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overlapping C. meleagridis subtypes found in both birds and humans; suggesting both 
anthroponotic and zoonotic transmission (Silverlas et al., 2012). This is evidenced by the fact 
that C. meleagridis is commonly reported in wastewater worldwide (Hashimoto et al., 2006; 
Hirata and Hashimoto, 2006; Feng et al., 2009; Li et al., 2012; Huang et al., 2017). In the 
present study, C. meleagridis was the most prevalent species detected in WWTP samples 
collected from WA and in many cases was the only species detected (Supplementary Table 5-
S1 - Digital appendix 3). However, it was not detected in NSW or QLD. Although a variety of 
bird species are commonly seen at WWTPs in Australia, particularly around lagoons and 
clarifiers (secondary and tertiary treatment), the raw sewage entries to most WWTPs are 
covered, and not exposed and accessible to birds and animals. Some of the C. meleagridis 
detected in WWTPs in WA could have been originated from humans, however, further 
investigation revealed that the raw influent samples were taken directly from the distribution 
chamber located just before the primary ponds, which was only covered with a layer of mesh, 
providing easy access to bird contamination. Alternatively, industrial sources of wastewater 
from poultry farms could also be a major contributor. The predominance of the bird-specific 
C. galli in WWTP samples from QLD also confirms the potential role birds may play in 
contamination of wastewater by Cryptosporidium, but currently data on the contribution of 
poultry farms to WWTP in both WA and QLD is lacking and is an important knowledge gap. 
To date, there has only been one report of C. galli in wastewater (Ramo et al., 2017), however, 
C. baileyi, another avian Cryptosporidium species, has been reported in several studies from 
China (Feng et al., 2009; Li et al., 2012; Huang et al., 2017). It is possible that the high levels 
of C. meleagridis and C. galli detected in WA and QLD respectively, were due to 
contamination in our laboratory. However, this is unlikely as neither species were included as 
controls on the same Illumina MiSeq run and quality filtering removed all reads <100. The 
high number of C. meleagridis reads in WA (107 to 58,246 reads/sample) and C. galli reads in 
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QLD (129 to 32,164 reads/sample) supports their validity. In addition, if it was due to gross 
contamination, then both species would be randomly distributed across all samples, with 
mixtures of both species in some samples. 
Two emerging human-pathogenic Cryptosporidium species, including C. ubiquitum 
(n = 2) and C. cuniculus (n = 1), were also found in wastewater samples from QLD at a lower 
frequency and abundance than other major species. Cryptosporidium cuniculus is a common 
parasite of rabbits and has been reported in source water in South Australia (Swaffer et al., 
2018) and linked to several sporadic human cases in Australia (Nolan et al., 2010, Nolan et al., 
2013; Sari et al., 2013 unpublished - KF279538; Koehler et al., 2014), the UK (Chalmers et 
al., 2011; Elwin et al., 2012), Nigeria (Molloy et al., 2010) and France (ANOFEL, 2010). To 
date there are no published reports of C. cuniculus detected in WWTP samples in Australia, 
however, it has been previously reported from WWTPs in Brazil, Peru and China (Li et al., 
2012; Ulloa-Stanojlović et al., 2016). Mainly infecting small ruminants, C. ubiquitum has been 
identified in a broad range of hosts including humans and wildlife (in particular rodents) with 
a wide geographic distribution across the world (Zahedi et al., 2016a). It has also been 
frequently reported from source water, stormwater runoff, stream sediment and wastewater 
across the world (Xiao et al., 2000; Nolan et al., 2013; Li et al., 2014). In Australia, C. 
ubiquitum has not been detected in the studies conducted to type Cryptosporidium isolates from 
humans (Ryan and Power, 2012); however, it has been identified in source water in Australia 
(Swaffer et al., 2018). More recently, the identification of similar C. ubiquitum subtypes in 
humans and in wastewater samples from China, Tunisia and the USA strengthens the 
hypothesis that sheep and wild rodents are a source of C. ubiquitum transmission to humans 
through contamination of untreated drinking water (Zhou et al., 2003; Liu et al., 2011; Ben 
Ayed et al., 2012; Li et al., 2014; Huang et al., 2017). 
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In the present study C. muris, a predominantly a rodent species of Cryptosporidium, was 
sporadically identified in wastewater samples from NSW and WA and was the second most 
prevalent species detected in QLD. There have been numerous reports of C. muris in humans 
and wastewater (Xiao et al., 2001; Ward et al., 2002; Zhou et al., 2003; Feng et al., 2009; Ben 
Ayed et al., 2012; Ryan and Power, 2012; Li et al., 2014; Spanakos et al., 2015; Huang et al., 
2017), suggesting both human contribution as well as faecal contamination by rodents in 
wastewater distribution systems. However, as the frequency of detection of C. muris in humans 
is low (1–3%) (Wang et al., 2012), rodents are the more likely source. The identification of 
other rodent Cryptosporidium genotypes (rat genotypes I–IV) across all states in the present 
study, also supports this hypothesis. 
Factors that influence oocyst density in wastewater are the incidence of cryptosporidiosis 
in the community (i.e. number of infected humans and animals in the community served by the 
WWTP), the intensity of infection (oocyst shedding), the size of the community (population), 
seasonality and dilution by other waste entering the WWTP (Domenech et al., 2017; King et 
al., 2017). In the present study, oocyst numbers per litre of sewage across the three states were 
estimated and ranged from 70 to 18,055 oocysts/L (mean = 3426 oocysts/L). This is similar to 
a previous study of WWTPs across South Australia and Victoria, with oocyst densities ranging 
from 3 to 21,335 oocysts/L with a mean density of 2355 oocysts/L (King et al., 2017). It is 
difficult, however, to compare across different studies using different methodologies. 
Worldwide, mean densities of between 10 and >700 oocysts/L have been commonly reported 
(Ajonina et al., 2012; Tonani et al., 2013; Nasser, 2016; Xiao et al., 2018) with a mean of 
60,000 oocysts/L reported in one study (Cantusio Neto et al., 2006). The somewhat higher 
number of oocysts detected in the present study compared to other studies may be due to the 
fact that the oocyst concentrations were determined directly from total DNA extracted from 
WWTP samples by qPCR (using ddPCR calibrated standards), which may have overestimated 
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the oocyst concentration, as DNA from lysed (and therefore no longer viable) oocysts would 
also have been detected. Previous studies have purified oocysts from WWTP samples and 
counted intact oocysts using USEPA method 1623, however, recovery efficiencies from 
wastewater samples can be highly variable, ranging from 5.5 ± 1.3% to as high as 85% (Nasser, 
2016). The DNA extraction efficiency in the present study is unknown. 
Estimation of Cryptosporidium risk from wastewater requires an evaluation of the 
efficiency of oocyst removal and inactivation along the treatment process and the reduction in 
the levels of oocysts (and their infectivity) in final treated effluent compared with oocyst counts 
in raw sewage (Xiao et al., 2018). Guideline values have traditionally set log10 removal targets 
based on end-use application (King et al., 2017), but these guidelines still do not incorporate 
the potential for inactivation of oocysts throughout the treatment process. A limitation of the 
present study is that samples were only taken from influent raw wastewater, and oocyst 
numbers were not investigated across the treatment train including the final effluent. Another 
limitation is that the viability/infectivity of oocysts detected in WWTP samples was not 
analysed. A recent study developed an integrated assay to determine oocyst density and 
infectivity from a single-sample concentrate (King et al., 2017), which will allow for improved 
QMRA analysis, as only analysing total oocyst numbers in raw sewage could result in an 
overestimation or underestimation of the Cryptosporidium risk in treated water. Finally, in the 
present study, the weather on sampling days (and preceding days) was not taken into account 
in the study design and future studies should include this data to better understand the effects 
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With the increasing importance of wastewater treatment and reuse, and considering that 
wastewater harbours an abundant and diverse range of pathogens, high-throughput sequencing 
is a highly efficient tool to explore the composition, abundance, and distribution patterns of 
microbial communities, including protozoans, present in engineered systems such as 
wastewater treatment facilities to ensure safer water supplies. In this Chapter, NGS was 
employed to explore snap shots of Cryptosporidium species WWTP influent samples, collected 
across three states (NSW, QLD and WA). The data generated demonstrated that 
Cryptosporidium is prevalent in the raw influent of wastewater treatment facilities across 
Australia, which suggests that the parasite may be more prevalent in human populations than 
diagnostic data indicates. However, it would appear that much of the Cryptosporidium may 
have come from industrial waste, livestock, wildlife and birds. NGS was central to unravelling 
the large diversity of Cryptosporidium species and genotypes in wastewater in Australia. These 
observations raise concerns regarding the environmental impact and public health risks 
associated with disposal and reuse of treated wastewater and highlight the need for updating 








In this thesis, the benefits of utilising both conventional (qPCR and Sanger sequencing) 
and cutting-edge molecular technologies (ddPCR and NGS), in a large scale to address existing 
key knowledge gaps on the animal sources/carriers of human infectious species of 
Cryptosporidium in Australian drinking water catchments were demonstrated. The main focus 
of the present thesis was to detect, quantify and determine the Cryptosporidium spp. present in 
faecal samples from dominant animals inhabiting Australian drinking water catchments and 
WWTP samples over time and space. Analysis included screening 5,774 animal faecal samples 
collected from 11 drinking water catchment across NSW, QLD and WA, and 730 raw influent 
samples from 25 Australian WWTPs across these states for the presence of Cryptosporidium 
spp. at the 18S rRNA (18S) locus using qPCR, and further quantification of oocyst load in 
samples positive for Cryptosporidium. In addition, Cryptosporidium spp. detected in animal 
faecal samples were typed by sequence analysis of an 825 bp fragment of the 18S gene and 
subtyped at the glycoprotein 60 (gp60) locus (832 bp), and faecal samples which initially 
produced mixed chromatograms and WWTP influent samples positive for Cryptosporidium 
spp. by qPCR, were further analysed using NGS of 18S amplicons on the MiSeq (Illumina) 
platform. 
The findings presented in this thesis have provided further evidence of the complex 
diversity and epidemiology of Cryptosporidium species in animals inhabiting Australian 
drinking water catchments and in WWTP influent, and suggest the potential role these animals 
play in dissemination of Cryptosporidium oocysts to drinking water sources and the associated 




species in both livestock and wildlife, particularly the detection of C. hominis in cattle and 
kangaroos and the high prevalence of C. parvum in cattle has implications for the management 
of drinking water sources, and warrants continued monitoring and identification of the 
sources/carriers of human pathogenic strains, which is essential for accurate risk assessment 
and optimal catchment management.
 
6.2 Epidemiology of zoonotic Cryptosporidium species in animals 
 
Cryptosporidium spp. are among the most common enteric protozoan parasites of 
humans, domestic and wild animals. They are a major cause of severe diarrhoea and death in 
children (second to rotrovirus) and currently there is neither a vaccine nor an effective treatment 
(Kotloff et al., 2013; Ryan and Xiao., 2014; Ryan et al., 2016). There are multiple species and 
genotypes of Cryptosporidium with varying host-specificity and pathogenicity, only some of 
which are infectious to humans. To date, more than 20 species of Cryptosporidium have been 
reported in humans, and wildlife and domestic animals are believed to act as reservoirs for the 
majority of these species. Due to the ubiquitous nature of Cryptosporidium, it is very difficult 
to accurately establish sources and transmission dynamics of Cryptosporidium in the 
environment, however zoonotic waterborne transmission is considered a major transmission 
route in the epidemiology of human cryptosporidiosis, and therefore water contamination by 
animal-derived Cryptosporidium oocysts is of growing concern (Xiao, 2010). Several studies 
have linked outbreaks of cryptosporidiosis in human populations with sheep and cattle grazing 
near the implicated reservoir, catchment or river, but only a single recent waterborne outbreak 
of C. cuniculus in the UK has been linked to wildlife (rabbits) (Ruecker et al., 2007; Yang et 




more conclusively link contamination of water supplies by animals, in particular wildlife in 
catchments, with outbreaks of cryptosporidiosis in human populations. 
To date, the majority of human cases of cryptosporidiosis worldwide are caused by two 
species; C. parvum and C. hominis (Putignani and Menichella, 2010; Xiao, 2010; Ryan and 
Xiao, 2014). Both species have been previousely reported in a wide range of domestic and wild 
animals (cf Zahedi et al., 2016), but a striking finding of the present study was the identification 
of C. parvum and C. hominis at a relatively high prevalence among cattle and kangaroo 
populations inhabiting Australian drinking water catchments (see Chapters 2 and 4). This 
provides supportive evidence for the central hypotheses of this thesis, which initially proposed 
that faecal contamination of water sources by animals could be a significant source of 
Cryptosporidium infection in humans. In particular, identification of the most commonly 
reported human-associated gp60 subtypes of C. hominis and C. parvum (IbA10G2, IdA15G1, 
IIaA13G1, IIaA15G2R, IIaA16G2R1, IIaA17G2R1, IIaA18G3R1, IIaA19G2R1, and 
IIaA19G3R1) in cattle and kangaroos in the present study, strongly suggests the potential role 
these animals may play as sources/carriers of human pathogenic strains in the zoonotic 
transmission and epidemiology of cryptosporidiosis. 
In addition to C. hominis and C. parvum, other species of Cryptosporidium including C. 
andersoni, C. bovis, C. canis, C. cuniculus, C. ditrichi, C. erinacei, C. fayeri, C. felis, C. 
meleagridis, C. muris, C. scrofarum, C. suis, C. tyzzeri, C. ubiquitum, C. viatorum, and C. xiaoi 
have been reported in both humans and a wide range of animals (cf Zahedi et al., 2016). In the 
present study, with the exception of C. andersoni, C. ditrichi, C. tyzzeri, and C. viatorum, all 
other species of Cryptosporidium had been previously detected in animals in catchment areas. 
This raises further questions about the complexity of transmission dynamics and epidemiology 




It is, however, important to stress that swimming pools are likely to be a more important 
source of Cryptosporidium transmission in the human population compared to drinking water 
(Ryan et al., 2017). This is particularly important as drinking water-associated outbreaks of 
diarrhoeal illness due to Cryptosporidium and other pathogens are declining, particularly in 
high-income countries, but the number of outbreaks of cryptosporidiosis and other diarrhoeal 
diseases associated with swimming pools and water parks have increased dramatically (Hlavsa 
et al., 2015; Ryan et al., 2017). 
 
6.3 Cryptosporidium and the Australian water industry 
 
The quality and safety of drinking water in catchments is important to all members of the 
society, and drinking water must be fit for human consumption. This makes it essential for the 
water industry to ensure that they effectively manage risks to drinking water safety from 
catchments to taps, and deliver highly reliable drinking water to their customers. In addition, 
over the last few years, due to extremes in climatic conditions, management of water resources 
has become even more important globally. Most drinking water utilities in developed countries 
utilise holistic ‘catchment to consumer’ multi-barrier approaches to manage and assess risks 
that exist within public drinking water source areas used to supply drinking water. This 
approach is based on the premise that no single treatment mechanism is infallible and each 
barrier reduces risk to water quality incidents when it is applied in a robust manner. The most 
important barrier in water quality protection is the effective protection of the source or 
catchment, which is the first part of the multi barrier approach to providing safe drinking water. 
Human activities in catchment areas (e.g. farming, recreational activities), presence of livestock 
and wildlife, rainfall or storm events can all present a significant risk to water quality in 




protozoa) into the main water bodies. Therefore, catchment management is an important 
concept in water regulations and policies, and is considered as a critical water quality control 
point to assess microbial contamination (Ferrier and Jenkins, 2010). 
Recognition of the limited utility of traditional indicator organisms to assess risks from 
non-bacterial pathogens and the inability of epidemiological studies to detect small differences 
in illness rates led regulatory authorities to develop quantitative microbial risk assessment 
(QMRA) based approaches to assess drinking water safety and set regulatory targets (Sinclair 
et al., 2015). QMRA is a probabilistic modelling technique, and it is the main method used to 
estimate the microbiological risk of infection from exposure to a microorganism (Hamilton et 
al., 2006). In order to conduct basic QMRA, data that can be used to generate probability 
density functions of the occurrence/numbers of a particular pathogen are required. Thus, 
QMRA can estimate how safe the water is, how much the safety varies and how certain the 
estimate of safety is. QMRA gives a detailed breakdown of the contribution of each step in the 
chain from catchment-to-tap to the overall risk (reduction), along with the potential effects of 
hazardous events (such as those following heavy rainfall) and some indication of data 
variability and uncertainty. Water utilities can use this information to decide where 
optimisation or additional controls would be most effective (Schijven et al., 2011) and to 
determine whether treatment is meeting health-based targets with the required level of certainty 
(Smeets et al., 2010). 
The Australian Drinking Water Guidelines 2011 (ADWG) (NHMRC–NRMMC 2011) 
contain mostly qualitative information on treatment requirements. The ADWG promote having 
appropriate disinfection and filtration, and a ‘catchment to consumer’ multi-barrier approach 
to manage and assess risks as discussed above. The ADWG also provide some general guidance 
on targets for these treatments, but do not set out a quantifiable approach to defining treatment 




In contrast, the Australian Guidelines for Water Recycling (2006; 2008; 2009; the 
AGWR series) (NRMMC-EPHC-AHMC-NHMRC 2006-2009) stipulate that recycled water 
should be treated to reduce human infectious pathogen concentrations by a quantifiable extent, 
often termed the pathogen “log reduction value” (LRV), to meet a quantifiable “health-based 
target” (HBT). A tolerable disease burden, expressed in units of disability-adjusted life year 
(DALY) is used to provide the HBT to be achieved through the LRV delivered by treatment. 
The DALY was developed by Harvard University for the World Bank to provide a consistent 
framework to quantify and compare the health burden of a wide range of diseases and injuries 
on populations (World Bank, 1993). This measure was developed as an alternative approach to 
simply using the number of deaths (mortality) or illnesses (morbidity) to rank the effects of 
diseases on populations. The DALY integrates disease impacts including premature death, 
degree of disability caused by an illness, and the length of time lived with disability into a 
single measure, which can be used to compare the importance of different diseases, injuries, 
and risk factors as part of health decision-making and planning processes (Sinclair et al., 2015). 
The so-called “tolerable” disease burden is defined as the exposed population not experiencing 
more than one additional DALY per million exposed persons annually - on average. This is 
often expressed as the 1 μDALY tolerable disease burden target. 
While the ADWG currently does not have numerical targets for microbial safety of 
drinking water, it is anticipated that this discrepancy will soon be addressed and that a 
combination of QMRA (to determine the likelihood of infection and illness occurring from 
exposure to specific pathogens contained in water) and the metric of DALYs (to convert the 
likelihood of illness into impacts or burdens of disease) will be used to define microbial safety 
(O’Toole et al., 2015). The target being considered is 1 μDALY per person per year, the same 
target as defined in the World Health Organization guidelines for drinking water quality (WHO 




(AGWR) (NRMMC/EPHC/AHMC 2006-2009). This allows for up to approximately 6% of 
diarrhoeal disease caused by Cryptosporidium to be associated with consumption of drinking 
water (O’Toole et al., 2015) and a log10 reduction of 6.15 of Cryptosporidium in drinking water 
to meet annual 1 µDALY health targets (Sinclair, 2012). As a result of this, accurate modelling 
and risk assessments will become even more important to the water industry. Thus, data about 
the prevalence of human-infectious Cryptosporidium species in source waters and catchments 
will become increasingly important for QMRA processes. However, currently, in the case of 
Cryptosporidium, standard monitoring data for QMRA analysis are based on fluorescence 
microscopy, which does not include species and subtype identification (or information on 
viability). This results in inaccurate risk assessments that either under or overestimate the 
public health risk. To perform accurate QMRA analysis, quantitative data on oocyst excretion 
rates for the different hosts in various catchments, quantitative data on the prevalence of 
zoonotic and non-zoonotic species in the various hosts over time and space, host prevalence 
data, infectivity levels (i.e. percentage that are still viable) under different climatic conditions, 
are essential to accurately model oocyst inputs into source waters. 
 
6.4  Practical benefits of the present research 
 
The data generated by the present thesis will be applied to QMRA models for each 
catchment to provide site-specific analysis and highlight key risks that need to be addressed. 
As sampling for this project occured over two years, it enables authorities to investigate the 
fate of oocysts during different seasons and different weather events from drought to heavy 
rainfall. This is essential, as the risk of waterborne infections varies widely over time depending 
not only on the Cryptosporidium load coming from different hosts and the prevalence of 




greatly affected by temperature and rainfall (King and Monis, 2007). An increased 
Cryptosporidium load, which enters the water source from surface runoff, may put higher 
pressure on water treatment and, as a result increased risk of waterborne infections. The risk 
outcome generated by QMRA analysis of the present data can then be compared to the soon to 
be implemented Australian health based targets and improved management strategies devised. 
In addition to providing essential data to improve management strategies, QMRA analysis can 
also be used retrospectively to gain insights about conditions leading to past outbreak and to 
model outbreaks while they are occurring to estimate the outbreak magnitude and the potential 
effectiveness of additional interventions (Seto et al., 2007). 
The development of more targeted control measures against Cryptosporidium, resulting 
from QMRA modeling based on the much more accurate input data generated from the present 
study, will reduce the transmission of Cryptosporidium and limit outbreaks of disease. For 
example, QMRA will allow water authorities to: (1) identify relative risks from various 
contamination sources; (2) identify accurate detection limits that would be needed to monitor 
Cryptosporidium at levels of public health relevance; (3) characterise differential risks to 
sensitive subpopulations (e.g. children); (4) the relative risks of temporally varying inputs etc.; 
(5) provide quantitative insights into managing control points; (6) determine the value of 
interventions (i.e. is it better to spend money in the catchment to limit oocyst inputs, or better 
to invest in treatment barriers?); and (7) to develop “what if” scenarios and model alternative 
management scenarios to provide the ability to generate scientifically defensible, site specific 
criteria for improved management. In addition, recommendations for more targeted, cost-
effective control strategies will be disseminated via liaison with (1) the major utilities, (2) 
Water research Australia (WaterRA) (3) the Water Services Association of Australia (WSAA) 





6.5 Limitations of the present study and future needs for the water industry 
 
Despite the recent developments in the molecular epidemiology of Cryptosporidium spp., 
including the newly gained knowledge reported in the present thesis on quantitative prevalence 
and genotypes of zoonotic Cryptosporidium spp. in Australian watersheds, there are still 
research gaps in the understanding of the public health significance of Cryptosporidium in 
animals in drinking water catchments. 
The viability/infectivity of Cryptosporidium oocysts shed by animals is vital for accurate 
QMRA analysis in order to better understand transmission dynamics of Cryptosporidium spp. 
and the associated human health risks. However, current monitoring methods (methods 1622 
and 1623) do not determine viability of oocysts, yet anecdotal evidence suggest that some 
species may be more robust than others and the viability of oocysts under the very different 
climatic conditions may vary. Solar inactivation, desiccation, temperature and residence time 
in the catchment and water, and transport, including hydro-dynamically-driven accumulation, 
settlement, dispersion, dilution can all affect final concentration and the viability of 
Cryptosporidium oocyst in the drinking water (King et al., 2008), and therefore should be 
factored into risk assessments in future studies. In addition, obtaining sufficient quantities of 
C. hominis oocysts for viability/infectivity analysis requires either growing the parasite in 
gnotobiotic pigs or purifying the parasite from large quantities of faeces from an infected 
person or animal, both of which are impractical and costly. This has been a major barrier both 
to the development of detection and infectivity assays for C. hominis. 
Cryptosporidium oocyst viability has conventionally been determined by using in vitro 
excystation, while mouse infectivity assays have been utilized to determine whether oocysts 
are infectious (Ryan and Hijjawi, 2015). The majority of in vitro cultivation studies to date 




hampered by lack of reproducibility and difficulties in continuous long-term proliferation of 
Cryptosporidium spp. in in vitro culture, which requires urgent attention. Recently, a hollow-
fibre culture system and a 3D human intestinal tissue model have been established for long-
term culture of C. parvum, but neither model currently support growth of other species, in 
particular C. hominis (the main species infecting humans) (Moranda et al., 2016; DeCicco 
RePass et al., 2017). In addition, limitations of the hollow-fibre culture system and 3D model 
culture systems include that they are: (1) not suitable for viability assays; (2) expensive (up to 
US$5,000 per experiment); (3) complicated to use (i.e. the hollow-fibre system requires daily 
monitoring and replacement of expensive growth medium every 2 days); (4) growth inside the 
hollow-fibre cartridge cannot be observed directly using a microscope; (5) they do not generate 
precise constant culture conditions; and (6) the conditions for C. hominis growth in these 
models has not been yet determined. 
Lack of suitable subtyping tools is another major hurdle to study Cryptosporidium 
transmission patterns and population genetic structure (Feng et al., 2014). Application of 
multilocus sequence typing (MLST) based on both length polymorphism and SNP potentially 
can increase the resolution of typing. However, in the case of Cryptosporidium, current MLST 
tools have been developed based on microsatellites from the genome of C. parvum and C. 
hominis, and can only be applied to genetically related species. Therefore, there is an urgent 
need for  more extensive whole genome sequence analysis of a more diverse range of 
Cryptosporidium species, in particular zoonotic strains, to develop MLST tools for high-
resolution subtyping of all other species. In addition, whole genome sequencing of 
Cryptosporidium spp. will greatly support research into the within-host genetic diversity of 
Cryptosporidium subtypes, as well as evolution of the genus, virulence and mechanisms 
controlling host specificity of Cryptosporidium. This in turn will promote the development of 




Continued improvements in monitoring and removal methods for Cryptosporidium in 
water (e.g. recreational water, drinking source water, and treated and/or untreated wastewater), 
more rigorous enumeration practices, and enhanced analytical and risk assessment techniques 
are essential for the water industry to ensure safe water distribution. In particular, there is a 
need for further monitoring to fill spatial and temporal data gaps regarding the occurrence of 
Cryptosporidium in source water. This will greatly help with generating more accurate data for 
better microbial risk assessments. 
Lastly, given the public health significance of water-associated outbreaks of 
cryptosporidiosis, substantial enhancement in surveillance of community-wide cryptosporidial 
infection is required. Currently, in Australia, due to considerable variation in testing practices 
and reporting procedures between different States and Territories, it is difficult to establish a 
comprehensive picture of the true burden of community-wide cryptosporidiosis. This 
highlights a need to develop a national practice protocol for surveillance of Cryptosporidium 
species in the community. The surveillance should include a systematic approach to elevated 
rates of diarrhoeal illness across the community in particular among public institutions like 
childcare facilities and nursing homes, a follow-up of individual cases of cryptosporidiosis, 
active contact with laboratories, and possible activation of other sentinel systems, including 
school absenteeism, general practice systems and oncology units. Geographic Information 
Systems (GIS) mapping of such data may be also useful as an adjunct to identify and track 
outbreaks. In addition, a well-validated system is required to accurately extrapolate the number 





6.6 Concluding remarks 
 
This thesis used innovative approaches to understand the epidemiology and public health 
risks of Cryptosporidium species in animals in Australian drinking water catchments across 
three states including NSW, QLD and WA. For the first time in Australia, cutting-edge 
molecular tools were used on a large scale to address key knowledge gaps on the lack of 
quantitative prevalence and genotyping data on zoonotic Cryptosporidium species infecting 
animal hosts in Australian drinking water catchments over time and space. The data generated 
in this thesis will be used to conduct modeling and quantitative microbial risk assessments 
(QMRA) for the various catchments. 
As a result of this thesis, five papers have been published, with another manuscript under 
review. Lastly, work carried out during my PhD tenure has also contributed to four additional 
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More than 15% of the world's population has no access to safe
drinking water (Cauchie et al., 2014). Waterborne parasitic proto-
zoan diseases with worldwide distribution, result in four billion
cases of diarrhoea, 1.6 million deaths annually (www.who.int) and
62.5 million Disability Adjusted Life Years (DALYs) worldwide
(Wright and Gundry, 2009; WHO, 2009). Yet, despite the latest
advances made in water treatment measures, protecting drinking
water supplies against waterborne pathogens remains by far, as one
of the most challenging concerns for the entire drinking water
supply chainworldwide (Cotruva et al., 2004; Betancourt and Rose,
2004; Thompson and Smith, 2011; Plutzer, 2013; Burnet et al.,
2014). In response to this, in 2009, the World Health Organization
has developed guidelines for water suppliers on how to implement
“Water Safety Plans” (WSPs), in the hope of halving the number of
people without safe access to drinking water by the end of 2015
(WHO, 2009).
In less developed countries, lack of basic infrastructure for
providing safe drinking water is considered a major cause of poor
water quality which contributes to the spread of endemic/epidemic
waterborne diseases. However, even in industrialized nations,
highly advanced infrastructures are not yet a protective factor
against outbreaks (Cummins et al., 2010; Smith and Nichols, 2010;
Castro-Hermida et al., 2010; Burnet et al., 2014; Smolders et al.,
2015). This appears to be largely due to a lack of knowledge about
the epidemiology and transmission dynamics of waterborne
pathogens (e.g. from animals ranging within the catchments)
which leads to poor management practices for drinking water
catchments (Gormley et al., 2011; Castro-Hermida et al., 2010).
Waterborne parasitic protozoans are responsible for the ma-
jority of waterborne outbreaks worldwide, with socio-economic
impacts even in developed countries (Cotruva et al., 2004; Pond,
2005; Baldursson and Karanis, 2011; Cauchie et al., 2014). Of
these, Cryptosporidium was the etiological agent in 60.3% (120) of
the waterborne protozoan parasitic outbreaks that have been re-
ported worldwide between 2004 and 2010 (Baldursson and
Karanis, 2011). For the global water industry, therefore, Crypto-
sporidium represents the major public health concern, as its oocyst
(the environmentally stable stage) is able to survive and penetrate
routine wastewater treatment and is resistant to inactivation by
commonly used drinking water disinfectants (Fayer et al., 2001;
Baldursson and Karanis, 2011; Burnet et al., 2014). As a result of
these waterborne outbreaks of cryptosporidiosis, Cryptosporidium
testing in source or finished water is now mandatory in most
industrialised nations. For example, the U.S. EPA, working with the
U.S. public water supply industry, developed and implemented the
Long-term Stage 2 Enhanced Surface Water Treatment Rule
(LT2ESWTR), known as LT2 to control Cryptosporidium in public
water supplies (US EPA, 2006). LT2 requires all public water sup-
pliers using surface water sources and serving populations >10,000
to monitor their sources for Cryptosporidium by analysing at least
24 consecutive monthly samples. In the UK, the Drinking Water
Inspectorate (DWI) requires that water companies carry out risk
assessments on all their water supply sites to ascertain the level of
risk Cryptosporidium poses to the final treated water quality. Those348at high risk need additional treatment (in the form of properly
controlled coagulation/flocculation filtration systems or membrane
or UV treatment systems). The UK regulations also require com-
panies to design and continuously operate adequate treatment and
disinfection. A proven failure to comply with this is now an offence
(DWI, 2010).
Cryptosporidium species are able to infect a broad range of hosts
including humans, domestic and wild animals (mammals, birds,
fish, marsupials, reptiles and amphibians) worldwide (Table 1),
causing asymptomatic or mild to severe gastrointestinal disease in
their host species (Monis and Thompson, 2003; Hunter et al., 2007;
Ryan and Power, 2012; Xiao, 2010; Kvac et al., 2014a; Ryan et al.,
2014). Current treatment options for cryptosporidiosis are limited
and only one drug, nitazoxanide (NTZ), has been approved by the
United States (US) Food and Drug Administration (FDA). This drug,
however, exhibits only moderate clinical efficacy in children and
immunocompetent people, and none in people with HIV (Abubakar
et al., 2007; Amadi et al., 2009; Pankiewicz et al., 2015; Gargala,
2008; Rossignol, 2010).
Oocyst transport to surface water can occur by deposition of
manure directly in the water or surface runoff. Hence, humans,
wildlife and domestic livestock all potentially contribute Crypto-
sporidium contamination to water systems (Ryan et al., 2014).
Identification of the sources/carriers of human pathogenic strains is
therefore essential for accurate risk assessment and optimal
catchment management. However, most studies to date have
focused on humans and the potential role of livestock in the
epidemiology of zoonotic cryptosporidiosis, while wildlife as a
potential risk factor to source water, has only been studied oppor-
tunistically. Thus, the aim of this review is to summarize available
information about molecular characterisation of Cryptosporidium
species in wildlife with emphasis on the public health significance
of zoonotic species.2. Taxonomy and zoonotic potential of Cryptosporidium
species
The application of advanced molecular techniques has led to an
improved taxonomy and systematics, and better understanding of
Cryptosporidium phylogeny (Ryan et al., 2014). Given the morpho-
logical similarity of oocysts by microscopy, these advances are
crucial for confident identification, description of host/parasite
intractions and ultimately accurate risk assessment. Currently, 29
Cryptosporidium species have been recognised as valid (Table 1),
including the recently described C. rubeyi in ground-dwelling
squirrels (Spermophilus sp.) (Li et al., 2015a). More than 17 species
have been identified in humans (Table 1). Of these, C. parvum and
C. hominis are by far the most common species reported in humans
worldwide (Xiao, 2010; Ryan and Xiao, 2014) and have been
responsible for the majority of waterborne outbreaks typed to date
with the exception of a waterborne outbreak in the UK caused by C.
cuniculus from rabbits (Oryctolagus cuniculus) (Chalmers et al.,
2009; Xiao, 2010; Ryan et al., 2014).
The most widely molecular markers used for typing of Crypto-
sporidium isolates are the 18S ribosomal RNA (18S rRNA) gene and
the 60-kDa glycoprotein (gp60) gene. The latter locus encodes a
Table 1
Valid Cryptosporidium species confirmed by molecular analysis.
Species name Author(s) Type host(s) Major
host(s)
Reports in humans




et al., 2004; Costa
et al., 2015
Scophthalmus maximus (Turbot) Turbot None reported
C. huwi Ryan et al., 2015 Poecilia reticulata (Guppy), Paracheirodon
innesi (Neon tetra) and Puntius tetrazona
(Tiger barb)
Fish None reported




Kvac et al., 2014a
C. scrofarum Kvac et al., 2013 Sus scrofa (Pig) Pigs Kvac et al., 2009a, 2009b
C. viatorum Elwin et al., 2012 Homo sapiens (Human) Humans Elwin et al., 2012; Insulander et al., 2013
C. tyzzeri Tyzzer, 1912; Ren
et al., 2012
Mus musculus (Mouse) Rodents Raskova et al., 2013
C. cuniculus Robinson et al., 2010 Oryctolagus cuniculus (European rabbit) Rabbits Chalmers et al., 2009; Anon, 2010; Molloy et al., 2010; Chalmers et al., 2011;
Anson et al., 2014; Koehler et al., 2014; Chalmers, 2012
C. ubiquitum Fayer et al., 2010 Bos taurus (Cattle) Ruminants,
rodents,
primates
Commonly reported (cf. Fayer et al., 2010; Elwin et al., 2012)
C. xiaoi Fayer et al., 2010 Ovis aries (Sheep) Sheep and
goats
Adamu et al., 2014
C. ryanae Fayer et al., 2008 Bos taurus (Cattle) Cattle None reported
C. macropodum Power and Ryan,
2008
Macropus giganteus (Kangaroo) Marsupials None reported
C. fragile Jirku et al., 2008 Duttaphrynus melanostictus (Toad) Toads None reported
C. fayeri Ryan et al., 2008 Macropus rufus (Kangaroo) Marsupials Waldron et al., 2010
C. bovis Fayer et al., 2005 Bos taurus (Cattle) Cattle Khan et al., 2010; Ng et al., 2012; Helmy et al., 2013
C. suis Ryan et al., 2004 Sus scrofa (Pig) Pigs Xiao et al., 2002a; Leoni et al., 2006; Cama et al., 2007; Wang et al., 2013a
C. galli Pavalasek, 1999;
Ryan et al., 2003
Spermestidae, Frangillidae, Gallus gallus,
Tetrao urogallus, Pinicola enucleator
(Birds)
Birds None reported
C. hominis Morgan Ryan et al.,
2002




Sparus aurata (Gilt-head sea bream) and
Dicentrarchus labrax (European seabass)
Fish None reported
C. canis Fayer et al., 2001 Canis familiaris (Dog) Dogs Many reports (cf. Lucio-Forster et al., 2010)
C. andersoni Lindsay et al., 2000 Bos taurus (Cattle) Cattle Leoni et al., 2006; Morse et al., 2007; Waldron et al., 2011; Agholi et al.,
2013; Jiang et al., 2014; Liu et al., 2014
C. varanii Pavlasek et al., 1995 Varanus prasinus (Emerald Monitor) Lizards None reported
C. baileyi Current et al., 1986 Gallus gallus (Chicken) Birds None reported
C. parvum Tyzzer, 1912 Bos taurus (Cattle) Ruminants Commonly reported in humans
C. meleagridis Slavin, 1955 Meleagris gallopavo (Turkey) Birds and
humans
Commonly reported in humans





C. felis Iseki, 1979 Felis catis (Cat) Cats Many reports (cf. Lucio-Forster et al., 2010)
C. wrairi Vetterling et al.,
1971
Cavia porcellus (Guinea pig) Guinea pigs None reported
C. muris Tyzzer, 1907; and
1910
Mus musculus (House mouse) Rodents Many reports e Guyot et al., 2001; Gatei et al., 2002; Tiangtip and
Jongwutiwes, 2002; Gatei et al., 2003; Palmer et al., 2003; Gatei et al., 2006;
Leoni et al., 2006; Muthusamy et al., 2006; Azami et al., 2007; Al-Brikan
et al., 2008; Neira et al., 2012; Hasajova et al., 2014; Petrincova et al., 2015;
Spanakos et al., 2015
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Appendix 1precursor protein, that is cleaved to produce mature cell surface
glycoproteins (gp45/gp40 and gp15) implicated in zoite attachment
to, and invasion of enterocytes (Xiao, 2010; Ryan et al., 2014). Most
of the genetic heterogeneity in the gp60 gene is the variation in the
number of a tri-nucleotide repeat (TCA, TCG or TCT) in the 50 end
(gp40) of the coding region, although extensive sequence poly-
morphism is also present in the rest of the gene. The repeats are
used to define the subtype families within a species, whereas the
remaining polymorphic sites are used to identify subtypes within a
subtype family (Ryan et al., 2014).
3. Wildlife associated outbreaks and water contamination
Relatively little is known about the distribution of zoonotic and34non-zoonotic Cryptosporidium species and subtypes in wildlife
populations (Appelbee et al., 2005; Ziegler et al., 2007; Ryan et al.,
2014). Conclusive molecular evidence, linking contamination of
water supplies by wild animals in catchments with outbreaks of
cryptosporidiosis in human populations is scant. However, a recent
waterborne outbreak in the UK caused by C. cuniculus from rabbits
has highlighted the importance of wildlife in the dissemination of
Cryptosporidium to drinking water sources and the associated hu-
man health risk (Chalmers et al., 2009; Elvin et al., 2012).
A wide range of Cryptosporidium species and genotypes have
been identified in drinking source water, storm water runoff,
stream sediment, wastewater and seawater in various geographic
locations including C. hominis, C. parvum, C. andersoni, C. muris,
C. cuniculus, C. meleagridis and C. canis as well as various wildlife9
Table 2




Wildlife hosts Zoonotic importance gp60 subtypes reported in wildlife References
C. hominis Fallow deer (Dama dama), Dugong
(Dugong dugon), Chinchillas (Chinchilla




white colobus (Colobus guereza),
Rhesus macaque (Macaca mulatta),
Cynomolgus monkey (Macaca
fascicularis), Francois' leaf monkey
(Trachypithecus francoisi), Lemurs
(Lemur sp.), Bandicoots (Isoodon
obesulus), Bushtail possums
(Trichosurus vulpecula), Estern grey
kangaroos (Macropus giganteus),
Brush-tailed rock-wallabies (Petrogale
penicillata), Wild dingo (Canis lupus




IbA12G3, IbA10G2R2, IiA17, IfA12G2,
IaA13R7, IaA13R8, IaA14R7, IdA20,
IeA11G3T3, IfA16G2, IkA7G4 (novel
subtype)
Morgan et al., 2002; Salyer et al., 2012;
Ye et al., 2012; Ng et al., 2011; Dowle
et al., 2013; Nolan et al., 2013; Karim
et al., 2014; Ryan et al., 2014; Liu et al.,
2015b; Parsons et al., 2015; Zahedi
et al., 2015
C. parvum Alpaca (Lama pacos), Swamp deer
(Cervus duvauceli), Red deer (Cervus
elaphus), Roe deer (Capreolus
capreolus), Fallow deer (Dama dama),
Addaxes (Addax nasomaculatus),
Arabian oryx (Oryx leucoryx),
Gemsboks (Oryx gazella), Sable
antelopes (sable antelopes), White-
tailed deer (Odocoileus Virginianus),
Game grey wolves (Canis lupus),
Racoon dog (Nyctereutes procyonoides
viverrinus), Rabbit (Oryctolagus
cuniculus), Nutria (Myocastor coypus),
Prezewalski's wild horse (Equus
przewalskii), Alpaca (Lama quanico
pacos), Eastern grey squirrel (Sciurus
carolinensis), Ground Squirrels
(Spermophilus beecheyi), Siberian
chipmunk (Tamias sibiricus), Hamsters




Bamboo rats (Rhizomys sinensis), Small
brown bat (Myotis lucifugus), Campbell
hamster (Phodopus campbelli), Golden
hamster (Mesocricetus auratus),
Capybara (Hydrochoerus hydrochaeris),
Racoon dog (Nictereutes procyonoides
viverrinus), Red fox (Vulpes vulpes),
Rhesus macaques (Macaca mulatta),
Toque macaques (Macaca sinica
sinica), Grey langurs (Semnopithecus
priam thersites), Purple-faced langurs
(Trachypithecus vetulus philbricki),
Common dolphins (Delphinus delphis),
Golden takins (Budorcas taxicolor
bedfordi), Eastern grey kangaroos
(Macropus giganteus), Asian house rat
(Rattus tanezumi), Brown rat (Rattus
norvegicus), Bamboo rats (Rhizomys
sinensis)





IIcA5G3, IIcA5G3a, IIoA13G1, IIpA9
(novel subtype)
Morgan et al., 1999a; Atwill et al.,
2001; Perez and Le Blancq, 2001;
Matsui et al., 2000; Matsubayashi
et al., 2004; Ryan et al., 2003, 2004;
Ekanayake et al., 2007; Feng et al.,
2007; Meireles et al., 2007; Paziewska
et al., 2007; Starkey et al., 2007; Ziegler
et al., 2007; Cinque et al., 2008; Lv
et al., 2009; Feng, 2010; Gomez-Couso
et al., 2012; Ravaszova et al., 2012; Ye
et al., 2012; Dowle et al., 2013; Nolan
et al., 2013; Liu et al., 2014; Lv et al.,
2009; Reboredo-Fernandez et al.,
2014; Bodager et al., 2015; Liu et al.,
2015a; Montecino-Latorre et al., 2015;
Qi et al., 2015;Wang et al., 2015;Wells
et al., 2015; Zahedi et al., 2015; Zhao
et al., 2015a, 2015b
C. cuniculus European rabbit (Oryctolagus
cuniculus), Eastern grey kangaroo




cryptosporidiosis in the UK and
has been identified in a human
in Australia
VaA18,VbA18, VbA19, VbA21, VaA22,
VbA24, VbA26, VbA29, VbA32,
VbA22R4, VbA23R3, VbA24R3,
VbA25R4,VbA26R4
Xiao et al., 2002a; Ryan et al.,
2003;Chalmers, 2012; Nolan et al.,
2010; Robinson et al., 2010; Elwin
et al., 2012; Zhang et al., 2012; Nolan
et al., 2013; Kapuke et al., 2014;
Koehler et al., 2014; Liu et al., 2014;
Puleston et al., 2014
C. ubiquitum Swamp deer (Cervus duvauceli), Deer
mouse (Peromyscus), Eastern grey
squirrels (Sciurus carolinensis), Red
Emerging human pathogen XIIa, XIIb, XIIc, XIId, XIIe, XIIf Perez and Le Blancq, 2001; da Silva
et al., 2003; Ryan et al., 2003; Feng
et al., 2007; Karanis et al., 2007; Ziegler
(continued on next page)
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Wildlife hosts Zoonotic importance gp60 subtypes reported in wildlife References
squirrel (Sciurus vulgaris), Eastern
chipmunk (Tamias striatus), Lemur
(Lemuroidea), North American beaver
(Castor canadensis), Woodchuck
(Marmota monax), Raccoon (Procyon
lotor), White-tailed deer (Odocoileus
virginianus), Sika deer (Cervus Nippon),
Roe deer (Capreolus capreolus),
Blesbok (Damaliscus pygargus
phillipsi), Ibex (Capara sibirica), Nyala
(Niyala anagasii), Coquerel's sifaca
(Propithecus coquereli), Large Japanese
field mouse (Apodemus speciosus),
Foxes
et al., 2007; Wang et al., 2008; Fayer
et al., 2010; Cinque et al., 2008; Feng,
2010; Robinson et al., 2010, 2011;
Feng et al., 2012; Abu Samraa et al.,
2013; Nolan et al., 2013; Murakoshi
et al., 2013; Li et al., 2014; Ma et al.,
2014; Perec-Matysiak et al., 2015; Qi
et al., 2015a, 2015b; Stenger et al.,
2015b
C. muris Wild rats (Rattus sp.), Mice (Mus sp.),
Greater bilblies (Macroties lagotis),
Girrafes house mice (Mus musculus),
Eastern grey squirrel (Sciurus
carolinensis), Golden hamster
(Mesocricetus auratus), Rock hyrax
(Procavia capensis), Large footed
mouse-eared bat (Myotis adversus),
Japanese field mouse (Apodemus
argenteus), Bilbies (Macrotis lagotis),
Bank voles (Clethrionomys glareolus),
Campbell hamster (Phodopus
campbelli), Siberian hamster (Phodopus
sungorus), Golden hamster
(Mesocricetus auratus), Mountain goats
(Oreamnos americanus), Cynomolgus
monkeys (Macaca fascicularis), East
African mole rat (Tachyoryctes
splendens), Ringed seal (Pusa hispida),
Donkey (Giraffa camelopardalis),
Ringed seal (Phoca hispida), Large
Japanese field mouse (Apodemus
speciosus), Cynomolgus monkey
(Macaca fascicularis), Slow loris
(Nycticebus coucang), Ostriches
(Struthio camelus), Mountain gorillas
(Gorilla beringei beringei), Asian house
rat (Rattus tanezumi), Brown rat
(Rattus norvegicus), House mouse (Mus
musculus)
Numerous reports in humans Chalmers et al., 1997; Hurkova et al.,
2003
Dubey et al., 2002; Morgan et al.,
1999a; Xiao et al., 2002a, 2004b;
Warren et al., 2003; Nakai et al., 2004;
Hikosaka and Nakai, 2005; Santín
et al., 2005; Azami et al., 2007; Brikan
et al., 2008; Kvac et al., 2008; Lupo
et al., 2008; Lv et al., 2009; Kodadkova
et al., 2010; Feng, 2010; Murakoshi
et al., 2013; Yang et al., 2011, 2013;
Ng-Hublin et al., 2013; Karim et al.,
2014, Qi et al., 2014; Sak et al., 2014;
Du et al., 2015; Laatamna et al., 2015;
Petrincova et al., 2015, Zhao et al.,
2015b
C. andersoni Bacterian camel (Camelus bactrianus),
European wisent (Bison bonasus),
Marmots Campbell hamster (Phodopus
campbelli), Golden hamster
(Mesocricetus auratus), Golden takins
(Budorcas taxicolor bedfordi), Giant
panda (Ailuropoda melanoleuca),
Macaca mulatta (Rhesus macaque),
American mink (Mustela vison)
Minor e Matsubayashi et al., 2005; Wang et al.,
2008; Lv et al., 2009; Stuart et al.,
2013; Du et al., 2015; Wang et al.,
2015; Zhao et al., 2015a
C. felis Rhesus macaques (Macaca mulatta);
Pallas's cat (Felis Manul)
Numerous reports in humans e Lucio-Forster et al., 2010; Ye et al.,
2012; Beser et al., 2015; Ebner et al.,
2015; Li et al., 2015c
C. canis dog
genotype
Unidentified fox, Coyote (Canis latrans) Numerous reports in humans e Xiao et al., 2002a; Ryan et al., 2004;
Zhou et al., 2004; Trout et al., 2006;
Ziegler et al., 2007; Elwin et al., 2012;
Koompapong et al., 2014
C. canis fox
genotype
Fox No reports in humans to date e Zhou et al., 2004; Swaffer et al., 2014
C. canis coyote
genotype
Coyotes No reports in humans to date e Xiao et al., 2002a; Zhou et al., 2004
C. erinacei European hedgehog (Erinaceus
europaeus), Horses
One report in humans XIIIaA21R11, XIIIaA22R9, XIIIaA21R10,
XIIIa20R10, XIIIaA19R12, XIIIaA22R11
Dyachenko et al., 2010; Laatamna
et al., 2013; Nolan et al., 2013; Kvac
et al., 2014a, 2014b; Meredith and
Milne, 2009
C. fayeri Southern brown bandicoot (Isodon
obesulus), Western-barred bandicoot
(Permeles bougainville), Koala
(Phascolarctos cincerus), Red kangaroo
(Macropus rufus), Eastern grey
Minor IVaA9G4T1R1, IVaA10, IVaA7,
IVbA9G1T1, IVcA8G1T1, IVdA7G1T1,
IVfA12G1T1
Power et al., 2005; Ryan et al., 2008;
Yang et al., 2008, 2011; Power, 2010;
Waldron et al., 2010; Feng et al.,
2011b; Nolan et al., 2013; Swaffer
et al., 2014; Vermeulen et al., 2015
A. Zahedi et al. / International Journal for Parasitology: Parasites and Wildlife 5 (2016) 88e10992
Appendix 1
351




Wildlife hosts Zoonotic importance gp60 subtypes reported in wildlife References
kangaroo (Macropus giganteus), Yellow
footed rock wallaby (Petrogale






Opossum (Didelphimorphia) No reports in humans to date XIaA4G1T1 Feng et al., 2011b
Opossum
genotype II
Virginia opossum (Didelphis virginiae) No reports in humans to date e Xiao et al., 2002b; Oates et al., 2012
C. meleagridis Mountain gorillas (Gorilla beringei
beringei), Brush-tailed rock wallabies
(Petrogale penicillata), deermouse
(Peromyscus sp.)
Major IIIbA, IIIgA (closest match to
IIIeA19G2R1)
Morgan et al., 2000; Cama et al., 2003;
Gatei et al., 2006; Leoni et al., 2006;
Muthusamy et al., 2006; Feng et al.,
2007; Elwin et al., 2012; Silverlås et al.,
2012; Kurniawan et al., 2013; Adamu
et al., 2014; Ryan and Xiao, 2014;
Ghaffari and Kalantari, 2014; Sak et al.,
2014; Rahmouni et al., 2014; Wang
et al., 2014; Stensvold et al., 2015;
Vermeulen et al., 2015
C. tyzerri Mice (Mus musculus), Brown rats
(Rattus norvegicus), Large-footed bat
(Myotus adversus), Yellow-necked
mouse (Apodemus flavicollis), Bank
vole (Myodes glareolus), Common vole
(Microtus arvalis), Red panda (Ailurus
fulgens), Leopard (Panthera pardus),
Takin (Budorcas taxicolor), Prairie
bison (Bison bison), Lesser panda
(Ailurus fulgens), Black leopards
(Pantera pardus), Bobcats (Lynx rufus)
Occasionally reported in
humans
IXaA5R2, IXaA6R1, IXaA6R2, IXaA6R3,
IXbA6, IXbA6R2
Morgan et al., 1999a, Xiao et al., 2002a;
Bajer et al., 2003; Alves et al., 2005;
Foo et al., 2007; Karanis et al., 2007;
Ziegler et al., 2007; Lv et al., 2009; Feng
et al., 2011b; Carver et al., 2012; Kvac
et al., 2012; Ren et al., 2012; Raskova
et al., 2013; Silva et al., 2013; Swaffer
et al., 2014
C. macropodum Red kangaroo (Macropus rufus),
Eastern grey kangaroo (Macropus
giganteus), Swamp wallaby (Wallabia
bicolor), Western grey kangaroos
(Macropus fuliginosus)
No reports in humans to date e Power et al., 2004, 2005; Power and
Ryan, 2008; Power, 2010; Yang et al.,
2011; Nolan et al., 2013
C. bovis Yaks, foxes, Gorillas (single report),
Roe deer (Capreolus capreolus)
Occasionally reported in
humans
e Robinson et al., 2011; Helmy et al.,
2013; García-Presedo et al., 2013b; Sak
et al., 2013; Qi et al., 2015b; Qin et al.,
2014
C. ryanae Roe deer (Capreolus capreolus), Water
buffaloes (Bubalus bubalis)
No reports in humans to date e Feng et al., 2012; García-Presedo et al.,
2013b
C. wrairi Guinea pig (Cavia porcellus), California
ground squirrels (Spermophilus
beecheyi)
No reports in humans to date VIIaA13T1, VIIaA17T1, VIIaA16T1 Atwill et al., 2004; Feng et al., 2007,
2011b, Lv et al., 2009
C. scrofarum Asian house rat (Rattus tanezumi),
Brown rat (Rattus norvegicus), Eurasian
wild boars (Sus scrofa)
Occasionally reported in
humans
e García-Presedo et al., 2013a; Ng-
Hublin et al., 2013, Nemeic et al., 2013;
Bodager et al., 2015; Parsons et al.,
2015
C. suis Chimpanzees (Pan troglodytes




e Nemeic et al., 2012, 2013; Bodager
et al., 2015; Parsons et al., 2015
C. suis-like Asian house rat (Rattus tanezumi) No reports in humans to date e Ng-Hublin et al., 2013
C. rubeyi California ground squirrel (S. beecheyi),
Belding's ground squirrel (S. beldingi),
Golden
Mantled ground squirrel (S. lateralis)
No reports in humans to date e Pereira et al., 2010; Li et al., 2015a
Bear genotype Black bear (Ursus americanus) No reports in humans to date e Xiao et al., 2000
Bat genotype I Chinese rufous horseshoe bat
(Rhinolophus sinicus), Stoliczka's
trident bat (Aselliscus stoliczkanus)
No reports in humans to date e Wang et al., 2013b
Bat genotype II Chinese rufous horseshoe bat
(Rhinolophus sinicus), Fulvus roundleaf
bat (Hipposideros fulvus), Leschenault's
rousette (Rousettus leschenaultii)
No reports in humans to date e Wang et al., 2013b
Bat genotype III Big brow bat (Eptesicus fuscus) No reports in humans to date e Kvac et al., 2015
Bat genotype IV Western barbastelle (Barbastella
barbastellus)
No reports in humans to date Kvac et al., 2015
Beaver genotype North American beaver (Castor
canadensis)





No reports in humans to date e Hill et al., 2008
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Chipmunk
genotype I
Chipmunk sp. (Tamias sp.), Eastern
grey squirrel (Sciurus carolinensis),
Deer mice (Peromyscus maniculatus)
Emerging human pathogen XIVaA18G2T1, XIVaA18G2T2 Jiang et al., 2005; Feltus et al., 2006;
Feng et al., 2007; ANOFEL, 2010;
Insulander et al., 2013; Lebbad et al.,
2013; Guo et al., 2015
Chipmunk
genotype II
Eastern chipmunk (Ramias striatus) No reports in humans to date e Feng et al., 2007; Stenger et al., 2015a
Chipmunk
genotype III
Siberian chipmunk (Tamias sibiricus) No reports in humans to date e Lv et al., 2009
Deer mouse
genotype I




Deer mouse (Peromyscus) No reports in humans to date e Xiao et al., 2002b; Feng et al., 2007
Deer mouse
genotype III
Deer mouse (Peromyscus) No reports in humans to date e Feng et al., 2007; Stenger et al., 2015b
Deer mouse
genotype IV
Deer mouse (Peromyscus) No reports in humans to date e Feng et al., 2007
Ferret genotype Ferret (Mustelidae), Siberian chipmunk
(Tamias sibiricus), River otters (Lontra
canadensis), Black-footed ferret
(Mustela nigripes), Red squirrel (Sciurus
vulgaris)
No reports in humans to date VIIIaA5G2 Xiao et al., 2002a; Abe and Iseki, 2003;
Gaydos et al., 2007; Kvac et al., 2008;
Lv et al., 2009; Feng et al., 2011b
Giant panda
genotype






ground squirrels (Urocitellus beldingi),
California ground squirrels
(Otospermophilus beecheyi), Black-
tailed prairie dog (Cynomys
ludovicianus)
No reports in humans to date e Atwill et al., 2004; Pereira et al., 2010;
Stenger et al., 2015b
Hamster
genotype
Siberian hamster (Phodopus sungorus) No reports in humans to date e Lv et al., 2009
Horse genotype Przewalski's wild horse (Equus
przewalski), Four-toed hedgehog
(Atelerix albiventris)
Identified in humans in the UK VIaA11G3, VIbA13 Ryan et al., 2003; Robinson et al., 2008;
Abe and Matsubara, 2015
Mink genotype River otter (Lontra canadensis),
American minks (Mustela vison),
Ermine (Mustela ermine)
Several reports in humans XaA5G1 Feng et al., 2007, Wang et al., 2008;
Feng et al., 2011b; Ng-Hublin et al.,






House mouse (Mus musculus)
House mouse (Mus musculus)
No reports in humans to date
No reports in humans to date
e
e
Foo et al., 2007; Silva et al., 2013
Silva et al., 2013
Muskrat
genotype I
Muskrat (Ondatra zibethicus), Boreal
red-backed vole (Myodes rutilus)
No reports in humans to date e Xiao et al., 2002a; Zhou et al., 2004;
Feng et al., 2007
Muskrat
genotype II
Muskrat (Ondatra zibethicus), Red fox
(Vulpus vulpus), Deer mouse
(Peromyscus maniculatus), Meadow
vole (Microtus pennsylvanicus)




Large Japanese field mouse (Apodemus
speciosus)
No reports in humans to date e Murakoshi et al., 2013
Rat genotype I Brown rat (Rattus norvegicus) No reports in humans to date e Ng-Hublin et al., 2013
Rat genotype II Brown rat (Rattus tanezum), Wild black
rat (Rattus rattus), Brown rat (Rattus
norvegicus).
No reports in humans to date e Lv et al., 2009; Paparini et al., 2012;
Ng-Hublin et al., 2013; Silva et al.,
2013
Rat genotype III Asian house rat (Rattus tanezumi),
Wild black rat (Rattus rattus).
No reports in humans to date e Lv et al., 2009; Paparini et al., 2012;
Ng-Hublin et al., 2013; Silva et al.,
2013
Rat genotype IV Tanezumi rat (Rattus tanezumi), Asian
house rat (Rattus tanezumi), Brown rat
(Rattus norvegicus)
No reports in humans to date e Ng-Hublin et al., 2013
Seal genotypes I
and II
Ringed seals (Phoca hispida), Harbour
seals (Phoca vituline), Hooded seal
(Cystophora cristata)
No reports in humans to date e Santín et al., 2005; Bass et al., 2012





Southern elephant seal (Mirounga
leonina)




Weddel seal (Leptonychotes weddellii) No reports in humans to date e Rengifo-Herrera et al., 2013
Shrew genotype No reports in humans to date e
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Northern short-tailed shrew (Blarina
brevicauda), Wildebeest
(Connochaetes), White-toothed shrew
(Crocidura russula), Common shrew
(Sorex araneus), Masked shrew (Sorex
scinereus), Pygmy shrew (Sorex
minutus), Brewer's mole (Parascalops
brewer), Ermine (Mustela ermine)
Torres et al., 2000; Alves et al., 2005;
Feng et al., 2007; Ziegler et al., 2007
Skunk/skunk-
like genotype
Striped skunk (Mephitis mephitis),
Raccoon (Procyon lotor), Eastern grey
squirrel (Sciurus carolinensis), River
otter (Lontra canadensis), Raccoon
(Procyon lotor), Southern elephant seal
(Mirounga leonina), Raccoon (Procyon
lotor), Shunk (Mephitis mephitis),
American red (Tamiasciurus
hudsonicus), Fox squirrel (Sciurus
niger)
Has been reported in humans e Xiao et al., 2002b; Zhou et al., 2004;
Feng et al., 2007; Ziegler et al., 2007;
Robinson et al., 2008; Chalmers et al.,
2009; Feng et al., 2011b; Rengifo-
Herrera et al., 2011; Elwin et al., 2012;
Stenger et al., 2015b
Vole genotype Meadow vole (Microtus
pennynsylvanicus)
No reports in humans to date e Feng et al., 2007
Wildbeast
genotype
Black wildbeast (Connochaetos) No reports in humans to date e Alves et al., 2005
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which probably represent as yet unidentified wildlife genotypes
and which also highlight the potential for contamination of water
supplies by wildlife (Zhou et al., 2004; Jiang et al., 2005; Yang et al.,
2008; Jellison et al., 2004; Nichols et al., 2010; Koompapong and
Sukthana, 2012; Van Dyke et al., 2012; Xiao et al., 2012; Galvan
et al., 2014; Li et al., 2014; Mahmoudi et al., 2015). For example,
studies on Cryptosporidium contamination from wildlife from New
York watersheds have shown that wildlife are the major source of
Cryptosporidium in protected drinking source water, including
some emerging human pathogens such as C. ubiquitum and chip-
munk genotype I (Jiang et al., 2005; Feng et al., 2007).
3.1. Cryptosporidium in mammals
Due to the morphological similarity of Cryptosporidium oocysts
from different host species, initial findings of Cryptosporidium in-
fections in wild animals were assumed to be due to C. parvum
leading to an overestimation of the potential role of wildlife as
reservoirs of human disease (Appelbeea et al., 2005). However,
with the assistance of advanced molecular techniques, many of
these species were identified as host-adapted genotypes (Table 2).
Both wild terrestrial and marine mammals have been studied as
potential reservoirs for human-infectious Cryptosporidium species
and genotypes using molecular tools (Table 2). The prevalence of
Cryptosporidium inwild placental mammal hosts has been reported
in detail in a recent review (Feng, 2010) and varies widely between
mammalian hosts.
3.1.1. Cryptosporidium hominis
Although humans are the major host species for C. hominis, it
has been reported in a number of wildlife hosts including a dugong
and non-human primates (Table 2) (Xiao et al., 1999; Ye et al., 2012;
Karim et al., 2014; Bodager et al., 2015; Parsons et al., 2015). C.
hominis/Cryptosporidium parvum-like sequences were identified in
red and black-and-white colobus monkeys in Uganda (Salyer et al.,
2012). However, typing was obtained using a short fragment of the
Cryptosporidium oocyst wall protein (COWP) gene, which is not
reliable for differentiating Cryptosporidium species. In Australia, a
number of recent studies have also identified C. hominis/C. parvum-354like isolates at the 18S locus in marsupials including bandicoots,
brushtail possums, eastern grey kangaroos and brush-tailed rock-
wallabies (Hill et al., 2008; Ng et al., 2011; Dowle et al., 2013;
Vermeulen et al., 2015). However, despite efforts, the identifica-
tion of C. hominis/C. parvum could not be confirmed at other loci.
This might be due to low numbers of oocysts and the multi copy
nature of the 18S rRNA gene. Another study reported a C. hominis-
like sequence at the 18S locus in a wild dingo, but was also unable
to confirm this at other loci (Ng et al., 2011).
Subtyping of C. hominis at the gp60 locus has identified nine
subtype families (Ia to Ij) (Ryan et al., 2014). To date, few C. hominis
subtypes have been reported inwild mammals but include subtype
IbA12G3 in Rhesus macaques, subtype IiA17 in Cynomolgus mon-
keys and Rhesus monkeys and subtype IfA12G2 in baboons and
Mitumba chimpanzees (Feng et al., 2011b; Karim et al., 2014;
Bodager et al., 2015; Parsons et al., 2015).
Recently, C. hominis has been identified and enumerated from
eastern grey kangaroos and cattle faecal samples from Sydney
catchments and characterised at multiple loci (Zahedi et al., 2015).
In that study, C. hominis isolates were typed at three loci (18S, a
novel mucin-like glycoprotein that contains a C-type lectin domain
and the gp60 gene) (Zahedi et al., 2015). The C. hominis IbA10G2
subtype was identified in the marsupials and cattle (Zahedi et al.,
2015), which is the main subtype associated with outbreaks of
cryptosporidiosis by C. hominis (Xiao, 2010).3.1.2. C. parvum
C. parvum was first described in mice (Tyzzer, 1912) and is pri-
marily a parasite of artiodactyls and humans (Xiao, 2010). C. parvum
has however been frequently reported in wildlife, infecting a broad
range of wild species including various rodents, bovids, camelids,
equids, canids, non-human primates and marine mammals
(Table 2) (Morgan et al., 1999a; Atwill et al., 2001; Perez and Le
Blancq, 2001; Matsubayashi et al., 2004; Ryan et al., 2004;
Appelbee et al., 2005; Feng et al., 2007; Meireles et al., 2007;
Paziewska et al., 2007; Starkey et al., 2007; Ziegler et al., 2007;
Gomez-Couso et al., 2012; Ye et al., 2012; Abu Samraa et al., 2013;
Liu et al., 2013; García-Presedo et al., 2013b; Reboredo-Fernandez
et al., 2014; Montecino-Latorre et al., 2015; Wells et al., 2015;
Matsui et al., 2000).
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but red deer, fallow deer, addaxes, Arabian oryx, gemsboks, and
sable antelopes are among mammals to be infected with C. parvum
in captivity (Perez and Le Blancq, 2001; Ryan et al., 2003; Hajdusek
et al., 2004; Abe et al., 2006; Feng et al., 2007; Meireles et al., 2007;
Matsubayashi et al., 2004; Bodager et al., 2015; Wang et al., 2015;
Zhao et al., 2015a).
Subtyping of C. parvum at the gp60 locus has identified fourteen
subtype families (IIa to IIo (Ryan et al., 2014)). Few studies which
identified C. parvum inwild mammals have conducted typing at the
gp60 locus but a variety of C. parvum subtypes including IIdA15G1,
IIdA18G1, IIdA19G1 have been reported from golden takins, lemurs,
chipmunks and hamsters, and IIaA15G2R1, IIaA19G2R1,
IIaA19G3R1, IIaA19G4R1, IIaA20G3R1, IIaA20G4R1, IIaA20G3R2 and
IIaA21G3R1 have been reported from deer and Eastern grey kan-
garoos (Lv et al., 2009; Bodager et al., 2015; Montecino-Latorre
et al., 2015; Zhao et al., 2015a; Zahedi et al., 2015). These are all
C. parvum subtypes that have been reported in humans (Xiao,
2010).
3.1.3. Cryptosporidium cuniculus
C. cuniculus (previously known as rabbit genotype) was first
described in rabbits by Inman and Takeuchi (1979), who described
the microscopic detection and ultra-structure of endogenous
Cryptosporidium parasites in the ileum of an asymptomatic female
rabbit. Molecular characterisation of C. cuniculus was first con-
ducted on rabbit faecal samples from the Czech Republic (Ryan
et al., 2003) and C. cuniculus was formally re-described as a spe-
cies in 2010 (Robinson et al., 2010). Since then, it has been described
from rabbits across a wide geographic area including Australia,
China, the UK, the Czech Republic, Poland, France and Nigeria (Ryan
et al., 2003; Nolan et al., 2010; Shi et al., 2010; Chalmers et al., 2011;
Zhang et al., 2012; Nolan et al., 2013; Liu et al., 2014; Koehler et al.,
2014; Puleston et al., 2014; Zahedi et al., 2015). C. cuniculus has a
close genetic relationship with C. hominis and its zoonotic potential
became clear in 2008, when it was responsible for a drinking-water
associated outbreak of cryptosporidiosis in the UK (Chalmers et al.,
2009; Robinson et al., 2011; Puleston et al., 2014) and has also been
identified in many sporadic human cases of cryptosporidiosis
(Robinson and Chalmers, 2011; Chalmers et al., 2011; Elwin et al.,
2012; Koehler et al., 2014). It is also the third most commonly
identified Cryptosporidium species in patients with diarrhoea in the
UK (Chalmers et al., 2011). Subtyping at the gp60 locus has iden-
tified two distinct subtype families, designated Va and Vb
(Chalmers et al., 2009). Most cases described in humans relate to
clade Va and the first waterborne outbreak was typed as VaA22
(Robinson et al., 2008; Chalmers et al., 2009). C. cuniculus has been
reported in rabbits and humans (subtypes VaA9eVaA22 and
VbA20eVbA37 e see Wang et al., 2012) but has recently been
identified in marsupials (subtype VbA26) (and a human e subtype
VbA25) in Australia (Nolan et al., 2013; Koehler et al., 2014). The
widespread occurrence of C. cuniculus genotypes in rabbits and the
fact that it has been now been identified in marsupials in Australia
suggests that C. cuniculus might be a species more ubiquitous than
previously thought, and might be able to spread to other mammals
as well as humans. Therefore, there is a need to diligently monitor
for C. cuniculus in the vicinity of drinking water catchments and in
drinking water.
3.1.4. Cryptosporidium ubiquitum
C. ubiquitum (previously cervine genotype, cervid, W4 or ge-
notype 3) was first identified by Xiao et al. (2000) in storm water
samples in lower New York State (stormwater isolateW4, GenBank
accession no. AF262328). Subsequently, Perez and Le Blancq (2001)
identified this genotype in white-tailed deer-derived isolates from35lower New York State and referred to it as genotype 3. Since then it
has been described in a wide variety of hosts worldwide including
humans and was formally described as a species in 2010 (Fayer
et al., 2010). C. ubiquitum is of public health concern because of
its wide geographic distribution and broad host range (Li et al.,
2014). In addition to domestic animals (in particular sheep) and
wildlife, C. ubiquitum has been frequently reported from drinking
source water, stormwater runoff, stream sediment and wastewater
in various geographic locations, suggesting potential contamina-
tion of water sources with oocysts of C. ubiquitum shed by animals
inhabiting water catchments (Nolan et al., 2013; Li et al., 2014). C.
ubiquitum is considered an emerging zoonotic pathogen (Li et al.,
2014), as it has been identified in many human cases of crypto-
sporidiosis in the United Kingdom, Slovenia, the United States,
Canada, Spain, New Zealand, Venezuela and Nigeria (Charlmers
et al., 2011; Wong and Ong, 2006; Fayer et al., 2010; Cieloszyk
et al., 2012; Elwin et al., 2012; Blanco et al., 2015; Qi et al., 2015a).
In wildlife, C. ubiquitum has been reported sporadically in ro-
dents, wild ruminants, carnivores, marsupials and primates
(Table 2) (Perez and Le Blancq, 2001; da Silva et al., 2003; Ryan
et al., 2003; Feng et al., 2007; Feng, 2010; Karanis et al., 2007;
Ziegler et al., 2007; Wang et al., 2008; Fayer et al., 2010; Cinque
et al., 2008; Robinson et al., 2011; Feng et al., 2011b; Abu Samraa
et al., 2013; Mi et al., 2013; Murakoshi et al., 2013; Li et al., 2014;
Ma et al., 2014; Perec-Matysiak et al., 2015; Qi et al., 2015a,
2015b; Stenger et al., 2015b; Vermeulen et al., 2015).
Because C. ubiquitum is genetically distant from C. hominis and
C. parvum, until recently, gp60 homologs had not been sequenced.
However, the gp60 gene of C. ubiquitum was identified by whole-
genome sequencing and six subtype families (XIIaeXIIf) within
C. ubiquitumwere identified (Li et al., 2014). Application of this new
tool to human, animal, and environmental (water) isolates has
suggested that sheep and rodents are a key source of C. ubiquitum
transmission to humans, through either direct human contact with
infected animals or by contamination of drinking source water (Li
et al., 2014). For example, in the US, all C. ubiquitum specimens
from humans characterized belonged to the same subtype families
found in wild rodents in the US (XIIb, XIIc and XIId) (Li et al., 2014).
However, as persons in the United States usually have little direct
contact with wild rodents, the authots concluded that transmission
of C. ubiquitum to humans from rodents was likely to come from
drinking untreated water contaminated by wildlife (Li et al., 2014).
3.1.5. Cryptosporidium muris
C. muris is a gastric parasite and was first identified in the gastric
glands of mice in 1907 by Tyzzer (1907). Since then, molecular tools
have shown that it has a wide host range, including various
mammals (rodents, canids, felids, suids, giraffida, equids, non-
human primates and marsupials) and birds (Tables 1 and 2). C.
muris is considered a zoonotic species as there have been numerous
reports of C. muris in humans and one report in human sewage
(Guyot et al., 2001; Gatei et al., 2002; Tiangtip and Jongwutiwes,
2002; Gatei et al., 2003; Palmer et al., 2003; Gatei et al., 2006;
Leoni et al., 2006; Muthusamy et al., 2006; Azami et al., 2007; Al-
Brikan et al., 2008; Neira et al., 2012; Hasajova et al., 2014; Pet-
rincova et al., 2015; Spanakos et al., 2015; Hurkova et al., 2003).
In a recent human infectivity study, C. muriswas examined in six
healthy adults (Chappell et al., 2015). Volunteers were challenged
with 105 C. muris oocysts and monitored for 6 weeks for infection
and/or illness. All six patients became infected. Two patients
experienced a self-limited diarrhoeal illness. C. muris oocysts shed
during the study ranged from 6.7  106 to 4.1  108, and C. muris-
infected subjects shed oocysts longer than occurred with other
species studied in healthy volunteers. Three volunteers shed oo-
cysts for 7 months (Chappell et al., 2015). The authors concluded5
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diarrhoea and result in persistent, asymptomatic infection
(Chappell et al., 2015), which confirms the zoonotic status of
C. muris and highlights the public health risks of finding C. muris in
wildlife in drinking water catchments.
3.1.6. Cryptosporidium andersoni
Like C. muris, C. andersoni is also a gastric parasite and primarily
infects the abomasum of cattle and to a lesser extent, sheep and
goats (Ryan et al., 2014; Wang et al., 2012). C. andersoni produces
oocysts that are morphologically similar to, but slightly smaller
than those of C. muris (7.4e8.8  5.8e6.6 mm vs
8.2e9.4  6.0e6.8 mm, respectively) and was originally mistakenly
identified in cattle as C. muris based on its oocyst size. In 2000, it
was described as a new species based on the location of endoge-
nous stages in the abomasum, its host range, and genetic distinct-
ness at multiple loci (Lindsay et al., 2000). It has only occasionally
being detected in wild animals (Table 2) (Ryan et al., 2004; Wang
et al., 2008, 2015; Lv et al., 2009; Feng et al., 2010; Zhao et al.,
2015a). Several studies have reported that C. andersoni is the
dominant species in source and tap water (Feng et al., 2011; Nichols
et al., 2010), suggesting that cattle may be the primary source of
contamination. Interestingly, in a recent study, it was found at a
prevalence of 15.6% (19/122) and 0.5% (1/200) in captive and wild
giant pandas, respectively in China (Wang et al., 2015). It is occa-
sionally detected in humans (Leoni et al., 2006; Morse et al., 2007;
Waldron et al., 2011; Agholi et al., 2013; Jiang et al., 2014; Liu et al.,
2014). Two studies in China by the same research group have re-
ported that C. andersoni was the most prevalent Cryptosporidium
species detected in humans (Jiang et al., 2014; Liu et al., 2014).
However, further research is required to better understand the
zoonotic importance of C. andersoni.
3.1.7. Cryptosporidium canis
C. canis (previously dog genotype 1) was first identified as the
dog genotype by Xiao et al. (1999) and described as a species in
2001 (Fayer et al., 2001), on the basis that C. canis oocysts were
infectious for calves but notmice andwere genetically distinct from
all other species. C. canis and its sub-genotypes (C. canis fox geno-
type and C. canis coyote genotype) have been reported in dogs,
foxes and coyotes (Table 2) (Xiao et al., 2002a; Zhou et al., 2004;
Fayer, 2010; Feng, 2010). C. canis has also been reported world-
wide in humans (Lucio-Forster et al., 2010; Fayer, 2010; Elwin et al.,
2012; Mahmoudi et al., 2015; Parsons et al., 2015).
3.1.8. Cryptosporidium erinacei
Little is known about epidemiology and pathogenicity of zoo-
notic C. erinacei in wildlife. C. erinacei (previously known as
hedgehog genotype) was first identified morphologically in a
captive four-toed hedgehog (Ateletrix albiventris) in 1998 (Graczyk
et al., 1998). An isolate from a European hedgehog originating
fromDenmarkwas typed in 2002 (Enemark et al., 2002) and shown
to be distinct. Subsequent studies have identified C. erinacei in
hedgehogs, horses and humans (Dyachenko et al., 2010; Laatamna
et al., 2013; Kvac et al., 2014a, 2014b; Meredith andMilne, 2009). At
the gp60 locus, C. erinacei isolates are identified as subtype family
XIII (Dyachenko et al., 2010; Laatamna et al., 2013; Lv et al., 2009;
Kvac et al., 2014b). Previously reported C. erinacei subtypes
include XIIIaA20R10 (KF055453), XIIIaA21R10 (GQ214085),
XIIIaA22R9 (KC305644), XIIIaA19R12 (GQ214081), and XIIIaA22R11
(GQ259140) Kvac et al., 2014b).
3.1.9. Cryptosporidium fayeri and Cryptosporidium macropodum
The two main species identified in a wide range of marsupials
are C. fayeri and C. macropodum (previously marsupial genotype I356and II) (Table 2) (Morgan et al., 1997; Power et al., 2004, 2005;
Power and Ryan, 2008; Ryan et al., 2008; Nolan et al., 2010;
Power, 2010; Ng et al., 2011a; Yang et al., 2011; Ryan and Power,
2012; Nolan et al., 2013; Vermeulen et al., 2015; Zahedi et al.,
2015). Neither of these species is associated with diarrhoea in
their marsupial hosts (Ryan and Power, 2012). C. macropodum has
not been reported in humans but cryptosporidiosis caused by
C. fayeri has been reported in a 29-year-old female patient in
Australia (Waldron et al., 2010). The woman was immuno-
competent but suffered prolonged gastrointestinal illness. The pa-
tient resided in a national forest on the east coast of New South
Wales, Australia, an area where marsupials are abundant. She had
frequent contact with partially domesticated marsupials (Waldron
et al., 2010). Identification of C. fayeri in a human patient is a
concern for water catchment authorities in the Sydney region. The
main water supply for Sydney, Warragamba Dam, covers 9050 km2
and is surrounded by national forest inhabited by diverse and
abundant marsupials. At the gp60 locus, the subtype family IV has
been identified with 6 subtypes (IVaeIVf) (Power et al., 2009).
Subtyping of the human-derived isolate of C. fayeri identified
IVaA9G4T1R1, which has also been identified in eastern grey kan-
garoos in Warragamba Dam, suggesting possible zoonotic trans-
mission (Power, 2010; Waldron et al., 2010).
In addition to C. fayeri and C. macropodum, there have been
several other host-adapted genotypes identified in Australian
marsupials. Possum genotype I has been described in brushtail
possums, a host species found in a range of habitats throughout
Australia (Hill et al., 2008) and the novel kangaroo genotype I in
western grey kangaroos (Yang et al., 2011). Possum genotype I and
kangaroo genotype I have not been reported in humans or other
animals and their zoonotic potential is unknown.
3.1.10. Cryptosporidium meleagridis
Although primarily a bird parasite (see section 3.2.1 and
Table 3), C. meleagridis has been identified in deermice, mountain
gorillas and marsupials (Feng et al., 2007; Sak et al., 2014;
Vermeulen et al., 2015). It is also the third most prevalent species
infecting humans (Morgan et al., 2000; Cama et al., 2003; Gatei
et al., 2006; Muthusamy et al., 2006; Leoni et al., 2006; Berrilli
et al., 2012; Elwin et al., 2012; Neira et al., 2012; Silverlås et al.,
2012; Kurniawan et al., 2013; Sharma et al., 2013; Wang et al.,
2014; Adamu et al., 2014; Ghaffari and Kalantari, 2014; Ryan and
Xiao, 2014; Ghaffari and Kalantari, 2014; Rahmouni et al., 2014;
Wang et al., 2014; Stensvold et al., 2014, 2015). In some studies,
C. meleagridis prevalence is similar to that of C. parvum (Gatei et al.,
2002; Cama et al., 2007). The ability of C. meleagridis to infect
humans and other mammals, and its close relationship to C. parvum
and C. hominis at multiple loci, has led to the suggestion that
mammals actually were the original hosts, and that the species has
later adapted to birds (Xiao et al., 2002a,). Subtyping at the gp60
locus has identified seven subtype families (IIIa to IIIg) (Stensvold
et al., 2015). More details on transmission dynamics will be dis-
cussed in section 3.2.1.
3.1.11. Other Cryptosporidium species and genotypes reported in
wild mammals
A number of other Cryptosporidium species and genotypes have
been identified in wildlife (Table 2). Most are host-adapted geno-
types that are not of public health significance, however several
have been identified in humans (Table 2). Of these, the chipmunk
genotype I is considered an emerging human pathogen (Jiang et al.,
2005; Feltus et al., 2006; Feng et al., 2007; ANOFEL, 2010;
Insulander et al., 2013; Lebbad et al., 2013; Guo et al., 2015). At
the gp60 locus, 15 different subtypes have been identified but
subtypes differ only in the number of tandem repeats (TCA/TCG/
Table 3
Cryptosporidium species and genotypes in avian hosts confirmed by molecular analysis (Modified from Ryan and Xiao, 2014).
Species name Major host(s) Site of
infection
References
C. meleagridis Turkey (Meleagris gallopavo), Indian ring-necked parrot (Psittacula
kameri), Red-legged partridge (Alectoris rufa), Cocktails (Nymphicus
hollandicus), Bohemian waxwing (Bombycilla garrulous), Rufousturle
dove (Streptopelia orientalis), Fan-tailed pigeon (Columba livia),
Chicken (Gallus gallus), Quails (Coturnixcoturnix japonica), Pekin
ducks (Anas platyrhynchos), Domestic Pigeons (Columba livia
domestica), European turtle dove (Streptopelia turtur), Red-legged
partridge (Alectoris rufa)
Intestine Morgan et al., 2000; Glaberman et al., 2001; Abe and Iseki, 2004; Abe
and Makino 2010; Wang et al., 2010; Qi et al., 2011; Berrilli et al.,
2012; Wang et al., 2012; Baroudi et al., 2013; Wang et al., 2014;
Koompapong et al., 2014; Maca and Pavlasek, 2015; Reboredo-
Fernandez et al., 2015
C. baileyi Turkey (Meleagris gallopavo), Chicken (Gallus gallus), Brown squail
(Synoicus australis), Cocktails (Nymphicus hollandicus), Whooping
crane (Grus vipio), Grey-bellied bulbul (Pycnonotus spp.), Black
vulture (Coragyps atratus), Saffron finch (Sicalis flaveola), Mixed-bred
falcons (Falcorusticolus x Falco cherrug), Reddy Shelduck
(Tadornaferruginea), Red-billed leiothrixes (Leiothrix lutea), Pekin
ducks (Anas platyrhynchos), Buffy-fronted seedeater (Sporophila
frontalis), Javva sparrows (Padda oryzivora), Mynas (Acridotheres
tristis), Zebra finches (Taeniopygia guttata), Crested Lark (Galerida
cristana), Gouldian finch (Chloebia gouldiae), Black-billedmagpie (Pica
pica), Ostriches (Struthio camelus), Quails (Coturnixcoturnix japonica),




Morgan et al., 2001; Abe and Iseki, 2004; Ng et al., 2006; Huber et al.,
2007; Kimura et al., 2004; Nakamura et al., 2009; Abe and Makino,
2010; Wang et al., 2010; Qi et al., 2011; Wang et al., 2012; Baroudi
et al., 2013; Baines et al., 2014; Hamidinejat et al., 2014; Wang et al.,
2014; Li et al., 2015c; Maca and Pavalasek, 2015
C. galli Chicken (Gallus gallus), Finches (Spermestidae and Fringillidae),
Capercaille (Tetrao urogallu), Pine grosbeak (Pinicola enuncleator),
Turqoise parrots (Neophema pulchella), Cuban flamingo
(Phoenicopterus ruber ruber), Rhinoceros hornbill (Buceros rhinoceros),
Red-cowled cardinal (Paroaria dominicana), Zebra finches
(Taeniopygia guttata), Chocolate parson finches (Peophila cincta),
Chesnut finches (Lonchura castaneothorax), Painted firetali finches
(Ebmlema picta), Canaries (Serinus sp.), Glosters (Serinus canaria),
Green-winged saltatros (Saltator similis), Slate-collard seedeater
(Sporophila schistaceca), Great-billed seed-fench (Oryzoborus
maximiliani), Ultermarine grosbeak (Cyanocompsa brissonii),
Bohemian waxwing (Bombycilla garrulous), Silver-eared Mesia
(Leiothrix argentauris), Cockatiel (Nymphicus hollandicus), Chopi
blackbird (Gnorimopsar chopi), Green-winged saltator (Saltator
similis), Rufous-collared sparrow (Zonotrichia capensis)
Preventriculus Ryan et al., 2003; Ng et al., 2006; Antunes et al., 2008; Nakamura
et al., 2009; da Silva et al., 2010; Qi et al., 2011; Nakamura et al., 2014
Avian
genotype I
Red factor canary (Serinus canaria), Canary (S. canaria), Indian
peafowl (Pavo cristatus)




Eclectus (Eclectus roratus), Galah (Eolophus roseicapilla), Cockatiel
(Nymphicus hollandicus), Major Mitchel Cockatoo (Cavcatua lead
beater), Ostriches (Struthio camelus), White-eyed parakeet (Aratinga
leucophthalma)
e Meireles et al., 2006; Ng et al., 2006; Nakamura et al., 2009; Seva




Galah (Eolophus roseicapilla), Cockatiel (Nymphicus hollandicus), Java
sparrow (Padda oryzivora), Son conure (Aratinga solstitialis), Peach
faced lovebirds (Agapornis roseicollis), Seagull (Laridae sp), Blue-
fronted amazon (Amazona aestival), Cockatiel (Nymphicus
hollandicus), Rufous-collared sparrow (Zonotrichia capensis), Lovebird
(Agapornis species), Cockatiel (Nymphicus hollandicus)
e Ng et al., 2006; Nakamura et al., 2009; Makino et al., 2010;
Koompapong et al., 2014; Nakamura et al., 2014; Ravich et al., 2014;








Cockatiel (Nymphicus hollandicus), Budgerigar (Melopsittacus
undulates)
e Abe and Makino, 2010; Qi et al., 2011; Zhang et al., 2015
Duck
genotype




Eurasian woodcock (Scolopax rusticola) e Ryan et al., 2003; Ng et al., 2006
Goose
genotype I
















Canada geese (Branta canadensis) e Jellison et al., 2004
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Appendix 1TCT) and comprise a single subtype family (XIVa). Analysis in-
dicates that subtypes from humans and wildlife are genetically
similar and zoonotic transmission might play a potential role in
human infections (Guo et al., 2015). The skunk and mink genotypes
have also been reported in a few human cases of cryptosporidiosis
(Robinson et al., 2008; Chalmers et al., 2009; Rengifo-Herrera et al.,
2011; Elwin et al., 2012; Ng-Hublin et al., 2013; Ebner et al., 2015).3.2. Cryptosporidium in birds
The mobility of migratory birds, together with their distribution
and ability to form large colonies, makes them potentially suitable
to spread pathogens. Due to their easy access to drinking water
catchments and other water sources, wild birds are believed to be a
potential risk to drinking water safety. The epidemiology of avian
cryptosporidiosis, in particular zoonotic Cryptosporidium species
infecting birds is therefore of public health importance. Currently
only three avian Cryptosporidium spp. are recognised;
C. meleagridis, C. baileyi and C. galli (Table 3) (Ryan and Xiao, 2014).3.2.1. C. meleagridis
C. meleagridis infects the intestinal (small and large intestine and
bursa) epithelial cells of a wide range of birds (Table 3) (Ryan and
Xiao, 2014). It was first detected in a wild turkey (Meleagris gallo-
pavo) by Tyzzer in 1929, but named as a valid Cryptosporidium
species in 1955 (Slavin, 1955). C. meleagridis oocysts have been
experimentally infected into broiler chickens, ducks, turkeys,
calves, pigs, rabbits, rats and mice (Darabus and Olariu, 2003; Ryan
and Xiao, 2014). It has also been reported as one of the most
commonly detected human-infectious Cryptosporidium species in
wastewater (Feng et al., 2007, 2011a; Li et al., 2012).
Molecular analysis has revealed that C. meleagridis has relatively
low host specificity, and many C. meleagridis subtypes at other loci
have been found in both birds and humans and both anthroponotic
and zoonotic transmission routes have been suggested (Cama et al.,
2003; Elwin et al., 2012; Silverlås et al., 2012). Subtyping at the
gp60 locus has identified seven subtype families (IIIaeIIIg) and the
likely occurrence of cross-species transmission of C. meleagridis
between birds and humans (Wang et al., 2014). Human volunteer
studies have shown that healthy adults can be infected and become
ill from ingestion of C. meleagridis oocysts (Chappell et al., 2011). In
the study by Chappell et al., five volunteers were challenged with
105 C. meleagridis oocysts and monitored for six weeks for faecal
oocysts and clinical manifestations. Four volunteers had diarrhoea;
three had detectable faecal oocysts; and one infected volunteer
remained asymptomatic. All infections were self-limited and oo-
cysts were cleared within 12 days of challenge (Chappell et al.,
2011).3.2.2. Cryptosporidium baileyi
C. baileyi is generally associated with the respiratory form of
cryptosporidiosis in birds and has been predominantly reported in
broiler chickens. Compared to C. meleagridis, C. baileyi is capable of
infecting a larger spectrum of avian hosts (Table 3), targeting
various sites of infection mostly associated with digestive and
respiratory tracts (Ryan and Xiao, 2014). Experimental cross-
transmission of C. baileyi to other birds has been successfull,
however there has been no reports of cross-transmission between
birds and other vertebrates (Lindsay and Blagburn, 1990; Cardozo
et al., 2005), except for a single unsubstantiated report of human
infection with C. baileyi which did not include any molecular
analysis (Ditrich et al., 1991). Therefore, C. baileyi is not considered
to be of public health significance.3583.2.3. Cryptosporidium galli
Unlike other avian species, C. galli is a gastric species with
endogenous developmental stages occurring in the glandular
epithelial cells of the proventriculus (Pavlasek, 1999, 2001; Ryan
et al., 2003; Ng et al., 2006; Ryan and Xiao, 2014). It predomi-
nantly infects birds of the family Spermestidae, Fringilidiae and
domestic chickens (Gallus gallus), and seems to be more prevalent
among songbirds (Table 3). Successful experimental cross-
transmission of C. galli to other chickens have been reported,
however the full extent of its host range is still unknown (Ryan,
2010). It has not been reported in humans.
3.2.4. Other Cryptosporidium species and genotypes reported in
birds
In addition to C. meleagridis, other zoonotic species of Crypto-
sporidium reported in birds include C. hominis, C. parvum, C muris
and C. andersoni (Zylan et al., 2008; Jellison et al., 2009; Ryan, 2010;
Reboredo-Fernandez et al., 2015; Gomes et al., 2012). In addition,
twelve genotypes; avian genotypes IeV, the black duck genotype,
the Eurasian woodcock genotype and goose genotypes IeV have
been reported (Table 3). To date, there is no evidence of human
cryptosporidiosis caused by these genotypes.
3.3. Cryptosporidium in fish and marine mammals
Cryptosporidium has been described in both fresh and marine
water piscine species with parasitic stages located either on the
stomach or intestinal surface, or deep within the epithelium
(Table 4). The first account of Cryptosporidium in a piscine host was
Cryptosporidium nasorum, identified in a Naso tang, a tropical fish
species (Hoover et al., 1981). However, currently only three species
are recognized; C. molnari, C. scophthalmi and C. huwi (previously
known as piscine genotype I) (Alvarez-Pellitero and Sitja-Bobadilla,
2002; Alvarez-Pellitero et al., 2004; Palenzuela et al., 2010; Costa
et al., 2015; Ryan et al., 2015), none of which have been reported in
humans. In fish hosts, Cryptosporidium fish species and genotypes
are typically located either in the stomach or intestine and the
parasite can cause clinical manifestations, such as emaciation,
decrease in growth rate, anorexia, whitish faeces, abdominal
swelling, and ascites (Alvarez-Pellitero et al., 2004; Ryan et al.,
2015). Most studies on Cryptosporidium in fish have been re-
ported in farmed or aquarium fish (Table 4) and little data are
currently available regarding the molecular identification of Cryp-
tosporidium species and genotypes in wild fish populations and, in
particular, in edible fish (Palenzuela et al., 2010; Reid et al., 2010;
Barugahare et al., 2011; Gibson-Keuh et al., 2011; Koinari et al.,
2013; Certard et al., 2015).
In addition to the three recognized species of Cryptosporidium in
piscine hosts, numerous Cryptosporidium species and genotypes
have been reported in fish including; piscine genotypes 2 to 8, un-
named novel genotypes (n ¼ 5), rat genotype III, C. parvum,
C. hominis, C. xiaoi and C. scrofarum (Table 4). Of these, only
C. parvum, C. hominis and C. scrofarum are of public health interest.
Cryptosporidium scrofarum was identified in a whiting (Reid et al.,
2010); C. parvum was found in School whiting, Nile tilapias, a Sil-
ver barb, Arctic char and European whitefish and C. hominis was
reported in Mackerel scad (Reid et al., 2010; Gibson-Kueh et al.,
2011; Koinari et al., 2013; Certad et al., 2015). In one of the most
recent studies, C. parvum was identified in freshwater fish from
Lake Geneva (Lac Leman) by both histology and molecular analysis
(Certad et al., 2015). In that study, the overall prevalence of Cryp-
tosporidium was 36.6% (15/41); the prevalence of C. parvum and
C. molnari was 86.7% (13/15) and 6.7% (1/15), respectively, while
6.7% (1/15) were mixed C. parvum and C. molnari infections (Certad
et al., 2015). Histological analysis identified C. parvum
Table 4
Cryptosporidium sp. reported in fish using molecular tools (modified from Ryan et al., 2014).
Species Host Site of
infection
Reference
C. molnari Gilthead sea bream (Sparus aurata), European sea bass (Dicentrarchus labrax), Murray




Palenzuela et al., 2010; Barugahare
et al., 2011; Certad et al., 2015
C. scophthalmi Turbot (Scophthalmus maximus) Intestine Costa et al., 2015
C. huwi (previously piscine
genotype 1)
Guppy (Poecilia reticulata) Stomach Ryan et al., 2004; Ryan et al., 2015
Piscine genotype 2 Angelfish (Pterophyllum scalare) Stomach Murphy et al., 2009
Piscine genotype 3 Mullet (Mugil cephalus) Intestine Reid et al., 2010
Piscine genotype 4 Golden algae eater (Crossocheilus aymonieri), Kupang damsel (Chrysiptera
hemicyanes), Oscar fish (Astronatus ocellatis), Neon tetra (Paracheirodon innesi)
Intestine Reid et al., 2010; Morine et al., 2012
Piscine genotype 5 Angelfish (Pterophyllum scalare), Butter bream (Monodactylidae), Golden algae eater
(Crossocheilus aymonieri)
e Zanguee et al., 2010
Piscine genotype 6/genotype
6-like
Guppy (Poecilia reticulata), Gourami (Trichogaster trichopterus) e Zanguee et al., 2010; Morine et al.,
2012
Piscine genotype 7 Red eye tetra (Moenkhausia sanctaefilomenae) e Morine et al., 2012
Piscine genotype 8 Oblong silver biddy (Gerres oblongus) e Koinari et al., 2013
Rat genotype III, C. hominis, C.
parvum, C. xiaoi and
C. scrofarum
Whiting (Sillago vittata), Barramundi (Lates calcarifer), Arctic char (Salvelinus alpinus),
Nile tilapias (Oreochromis niloticus), Silver barb (Puntius gonionotus), Mackerel scad
(Decapterus macarellus), European whitefish (Coregonus lavaretus), School whiting
(Sillago vittata)
e Reid et al., 2010; Gibson-Kueh et al.,




Orange clownfish (Amphiprion percula), Azure damsel (Chrysiptera hemicyanea), Blue
tang (Paracanthurus hepatus), Platyfish (Xiphophorus maculatus), Oscar (Astronotus
ocellatus), Goldfish (Carassius auratus)
e Yang et al., 2015
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C. parvumwas infecting the fish, rather than being passively carried
which has important public health implications.
Subtyping of Cryptosporidium isolates in fish has identified
C. parvum subtype IIaA18G3R1 in School whiting from Australia
(Reid et al., 2010), three C. parvum subtypes (IIaA14G2R1,
IIaA15G2R1 and IIaA19G4R1) in Nile tilapia, silver barb and mack-
erel scad and a C. hominis subtype (IdA15G1) in mackerel scad in
Papua New Guinea (Koinari et al., 2013), and C. parvum subtypes
IIaA15G2R1, IIaA16G2R1 and IIaA17G2R1 in Arctic char and Euro-
pean whitefish from France (Certad et al., 2015). All of these
C. parvum subtypes are zoonotic and commonly found in cattle and
humans (Xiao, 2010). The identification of the C. hominis subtype
probably reflects human sewage contamination of the water.
Clearly further studies in this area are required to better understand
the transmission dynamics of Cryptosporidium in fish.
3.4. Cryptosporidium in amphibians and reptiles
Little is known about Cryptosporidium species infecting am-
phibians. Of the three orders of amphibians; Anura, Caudata and
Gymnophonia, Cryptosporidium has been only reported in Anura
which includes frogs and toads and only one species, C. fragile is
recognised (Table 5) (Jirku et al., 2008). In transmission experi-
ments, C. fragile was not infective in one fish species (Poecilia
reticulate), four amphibian species (Bufo bufo, Rana temporaria,
Litoria caerulea and Xenopus laevis), one species of reptile (Pan-
therophis guttatus) and SCID mice (Jirku et al., 2008). This species
has not been reported in humans.
Cryptosporidium infections are ubiquitous in reptiles and have
been reported inmore than 57 reptilian species (O'Donoghue,1995;
Ryan and Xiao, 2014). Unlike in other animals in which Crypto-
sporidium infection is usually self-limiting in immunocompetent
individuals, cryptosporidiosis in reptiles is frequently chronic and
sometimes lethal in some snakes. Both intestinal and gastric
cryptosporidiosis has been described in snakes and lizards. To date,
two species are recognised; C. serpentis (gastric) and C. varanii
(C. saurophilum) (intestinal) (Levine, 1980; Pavlasek et al., 1995;
Koudela and Modry, 1998; Pavlasek and Ryan, 2008); neither of
which have been reported in humans, but C. serpentis has been35identified in cattle (Azami et al., 2007; Chen and Qiu, 2012). A new
intestinal species, Cryptosporidium ducismarci (tortoise genotype II)
has been reported in several species of tortoises, snakes and lizards
(Traversa, 2010). Because only molecular data are presented, this
species is regarded as a nomen nudum, pending the support of
morphological and biological data.
C. parvum, C. muris and Cryptosporidium tyzzeri are also
commonly reported in reptiles, particularly snakes but this is
thought to be due to mechanical transmission due to predation of
infected rodents and is not thought to present a substantial zoo-
notic risk (Morgan et al., 1999; Xiao et al., 2004b; Pedraza-Diaz
et al., 2009; Díaz et al., 2013; da Silva et al., 2014). In addition,
various host-adapted genotypes have been identified including
tortoise genotype I and snake genotypes I and II (cf. Ryan and Xiao,
2014), which have not been reported in humans (Table 5) (Xiao
et al., 2004b; Pedraza-Diaz et al., 2009; Traversa, 2010; Seva Ada
et al., 2011; Richter et al., 2011; Rinaldi et al., 2012; da Silva et al.,
2014; Abe and Matsubara, 2015). There is also a single report of
avian genotype V from green iguanas (Iguana inguana) (Kik et al.,
2011).
4. The role of urbanisation in the transmission of zoonotic
Cryptosporidium species from wildlife
The risk of waterborne outbreaks of cryptosporidiosis depends
on a complex interplay of factors, associated with both the envi-
ronment and the biology and ecology of host and parasite. Cryp-
tosporidium detection in an animal faecal sample does not
necessarily mean active infection in the host, nor does this guar-
antee that the parasite prevalence and the host-population dy-
namics are conducive to an outbreak. For these reasons the
epidemiological potential of detection of Cryptosporidium in wild-
life cannot be easily and fully extrapolated. An increased epidemi-
ological risk, however, can be identified when there is an overlap
between humans and the distribution and dispersal of animal
hosts. This is largely due to human encroachment into wildlife-
populated areas, which, by extension, also includes conversion of
natural environments to drinking water catchments. Similarly, ur-
ban environments may also represent attractive new habitats for
animals harbouring zoonotic Cryptosporidium spp. Thus, it is clear9
Table 5
Amphibian and reptile Cryptosporidium species and genotypes and their hosts confirmed by molecular analyses (modified from Ryan et al., 2014).
Species/genotype Amphibian/Reptile host species Site of infection Reference
C. fragile Black-spined toads (Duttaphrynus melanostictus) Stomach Jirku et al., 2008
C. serpentis Amazon tree boa (Corallus hortulanus), Black rat
snake (Elaphe obsoleta obsolete), Bornmueller's
viper (Vipera bornmuelleri), Bull snake (Pituophis
melanoleucus melanoleucus), California kingsnake
(Lampropeltis getulus californiae), Cornsnake (Elaphe
guttata guttata), Common death adder (Acanthophis
antarticus), Desert monitor (Varanus griseus),
Eastern/Mainland Tiger snake (Notechis scutatus),
Frilled lizard (Chlamydosaurus kingui), Giant
madagascar or Oustalet's chameleon (Chamaeleo
oustaleti), Leopard gecko (Eublepharis macularius),
Mexican black kingsnake (Lampropeltis getulus
nigritus), Milk snake (Lampropeltis triangulum),
Mountain viper (Vipera wagneri), Python (Python
molurus), Savannah monitor (Varanus
exanthematicus), Skink (Mabuya perrotetii), Taipan
(Oxyuranus scutellatus), Red-tailed boa (Boa
constrictor constrictor), Rainbow boa (Epicrates
cenchria cenchria)
Stomach Kimbell et al., 1999; Morgan et al., 1999b; Hajdusek
et al., 2004; Xiao et al., 2004b; Pedraza-Díaz et al.,
2009; Richter et al., 2011; Seva-Ada et al., 2011;
Rinaldi et al., 2012; Díaz et al., 2013; da Silva et al.,
2014; Abe and Matsubara, 2015
C. varanii African fat-tailed gecko (Hemitheconyx
caudicinctus), Leopard gecko (Eublepharis
macularius), Boa constrictor (Boa constrictor),
Cornsnake (Elaphe guttata guttata), Leopard gecko
(Eublepharis macularius), Desert monitor (Varanus
griseus), Gecko (Gekkoninae sp.), Green iguana
(Iguana iguana), Lampropeltis sp; Louisiana pine
snake (Pituophis ruthveni), Plated lizard
(Gerrhosaurus sp.), Schneider's Skink (Eumeces
schneideri), Taipan (Oxyuranus scutellatus), Baron's
green racer (Philodryas baroni), Yellow anaconda
(Eunectes notaeus), Cornsnake (Elaphe guttata
guttata), Mato Grosso lancehead (Bothrops
matogrossensis)
Intestine and Cloaca Koudela and Modry, 1998; Morgan et al., 1999b;
Hajdusek et al., 2004; Xiao et al., 2004b; Plutzer and
Karanis, 2007; Pedraza-Díaz et al., 2009; Richter
et al., 2011; da Silva et al., 2014; Abe andMatsubara,
2015
Lizard genotype/C. serpentis-like Leopard gecko (Eublepharis macularius), Cornsnake
(Pantherophis guttatus), Chinese wonder gecko
(Teratoscincus scincus)
e Xiao et al., 2004b; Richter et al., 2011, Abe and
Matsubara, 2015
Tortoise genotype I Indian star tortoises (Geochelone elegans), Herman's
tortoise (Testudo hermanii), Ball python (Python
regius), Russian tortoise (Agrionemys [Testudo]
horsfieldii)
Stomach Xiao et al., 2002b, 2004b, Alves et al., 2005; Pedraza-
Díaz et al., 2009; Griffin et al., 2010; Richter et al.,
2012
Tortoise genotype II (C. duismarci) Marginated tortoise (Testudo marginata), Ball
python (Python regius), Veiled chameleon
(Chamaeleo calyptratus), Pancake tortoise
(Malacochersus tornieri), Russian tortoise
(Agrionemys [Testudo] horsfieldii)
Intestine Traversa et al., 2008; Pedraza-Díaz et al., 2009;
Griffin et al., 2010; Traversa, 2010; Richter et al.,
2012
Snake genotype I New Guinea Viper boa (Candoia asper), Japanese
grass snakes (Rhabdophis tigris)
e Xiao et al., 2002b; Kuroki et al., 2008
e
Snake genotype II Boa constrictor (Boa constrictor ortoni) Xiao et al., 2004b
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Appendix 1that wildlife-associated Cryptosporidium is an increasing concern
for cryptosporidiosis in humans.
During the last 100 years in many countries of the world, there
have been dramatic changes in natural/rural landscapes due to
urbanization (Mackenstedt et al., 2015). Although urbanization is
one of the leading causes of species extinction (McKinney, 2006),
for adaptable species, urban and periurban areas can be very
attractive due to increased food and water resources (waste food,
pet food, garden produce, water tanks etc) (Mackenstedt et al.,
2015). In these environments, wildlife species may reach far
higher population densities than in more natural or rural land-
scapes (Bradley and Altizer, 2007), potentially increasing the fae-
caleoral transmission of oocysts between wildlife and humans and
contamination of drinking water catchments.
Shifting boundaries between wildlife and humans have been
responsible for the emergence of species like C. ubiquitum and
chipmunk genotype I in human populations. For example, squirrels
host C. ubiquitum, chipmunk genotype I, the skunk genotype and
other Cryptosporidium genotypes associated with human disease360(Feng et al., 2007; Kvac et al., 2008; Ziegler et al., 2007; Stenger
et al., 2015b), and because they frequently share habitats with
humans they may be a significant reservoir of human infection.
Squirrels can reach relatively high densities in suitable habitats,
resulting in high rates of environmental loading of Cryptosporidium
oocysts (Atwill et al., 2001). For example, California ground squir-
rels can reach densities as high as 92 adults hectare1 (Owings
et al., 1977; Boellstorff and Owings, 1995), which when combined
with shedding of up to 2  105 oocysts animal1 day1 results in
rates of environmental loading equivalent to
1  107 oocysts hectare1 day1 (Atwill et al., 2004). Further
analysis of squirrel populations however has suggested that most
tree squirrels host zoonotic species and genotypes while ground
squirrels host species and genotypes that are tribe-specific and
unlikely to cause human disease, despite overlapping ranges
(Stenger et al., 2015b). This highlights the importance of extensive
molecular epidemiological studies of wildlife to better understand
the public health risks.
While urban-environment-induced increases in wildlife
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Appendix 1population densities are conducive to elevated rates of Cryptospo-
ridium transmission, the host specificity of some wildlife species
and genotypes may limit the potential for spillover of wildlife ge-
notypes to sympatric populations of humans. For example, in
Australia, the common brushtail possum is one of the most abun-
dant native marsupials in urban environments, having successfully
adapted to utilise anthropogenic resources (Hill et al., 2008). A
higher Cryptosporidium prevalence in urban compared towoodland
possum populations (11.3 versus 5.6%) has been reported, but the
majority of possums sampled shed low numbers of host adapted
(possum genotype) oocysts (1 to 102) (Hill et al., 2008). However,
the finding a C. fayeri clinical infection in a human, which had
previously been thought to be a host-adapted species (Waldron
et al., 2010), highlights our lack of knowledge about the human
infectious potential of many species and genotypes of Cryptospo-
ridium infecting wildlife.
5. Perspectives for the water industry
Management of Cryptosporidium public health risks for the
drinking water industry requires the implementation of a holistic
approach including research, monitoring Cryptosporidium oocysts
in animals and source water and catchment management (e.g.,
access protection, vegetation cover, etc). As watersheds are
vulnerable to contamination with both zoonotic and non-zoonotic
species from wildlife, sensitive detection of Cryptosporidium oo-
cysts in water and correct identification of oocysts to the species/
genotype level are essential for source water management and risk
assessment (Li et al., 2015b). The routine practice of assessing
Cryptosporidium contamination of catchments and drinking water
supplies using total oocyst counts based on the U.S. Environmental
Protection Agency (EPA) Method 1622/1623, cannot differentiate
Cryptosporidium species and cannot reliably access viability
(infectivity). This microscopy-based method, therefore over-
estimates the human health risk, as wildlife in catchments
frequently carry non-zoonotic genotypes and species and not all
oocysts are viable.
The introduction of molecular identification techniques has
therefore been an important advance for water management and
quantification of the risk to drinking water supplies from Crypto-
sporidium-infected wildlife (Nolan et al., 2013; Zahedi et al., 2015).
Identification of Cryptosporidium to the species/genotype level is
especially challenging for environmental (faecal and water) sam-
ples because of the usual presence of very low numbers of oocysts
and high concentrations of PCR inhibitors and non-target organ-
isms (Li et al., 2015b). It is essential however, for the assessment of
the public health importance of Cryptosporidium oocysts from
wildlife. Recently, the use of fluorescence resonance energy trans-
fer (FRET) probes combined with melt curve analysis has been used
for rapid and sensitive differentiation of zoonotic from non-
zoonotic species in water samples (Li et al., 2015b). Another study
of a drinking water supply in Australia, found no C. hominis in any
water sample tested, but Cryptosporidium genotypes associated
with native and non-native wildlife made up 70% of all isolates
typed (Swaffer et al., 2014). Similarly, Ruecker et al. (2012) reported
that non-zoonotic wildlife species and genotypes of Cryptospo-
ridium accounted for 64.3% of Cryptosporidium identified in envi-
ronmental water samples in Canada and that only 7.2% of human-
infectious species were detected. A low prevalence of C. hominis
and C. parvum was also reported by Nolan et al. (2013) in Mel-
bourne catchments, who detected C. hominis and C. parvum in only
0.6% of samples, despite screening >2000 animal faecal samples.
However, the human-infectious potential of many wildlife-adapted
Cryptosporidium is currently unknown and the UK outbreak caused
by C. cuniculus should act as a caution against assuming these36unusual species and genotypes are not significant (Chalmers et al.,
2009; Robinson et al., 2011).
Accurate, quantitative identification of Cryptosporidium in
wildlife excreta is an essential starting point for estimating catch-
ment loads (Davies et al., 2003). Quantitative PCR (qPCR) (real-time
PCR) therefore represents an invaluable tool that enables rapid,
high-throughput and cost-effective detection and quantitation of
Cryptosporidium oocysts and is increasingly being used to monitor
oocyst shedding by animals in catchments (Yang et al., 2014a). Due
to the intrinsic constraints of qPCR however, standards of known
concentration are required to generate calibration curves used to
estimate the concentration of pathogens in a sample (Hindson
et al., 2013; Racki et al., 2014). Therefore the quantification of the
target molecules in the unknown sample is only as good as that of
the standards used. Droplet digital PCR (ddPCR) (Hindson et al.,
2013) is the third-generation implementation of conventional
PCR that facilitates the quantitation of nucleic acid targets without
the need for calibration curves (Vogelstein and Kinzler, 1999). A
recent study compared ddPCR with qPCR for the quantitative
detection of Cryptosporidium DNA in animal and human faecal
samples (Yang et al., 2014b) and revealed that ddPCR appeared to
be less sensitive to inhibitors than qPCR and that inaccurate cali-
bration of qPCR standards resulted in qPCR overestimating the
numbers of oocysts present (Yang et al., 2014b). This has important
implications for catchment risk management. However, qPCR is
cheaper and provides better throughput and therefore using ddPCR
to precisely quantify qPCR standards would be one way to combine
the advantages of the two technologies and provide more accurate
assessment of Cryptosporidium catchments loads from wildlife
faecal samples.
Besides quantitative considerations, measuring the infectivity is
also important for adjusting the risk profile of oocysts fromwildlife
in source waters (Swaffer et al., 2014). For example, a recent study
has shown that the infectivity fraction of oocysts within source
water samples in South Australian catchments was low (~3.1%),
which provided a much more accurate water quality risk assess-
ment (Swaffer et al., 2014). This low infectivity fraction is consistent
with source water infectivity reported by Di Giovanni et al. (1999)
of 4.9% and Lalancette et al. (2012) of 0%. The ability to routinely
measure oocyst infectivity has been hampered by a number of is-
sues including the distribution and low numbers of oocysts, costs
and reproducibility (Di Giovanni and LeChevallier, 2005; Swaffer
et al., 2014). However, recent improvements in cell culture immu-
nofluorescence assays have led to the development of a single
format assay that provides information on method performance
(recovery rate), oocyst number, oocyst infectivity and genotype of
infectious oocysts, overcoming these obstacles (King et al., 2015).
This assay should therefore enable a more comprehensive under-
standing of Cryptosporidium risk for different water sources,
assisting in the selection of appropriate risk mitigation measures
(King et al., 2015). It is however important to remember that the
detection of non-viable oocysts in the 10e20 L of the water column
that is usually sampled, does not mean that other oocysts in the
water body are also non-viable.
Factors that affect the viability of Cryptosporidium oocyst load in
faecal samples from wildlife in the catchment and water (runoffs,
water column and sediments), include solar inactivation, desicca-
tion, temperature and residence time in catchments and these
dynamics should be factored into risk assessments (Hijen et al.,
2006; King and Monis, 2007; Monis et al., 2014). Transport,
including hydrodynamically-driven accumulation, settlemement,
dispersion, dilution etc. can also affect oocyst concentrations in the
water, either positively or negatively. Peak flow periods (when the
maximum area of catchment is contributing to stream flow), are a
major driver behind the transport of oocysts to surface water.1
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Appendix 1Therefore monitoring the distribution of Cryptosporidium during
elevated flow conditions caused by rainfall run-off is important
given the demonstrated positive and significant correlation be-
tween Cryptosporidium concentration with flow and turbidity
(Swaffer et al., 2014). Measuring the infectivity of different wildlife-
derived Cryptosporidium species under different climactic condi-
tions is therefore crucial for accurate risk assessment of public
health implications, particularly as more extreme precipitation is
predicted globally (IPCC, 2013 e www.ipcc.ch) (Ryan et al., 2014).
There are still many research gaps in our understanding of the
public health significance of wildlife in drinking water catchments
and taxonomic and molecular epidemiological studies on Crypto-
sporidium spp. in wildlife, especially those in watersheds are still
scarce.Whole genome studies in Cryptosporidium species will assist
with the development of gp60 and other typing tools to better
access the zoonotic potential and transmission dynamics of Cryp-
tosporidium inwildlife. Morphological and biological data including
pathogenicity and oocyst shedding rates are not yet available for
some common zoonotic Cryptosporidium species and genotypes in
wildlife. There is also a need to confirm if molecular detection of
zoonotic Cryptosporidium species in wildlife is commonly associ-
ated with actual infections or mechanical transmission (Ryan et al.,
2014). C. cuniculus is the only species besides C. hominis and
C. parvum, known to be associated with a waterborne outbreak of
human cryptosporidiosis, yet little is known about the prevalence
and oocyst shedding rates of C. cuniculus in rabbits.
The evolution of methods to enumerate and genotype oocysts
and determine oocyst infectivity provides much-needed tools to
refine the human health risk fromwildlife in catchments and future
studies will provide water quality managers with much more ac-
curate and informed data for modelling and quantitative microbial
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Summary
Cryptosporidium is a major cause of moderate- to- severe diarrhoea in humans world-
wide, second only to rotavirus. Due to the wide host range and environmental persis-
tence of this parasite, cryptosporidiosis can be zoonotic and associated with foodborne 
and waterborne outbreaks. Currently, 31 species are recognized as valid, and of these, 
Cryptosporidium hominis and Cryptosporidium parvum are responsible for the majority 
of infections in humans. The immune status of the host, both innate and adaptive 
immunity, has a major impact on the severity of the disease and its prognosis. Immu-
nocompetent individuals typically experience self- limiting diarrhoea and transient gas-
troenteritis lasting up to 2 weeks and recover without treatment, suggesting an 
efficient host antiparasite immune response. Immunocompromised individuals can suf-
fer from intractable diarrhoea, which can be fatal. Effective drug treatments and vac-
cines are not yet available. As a result of this, the close cooperation and interaction 
between veterinarians, health physicians, environmental managers and public health 
operators is essential to properly control this disease. This review focuses on a One 
Health approach to prophylaxis, including the importance of understanding transmis-
sion routes for zoonotic Cryptosporidium species, improved sanitation and better risk 
management, improved detection, diagnosis and treatment and the prospect of an 
effective anticryptosporidial vaccine.
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to prophylaxis
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1  | INTRODUCTION
Cryptosporidium species are protozoan parasites that infect a broad 
range of hosts including humans, domestic and wild animals world-
wide, causing asymptomatic or mild- to- severe gastrointestinal disease 
in their host species.1–6 Currently, 31 Cryptosporidium species have 
been recognized as valid, and of these, by far the most common spe-
cies reported in humans worldwide are C. parvum and C. hominis.7–12
Human cryptosporidiosis is frequently accompanied by abdominal 
pain, fever, vomiting, malabsorption and diarrhoea that may some-
times be profuse and prolonged.13,14 The immune status of the host, 
both innate and adaptive immunity, has a major impact on the severity 
of the disease and its prognosis. Immunocompetent individuals typ-
ically experience self- limiting diarrhoea and transient gastroenteritis 
lasting up to 2 weeks and recover without treatment, suggesting an 
efficient host antiparasite immune response. Immunocompromised 
individuals, including HIV/AIDS patients (not treated with antiretro-
viral therapy), often suffer from intractable diarrhoea, which can be 
fatal.15 An effective vaccine for cryptosporidiosis is not yet available.
The Global Enteric Multicenter Study (GEMS) study, which was a 
three- year matched case–control study of moderate- to- severe diar-
rhoea in over 22 000 infants and children at seven sites across Africa 
and Asia aged 0–59 months, found that Cryptosporidium was second 
only to rotavirus as a major cause of severe diarrhoea.16,17 More recent 
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matched case–control studies of diarrhoea have confirmed this.18 
Similarly, a birth cohort study conducted by a Global Network for the 
Study of Malnutrition and Enteric Diseases (MAL- ED) has assessed 
pathogen- specific burdens in diarrhoeal and nondiarrhoeal stool spec-
imens from 2145 children aged 0–24 months, over five years at eight 
community sites in Africa, Asia and South America, and identified 
Cryptosporidium spp. as one of the five highest attributable burdens of 
diarrhoea in the first year of life.19 Globally, cryptosporidiosis is esti-
mated to be responsible for the majority of deaths among children 
under 5 years of age 20–22 and Cryptosporidium infection in children 
is also associated with malnutrition, persistent growth retardation, 
impaired immune response and cognitive deficits.23,24 The mechanism 
by which Cryptosporidium affects child growth seems to be associat-
ed with inflammatory damage to the small intestine.25 Undernutrition 
(particularly in children) is both a sequela of and a risk factor for cryp-
tosporidiosis, particularly in low- income countries.26–31 FAO’s execu-
tive summary of the State of Food Insecurity in the World (http://www.
fao.org/docrep/018/i3458e/i3458e.pdf) indicates there are 842 mil-
lion chronically malnourished persons worldwide, which significantly 
contributes to impaired immunity and thus increased susceptibility to 
infection with Cryptosporidium, perpetuating the cycle of chronic diar-
rhoea and malnutrition. In developed countries, Cryptosporidium is less 
common 15 and accounts for ~9% of diarrhoeal episodes in children.32
Cryptosporidiosis is a highly prevalent and extremely widespread 
disease,6 and several factors contribute to this. Infected individuals 
shed large numbers of oocysts, which are environmentally very robust, 
resistant to inactivation by commonly used drinking water disinfec-
tants including chlorine treatment and are able to survive routine 
wastewater treatments.33,34 Cryptosporidium oocysts are highly infec-
tious; in human volunteer studies, as few as 10 or less Cryptosporidium 
oocysts can produce disease in healthy adults.35,36 A quantitative 
risk assessment has estimated that ingestion of a single oocyst of 
the C. parvum IOWA isolate will result in clinical disease in 2.79% of 
immunologically normal persons.37 Another contributing factor to the 
high prevalence and widespread distribution of Cryptosporidium is the 
lack of treatment options. Only one drug, nitazoxanide (NTZ, Alinia; 
Romark Laboratories, Tampa, FL, United States), has been approved 
by the US Food and Drug Administration (FDA). This drug, however, 
exhibits only moderate clinical efficacy in malnourished children and 
immunocompetent people, and none in immunocompromised individ-
uals like people with HIV.38,39
Because oocysts of Cryptosporidium species from humans and 
animals are ubiquitous in the environment, cryptosporidiosis can be 
acquired through multiple routes (reviewed by Robertson et al.40). 
Transmission of oocysts is by the faecal–oral route, either direct-
ly or indirectly. For humans, direct transmission can be from person 
to person primarily due to poor hygiene among household mem-
bers and attendees in day care centres, aged care facilities and oth-
er institutions, or from animals to persons such as farmworkers and 
pet owners. Most indirect transmission is from contaminated drink-
ing or recreational water. Contaminated food can also be a source of 
transmission, and contamination can occur at every step throughout 
the food preparation process, from farm to table.41,42 Findings from 
animal models, human case reports and a few epidemiological studies 
suggest that Cryptosporidium may also be transmitted via inhalation 
of aerosolized droplets or by contact with fomites contaminated by 
coughing (see 43).
The “One Health” approach to tackle zoonotic diseases, defined 
as “One Medicine” by Schwabe44, is a worldwide strategy to improve 
health and well- being through the mitigation and prevention of disease 
risks that originate at the interface between humans, animals and their 
various environments. This review focuses on a One Health approach 
to prophylactic prevention of cryptosporidiosis, including improved 
detection, diagnosis and treatment, the importance of understanding 
zoonotic transmission, better environmental and risk management and 
the prospect of an effective anticryptosporidial vaccine.
2  | DETECTION, DIAGNOSIS AND  
TREATMENT
Cryptosporidium presents many challenges for detection and diag-
nosis. The use of different diagnostic methods and the inconsistent 
application of typing techniques can make direct comparisons difficult 
or even impossible between clinical, veterinary and environmental 
testing or between different regions and countries.45 Detection of 
Cryptosporidium in clinical pathology laboratories is still based mainly 
on microscopic detection via stains and/or fluorescent antibodies 
(IFA) and other antigenic detection methods. Although microscopy 
needs relatively simple instruments and cheap consumables, it is 
labour intensive, requires a skilled operator and lacks sensitivity and 
specificity.45 Morphological characters for identifying Cryptosporidium 
are few,46,47 and differential staining techniques are usually required 
due to the fact that oocysts are similar in size and shape to yeasts, 
faecal components and other debris.47,48 Acid fast (AF)- modified 
Ziehl–Neelsen staining is one of the most common differential stain-
ing techniques.45,48 However, the detection limits of conventional 
microscopy for Cryptosporidium have been reported to be as low as 
50 000 to 500 000 oocysts per gram of human faeces,49 resulting in 
low levels of infection or sporadic shedding possibly going unnoticed 
when conventional methods of detection are used. Sporadic shedding 
is such that studies have shown that three separate faecal samples 
should be examined for immunocompetent patients and two samples 
for patients with AIDS for confident diagnosis of cryptosporidial infec-
tions using acid- fast staining.50 IFA stains offer superior sensitivity; in 
some studies, about 97% sensitivity compared with only about 75% 
sensitivity for acid- fast staining.51 However, IFA is more expensive 
than acid- fast staining and requires a fluorescence microscope and 
trained staff.51 This is particularly problematic in resource- poor areas 
where cryptosporidiosis is a major health problem. A recent study pro-
posed the use of phase- contrast microscopy (PCM) as a specific and 
inexpensive method for detection of Cryptosporidium; however, this 
method still lacks sensitivity.52
Other antigen detection formats such as enzyme- linked immu-
nosorbent assays (ELISAs), enzyme immunoassays (EIAs) and immu-
nochromatographic (dipstick) assay for Cryptosporidium are also 
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commercially available and have the advantage of reducing assay times 
and being amenable to automation. However, diagnostic sensitivi-
ties are variable (70%–100%)51,53–55; some rapid tests have reduced 
specificity and sensitivity for species other than C. parvum or C. homi-
nis,56,57 and confirmation of positive reactions is needed.55 Biosensor 
chips, that detect and quantitate C. parvum in real- time via anti- C. par-
vum IgM binding, have also been developed58,59; however, detection 
limits are relatively high (100 or more oocysts) and they have yet to be 
fully evaluated on water or faecal samples. Another major limitation of 
both conventional microscopy and antigen detection methods is that 
they cannot identify to species or subtype level, which is essential for 
understanding transmission dynamics and outbreaks, in particular for 
zoonotic species.
Polymerase chain reaction (PCR)- based techniques have permitted 
specific and sensitive detection and differentiation of Cryptosporidium 
spp. for clinical diagnosis and environmental monitoring.45 Real- time 
or quantitative PCR (qPCR) assays have been developed to quantitate 
the numbers of Cryptosporidium oocysts present in human and animal 
faecal and water samples 60–63 with 100% specificity and sensitivities 
as low as 200 oocysts per gram of faeces, which equates to 2 oocysts 
per PCR.60 Multiplex qPCR assays have also been developed for the 
detection of Cryptosporidium and other common causes of diarrhoea 
such as Giardia duodenalis and Entamoeba histolytica, which have the 
advantage of identifying mixed infections.64–66 The most widely used 
molecular markers for identification and typing of Cryptosporidium 
species are the 18S ribosomal RNA (18S rRNA) gene and the  60- kDa 
glycoprotein (gp60) gene, respectively.4,10 Miniaturized fluidic devic-
es, which can detect to species level, have also been developed, 
mainly for the water industry (reviewed by Bridle et al.67), but as with 
antibody- based biosensor chips, have yet to be fully validated and are 
costly.
New drug targets for Cryptosporidium are urgently needed, as 
the only FDA- approved drug, nitazoxanide, does not provide bene-
fit for malnourished children and immunocompromised patients with 
cryptosporidiosis. However, Cryptosporidium has completely lost the 
plastid- derived apicoplast present in many other apicomplexans, and 
the remnant mitochondrion lacks the citrate cycle and cytochrome- 
based respiratory chain.68 Therefore, many classic drug targets are 
unavailable in Cryptosporidium. Progress in developing anticrypto-
sporidial drugs has also been affected by the inability to generate 
large numbers of Cryptosporidium oocysts in vitro and an inability to 
genetically manipulate the organism.69,70 The recent development 
of a hollow- fibre in vitro culture system to generate large numbers 
of oocysts (up to 108 oocysts per day) 71 and advances in genetical-
ly engineering Cryptosporidium 72 will transform the development of 
novel therapeutics.
To date, the best studied drug target is the bacterial- derived inosine 
5′- monophosphate dehydrogenase (IMPDH) gene, as Cryptosporidium 
does not contain guanine salvage enzymes and is totally dependent 
on this enzyme to convert adenosine salvaged from the host into gua-
nine nucleotides.73–76 This coupled with the parasite’s high metabolic 
demand for nucleotides due to the complicated life cycle of this para-
site make IMPDH an important drug target.77–85
Other drug targets include long- chain fatty acyl- coenzyme A syn-
thetases (LC- ACS), which are essential in fatty acid metabolism,68 and 
a recent study reported good efficacy of the ACS inhibitor triacsin C 
against cryptosporidial infection in mice.86 A parasite cysteine pro-
tease inhibitor was also effective in vitro and in an animal model.87 
Other studies have focused on repurposing existing drugs to over-
come the prohibitive costs of de novo drug development (estimated 
to be between $500 million and $2 billion per compound successful-
ly brought to market).88 For example, several compounds from the 
Medicines for Malaria Venture (MMV) Open Access Malaria Box have 
exhibited activity against C. parvum 89 and drugs such as the human 3- 
hydroxy- 3- methyl- glutaryl- coenzyme A (HMG- CoA) reductase inhib-
itor, itavastatin and Auranofin (Ridaura®) initially approved for the 
treatment of rheumatoid arthritis and have been shown to be effective 
against Cryptosporidium in vitro,90,91 which holds promise for further in 
vivo testing in animals and humans.
3  | ZOONOTIC CRYPTOSPORIDIUM  SPECIES
Due to the morphological similarity of Cryptosporidium oocysts from 
different host species, initial findings of Cryptosporidium infections in 
both domestic and wild animals were assumed to be due to C. par-
vum leading to an overestimation of the potential role of animals 
as reservoirs of human disease.92 However, with the assistance of 
advanced molecular techniques, many of these species in wildlife 
particularly were identified as host- adapted genotypes.6,10 Of the 
31 Cryptosporidium species that have been recognized as valid, more 
than 20 species and genotypes have been identified in humans includ-
ing C. hominis, C. parvum, C. meleagridis, C. felis, C. canis, C.  cuniculus, 
C. ubiquitum, C. viatorum, C. muris, C. suis, C. fayeri, C. andersoni, 
C. bovis, C. scrofarum, C. tyzzeri, C. erinacei and Cryptosporidium horse, 
skunk and chipmunk I genotypes, with C. hominis and C. parvum 
most commonly reported.4,6,10 These Cryptosporidium spp. infect 
both immunocompetent and immunocompromised persons.6,10 Of 
these, C. parvum and C. hominis are by far the most common spe-
cies reported in humans worldwide 4,93 and are responsible for most 
cryptosporidiosis outbreaks, with C. hominis responsible for more 
outbreaks than C. parvum in most regions.4 Although humans are the 
major host species for C. hominis, there have been isolated reports in 
domestic animals and wildlife hosts including sheep, goats, cattle, a 
dugong, non- human primates and kangaroos94–102 (Zahedi, A., Monis, 
P., Aucote, S., King, B., Paparini, A., Jian, F., Yang, R., Oskam, C Ball, 
A., Robertson, I., Ryan, unpublished) and in fish.103 Cryptosporidium 
parvum is primarily a parasite of artiodactyls and humans 4 but has also 
been frequently reported in wildlife, including various rodents, bovids, 
camelids, equids, canids, non- human primates and marine mammals 
(see 10) and in fish.103–106 Cryptosporidium meleagridis, although pri-
marily a bird parasite, is the third most prevalent species infecting 
humans,4,6,93 and in some studies, C. meleagridis prevalence is similar to 
that of C. parvum.107,108 Cryptosporidium cuniculus (previously known 
as rabbit genotype) was responsible for a drinking water- associated 
outbreak of cryptosporidiosis in the UK 109–111 and has also been 
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identified in many sporadic human cases of cryptosporidiosis.112–115 
It is also the third most commonly identified Cryptosporidium spe-
cies in patients with diarrhoea in the UK.112 Human infections with 
C. canis and C. felis have been reported mainly in studies conducted 
in children in developing countries 6 where they are responsible for 
as much as 3.3% and 4.4%, respectively, of overall cryptosporidiosis 
cases.116 Cryptosporidium muris is also considered a zoonotic species 
as there have been numerous reports of C. muris in humans and one 
report in human sewage.117–129 In a recent human infectivity study, 
C. muris was examined in six healthy adults.130 Volunteers were chal-
lenged with 105 C. muris oocysts and monitored for 6 weeks for infec-
tion and/or illness. All six patients became infected. Only two of the 
infected volunteers had a diarrhoeal illness (a 33% illness attack rate). 
Three other volunteers passed an occasional unformed stool or typi-
cally had a single soft stool per day without any accompanying gas-
trointestinal symptoms.130 Like C. muris, C. andersoni is also a gastric 
parasite and primarily infects the abomasum of cattle and to a lesser 
extent, sheep and goats.6,93 It is occasionally detected in humans (cf. 
10). Two studies in China by the same research group have reported 
that C. andersoni was the most prevalent Cryptosporidium species 
detected in humans.131,132 However, further research is required to 
better understand the zoonotic importance of C. andersoni.
Cryptosporidium ubiquitum is of public health concern because of 
its wide geographic distribution and broad host range.133 It has been 
frequently reported from drinking source water and wastewater in 
various geographic locations, and is considered an emerging zoonotic 
pathogen as it has been identified in many human cases of crypto-
sporidiosis.133 Subtyping at the gp60 locus has suggested that sheep 
and wild rodents are a key source of C. ubiquitum transmission to 
humans, through either direct human contact with infected animals 
or by contamination of drinking source water.133 It is thought that 
human encroachment into wildlife territories has been responsible for 
the emergence of C. ubiquitum and other genotypes such as chipmonk 
genotype I and to a lesser extent, skunk and mink genotypes in human 
populations.113,133–142 This highlights the importance of extensive 
molecular epidemiological studies of wildlife to better understand the 
public health risks.
4  | RISK MANAGEMENT
A key part of a One Health approach to Cryptosporidium prophylaxis 
is a better understanding of environmental, epidemiological and aeti-
ological factors associated with cryptosporidial infections to enable 
more targeted risk management. The far- reaching One Health strat-
egy aims at integrating multidisciplinary knowledge and evidence, and 
at coordinating the interventions, to create a global synergism cater-
ing for all aspects of health care for humans, animals and the environ-
ment (the One Health Triad).
Under an environmental perspective, the prophylaxis of water-
borne cryptosporidiosis must consider optimal management (or design) 
of source, recycled and recreational waters. Protection of source water 
and swimming pools is a key element of Cryptosporidium prevention as 
contamination of drinking water and swimming pools is a major mode 
of transmission (see ref 33,143,144) and is often achieved by restrict-
ing the access to catchments and water bodies, while swimming pools 
are designed and monitored according to construction standards and 
guidelines. Infection prevention and management, however, can only 
be achieved through a deep understanding of the routes of transmis-
sion, sources of contamination (human and animal), disease prevalence 
in the population and the risk factors in the final host.
The link between Cryptosporidium in drinking water and sporad-
ic infections is well documented33,143,144; however, the association 
between drinking water contamination and endemic cryptosporidiosis 
is not well established. For example, some studies reporting drinking 
unsafe water as a risk factor for endemic cryptosporidial infection 
145,146 and others report no association.147–149 Seasonal patterns 
are also thought to be associated with an increased transmission 
risk,150,151 such as when recreational waters are more heavily utilized.
High- precipitation events favour the transfer and survival of 
oocysts in surface waters and/or groundwater.152,153 This may result 
in contamination of source water and increased risk of cryptospo-
ridiosis depending on the source of contamination.153 Indeed, the 
average odds of identifying Cryptosporidium oocysts in fresh surface 
waters is 2.61 (95% CI=1.63–4.21; I²=16%) times higher during and 
after extreme weather events.154 Shifts in precipitation patterns 
(intensity and location) is one of the climate change predictions for 
the future,155 and this will clearly impact both waterborne and food-
borne transmissions of Cryptosporidium, and therefore, future human 
exposures may differ significantly from current patterns as the climate 
changes.156 Hydrodynamic modelling has been shown to represent a 
valid and cost- effective support, for decision- making and understand-
ing of events.157 Quantitative microbial risk assessment (QMRA) is 
another widely used tool to estimate health impacts from exposure 
to Cryptosporidium and other pathogens 154 and has been applied 
to climate change.158 The tool, called CC- QMRA (Climate Change 
Quantitative Microbial Risk Assessment), quantifies the anticipated 
impacts in terms of relative infection risks under climate change sce-
narios for Cryptosporidium and other pathogens and can be used to 
evaluate impacts of climate change on infection risks from waterborne 
and foodborne transmissions of Cryptosporidium.159 For example, CC- 
QMRA can be used to evaluate the effectiveness of interventions such 
as upgrading wastewater and drinking water treatment and strength-
ening drinking water and bathing water regulations.
Quantification and identification of Cryptosporidium in wildlife 
excreta is an essential starting point for estimating catchment loads.160 
Variables such as soil physicochemical properties, hydrology, orog-
raphy and meteorology can all affect oocyst viability, transport and 
fate. Source water contamination can be avoided or reduced by the 
implementation of management strategies such as wildlife population 
control, revegetation, landscaping and soil conditioning. In addition, 
effective risk management cannot overlook the prevalence, infectivity 
and zoonotic potential of Cryptosporidium isolates in the animal pop-
ulations within the catchment. Similarly, recreational waters such as 
swimming pools, sauna, spas, aquatic parks are also potential sourc-
es of outbreaks, depending on the age and health status of the users 
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(and maintenance). Personal hygiene practices (e.g. showering before 
swimming in public swimming pools, washing hands before cooking, 
eating and after defecation and washing fruits and vegetables before 
consumption) are an essential part of any prevention strategy and can 
prevent/reduce disease transmission.161–164 Enforcing and encourag-
ing similar practices, however, become absolutely crucial during out-
breaks and in the presence of hypersusceptible final hosts.
It has been shown that an important host risk factor includes 
HIV status. Cryptosporidium is an important pathogen regardless of 
HIV prevalence16; however, HIV- positive children are between 3 and 
18 times more likely to have Cryptosporidium than those who were 
HIV negative.165–167 With the widespread availability of antiretrovi-
ral therapy, particularly in industrialized countries, the incidence of 
cryptosporidiosis has decreased among people living with AIDS.168 
However, the increasing number of transplant recipients and those 
receiving immunosuppressive drugs may contribute significantly to 
the burden in the future.169,170 Malnutrition is also a risk factor for 
both diarrhoea and prolonged diarrhoea caused by Cryptosporidium, 
with significantly higher rates of infection in malnourished children 
controlling for HIV status.171–174 An unknown number of individuals 
experience asymptomatic Cryptosporidium infection.175 This clinically 
silent infection may remain undetected and untreated and therefore 
may contribute not only to parasite transmission but also to malnutri-
tion and the associated clinical sequelae. Breastfeeding may provide 
some protection, as a recent study of Bangladeshi infants reported 
that protection from Cryptosporidium infection was associated with 
high anti- Cryptosporidium IgA in breastmilk.176
5  | VACCINES
The development of vaccines for cryptosporidiosis, particularly in vul-
nerable populations such as children and malnourished populations, 
is urgent, but has been hampered by an incomplete understanding 
of the host immune response to Cryptosporidium.177,178 Therefore, a 
better understanding of host–parasite interactions is crucial for the 
development of an effective vaccine.177 Given that adults in highly 
endemic areas are partly immune to reinfection, and human chal-
lenge studies have shown that previous infection or exposure leads 
to a higher infectious dose [ID50],
179,180 development of a successful 
vaccine should be possible. It is known that both innate and adaptive 
host response are important in the control of Cryptosporidium infec-
tion.181–183 Yet the nature of these responses, particularly in humans, 
is not completely understood.178,184
Early mediators of innate immune protection include the thick 
mucus layer of the small intestine, intestinal epithelial cells and chemo-
kines, cytokines and antimicrobial peptides secreted into the intestinal 
lumen and/or underlying submucosa and bloodstream.178 Important 
cytokines include γ- interferon (IFN- γ), which is secreted early in infec-
tion by natural killer (NK) cells, macrophages and dendritic cells, which 
are thought to play a major role in orchestrating both the innate and 
adaptive immune responses.178,182 Th1 inflammatory response and 
cytokines, such as interleukin 12, 15 and 18, are also important in the 
resistance and recovery to Cryptosporidium infection.185–190 Treatment 
of both immunocompetent and immunodeficient mice with IL- 12 before 
infection prevented or greatly reduced the severity of infection and was 
attributed to a decrease in IFN- γ reduction.190 Data suggest that IL- 15 
has an important role in activating an NK cell- mediated pathway that 
leads to the elimination of Cryptosporidium from the intestine.186 IL- 
18 is produced by epithelial cells in the gut and a number of different 
immune cells and is upregulated in response to C. parvum infection, and 
it has been proposed that one of the functions of IL- 18 is to promote 
IFN- γ expression by macrophages.187 Toll- like receptors expressed by 
epithelial cells have been shown to be important in modulation of the 
host immune response and subsequent parasite clearance.191–197
MicroRNA (miRNA) regulation also appears to play an important 
role in host cell protection against Cryptosporidium.198–203 miRNA are 
small RNA molecules of 23 nucleotides that result in gene silencing 
via translational suppression or mRNA degradation and are a mecha-
nism to fine- tune cellular responses to the environment, and may be 
regulators of host antimicrobial immune responses.201 More than 700 
miRNAs have been identified in humans and are postulated to con-
trol 20%–30% of human genes. miRNA- mediated post- transcriptional 
gene regulation may regulate expression of genes critical to epithelial 
antimicrobial defence, and one cellular miRNA (let-7i) has been shown 
to target Toll- like receptor 4 (TLR4) and regulate TLR4- mediated 
anti- C. parvum defence.198 Functional manipulation of select miRNA 
expression levels in epithelial cells has been shown to alter C. parvum 
infection burden in vitro.201,202 The intercellular adhesion molecule- 1 
(ICAM- 1; CD54) is a 90- kDa member of the Ig superfamily expressed 
by several cell types including endothelial cells and epithelial cells and 
is thought to facilitate adhesion and recognition of lymphocytes at 
infection sites as ICAM- 1 is constitutively present on endothelial cells 
and epithelial cells, but its expression is increased by pro- inflammatory 
cytokines or following microbe infection. Evidence has shown that 
miR- 221- mediated translational suppression controls ICAM- 1 expres-
sion through targeting the ICAM- 1 3′- untranslated region (UTR), in 
epithelial cells in response to C. parvum infection, as transfection of an 
miR- 221 precursor in an vitro model of human biliary cryptosporidiosis 
abolished C. parvum- stimulated ICAM- 1 protein expression.201
Mannose- binding lectin (MBL) is an evolutionarily conserved pro-
tein, secreted by hepatocytes, that functions in human innate immunity 
by binding to microbial surfaces and promoting opsonophagocytosis. 
MBL has been shown to be important in the protection against crypto-
sporidiosis, as children and HIV- infected adults with mannose- binding 
lectin deficiency have increased susceptibility to cryptosporidiosis 
and more severe disease.204–206 The genetic contribution to defi-
cient or low serum levels of MBL results from polymorphisms in the 
MBL2 gene (MBL1 is a pseudogene), which create low MBL- producing 
MBL2 genotypes in ~5% of the world’s population.206 In one study on 
a cohort of preschool children from Dhaka, Bangladesh, polymorphisms 
in the MBL2 gene (and corresponding haplotypes) and deficient serum 
levels of MBL were associated with increased susceptibility to infection 
with Cryptosporidium. MBL deficiency of <500 ng/mL was associated 
with single and multiple symptomatic episodes of Cryptosporidium 
infection, with an OR of 7.6 for children with multiple symptomatic 
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infections with Cryptosporidium.206 The mechanism by which MBL 
controls Cryptosporidium infection and protects children from it is still 
not clearly understood.
Adaptive immunity creates immunological memory after an initial 
response to Cryptosporidium and leads to an enhanced response to sub-
sequent encounters with Cryptosporidium. For example, antibodies to 
the parasite antigen gp15 were associated with protection against rein-
fection.207 The adaptive immune response to Cryptosporidium is char-
acterized as a T- helper 1 (Th1) response,188 and the importance of the 
adaptive immune response during Cryptosporidium infection is highlight-
ed by the susceptibility of patients with AIDS to cryptosporidiosis, as well 
as the resolution of infection observed following CD4+ T lymphocyte 
cell reconstitution in patients given antiretroviral therapy.184,208 Low 
absolute CD4+ T cell counts in patients with HIV/AIDS were thought 
to be responsible for persistent and severe cryptosporidiosis; however, 
research with Simian immunodeficiency virus (SIV)- infected macaques 
reported that persistent cryptosporidiosis was more dependent on 
SIV load and profound viral damage to gut lymphoid tissue and rapid 
depletion of mucosal CD4+ T cells during the acute phase of viral infec-
tion, than on declining circulating CD4+ T cell levels during chronic SIV 
infection.209 This suggests that depletion of local CD4+ T cells may be 
more predictive of disease severity than absolute CD4+ T cell numbers. 
The importance of other T cells such as CD8+ has not been extensively 
studied but do appear to play a role.178 The role of humoral immunity in 
protection from cryptosporidiosis is not well understood, and no clear 
surrogate marker of protective immunity exists (reviewed in 46, 179).
The ideal Cryptosporidium vaccine should provide rapid lifelong 
immunity in all vaccinated individuals, be broadly protective against the 
most common species and subtypes of Cryptosporidium, prevent disease 
transmission, and be readily accessible, stable and cheap.177,178 Ensuring 
cross- reaction against the most common species infecting humans, 
however, will be difficult, as more than 20 Cryptosporidium species and 
genotypes can infect humans as discussed above. For example, a recent 
study showed that infection of gnotobiotic pigs with C. hominis resulted 
in complete protection against subsequent infection with C. hominis, but 
incomplete protection against infection with C. parvum210; therefore, 
multiple species will need to be targeted to provide sufficient cross- 
protection. In addition, as children, malnourished and immunocompro-
mised individuals are the most important vaccine targets, and they may 
not be able to develop a strong and sustained immune- mediated pro-
tection in response to vaccination. Indeed, malnutrition has been cited 
as an important factor underlying limited efficacy of vaccines.211 It is 
therefore likely that adjuvants such as TLR ligands 212 will be required to 
enhance the immune response in target populations.192,195
Several antigens, aimed at raising immunoglobulin G antibod-
ies, are being developed as vaccine candidates.177 Some of the best 
studied are gp15,213–218 cp15 219–224 and cp23.222,225,226 The gp15 
antigen is derived from the glycoprotein gp60, which is cleaved by a 
parasite serine proteinase into two surface proteins—gp15 and gp40, 
both of which play an essential role in parasite motility and attachment 
to and invasion of host epithelial cells,227 and can stimulate γ- interfer-
on production by peripheral blood mononuclear cells of those previ-
ously infected.213 The gp15 antigen is relatively conserved between 
C. parvum and C. hominis, and studies in Bangladesh indicated that 
there is a significant cross- reactivity between them and that antibodies 
to gp15 were associated with shorter duration of illness.216 Similarly, 
in a study in Kenya, AIDS patients without diarrhoea had significantly 
higher serum IgG levels to gp15 than those with diarrhoea.228
cp15 is an immunodominant protein present on the oocyst surface 
and is associated with internal structures and bears no apparent simi-
larity to gp15.227 Immunization of pregnant goats with cp15 vaccines 
protected offspring.229 The impact of malnutrition, however, on vacci-
nation was demonstrated in recent research on intranasal vaccination 
of nourished and malnourished mice, with the cp15 antigen primed 
with a live enteric bacterial vector.224 The authors reported that mal-
nutrition blunted antigen- specific cell- mediated responses to cp15 
and that vaccination resulted in only transient reduction in stool shed-
ding of Cryptosporidium and was not protective against disease.224
cp23 is an immunodominant protein, geographically conserved 
among C. parvum isolates, is present in both the sporozoite and 
merozoite stages,177 and antibodies to it are frequently detect-
ed following Cryptosporidium infection.228,230 Serum antibodies 
to both gp15 and cp23 are associated with protection from diar-
rhoea in immunocompetent adult human volunteers infected with 
Cryptosporidium.180,207,231,232 Thus, a multivalent vaccine, incorporat-
ing multiple antigens or antigenic epitopes, may enhance protection 
against infection. For example, a divalent cp23 and cp15 vaccine pro-
longed the prepatent period and decreased oocyst shedding in mice 
vaccinated with the divalent vaccine compared with vaccination with 
cp23 alone.222 Similarly, a reverse vaccinology approach based on 
genome mining that included three antigens; the well- characterized 
cp15, a calcium- activated apyrase involved in the invasion process 
of Cryptosporidium and profilin, an agonist of the innate immune sys-
tem through its recognition by Toll- like receptors, induced specific 
and potent humoral and cellular immune responses in mice; howev-
er, further studies are necessary to verify the protection induced by 
these antigens.223 The development of an effective vaccine against 
Cryptosporidium is still a challenge and a better understanding of which 
immune responses are necessary for protection is essential to the 
development of immune- based interventions.
6  | CONCLUSIONS
Recent developments have improved our understanding of both the 
genetics of and immune response in cryptosporidial infections. However, 
many knowledge gaps remain. Current diagnostic tests each have their 
limitations in cost, performance, differentiation of clinical significance 
and assessment of co- infections with other pathogens. Inaccessibility of 
diagnostic testing in nonindustrialized has meant that the knowledge of 
the epidemiology of Cryptosporidium infection in early infancy is scarce, 
and as a result, the burden of cryptosporidiosis is under- reported and 
underestimated, which reinforces ineffective clinical and public health 
management of Cryptosporidium. Rapid, cost- effective and reliable 
diagnostic tests therefore need to be developed for nonindustrialized 
countries to improve detection, reporting and interpretation of results 
Appendix 2
374
     |  541Ryan et al.
in the setting of multiple infections. With the recent improvements in 
cell culture and genetic manipulation, identification of novel or repur-
posed therapeutics should be radically transformed. Vaccines have the 
potential to reduce the significant burden of disease, but the extent and 
types of immunity necessary, and the methods by which to administer 
and induce protective immunity need further study.
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Abstract
Cryptosporidium is one of the most common zoonotic waterborne parasitic diseases world-
wide and represents a major public health concern of water utilities in developed nations. As
animals in catchments can shed human-infectious Cryptosporidium oocysts, determining
the potential role of animals in dissemination of zoonotic Cryptosporidium to drinking water
sources is crucial. In the present study, a total of 952 animal faecal samples from four domi-
nant species (kangaroos, rabbits, cattle and sheep) inhabiting Sydney’s drinking water
catchments were screened for the presence of Cryptosporidium using a quantitative PCR
(qPCR) and positives sequenced at multiple loci. Cryptosporidium species were detected in
3.6% (21/576) of kangaroos, 7.0% (10/142) of cattle, 2.3% (3/128) of sheep and 13.2%
(14/106) of rabbit samples screened. Sequence analysis of a region of the 18S rRNA locus
identified C. macropodum and C. hominis in 4 and 17 isolates from kangaroos respectively,
C. hominis and C. parvum in 6 and 4 isolates respectively each from cattle, C. ubiquitum in 3
isolates from sheep and C. cuniculus in 14 isolates from rabbits. All the Cryptosporidium
species identified were zoonotic species with the exception of C. macropodum. Subtyping
using the 5’ half of gp60 identified C. hominis IbA10G2 (n = 12) and IdA15G1 (n = 2) in kan-
garoo faecal samples; C. hominis IbA10G2 (n = 4) and C. parvum IIaA18G3R1 (n = 4) in cat-
tle faecal samples, C. ubiquitum subtype XIIa (n = 1) in sheep and C. cuniculus VbA23
(n = 9) in rabbits. Additional analysis of a subset of samples using primers targeting con-
served regions of the MIC1 gene and the 3’ end of gp60 suggests that the C. hominis
detected in these animals represent substantial variants that failed to amplify as expected.
The significance of this finding requires further investigation but might be reflective of the
ability of this C. hominis variant to infect animals. The finding of zoonotic Cryptosporidium
species in these animals may have important implications for the management of drinking
water catchments to minimize risk to public health.
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Cryptosporidium is one of the most prevalent waterborne parasitic infections [1] and repre-
sents a public health concern of water utilities in developed countries, including Australia.
Currently, 31 Cryptosporidium species have been recognised based on biological and molecular
characteristics including two recently described species; C. proliferans and C. avium [2, 3, 4, 5,
6]. Of these, C. parvum and C. hominis have been responsible for all waterborne outbreaks
typed to date, with the exception of a single outbreak in the UK caused by C. cuniculus [7, 8, 9].
In Australia, marsupials, rabbits, sheep and cattle are the dominant animals inhabiting
drinking water catchments and can contribute large volumes of manure to water sources [10].
Therefore, it is important to understand the potential contribution from these animals in
terms of Cryptosporidium oocyst loads into surface water. A number of genotyping studies
have been conducted on animals in Australian water catchments to date and have reported a
range of species including C. parvum, C. hominis, C. cuniculus, C. ubiquitum, C. bovis, C. rya-
nae, C. canis, C. macropodum, C. fayeri, C. xiaoi, C. scrofarum, and C. andersoni [11, 12, 13, 14,
15, 16, 17, 18, 19, 20, 21, 22, 23]. To date, in humans in Australia, C. hominis, C. parvum, C.
meleagridis, C. fayeri, C. andersoni, C. bovis, C. cuniculus, a novel Cryptosporidium species most
closely related to C. wrairi and the Cryptosporidium mink genotype have been reported [24, 25,
26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42]. The aim of the present study was
to use molecular tools to identify the Cryptosporidium sp. infecting the kangaroos, rabbits, cat-
tle and sheep population inhabiting Sydney’s drinking water catchments and so better under-
stand the potential health risks they pose.
Materials and Methods
Sample collection and processing
Animal faecal samples were collected by WaterNSW staff from watersheds within the
WaterNSW area of operations. Sampling was carried out either on land owned by
WaterNSW or on private land owned by farmers who gave permission to WaterNSW staff
to conduct this study on their property. To minimize cross-contamination and avoid re-
sampling the same animals, animals were observed defecating and then samples were col-
lected randomly from freshly deposited faces from the ground, using a scrapper to expose
and scoop from the center of the scat pile. Samples were collected on a monthly interval
over an 18 months period (July, 2013 to February, 2015) into individual 75 ml faecal collec-
tion pots, and stored at 4˚C until required (no animal was sacrificed). As faecal samples
were collected from the ground and not per rectum, animal ethics approval was not
required. Instead, an animal cadaver/tissue notification covering all the samples collected
was supplied to the Murdoch University Animal Ethics Committee. The animal sources of
the faecal samples were confirmed by watching the host defecate prior to collection and also
with the aid of a scat and tracking manual published for Australian animals [43]. Faecal
samples were collected from two previously identified hotspot zones from eastern grey kan-
garoos (Macropus giganteus) (n = 576), cattle (n = 142), sheep (n = 128) and rabbits
(n = 106). This study did not involve collecting samples from endangered or protected ani-
mal species. Samples were shipped to Murdoch University and stored at 4˚C until required.
Enumeration of Cryptosporidium oocysts in faecal samples
Enumeration of Cryptosporidium oocysts by microscopy was conducted in duplicate for a sub-
set of samples (n = 8) by Australian Laboratory Services (Scoresby, Vic). To quantify recovery
efficiency, each individual faecal composite or homogenate was seeded with ColorSeed
Zoonotic Cryptosporidium Species in Animals
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(Biotechnology Frontiers Ltd. [BTF], Sydney, Australia). Cryptosporidium oocysts were puri-
fied from faecal samples using immunomagnetic separation (IMS) employing the Dynal GC
Combo kit (Dynal, Oslo, Norway) as described by Cox et al., (2005) [44]. Oocysts were stained
with Easystain and 4’,6’,-diamidino-2-phenylindole (DAPI; 0.8 μg.ml-1) (Biotechnology Fron-
tiers Ltd. [BTF], Sydney, Australia) and examined with an Axioskop epifluorescence micro-
scope (Zeiss, Germany) using filter set 09 (blue light excitation) for Easystain (BTF), filter set
02 (UV light excitation) for DAPI staining, and filter set 15 (green light excitation) for Color-
Seed (BTF). The identification criteria described in U.S. EPA method 1623 [45] were used for
Easystain-labeled and DAPI-stained objects.
DNA isolation
Genomic DNA was extracted from 250mg of each faecal sample using a Power Soil DNA Kit
(MO BIO, Carlsbad, California). A negative control (no faecal sample) was used in each extrac-
tion group.
PCR amplification of the 18S rRNA gene
All samples were screened for the presence of Cryptosporidium at the 18S rRNA locus using a
quantitative PCR (qPCR) previously described [46, 47]. qPCR standards were Cryptosporidium
oocysts (purified and haemocytometer counted), diluted to a concentration of 10,000 oocysts/
μl. DNA was extracted from this stock using a Powersoil DNA extraction kit (MO BIO, Carls-
bad, California, USA). The 10,000 oocyst/μl DNA stock was then serially diluted to create
oocyst DNA concentrations equivalent to 1000, 100, 10, 1 oocysts/μl DNA respectively to be
used for standard curve generation using Rotor-Gene 6.0.14 software. Absolute numbers of
Cryptosporidium oocysts in these standards were determined using droplet digital PCR
(ddPCR) at the 18S locus using the same primer set and these ddPCR calibrated standards
were used for qPCR as previously described [47]. Each 10 μl PCR mixture contained 1x Go
Taq PCR buffer (KAPA Biosystems), 3.75 mM MgCl2, 400 μM of each dNTP, 0.5 μM 18SiF
primer, 0.5 μM 18SiR primer, 0.2 μM probe and 1U/reaction Kapa DNA polymerase (KAPA
Biosystems). The PCR cycling conditions consisted of one pre-melt cycle at 95˚C for 6 min
and then 50 cycles of 94˚C for 20 sec and 60˚C for 90 sec.
Samples that were positive by qPCR were amplified at the 18S locus using primers which
produced a 611 bp product (Table 1) as previously described [48] with minor modifications;
the annealing temperature used in the present study was 57˚C for 30 sec and the number of
cycles was increased from 39 to 47 cycles for both primary and secondary reactions. PCR
contamination controls were used including negative controls and separation of preparation
and amplification areas. A spike analysis (addition of 0.5 μL of positive control DNA into
each sample) at the 18S locus by qPCR, was conducted on randomly selected negative sam-
ples from each group of DNA extractions to determine if negative results were due to PCR
inhibition, by comparing the Ct of the spike and the positive control (both with same amount
of DNA).
PCR amplification of the lectin (Clec) gene
Samples that were typed as C. parvum,C. hominis and C. cuniculus at the 18S locus were also
typed using sequence analysis at a unique Cryptosporidium specific gene (Clec) that codes for a
novel mucin-like glycoprotein that contains a C-type lectin domain [55, 56]. Hemi-nested
primers were designed for this study using MacVector 12.6 (http://www.macvector.com). The
external primers Lectin F1 5’ TCAACTAACGAAGGAGGGGA3’ and Lectin R1 5’ GTGGTGT
AGAATCGTGGCCT3’ produced a fragment size of 668 bp for C. hominis and 656 bp for C.
Zoonotic Cryptosporidium Species in Animals
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parvum. The secondary reaction consisted of primers, Lectin F2 5’ CCAACATACCATCCT
TTGG 3’ and Lectin R1 5’ GTGGTGTAGAATCGTGGCCT 3’ (Table 1), which produced a
fragment of 518 bp for C. hominis, 506 bp for C. parvum and 498 bp for C. cuniculus. The
cycling conditions for the primary amplification was 94˚C for 3 min, followed by 94˚C for 30
sec, 58˚C for 30 sec, 72˚C for 1 min for 40 cycles, plus 5 min at 72˚C for the final extension.
The same cycling conditions were used for the secondary PCR, with the exception that the
number of cycles was increased to 47 cycles. The 25 μl PCR mixture consisted of 1 μl of DNA,
1x Go Taq PCR buffer (KAPA Biosystems), 200 μM of each dNTP (Promega, Australia), 2 mM
MgCl2, 0.4 μM of each primer, 0.5 units of Kapa DNA polymerase (KAPA Biosystems). The
specificity of this locus for Cryptosporidium has been previously confirmed [41]. Enumeration
of Cryptosporidium oocysts by qPCR was conducted using a specific C. hominis and C. parvum
assay targeting the Clec gene as previously described [41].
PCR amplification of the gp60 gene
Samples that were typed as C. hominis, C. parvum,C. cuniculus and C. ubiquitum at the 18S
locus were subtyped at the 60 kDa glycoprotein (gp60) locus using nested PCR as previously
described (Table 1) [57, 49 50, 58].
Sequence analysis and phylogenetic analysis
The amplified DNA from secondary PCR products were separated by gel electrophoresis and
purified for sequencing using an in house filter tip method [41]. Purified PCR products from
all three loci, were sequenced independently using an ABI Prism™ Dye Terminator Cycle
Sequencing kit (Applied Biosystems, Foster City, California) according to the manufacturer’s
instructions at 57˚C, 58˚C and 54˚C annealing temperature for the 18S rRNA, lectin and gp60
loci, respectively. Sanger sequencing chromatogram files were imported into Geneious Pro
8.1.6 [59], edited, analysed and aligned with reference sequences from GenBank using Clus-
talW (http://www.clustalw.genome.jp). Distance, parsimony and maximum likelihood trees
were constructed using MEGA version 7 [60].
Table 1. List of primers used in this study to amplify Cryptosporidium species at 18S, lectin (Clec), gp60, lib13 and MIC1 gene loci.
Gene Forward Primer Reverse Primer Reference
18S 50 ACCTATCAGCTTTAGACGGTAGGGTAT 30 50 TTCTCATAAGGTGCTGAAGGAGTAAGG 30 [48]
50 ACAGGGAGGTAGTGA CAAGAAATAACA 30 50 AAGGAGTAAGGAACAACCTCCA 30
lectin (Clec) 50 TCAACTAACGAAGGAGGGGA 3’ 50 GTGGTGTAGAATCGTGGCCT 30 Present Study
50 CCAACATACCATCCTTTGG 30 50 GTGGTGTAGAATCGTGGCCT 30
gp60 50 ATAGTCTCGCTGTATTC30 50 GCAGAGGAACCAGCATC30 [49, 50]
50 TCCGCTGTATTCTCAGCC 30 50 GAGATATATCTTGGTGCG 30
18S 50 TTCTAGAGCTAATACATGCG 30 50 CCCATTTCCTTCGAAACAGGA 30 [51, 52]
50 CCCATTTCCTTCGAAACAGGA 30 50 CTCATAAGGTGCTGAAGGAGTA 30
gp60 50 ATAGTCTCCGCTGTATTC 30 50 GGAAGGAACGATGTATCT 30 [52, 53]
50 GGAAGGGTTGTATTTATTAGATAAAG 30 50 GCAGAG GAA CCAGCAT30
lib13 50 TCCTTGAAATGAATATTTGTGACTCG 30 50 AAATGTGGTAGTTGCGGTTGAAA 30 [54]
Probe: VIC-CTTACTTCGTGGCGGCGTMGB-NFQ
MIC1 50 TGCAGCACAAACAGTAGATGTG 30 50 ATAAGGATCTGCCAAAGGAACA 30 [52]
50 ACCGGAATTGATGAGAAATCTG 30 50 CATTGAAAGGTTGACCTGGAT 30
doi:10.1371/journal.pone.0168169.t001
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Independent confirmation by the Australian Water Quality Centre
(AWQC)
A total of eight blinded faecal samples consisting of seven C. hominis positives and one Crypto-
sporidium negative were sent to the Australian Water Quality Centre (AWQC) for indepen-
dent analysis. DNA was extracted using a QIAamp DNA Mini extraction kit (Qiagen,
Australia). Samples were screened using primers targeting the 18S rRNA locus (Xiao et al.,
2000 as modified by Webber at al., 2014) [51, 52], gp60 using producing an approx. 871 bp sec-
ondary product (Alves et al., 2003 as modified by Webber at al., 2014) [53, 52] and an approx.
400 bp primary product [50] as well as the lib13 [54] and MIC1 gene loci [52] as previously
described (Table 1). PCRs were conducted on a RotorGene 6000 HRM (Qiagen) or LightCy-
cler 96 (Roche) and amplification of the correct product was determined by DNA melting
curve analysis [52]. Amplicons with atypical DNA melting profiles were further characterized
by capillary electrophoresis using a DNA 1000 chip on a Bioanalyzer 2100 (Agilent) as per the
manufacturer’s instructions. The amplicons from all positive PCRs were purified using a Qia-
gen PCR purification kit according to the manufacturer’s instructions and submitted to the
Australian Genome Research Facility for DNA sequencing using BigDye3 chemistry on an
Applied Biosystems AB3730xl capillary DNA sequencer. Sequences were analyzed using Gen-
eious Pro 6.1.8 (Biomatters).
PCR amplification of open reading frames flanking gp60 and MIC1
Open reading frames flanking both ends of gp60 and MIC1 in the C. parvum genome were
used in BLAST searches (http://blast.ncbi.nlm.nih.gov/) to obtain homologous C. hominis
sequences. Alignments of the C. parvum and C. hominis open reading frame pairs were con-
structed using Geneious Pro 6.1.8 (Biomatters). Conserved primers were designed for each
alignment using the default settings and a target amplicon size of approximately 400 bp. The
resulting primers (Table 2) were subjected to BLAST searches to verify specificity.
Each 25 μl qPCR reaction contained 0.5 x GoTaq PCR Buffer (Promega), 1.5 mM MgCl2,
0.2 mM dNTP, 3.3 μM SYTO 9, 100 ng GP32, 0.5 μM forward primer, 0.5 μM reverse primer,
1 unit Promega GoTaq HS, and 2 μl of DNA extract. The qPCR was performed on a Light
Cycler96 (Roche), and cycling conditions consisted of one pre-melt cycle at 95˚C for 6 min
and then 40 cycles of 94˚C for 45 sec, 60˚C for 45 sec and 72˚C for 60 sec. High-resolution
DNA melting curve analysis was conducted from 65˚C to 97˚C using an acquisition rate of 25
reads /˚C. Blastocystis hominis DNA was used as a negative control and nuclease free water
was used as a no template control. Positive controls included C. parvum Iowa 2a (BTF, Sydney,
Australia) and C. hominis IbA10G2 (kindly provided by Ika Sari). Amplicons were sized by
capillary electrophoresis using a DNA 1000 chip on a Bioanalyzer 2100 (Agilent) as per the
manufacturer’s instructions.
Table 2. List of primers designed in the present study to amplify regions flanking the 5’ and 3’ ends of MIC1 and gp60.
Gene Flanking openreading frame Forward Primer Reverse Primer Product size (C. parvum
and C. hominis)
MIC1 cgd6_770 Chro. 60100(3’ end)hypothetical
proteinCDS
5’TGCGGTTGTATGACACCATCA3’ 5’TCTCTGGTGTTTGGCCTGAC 3’ 511





gp60 cgd6_1070 Chro. 60137(3’ end)
conservedhypothetical protein
5’AGCAAGACCGCAACTCAAGT 3’ 5’CCCATAGTGCCCAGCTTGAA 3’ 430
cgd6_1090 Chro. 60141(5’ end) hsp40 5’TATTTGGAGGTGGGGCCAAG 3’ 5’AAAACGGGTTTAGGGGTGGT 3’ 367
doi:10.1371/journal.pone.0168169.t002
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The prevalence of Cryptosporidium in faecal samples collected from each host species was
expressed as the percentage of samples positive by qPCR, with 95% confidence intervals calcu-
lated assuming a binomial distribution, using the software Quantitative Parasitology 3.0 [61].
Linear coefficients of determination (R2) and Spearman’s rank correlation coefficient (Spear-
man’s rho) were used for the analysis of agreement (correlation) between oocyst numbers per
gram of faeces determined by qPCR calibrated with ddPCR standards and enumeration of
Cryptosporidium oocysts by microscopy (IMS) using SPSS 21.0 for Windows (SPSS Inc. Chi-
cago, USA).
Results
Prevalence of Cryptosporidium in faecal samples collected from various
hosts
The overall PCR prevalence of Cryptosporidium species in 952 faecal samples collected from
four different host species was 5% (48/952) (Table 3). Cryptosporidium species were detected
in 3.6% (21/576) of the kangaroo faecal samples, 7.0% (10/142) of cattle faeces, 2.3% (3/128) of
sheep faeces and 13.2% (14/106) of rabbit faecal samples based on qPCR and sequence analysis
of the 18S rRNA locus (Table 3).
Cryptosporidium species detected in various hosts
Sequencing of secondary PCR amplicons at the 18S rRNA locus identified four of the 21 posi-
tive isolates from kangaroo faecal samples as C. macropodum, while the other 17 isolates were
identified as C. hominis (100% similarity for 550bp) (Table 4). Of the ten positives detected in
cattle faecal samples, six were C. hominis and four were C. parvum (Table 4). The three sheep
positive samples were identified as C. ubiquitum and all fourteen positives detected in rabbit
faecal samples were C. cuniculus (Table 4).
Sequence analysis at the lectin (Clec) locus was consistent with 18S gene results. Eleven of
17 C. hominis isolates from kangaroos were successfully amplified and confirmed as C. hominis
sequences. Eight of the 14 positives from rabbits successfully amplified at this locus and were
identified as C. cuniculus. Four of six C. hominis and all four C. parvum isolates from cattle
were also confirmed at this locus.
Table 3. Prevalence of Cryptosporidium species in faecal samples collected from four different host species in Sydney water catchments*. 95%
confidence intervals are given in parenthesis.




Prevalence% Species and subtype
Eastern grey
kangaroo
576 21 3.6 (95% CI: 2.3–5.5) C. hominis (n = 17)**,IbA10G2 (n = 12),IdA15G1 (n = 2),C.
macropodum (n = 4)
Cattle 142 10 7 (95% CI: 3.4–12.6) C. hominis (n = 6)**,IbA10G2 (n = 4),C. parvum (n = 4),
IIaA18G3R1 (n = 4)
Sheep 128 3 2.3 (95% CI: 0.5–6.7) C. ubiquitum (n = 3)**,XIIa (1)
Rabbit 106 14 13.2 (95% CI: 7.4–
21.2)
C. cuniculus (n = 14)**,VbA 23 (n = 9)
Total 952 48 5 (95% CI: 3.7–6.6)
* Based on PCR amplification and sequencing at the 18S rRNA gene, with subtyping based on DNA sequence analysis of a 400 bp amplicon from the 5’
end of the gp60 locus.
** Not all positive samples were successfully typed.
doi:10.1371/journal.pone.0168169.t003
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Table 4. Species and subtypes of Cryptosporidium identified in faecal samples from various hosts (and their GPS co-ordinates) at the 18S and
gp60 loci.
Host species Southing Easting 18S locus gp60 locus
Eastern grey kangaroo 1 -34.18861 150.2918 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 2 -34.203794 150.284394 C. macropodum -
Eastern grey kangaroo 3 -34.20207 150.2742 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 4 -34.193631 150.273387 C. macropodum -
Eastern grey kangaroo 5 -34.188607 150.291818 C. macropodum -
Eastern grey kangaroo 6 -34.20458 150.2881 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 7 -34.61547 150.59756 C. hominis no amplification
Eastern grey kangaroo 8 -34.23796 150.2598 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 9 N/A N/A C. hominis C. hominis IbA10G2
Eastern grey kangaroo 10 N/A N/A C. hominis C. hominis IbA10G2
Eastern grey kangaroo 11 N/A N/A C. hominis C. hominis IbA10G2
Eastern grey kangaroo 12 N/A N/A C. hominis C. hominis IbA10G2
Eastern grey kangaroo 13 -34.61686 150.68794 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 14 -34.63269 150.619 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 15 -34.63269 150.61897 C. hominis no amplification
Eastern grey kangaroo 16 -34.61422 150.59331 C. hominis C. hominis IbA15G1
Eastern grey kangaroo 17 -34.61415 150.59376 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 18 -34.61686 150.68794 C. hominis no amplification
Eastern grey kangaroo 19 -31.60846 150.60819 C. macropodum -
Eastern grey kangaroo 20 -34.61472 150.68475 C. hominis C. hominis IbA10G2
Eastern grey kangaroo 21 -34.61472 150.68475 C. hominis C. hominis IbA15G1
Cattle 1 -34.61278 150.585 C. hominis no amplification
Cattle 2 -34.60429 150.60170 C. hominis C. hominis IbA10G2
Cattle 3 -34.61283 150.58514 C. hominis no amplification
Cattle 4 -34.60429 150.60170 C. parvum C. parvum IIaA18G3R1
Cattle 5 -34.60642 150.60126 C. parvum C. parvum IIaA18G3R1
Cattle 6 -34.61373 150.5876 C. parvum C. parvum IIaA18G3R1
Cattle 7 -34.61373 150.5876 C. hominis C. hominis IbA10G2
Cattle 8 -34.6195 150.5242 C. hominis C. hominis IbA10G2
Cattle 9 -34.60429 150.60170 C. hominis C. hominis IbA10G2
Cattle 10 -34.63269 150.619 C. parvum C. parvum IIaA18G3R1
Sheep 1 -34.61556 150.68353 C. ubiquitum no amplification
Sheep 2 -34.61556 150.68353 C. ubiquitum no amplification
Sheep 3 -34.61743 150.68674 C. ubiquitum C. ubiquitum XIIa
Rabbit 1 -34.61954 150.62169 C. cuniculus no amplification
Rabbit 2 -34.61959 150.62172 C. cuniculus C. cuniculus VbA23
Rabbit 3 -34.61937 150.62178 C. cuniculus C. cuniculus VbA23
Rabbit 4 -34.61479 150.68492 C. cuniculus C. cuniculus VbA23
Rabbit 5 -34.61954 150.62169 C. cuniculus no amplification
Rabbit 6 -34.6195 150.52415 C. cuniculus no amplification
Rabbit 7 -34.61937 150.62178 C. cuniculus C. cuniculus VbA23
Rabbit 8 -34.61283 150.58514 C. cuniculus C. cuniculus VbA23
Rabbit 9 -34.61556 150.68353 C. cuniculus C. cuniculus VbA23
Rabbit 10 -34.61278 150.585 C. cuniculus no amplification
Rabbit 11 -34.61479 150.68492 C. cuniculus C. cuniculus VbA23
Rabbit 12 -34.60429 150.60170 C. cuniculus C. cuniculus VbA23
Rabbit 13 -34.18951 150.2885 C. cuniculus no amplification
Rabbit 14 -34.6327 150.619 C. cuniculus C. cuniculus VbA23
doi:10.1371/journal.pone.0168169.t004
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Sequences at the gp60 locus were obtained for 14 kangaroo and four cattle isolates that were
typed as C. hominis at the 18S rRNA locus. These samples failed to amplify at gp60 using the
primers of Strong et al., (2000) or Alves et al., (2003) [57, 53], which amplify an approx. 832 bp
fragment, but were successfully amplified using the nested primers by Zhou et al., (2003) [53],
which amplify a 400 bp product. In approx. 50% of samples, the primary reaction did not pro-
duce a visible band by gel electrophoresis but a band of the correct size was visible for the sec-
ondary PCR, which was then confirmed by sequencing.
The C. hominis subtypes IbA10G2 and IdA15G1 were identified in 12 and 2 kangaroo sam-
ples respectively and the IbA10G2 subtype was also identified in four cattle samples (Table 4
and Fig 1A). The four C. parvum isolates from cattle were identified as subtype IIaA18G3R1
and the C. cuniculus isolates were subtyped as VbA23 (n = 9) (Table 4 and Fig 1B and 1D). Of
the three C. ubiquitum positive isolates at 18S locus, only one isolate was successfully subtyped
and identified as C. ubiquitum subtype XIIa (Table 4 and Fig 1C). Nucleotide sequences
reported in this paper are available in the GenBank database under accession numbers;
KX375346, KX375347, KX375348, KX375349, KX375350, KX375351, KX375352, KX375353,
KX375354, KX375355.
Fig 1. Phylogenetic relationships of Cryptosporidium subtypes inferred from Neighbor-Joining (NJ) analysis of Kimura’s
distances calculated from pair-wise comparisons of gp60 sequences. (A) Relationships among C. hominis subtypes. (B)
Relationships among C. parvum subtypes. (C) Relationships between C. ubiquitum subtypes. (D) Relationships between C. cuniculus
subtypes. Percentage support (>50%) from 1000 pseudoreplicates from NJ analyses is indicated at the left of the supported node.
doi:10.1371/journal.pone.0168169.g001
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Independent confirmation by the Australian Water Quality Centre
(AWQC)
Blind independent analysis conducted by AWQC using the 18S rRNA nested PCR of Xiao
et al., (2000) [51] identified C. hominis in six samples, corresponding with the six positive sam-
ples from kangaroos, and failed to detect Cryptosporidium in the other two samples, one of
which corresponded with the negative sample. Amplification of a region of gp60 using the pro-
tocol described by Alves et al. [53] failed to produce an amplicon for either the primary or sec-
ondary reactions. Amplification of gp60using the protocol described by Zhou et al., (2003)
[50], failed to amplify the correct-sized product for the primary PCR but produced amplicons
of the correct size for the secondary PCR for the six positive samples, which when sequenced
were confirmed as C. hominis subtype IbA10G2. Amplification at the lib13 locus was also suc-
cessful for the six positive samples, which were confirmed as C. hominis. Amplification at the
MIC1 locus failed to produce any amplicons. The gp60 and MIC1 amplification failures were
further investigated using PCR assays designed to target open reading frames (ORFs) flanking
these two loci. All four primer sets produced strong amplification of the correctly sized frag-
ments for the C. parvum and C. hominis control DNA. The cgd6-1070 ORF (located down-
stream of gp60 in C. parvum), and cgd6-810 (upstream of MIC1), both amplified from four of
the six samples identified as C. hominis. In the case of the other 2 ORFs, weak amplification
was observed for one sample for cgd6-1090 (upstream of gp60) and for two samples for cgd6-
770 (downstream of MIC1). While only single bands were observed for the C. parvum and C.
hominis controls, most of the faecal sample extracts produced multiple bands.
Enumeration of Cryptosporidium oocysts in faecal samples
Oocyst numbers per gram of faeces for all PCR positive samples were determined using qPCR
at the Clec locus for 18 C. hominis and 4 C. parvum positives and for a subset of samples (n = 8)
using microscopy (Table 5). For the 8 samples for which both microscopy and qPCR data were
available, there was poor correlation between the two methods (R2 0.0095 and ρ (rho) =
0.2026) (Table 5). Based on qPCR, the highest numbers of oocysts was detected in Eastern grey
kangaroo isolate 12 (16,890 oocysts/g-1), which was identified as C. hominis subtype IbA10G2.
No oocysts (<2g-1) were detected by microscopy in this sample.
Discussion
The present study described the prevalence and molecular characterization of Cryptosporidium
species in faecal samples collected from kangaroo, cattle, sheep and rabbit faecal samples from
Sydney’s drinking water catchments. The overall prevalence of Cryptosporidium species in the
faecal samples collected from four animal hosts was 5% and was 3.6% in kangaroos, 7% in cat-
tle, 2.3% in sheep and 13.2% in rabbits. Overall, the prevalence of infection with Cryptosporid-
ium was generally lower than that reported previously in Sydney catchments; 25.8% [44] 6.7%
[62] and 8.5% [16] and Western Australian catchments; 6.7% [13]. In the study by Ng et al.,
(2011b) [16], the prevalence in eastern grey kangaroos was much higher (16.9%−27/160) than
the 3.6% prevalence in kangaroo faecal samples in the present study. The overall prevalence of
Cryptosporidium species in faecal samples collected from different species in the present study
was similar to the 2.8% (56/2,009) prevalence identified in faecal samples from animals in Mel-
bourne water catchments [20]. The lower prevalence in the present study and the Melbourne
study may be a consequence of testing a greater numbers of samples, seasonal and/or yearly
variation in prevalence and/or proximity to agricultural land.
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Based on sequence analysis using the 18S rRNA locus, a total of five Cryptosporidium spe-
cies were identified; C. macropodum (n = 4), C. hominis (n = 23), C. parvum (n = 4), C. ubiqui-
tum (n = 3) and C. cuniculus (n = 14). The prospect of livestock and wildlife being reservoirs
for C. hominis has human-health implications, so to verify this finding, a subset of faecal sam-
ples was subjected to blinded independent analysis. This additional testing initially identified
C. hominis following sequence analysis of a large fragment of the 18S rRNA gene amplified
using the Xiao et al., (2000) [51] nested PCR. It is noteworthy that the Xiao outer 18S PCR pro-
duced a clear amplification signal (threshold cycles between 24 and 29 for positive samples),
suggesting the presence of reasonable numbers of oocysts with no evidence of PCR inhibition
for this relatively large amplicon (approx. 1.2 kilobases). The lib13 Taqman assay also identi-
fied C. hominis in these same samples. However, amplification of gp60 using the Alves et al.,
(2003) [53] nested PCR failed to amplify any Cryptosporidium, either as a nested PCR or by
direct amplification using the inner primer set. Application of the Zhou et al., (2003) [53]
outer gp60 primers (which are equivalent to the pairing of the Alves outer forward and inner
reverse primers) also appeared to be unsuccessful (only four samples produced a band close to
the expected size), but the Zhou gp60 inner PCR amplified the correctly sized amplicon, which
was confirmed to be C. hominis IbA10G2.
The failure to amplify gp60 using the Alves et al., (2003) and Strong et al., (2000) [57, 53]
assays was unexpected, especially considering the high degree of conservation for the primer
binding sites across the C. parvum and C. hominis gp60 subtypes and the successful amplifica-
tion of the large 18S rRNA gene fragment, which demonstrates that the DNA quantity and
quality was sufficient for amplification within the first round of PCR. The lack of amplification
Table 5. Cryptosporidium oocyst numbers in positive samples per gram of faeces (g-1) determined using microscopy and qPCR. Note: microscopy
data was only available for 12 samples.
Host species Cryptosporidium species (18S) Oocyst numbers/g-1 microscopy % Oocyst recovery Oocyst numbers/g-1 qPCR
Eastern grey kangaroo 1 C. hominis 210 54 11,337
Eastern grey kangaroo 3 C. hominis 11,076 78 5,458
Eastern grey kangaroo 6 C. hominis <2 61 9,528
Eastern grey kangaroo 8 C. hominis <2 45 262
Eastern grey kangaroo 9 C. hominis <2 74 648
Eastern grey kangaroo 10 C. hominis <2 51 8,735
Eastern grey kangaroo 11 C. hominis <2 67 131
Eastern grey kangaroo 12 C. hominis <2 60 16,890
Eastern grey kangaroo 13 C. hominis - - 26
Eastern grey kangaroo 14 C. hominis - - 5,458
Eastern grey kangaroo 16 C. hominis - - 7,570
Eastern grey kangaroo 17 C. hominis - - 9,626
Eastern grey kangaroo 20 C. hominis - - 8,735
Eastern grey kangaroo 21 C. hominis - - 173
Cattle 2 C. hominis - - 144
Cattle 4 C. parvum - - 936
Cattle 5 C. parvum - - 1,819
Cattle 6 C. parvum - - 2,197
Cattle 7 C. hominis - - 4,205
Cattle 8 C. hominis - - 10,827
Cattle 9 C. hominis - - 15,804
Cattle 10 C. parvum - - 1,190
doi:10.1371/journal.pone.0168169.t005
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at other loci is unlikely to be due to PCR inhibition, as spike analysis indicated no inhibition.
To investigate this further, a published PCR assay targeting the MIC1 locus from both C. par-
vum and C. hominis [52] was also tested and failed to amplify the expected fragment from
these samples. The MIC1 gene encodes a thrombospondin-like domain-containing protein,
which is secreted in sporozoites prior to host cell attachment and localized to the apical com-
plex after microneme discharge [63]. As secreted proteins often play a critical role in determin-
ing virulence and host specificity in host-pathogen relationships, it has been hypothesized that
MIC1 may play a role in the differences in host range observed between C. parvum and C.
hominis [52]. Previous analysis of the CryptoDB has identified that both the gp60 and MIC1
loci are on chromosome 6 and in close proximity (60 kb) [52], and it has previously been
reported that these two genes are genetically linked [64]. Given that 3 different gp60 reverse
primers appear to have failed, as well as failure of at least one of the MIC1 primers, it would
require the occurrence of multiple individual single nucleotide polymorphisms for the results
to be accounted for by point mutations. Alternatively, a truncation or rearrangement on chro-
mosome 6 affecting the 3’ end of gp60 and MIC1 could affect these PCR assays. To test for any
deletions affecting these loci, PCR assays were developed targeting flanking ORFs. The PCR
assays targeting two ORFs in the region between MIC1 and gp60 (based on the C. parvum
chromosome 6 map) were positive for some of the samples tested, suggesting that a wholesale
deletion is not the cause for the failure to amplify MIC1 or the entire gp60. The other two PCR
assays produced equivocal results in the samples, although they yielded strong amplification in
the positive controls. The variable sample results may have been due to a combination of the
low amount of Cryptosporidium DNA present and non-specific amplification from other DNA
in the sample extracts. The latter is likely, considering that the positive controls produced a
single amplicon, whereas most of the sample extracts yielded multiple fragments of different
sizes.
Sequencing of chromosome 6 or the entire genome of this variant C. hominis is required to
determine the underlying cause for the failure to amplify MIC1 or the larger gp60 region. Con-
sidering the role of gp60 in host cell adhesion and the hypothesized role of MIC1 in infection,
it is possible that changes or loss of key genes involved in host specificity could explain the suc-
cess of this particular variant of C. hominis in infecting hosts other than humans. If the func-
tion of these genes has been altered to better support infection in non-human hosts, then the
infectivity of this variant in humans needs to be re-evaluated.
Of the detected species, all but C. macropodum have been reported to cause infection in
humans at varying frequencies [7, 10]. Cryptosporidium hominis and C. parvum are responsible
for the majority of human infections worldwide [7, 6]. In the present study, the prevalence of
the variant C. hominis in kangaroo and cattle faecal samples was 2.9% (95% CI: 1.7%-4.7%)
and 4.2% (95% CI: 1.6%-9%) respectively, and the prevalence of C. parvum in cattle faecal sam-
ples was 2.8% (95% CI: 0.8%-7.1%). Both of these parasites have been linked to numerous
waterborne outbreaks around the world [7, 1] and although this prevalence is relatively low,
both these host species represent a risk of waterborne transmission to humans. A number of
previous studies have identified C. hominis/C. parvum-like isolates at the 18S rRNA locus in
marsupials including bandicoots (Isoodon obesulus), brushtail possums (Trichosurus vulpe-
cula), eastern grey kangaroos (Macropus giganteus) and brush-tailed rock-wallabies (Petrogale
penicillata) [65, 66, 67]. However, in those studies, despite efforts, the identification of C. homi-
nis/C. parvum could not be confirmed at other loci. This may be due to low numbers of oocysts
and the multi-copy nature of the 18S rRNA gene, which provides better sensitivity at this
locus. Alternatively, failure to confirm identity in these other studies could be due the presence
of variants with substantial differences in the diagnostic loci used, causing those PCR assays to
fail. Such is the case in the present study, which for the first time has identified a novel C.
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hominis in kangaroo faecal samples based on analysis of multiple loci (18S rRNA, Clec,MIC1,
lib13 and gp60).
Cryptosporidium cuniculus, the most prevalent species detected here (13.2%), has been pre-
viously identified in rabbits, humans and a kangaroo in Australia [14, 20, Sari et al., 2013
unpublished—KF279538, 21]. It was implicated in a waterborne outbreak of cryptosporidiosis
in humans in England in 2008 [8, 9] and has been linked to a number of sporadic human cases
across the UK [68, 69], Nigeria [70] and France [71]. Cryptosporidium ubiquitum was detected
in three sheep samples and is a common human pathogen [7], but has not been identified in
Australia in the limited typing of Australian human Cryptosporidium isolates that has been
conducted to date [10], however it has been identified in surface waters in Australia (Monis
et al., unpublished).
Subtyping at the gp60 locus identified the C. hominis subtype IbA10G2 in twelve kangaroo
and four cattle faecal samples. This is a dominant subtype responsible for C. hominis-associ-
ated outbreaks of cryptosporidiosis in the United States, Europe and Australia [7, 72, 73, 74].
Cryptosporidium hominis has previously been reported in cattle in New Zealand [75], Scot-
land [76], India [77] and Korea [78]. Subtyping at the gp60 locus identified IbA10G2 [76,
75], and IdA15G1 [77]. It has been suggested that the IbA10G2 infects cattle naturally in par-
ticular circumstances and thus could act as a zoonotic infection source in some instances
[76]. Interestingly, the studies that detected IbA10G2 in cattle, used PCR-based assays that
only sequenced the 5’ end of gp60, similar to the assay used in this study, so it is possible that
these reports also represent detection of a variant C. hominis gp60. This is the first report of
the same subtype of C. hominis in kangaroos and cattle in the same catchment. In two kanga-
roo samples, the C. hominis IdA15G1 subtype was identified. This is also a common C. homi-
nis subtype identified in humans worldwide [28, 79, 80, 81, 74]. The source and human
health significance of the novel C. hominis detected in kangaroo and cattle samples in the
present study is currently unknown. Environmental pollution from human and domestic
animal faeces such as contamination of watersheds due to anthropogenic and agricultural
activities conducted in the catchment area, in particular livestock farming, could be a poten-
tial source for wildlife infections with C. hominis. However, further studies are required to
better understand the involvement of humans and livestock in the epidemiology of zoonotic
Cryptosporidium species in wildlife.
The C. parvum subtype IIaA18G3R1 was identified in four cattle samples. IIaA18G3R1 is
also a common subtype in both humans and cattle worldwide and has been reported widely in
both calves and humans in Australia [10]. Subtyping of the single C. ubiquitum isolate from
sheep identified XIIa. To date six subtype families (XIIa to XIIf) have been identified in C. ubi-
quitum [58]. Of these, XIIa, XIIb, XIIc, and XIId have been found in humans and therefore
XIIa is a potentially zoonotic subtype [54] The C. cuniculus subtype identified in the present
study was VbA23. Two distinct gp60 subtype families, designated Va and Vb have been identi-
fied in C. cuniculus [8]. Most cases described in humans relate to clade Va and the first water-
borne outbreak was typed as VaA22 [82, 8]. Previous studies in Australia have identified
subtype VbA26 from an Eastern grey kangaroo [42], subtypes VbA23R3 and VbA26R4 [14,
20], VbA22R4, VbA24R3 and VbA25R4 [20] in rabbits and subtype VbA25 [42] and VbA27
(Sari et al., 2013 unpublished—KF279538) in a human patient.
Accurate quantification of Cryptosporidium oocysts in animal faecal deposits on land is
important for estimating catchment Cryptosporidium loads. In the present study, oocyst con-
centration (numbers per gram of faeces—g-1) was also determined for 18 C. hominis and 4 C.
parvum positives using qPCR and for a subset of samples (n = 8) by microscopy. qPCR quanti-
tation was conducted at the Clec locus rather than the 18S rRNA locus as the former is unique
to Cryptosporidium and therefore more specific than the available 18S rRNA qPCR assays.
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There was poor correlation between qPCR and microscopy for the 8 samples for which data
from both methods were available, with qPCR detecting higher numbers of oocysts than
microscopy with the exception of one sample (Eastern grey kangaroo 3). Increased sensitivity
of qPCR and the estimation of much higher numbers of oocysts in faecal samples by qPCR ver-
sus microscopy has been previously reported [83]. A major limitation of qPCR is that the
quantitative data generated are only as accurate as the standards used. A study which com-
pared droplet digital PCR (ddPCR) (which provides absolute quantitation without the need
for calibration curves) with qPCR, reported that qPCR overestimated the oocysts counts com-
pared to ddPCR [47]. In the present study, the discrepancy between qPCR and microscopy
could be due to a number of different factors; (1) IMS for microscopy and direct DNA extrac-
tion from faeces were conducted on different subsamples of each faecal sample and therefore
the numbers of oocysts present in the subsamples may differ, (2) microscopy counts intact
oocysts whereas qPCR will detect not only oocysts but also sporozoites that have been released
from oocysts, other lifecycle stages and any free DNA, therefore qPCR may produce higher
counts than microscopy. In the present study, the mean oocysts g-1 for kangaroos and cattle
that were positive for C. hominis was 6,041 (range 26–16,890) and for cattle that were positive
for C. parvumwas 1535(range 936–2,197) as determined by PCR. By microscopy, oocysts
counts were available for kangaroo samples only and the mean was 5,643 (range <0.5–11,076).
A previous study in WaterNSW catchments, reported mean Cryptosporidium oocysts g-1 of 40
(range 1–5,988) for adult cattle, 25 for juvenile cattle (range <1–17,467), 23 for adult sheep
(range <1–152,474), 49 for juvenile sheep (range <1–641) and 54 for adult kangaroos (range
<1–39,423) [84]. The age of the kangaroos and cattle sampled in the present study are
unknown, but qPCR quantitation suggests that these were actual infections and not mechani-
cal transmission. However, future studies should include oocyst purification via IMS prior to
qPCR for more accurate quantitation. In addition, homogenisation of samples is important
when comparing microscopy and qPCR i.e faecal slurries should be made, mixed well and ali-
quots of that mixture used for both microscopy and qPCR to ensure better consistency
between techniques.
It is important to note that of the numbers of oocysts detected in animal faeces in catch-
ments, only a fraction of oocysts may be infectious. For example, a recent study has shown that
the infectivity fraction of oocysts within source water samples in South Australian catchments
was low (~3.1%) [85]. While it would be expected that oocysts in faecal samples would have
much higher infectivity than oocysts in source water, reports suggest that only 50% of oocysts
in fresh faeces are infectious, and that temperature and desiccation can rapidly inactivate
oocysts in faeces while solar inactivation, predation and temperature will all impact oocyst sur-
vival in water [86].
The identification of mostly zoonotic Cryptosporidium species in animals inhabiting Sydney
catchments indicates that there is a need to diligently monitor Cryptosporidium in source
waters. Such monitoring is also critical, given the resistance of Cryptosporidium oocysts to
chlorine [87]. Further studies are essential to confirm the nature of the C. hominis variant
detected in this study and to determine if it represents an infection risk for humans.
Conclusions
Of the five Cryptosporidium species identified in this study, four species are of public health
significance. The presence of zoonotic Cryptosporidium species in both livestock and wildlife
inhabiting drinking water catchments may have implications for management of drinking
water sources. Therefore, continued identification of the sources/carriers of human pathogenic
strains would be useful to more accurately assess risk.
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Next Generation Sequencing (NGS)a b s t r a c t
The extent of within-host genetic diversity of parasites has implications for our understanding of the epi-
demiology, disease severity and evolution of parasite virulence. As with many other species, our under-
standing of the within-host diversity of the enteric parasite Cryptosporidium is changing. The present
study compared Sanger and Next Generation Sequencing of glycoprotein 60 (gp60) amplicons from
Cryptosporidium hominis (n = 11), Cryptosporidium parvum (n = 22) and Cryptosporidium cuniculus (n = 8)
DNA samples from Australia and China. Sanger sequencing identified only one gp60 subtype in each
DNA sample: one C. hominis subtype (IbA10G2) (n = 11), four C. parvum subtypes belonging to IIa
(n = 3) and IId (n = 19) and one C. cuniculus subtype (VbA23) (n = 8). Next Generation Sequencing identi-
fied the same subtypes initially identified by Sanger sequencing, but also identified additional gp60 sub-
types in C. parvum and C. cuniculus but not in C. hominis, DNA samples. The number of C. parvum and C.
cuniculus subtypes identified by Next Generation Sequencing within individual DNA samples ranged from
two to four, and both C. parvum IIa and IId subtype families were identified within the one host in two
samples. The finding of the present study has important implications for Cryptosporidium transmission
tracking as well as vaccine and drug studies.
 2017 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.1. Introduction
Humans and animals often become co-infected with different
species and genotypes of the same parasite genus, resulting in
within-host parasite interactions (Holmes and Price, 1986; Read
and Taylor, 2001; Choisy and de Roode, 2010; Seppälä and Jokela,
2016). Importantly, the presence of co-infecting parasite species/
genotypes within a host can potentially modify parasite fitness
by allowing them to adapt to different selection pressures and
can drive the evolution of parasite virulence and alter host suscep-
tibility to other parasites, infection duration, disease severity,
transmission risks, clinical symptoms and consequently treatment
and prevention strategies (Vaumourin et al., 2015; Grinberg and
Widmer, 2016; Seppälä and Jokela, 2016). Therefore within-host
parasite interactions have important repercussions for human or
animal health. For instance, parasite co-infections within a single
host can result in gene exchange via recombination. This can driveparasite evolution by making the parasites more resistant to drugs.
Interactions among co-infecting parasite species, genotypes and
subtypes of the same parasite genus can also modify co-
evolutionary dynamics between the host and parasites. In addition,
parasite interactions can help with maintaining genetic variation
in parasite traits such as infectivity and virulence which are crucial
components of pathogen fitness and are important to better under-
stand disease dynamics and the changing epidemiology of parasitic
diseases (Seppälä et al., 2012; Vaumourin et al., 2015; Seppälä and
Jokela, 2016).
Cryptosporidium spp are ubiquitous enteric parasites that infect
a broad range of hosts including humans and animals (Xiao, 2010).
They are a major contributor to moderate-to-severe diarrhoeal dis-
ease in developing countries and are second only to rotavirus as a
cause of moderate-to-severe diarrhoea in children younger than
2 years (Kotloff et al., 2013). Of the 31 species currently recognised,
Cryptosporidium parvum and Cryptosporidium hominis account for
the majority of human infections and typed outbreaks (Xiao,
2010; Ryan et al., 2017), with the exception of Cryptosporidium
cuniculus which was responsible for a waterborne outbreak in the
UK (Puleston et al., 2014). The parasite is transmitted via the
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animal to animal contact, and via contaminated water; therefore
hosts are exposed to multiple sources of potentially genetically
diverse oocysts (Xiao, 2010; Grinberg and Widmer, 2016). Once
ingested, sporozoites excyst from the oocyst, invade the host cells
and undergo subsequent rounds of asexual and sexual
reproduction.
Currently, the only available drug for human infections
(nitazoxanide - Romark Laboratories, Florida, USA), has variable
efficacy (Abubakar et al., 2007; Amadi et al., 2009) and an effec-
tive vaccine has yet to be developed (Mead, 2014; Ryan et al.,
2016). Halofuginone lactate (Halocur; Intervet, New Zealand) is
commercially available against cryptosporidiosis in dairy calves,
with variable efficacy (Trotz-Williams et al., 2011; Almawly
et al., 2013). Therefore, Cryptosporidium control currently relies
mainly on improved sanitation and understanding its transmis-
sion dynamics.
Analysis of the extent of within-host genetic diversity in Cryp-
tosporidium has been hampered due to the difficulties in culturing
this parasite, with clonal lineages derived from individual sporo-
zoites unavailable (Grinberg and Widmer, 2016). Of the multilocus
sequencing typing strategies employed to examine within-host
genetic diversity, sequence analysis of the glycoprotein 60 (gp60)
gene is the most common (Xiao, 2010), as it is the most polymor-
phic locus in the genome (Abrahamsen et al., 2004). Despite the
importance of within-host genetic diversity for our understanding
of cryptosporidiosis epidemiology, relatively little is known (Cama
et al., 2006; Waldron and Power, 2011; Jeníková et al., 2011;
Shrestha et al., 2014; Ramo et al., 2014, 2016). Most studies have
relied on conventional PCR and Sanger-based genotyping methods,
and automated fragment analysis, however a major limitation of
these approaches is their inability to resolve complex DNA mix-
tures and detect low-abundance intra-isolate variants (Paparini
et al., 2015; Grinberg and Widmer, 2016).
Next Generation Sequencing (NGS) of amplicons offers the
advantage of massive parallelization of sequencing reactions to
more effectively identify low-abundance genotypes in mixed infec-
tions. To date, only one study has examined the extent of intra-
isolate diversity of Cryptosporidium at the gp60 locus using NGS
(Grinberg et al., 2013). In that study, NGS analysis of two C. parvum
samples from one geographic location (New Zealand) revealed
much higher levels of intra-isolate diversity compared with Sanger
sequencing. In the present study, we examined intra-host genetic
diversity of a much larger number of Cryptosporidium samples
(n = 41) from three different species (C. hominis, C. parvum and C.
cuniculus) and from two distinct geographic regions (Australia
and China), using both NGS and conventional Sanger sequencing
at the gp60 locus to better understand the epidemiology of this
important parasite. Animal faecal samples in Australia were col-
lected from watersheds within the WaterNSW (New South Wales)
area of operations and included two dairy farms and faecal samples
collected from the surrounding bushland. Faecal samples from
China were collected from a cattle breeding centre and two dairy
farms, all located in Henan province.2. Materials and methods
2.1. Sample collection and processing
A total of 41 DNA samples positive for Cryptosporidium, belong-
ing to three Cryptosporidium spp. (as determined by Sanger
sequencing – see Section 2.3), were analysed in the present study;
C. parvum (n = 22) from cattle (Bos taurus), C. hominis (n = 11) from
Eastern Grey kangaroos (Macropus giganteus), and C. cuniculus
(n = 8) from rabbits (Oryctolagus cuniculus).402.2. DNA isolation
Upon collection, faecal samples were stored at 4 C until anal-
ysed. Following five cycles of freeze–thaw, genomic DNA was
extracted from 250 mg of each faecal sample using a Power Soil
DNA Kit (MO BIO, Carlsbad, California, USA). Extraction blanks
(no faecal sample) were used in each extraction group. Purified
DNA was stored at 20 C prior to PCR. DNA extraction and post-
DNA extraction procedures were performed in separate dedicated
laboratories.2.3. Sanger sequencing
All samples were initially identified to species level at the 18S
locus using nested PCR amplification and Sanger sequencing of a
fragment of the 18S locus as previously described (Silva et al.,
2013). Samples were then subtyped at the gp60 locus using a
nested PCR to amplify an approximately 400 bp product using
the primers AL3531 (50-ATAGTCTCCGCTGTATTC-30) and AL3533
(50-GAGATATATCTTGGTGCG-30) for the primary PCR, and AL3532
(50-TCCGCTGTATTCTCAGCC-30) and LX0029 (50-CGAACCACATTA
CAAATGAAGT-30) for the secondary PCR (Sulaiman et al., 2005).
Each 25 ml PCR mixture contained 1 ml of genomic DNA, 1 Go
Taq PCR buffer (KAPA Biosystems, South Africa), 3.75 mM MgCl2,
400 mM of each dNTP, 0.4 mM of forward and reverse primers and
1 U of Kapa DNA polymerase (MO BIO). The PCR cycling conditions
were modified and consisted of an initial denaturation at 94 C for
3 min and then 40 cycles of 94 C for 45 s, 54 C for 45 s and 72 C
for 1 min, followed by a final extension step at 72 C for 7 min. PCR
contamination controls were used including negative controls. PCR
setup and DNA handling procedures were performed in separate
and dedicated exclusion hoods; PCR and post-PCR procedures were
performed in separate dedicated laboratories.
Gel electrophoresis was used to separate the amplified DNA
fragments from the secondary PCR products at the gp60 locus,
which were subsequently purified for sequencing using an in-
house filter tip method as previously described (Yang et al.,
2013). Purified PCR products were sequenced independently in
both directions using an ABI PrismTM Dye Terminator Cycle
Sequencing kit (Applied Biosystems, Foster City, California, USA)
according to the manufacturer’s instructions and with a 54 C
annealing temperature. Sanger sequencing chromatogram files
were imported into Geneious Pro 8.1.6 (Kearse et al., 2012), and
the nucleotide sequences of each gene were analysed and aligned
with reference sequences from GenBank using Clustal W (http://
www.clustalw.genome.jp).2.4. Next Generation Sequencing (NGS)
Partial Cryptosporidium gp60 gene sequences were amplified for
NGS on the MiSeq (Illumina) platform using the same assay
described for Sanger sequencing (Sulaiman et al., 2005), with the
exception that secondary PCR primers were modified to contain
MiSeq adapter sequences on the 50 end, as per standard protocols
for the MiSeq platform (Illumina Demonstrated Protocol: Metage-
nomic Sequencing Library Preparation). PCRs were performed in
25 ml volumes containing PCR buffer (KAPA Biosystems), 2 mM
MgCl2, 0.01 mg of BSA (Fisher Biotech, Australia), 1 mM dNTPs
(Fisher Biotech), 0.4 mM of each primer and 0.5 U of KAPA Taq
DNA Polymerase (KAPA Biosystems). Primary PCRs used 2 ml of
DNA as a template and secondary reactions contained 1–2 ml of
the primary product as a template. All PCRs contained no-
template controls and extraction reagent blank controls. All PCRs
were performed with an initial denaturation at 95 C for 5 min, fol-1
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1 min, and a final extension period at 72 C for 5 min.
From the resulting Cryptosporidium gp60 amplicons, sequencing
libraries for the MiSeq sequencing platform were produced accord-
ing to Illumina recommended protocols (Illumina Demonstrated
Protocol: Metagenomic Sequencing Library Preparation), with the
following amendments. Briefly, purified, uniquely indexed libraries
from individual DNA samples were pooled for sequencing in
equimolar quantities based on the fluorescent intensity of ampli-
con libraries after electrophoresis through a 2% agarose gel stained
with GelRed (Fisher Biotech) and visualised under UV light.
Sequencing was performed on an Illumina MiSeq using 500-cycle
V2 chemistry (250 paired-end reads) following the manufacturer’s
recommendations.
2.5. Bioinformatics analysis
Sequences were processed to retain only reads with perfect
AL3532 and LX0029 primer sequences (no mismatches allowed).
Primer sequences and distal bases were removed in Geneious Pro
8.1.6 (Kearse et al., 2012) and remaining reads were quality filtered
using USEARCH v9.1.13 (Edgar, 2010), retaining only sequences
with a <1% expected error rate (96.4% of sequences retained). Sin-
gletons, doubletons, and sequences with replicate copies less than
0.01% of the total number of unique sequences per sample (14.8%
of quality filtered sequences) were discarded due to their high
probability of being generated by sequencing and/or PCR error.
Chimeric sequences (<0.08%) were identified and removed using
USEARCH v9.1.13 (Edgar, 2010).
All remaining high quality sequences were compared, using
BLAST (Altschul et al., 1990), with an in-house reference database
containing 131 Cryptosporidium gp60 sequences from all charac-
terised C. parvum, C. hominis and C. cuniculus subtypes available
in GenBank (Supplementary Table S1). For C. hominis and C. par-
vum, gp60 subtypes were only assigned if NGS reads matched iden-
tically (100% pairwise identify and query coverage) to only one
gp60 subtype reference sequence. For C. cuniculus, all available ref-
erence GenBank sequences were 1–3 bp shorter at the 50 end com-
pared with the NGS reads obtained in the present study. To
accommodate this incongruity between query and reference
sequences, C. cuniculus subtypes were assigned only if NGS reads
matched to only one C. cuniculus gp60 subtype reference sequence
with 100% pairwise identify and 99% query coverage.3. Results
3.1. Sanger sequencing
Sanger sequencing identified one subtype per amplicon with
only one C. hominis subtype (IbA10G2) identified in all 11 C. homi-
nis DNA samples from Eastern Grey kangaroos. Four C. parvum sub-
types were identified in ruminant-derived DNA samples from
Australia and China: IIaA16G2R1 (n = 3), IIdA15G1 (n = 2),
IIdA18G3R1 (n = 2), IIdA19G1 (n = 15); and only one C. cuniculus
subtype (VbA23) was identified in all eight DNA samples positive
for C. cuniculus from rabbits (Table 1). Both IIa and IId C. parvum
subtype families were identified in Australian samples positive
for C. parvum, but only the IId C. parvum subtype family was iden-
tified in samples from China.
3.2. NGS
From the 41 DNA samples, a total of 566,719 high quality NGS
reads were obtained after initial quality filtering procedures. For
the 11 C. hominis DNA samples, there was 100% agreement402between Sanger and NGS sequencing with C. hominis IbA10G2,
the only subtype identified in assigned reads (Table 1). For the
22 C. parvum samples, however, although the subtype identified
by Sanger was also the main subtype identified by NGS, multiple
additional subtypes, ranging from 0.4% to 31% of the total assigned
reads, were identified. A total of 11 C. parvum subtypes were iden-
tified by NGS; IIaA14G2R1 (n = 3), IIaA15G2R1 (n = 3), IIaA16G2R1
(n = 3), IIaA16G3R1 (n = 2), IIdA14G1 (n = 2), IIdA15G1 (n = 2),
IIdA17G1 (n = 7), IIdA18G1 (n = 15), IIdA18G3R1 (n = 2), IIdA19G1
(n = 15), IIdA20G1 (n = 12). The number of C. parvum subtypes
identified by NGS within individual samples ranged from two to
four, with both IIa and IId subtype families identified within the
one host in two samples (i.e. AUSC9 and AUSC20) (Table 1).
For C. cuniculus, as with C. parvum, the subtype identified by
Sanger was also identified by NGS, with multiple additional sub-
types ranging from 0.4% to 6.7% of the total assigned reads identi-
fied. A total of three C. cuniculus subtypes were identified by NGS:
VbA22 (n = 8); VbA23 (n = 8); VbA25 (n = 8); with all three sub-
types identified within individual DNA samples.
The extremely high level of stringency used in identifying the C.
parvum, C. hominis, and C. cuniculus subtypes resulted in a high
number of unassigned reads that failed to match known reference
sequences with 100% pairwise identity and 100% query cover (or
99% for C. cuniculus) (Table 1).4. Discussion
In the present study, the extent of within-host diversity of gp60
subtypes in three Cryptosporidium spp. (C. hominis, C. parvum and C.
cuniculus) from two geographic locations (Australia and China) was
analysed using Sanger and NGS. Sanger sequencing identified only
one gp60 subtype in each DNA sample (positive for Cryptosporid-
ium); NGS identified the same subtype, but also identified addi-
tional within-host subtypes for samples positive for C. parvum
and C. cuniculus, but not for C. hominis. The direct Sanger sequenc-
ing of PCR amplicons employed in the present study is not neces-
sarily the best-suited method for uncovering within-host
diversity. Other tools such as sequencing clones and Single Strand
Conformational Polymorphism (SSCP) can also be employed to
identify minor sequence variants or to determine whether prod-
ucts of a PCR are homogeneous or heterogeneous. All the Aus-
tralian samples were sourced from water catchments in Sydney
(New South Wales), and Sanger-based typing of these samples
have been previously discussed (Zahedi et al., 2016). Typing of
the samples from China (collected from dairy cattle farms) has also
been previously reported (Wang et al., 2011, 2014).
Two C. parvum subtype families (IIa and IId) were identified by
both Sanger and NGS in ruminant-derived DNA samples from both
Australia and China, with four and 11 subtypes identified, respec-
tively. The IIa and IId subtypes are found in both humans and rumi-
nants and are responsible for zoonotic cryptosporidiosis (Xiao,
2010). One C. cuniculus subtype family (Vb) was identified by both
Sanger and NGS, with one and three subtypes identified in individ-
ual samples, respectively. Two gp60 subtype families (Va and Vb)
have been previously identified in C. cuniculus, with most human
cases of cryptosporidiosis caused by the Va subtype family, includ-
ing the first waterborne outbreak of cryptosporidiosis with C.
cuniculus in the UK which was typed as VaA22 (Puleston et al.,
2014). Both Sanger and NGS identified only one C. hominis subtype
(IbA10G2) in all 11 DNA samples from kangaroos. This is a domi-
nant subtype responsible for the majority of C. hominis-
associated outbreaks worldwide (Xiao, 2010) and the identification
of this subtype in kangaroos has previously been independently
confirmed (Zahedi et al., 2016).
Table 1
Comparison of glycoprotein 60 (gp60) subtypes identified in Cryptosporidium spp. from Australia and China using Sanger and Next Generation Sequencing. Genotypes in bold are
the main subtypes identified by Next Generation Sequencing, based on fraction of assigned reads.






Number and (%) of NGS
sequences assigned
NGS gp60 subtypes
EGK 1 EGK Australia C. hominis IbA10G2 15,609 7,896 (50.6) C. hominis IbA10G2
EGK 2 EGK Australia C. hominis IbA10G2 13,335 6,651(49.9) C. hominis IbA10G2
EGK 3 EGK Australia C. hominis IbA10G2 7,845 4,019 (54.2) C. hominis IbA10G2
EGK 4 EGK Australia C. hominis IbA10G2 1,963 845 43.0 C. hominis IbA10G2
EGK 5 EGK Australia C. hominis IbA10G2 1,840 858 (46.6) C. hominis IbA10G2
EGK 6 EGK Australia C. hominis IbA10G2 1,869 781 (41.8) C. hominis IbA10G2
EGK 8 EGK Australia C. hominis IbA10G2 2,024 900 (44.5) C. hominis IbA10G2
EGK 9 EGK Australia C. hominis IbA10G2 2,473 1,156 (46.7) C. hominis IbA10G2
EGK 10 EGK Australia C. hominis IbA10G2 12,760 6,291 (51.0) C. hominis IbA10G2
EGK 11 EGK Australia C. hominis IbA10G2 12,824 6,536 (51.5) C. hominis IbA10G2
EGK 12 EGK Australia C. hominis IbA10G2 12,927 6,663 (48.4) C. hominis IbA10G2
AUSC 9 Cattle Australia C. parvum IIdA18G3R1 10,524 4,871 (46.2) C. parvum IIdA18G3R1
228 (2.1) C. parvum IIaA16G3R1
AUSC 20 Cattle Australia C. parvum IIdA18G3R1 17,161 8,223 (47.9) C. parvum IIdA18G3R1
399 (2.3) C. parvum IIaA16G3R1
AUSC 21 Cattle Australia C. parvum IIaA16G2R1 24,600 2,670 (10.8) C. parvum IIaA16G2R1
531 (2.1) C. parvum IIaA15G2R1
102 (0.4) C. parvum IIaA14G2R1
AUSC 22 Cattle Australia C. parvum IIaA16G2R1 21,155 2,313 (10.9) C. parvum IIaA16G2R1
512 (2.4) C. parvum IIaA15G2R1
91 (0.4) C. parvum IIaA14G2R1
AUSC 24 Cattle Australia C. parvum IIaA16G2R1 21,838 2,458 (11.2) C. parvum IIaA16G2R1
485 (2.2) C. parvum IIaA15G2R1
95 (0.4) C. parvum IIaA14G2R1
AUSC 25 Rabbit Australia C. cuniculus VbA23 14,597 4,941 (33.8) C. cuniculus VbA23
437 (2.9) C. cuniculus VbA25
61 (0.4) C. cuniculus VbA22
AUSC 26 Rabbit Australia C. cuniculus VbA23 9,177 3,654 (39.8) C. cuniculus VbA23
349 (3.8) C. cuniculus VbA25
50 (0.5) C. cuniculus VbA22
AUSC 27 Rabbit Australia C. cuniculus VbA23 7,340 2,984 (40.6) C. cuniculus VbA23
492 (6.7) C. cuniculus VbA25
58 (0.7) C. cuniculus VbA22
AUSC 28 Rabbit Australia C. cuniculus VbA23 11,031 4,226 (38.3) C. cuniculus VbA23
487 (4.41) C. cuniculus VbA25
79 (0.7) C. cuniculus VbA22
AUSC 29 Rabbit Australia C. cuniculus VbA23 10,548 3,863 (36.6) C. cuniculus VbA23
401 (3.8) C. cuniculus VbA25
71 (0.6) C. cuniculus VbA22
AUSC 30 Rabbit Australia C. cuniculus VbA23 12,066 4,794 (39.7) C. cuniculus VbA23
387 (3.2) C. cuniculus VbA25
80 (0.6) C. cuniculus VbA22
AUSC 31 Rabbit Australia C. cuniculus VbA23 9,006 3,609 (40) C. cuniculus VbA23
312 (3.4) C. cuniculus VbA25
81 (0.8) C. cuniculus VbA22
AUSC 32 Rabbit Australia C. cuniculus VbA23 14,987 5,743 (38.3) C. cuniculus VbA23
581 (3.8) C. cuniculus VbA25
156 (1) C. cuniculus VbA22
ChS 1 Sheep China C. parvum IIdA15G1 15,851 7,577 (47.8) C. parvum IIdA15G1
932 (5.8) C. parvum IIdA14G1
ChG 3 Goat China C. parvum IIdA15G1 23,637 7346 (31) C. parvum IIdA14G1
6,681 (28.2) C. parvum IIdA15G1
ChC 6 Cattle China C. parvum IIdA19G1 22,857 11,169 (48.8) C. parvum IIdA19G1
2,430 (10.7) C. parvum IIdA18G1
359 (1.5) C. parvum IIdA17G1
171 (0.7) C. parvum IIdA20G1
ChC 7 Cattle China C. parvum IIdA19G1 17,491 8,103 (46.3) C. parvum IIdA19G1
1736 (1) C. parvum IIdA18G1
271 (1.5) C. parvum IIdA17G1
130 (0.7) C. parvum IIdA20G1
ChC 8 Cattle China C. parvum IIdA19G1 22,137 10,857 (49) C. parvum IIdA19G1
2,766 (12.4) C. parvum IIdA18G1
582 (2.6) C. parvum IIdA17G1
253 (1.1) C. parvum IIdA20G1
ChC 9 Cattle China C. parvum IIdA19G1 13,843 6,891 (49.7) C. parvum IIdA19G1
1,477 (10.6) C. parvum IIdA18G1
280 (2) C. parvum IIdA17G1
113 (0.8) C. parvum IIdA20G1
ChC 10 Cattle China C. parvum IIdA19G1 9,854 3,859 (39.1) C. parvum IIdA19G1
632 (6.4) C. parvum IIdA18G1
ChC 11 Cattle China C. parvum IIdA19G1 16,988 8,543 (50.2) C. parvum IIdA19G1
2,150 (12.6) C. parvum IIdA18G1










Number and (%) of NGS
sequences assigned
NGS gp60 subtypes
128 (0.7) C. parvum IIdA20G1
ChC 12 Cattle China C. parvum IIdA19G1 15,253 7,856 (51.5) C. parvum IIdA19G1
1,902 (12.4) C. parvum IIdA18G1
118 (0.7) C. parvum IIdA20G1
ChC 13 Cattle China C. parvum IIdA19G1 19,493 8,945 (45.8) C. parvum IIdA19G1
2,289 (11.7) C. parvum IIdA18G1
591 (3) C. parvum IIdA17G1
176 (0.9) C. parvum IIdA20G1
ChC 14 Cattle China C. parvum IIdA19G1 11,222 5,873 (52.3) C. parvum IIdA19G1
1,238 (11) C. parvum IIdA18G1
80 (0.7) C. parvum IIdA20G1
ChC 15 Cattle China C. parvum IIdA19G1 16,251 8,125 (49.9) C. parvum IIdA19G1
1,975 (12.1) C. parvum IIdA18G1
126 (0.7) C. parvum IIdA20G1
ChC 17 Cattle China C. parvum IIdA19G1 21,536 11,598 (53.8) C. parvum IIdA19G1
2,464 (11.4) C. parvum IIdA18G1
204 (0.9) C. parvum IIdA20G1
ChC 18 Cattle China C. parvum IIdA19G1 13,933 6,801 (48.8) C. parvum IIdA19G1
1,404 (10) C. parvum IIdA18G1
ChC 20 Cattle China C. parvum IIdA19G1 17,406 7,152 (41.1) C. parvum IIdA19G1
1,294 (7.4) C. parvum IIdA18G1
ChC 24 Cattle China C. parvum IIdA19G1 15,193 8,117 (51.3) C. parvum IIdA19G1
1,885 (12.4) C. parvum IIdA18G1
347 (2.2) C. parvum IIdA17G1
125 (0.8) C. parvum IIdA20G1
ChC 25 Cattle China C. parvum IIdA19G1 24,275 11,985 (49.3) C. parvum IIdA19G1
2,694 (11.1) C. parvum IIdA18G1
598 (2.4) C. parvum IIdA17G1
213 (0.8) C. parvum IIdA20G1
EGK, Eastern Grey kangaroo (Macropus giganteus).
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Appendix 4The finding of multiple gp60 subtypes (2–4) in individual hosts
in the present study is consistent with the study by Grinberg et al.
(2013) which identified 10 unique subtypes within a single C. par-
vum sample through NGS techniques. However, in that study, the
number of identified subtypes for a single sample using NGS is
much greater than that observed in our study. However, in the
study by Grinberg et al. (2013), two of the four least abundant sub-
types were only observed once (singletons) out of a total of 1,589
sequence types and the remaining two subtypes fell outside the
percentage cut-off used in this present study. Therefore, it is likely
that a more stringent analysis would have resulted in a reduced
number of subtypes being identified.
There are several limitations of the present study including the
possibility that assignment of multiple subtypes may have been
due to NGS sequence artefacts. Error rates for Illumina Miseq
sequencing have been estimated at an average of 0.9 errors per
100 bases (Loman et al., 2012; Salipante et al., 2014), which is con-
siderably less than for other benchtop sequencers, such as the Ion
Torrent (1.5 errors per 100 bases) (Loman et al., 2012; Salipante
et al., 2014). To accommodate for this potential source of error, we
employed a very high stringency for assignment to subtype: 100%
pairwise identity and 100% query cover (or 99% for C. cuniculus).
This resulted in a large number of unassigned reads (Table 1).
However, at the high stringency level used to assign subtypes, no
sequences were equivocally assigned to multiple subtypes, which
lends confidence to the data.
It is possible that PCR polymerase slippage artefacts contributed
to the number of subtypes detected. However, it does not account
for all the diversity. For example, co-occurrence of C. parvum IIa
and IId in two samples cannot be explained by PCR slippage, as this
would have required the occurrence of slippage by multiple trinu-
cleotides in the TCA repeat region repeatedly across samples,
which is unlikely, given the stability of imperfect repeat regions
(Bacon et al., 2000; Klintschar and Wiegand, 2003). In addition, if
PCR polymerase slippage was the main cause of subtype diversity404identified, then it would be expected that subtype diversity would
also have been seen in C. hominis, which was not the case.
It is possible that the lower PCR annealing temperature required
to amplify gp60 sequences for NGS (50 C) compared with Sanger
(54 C) resulted in non-target sequences being amplified and
sequenced alongside Cryptosporidium gp60 sequences, which
would contribute greatly to the number of unassigned sequences
in this analysis.
Another limitation of the present study is that both Sanger and
NGS were conducted using nested and not single round PCR.
Nested PCR approaches have an inherent risk of contamination
and have previously been shown to exhibit strong amplification
biases (Park and Crowley, 2010). By involving two sequential
rounds of amplification, nested PCR may not accurately represent
the extent of genetic diversity initially present in the sample,
because it introduces a bottleneck in the genetic variation between
the first and second round. However, attempts to produce ampli-
cons from single round PCRs were unsuccessful for most of the
samples and therefore a nested PCR approach was necessary. This
is a well-recognised but inherent problem of Cryptosporidium epi-
demiological analysis, as frequently Cryptosporidium-positive fae-
cal samples contain very low numbers of oocysts and high levels
of PCR inhibitors, which necessitates a nested PCR approach
(Paparini et al., 2015). However, while nested PCR bias may reduce
the number of variants detected, in the present study, multiple
subtypes were successfully identified in individual samples.
While multiple gp60 subtypes were identified within C. parvum
and C. cuniculus, only one subtype was identified in DNA samples
positive for C. hominis, which may reflect their local population
structures. Little information is available for C. cuniculus, but avail-
able data for C. parvum and C. hominis indicates a flexible reproduc-
tive strategy with panmictic (where genetic exchange occurs at
random with limited or no sub-structuring), clonal and epidemic
population structures (Mallon et al., 2003; Morrison et al., 2008;
Tanriverdi et al., 2008; Widmer and Sullivan, 2010; Drumo et al.,
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2015). The relative contribution of each type of population struc-
ture appears to vary between regions and hosts, and may reflect
the prevailing ecological transmission dynamics (Mallon et al.,
2003; Tanriverdi et al., 2008; Widmer and Sullivan, 2010; Herges
et al., 2012; Widmer et al., 2015). The finding of only one C. hominis
subtype by both Sanger and NGS in the kangaroo-derived DNA
samples may reflect a clonal population structure operating locally
in kangaroo populations from the main Sydney drinking water
catchment. Analysis of the population structure, however, requires
analysis of multiple loci which was not conducted in the present
study.
Importantly, the identification of only one C. hominis subtype by
both Sanger and NGS in the kangaroo-derived DNA samples sug-
gests a single, recent introduction of C. hominis into kangaroos,
which may spill over to infect other hosts in catchments, providing
a reservoir for human infection. However, further research is
required on a much larger number of samples belonging to differ-
ent subtypes. In addition, inferences regarding the population
structure are complicated by the fact that the rate of mutation of
the gp60 gene remains unknown, multi-locus analysis is required
and Cryptosporidium within-host genetic diversity may occur both
within and between the oocysts (Grinberg et al., 2013; Grinberg
and Widmer, 2016).
The extent of within-host genetic diversity at the gp60 locus, as
demonstrated by the present study, may have implications for
Cryptosporidium vaccine and drug development. For example, vac-
cine research for Cryptosporidium has focused on proteins involved
in attachment to, and invasion of, host cells (Mead 2014; Ludington
and Ward, 2015). Therefore, immunisation with predominant anti-
gens could result in vaccine failures in some regions where hetero-
geneous parasite populations dominate (Grinberg and Widmer,
2016). As with malaria, undetected low-level drug-resistant co-
infecting species and genotypes of Cryptosporidium within the
same host could also impact anti-Cryptosporidium drug discovery
studies and result in unexplained chemotherapy failure (Tyagi
et al., 2013; Grinberg and Widmer, 2016). These findings also have
implications for our understanding of the epidemiology and trans-
mission dynamics of Cryptosporidium, as previous studies have
relied on Sanger sequencing, which may not reflect the extent of
within-host diversity and result in incorrect assumptions regard-
ing transmission of the parasite. More extensive studies employing
NGS approaches on a wider range of samples are important to
determine the extent of Cryptosporidiumwithin-host genetic diver-
sity and should be an essential prerequisite for vaccine, drug and
epidemiological studies.
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As part of long-term monitoring of Cryptosporidium in water catchments serving Western Australia, New
South Wales (Sydney) and Queensland, Australia, we characterised Cryptosporidium in a total of 5774
faecal samples from 17 known host species and 7 unknown bird samples, in 11 water catchment areas
over a period of 30 months (July 2013 to December 2015). All samples were initially screened for
Cryptosporidium spp. at the 18S rRNA locus using a quantitative PCR (qPCR). Positives samples were then
typed by sequence analysis of an 825 bp fragment of the 18S gene and subtyped at the glycoprotein 60
(gp60) locus (832 bp). The overall prevalence of Cryptosporidium across the various hosts sampled was
18.3% (1054/5774; 95% CI, 17.3e19.3). Of these, 873 samples produced clean Sanger sequencing chro-
matograms, and the remaining 181 samples, which initially produced chromatograms suggesting the
presence of multiple different sequences, were re-analysed by Next- Generation Sequencing (NGS) to
resolve the presence of Cryptosporidium and the species composition of potential mixed infections. The
overall prevalence of confirmed mixed infection was 1.7% (98/5774), and in the remaining 83 samples,
NGS only detected one species of Cryptosporidium. Of the 17 Cryptosporidium species and four genotypes
detected (Sanger sequencing combined with NGS), 13 are capable of infecting humans; C. parvum, C.
hominis, C. ubiquitum, C. cuniculus, C. meleagridis, C. canis, C. felis, C. muris, C. suis, C. scrofarum, C. bovis, C.
erinacei and C. fayeri. Oocyst numbers per gram of faeces (g1) were also determined using qPCR, with
medians varying from 6021e61,064 across the three states. The significant findings were the detection of
C. hominis in cattle and kangaroo faeces and the high prevalence of C. parvum in cattle. In addition, two
novel C. fayeri subtypes (IVaA11G3T1 and IVgA10G1T1R1) and one novel C. meleagridis subtype
(IIIeA18G2R1) were identified. This is also the first report of C. erinacei in Australia. Future work to
monitor the prevalence of Cryptosporidium species and subtypes in animals in these catchments is
warranted.
© 2018 Elsevier Ltd. All rights reserved.1. Introduction
Globally, it is estimated that there are between 1.7 and 4.6
billion episodes of diarrhea every year with 2.2 million associated
deaths (Keusch et al., 2016; WHO, 2017). The transmission of manyan).
407gastrointestinal diseases is closely linked to water, yet the true
disease burden attributable to water-associated pathogens is
currently unknown, largely due to lack of adequate detection and
surveillance systems (Ryan et al., 2017). This is particularly the case
in countries such as Australia, that have a relatively low level of
endemic diarrhoeal disease, which means that even specially
designed high-quality epidemiological trials have a limited ability
to detect cases of diarrhoea attributable to drinking water (Sinclair
et al., 2015). Routine disease surveillance systems are even less
A. Zahedi et al. / Water Research 134 (2018) 327e340328
Appendix 5sensitive and detect only a small fraction of the pathogen infections
that occur in the community (O'Toole et al., 2015). For example, a
national survey of gastroenteritis in Australia in 2002, suggested a
ratio of about 500 community cases to one notified case (Hall et al.,
2006).
Cryptosporidium is one of the most prevalent waterborne para-
sitic infections. From the start of the last century to 2016, there were
a total of 905 reported waterborne outbreaks caused by protozoan
parasites and of these Cryptosporidium accounted for almost 60%
(524 outbreaks) (Karanis et al., 2007; Baldursson and Karanis, 2011;
Efstratiou et al., 2017). The largest Cryptosporidium outbreak
occurred in Milwaukee in 1993, which affected 403,000 individuals
via contaminated drinking water (MacKenzie et al., 1995), with an
estimated illness-associated cost of US$ 96.2M and 100 deaths
(Corso et al., 2003). Rates of waterborne parasitic protozoan out-
breaks have been increasing due to increased and improved sur-
veillance. Between 2010 and 2016, 381 outbreaks were reported,
nearly half of which (49% 188 outbreaks), were reported in
Australia and New Zealand (Efstratiou et al., 2017). However, the true
level of waterborne disease in Australia is unknown.
Currently, 34 Cryptosporidium species are recognised (Jezkova
et al., 2016; Zahedi et al., 2017), of which 17 have been reported
in humans worldwide. In Australia, seven Cryptosporidium species
(C. hominis, C. parvum, C. meleagridis, C. cuniculus, C. fayeri, C.
andersoni and C. bovis) have been reported in humans (Koehler
et al., 2014a, b; Zahedi et al., 2016a). However, C. hominis and
C. parvum have been responsible for the majority of human in-
fections throughout the world (Xiao, 2010; Ryan and Power, 2012)
and for all waterborne outbreaks typed to date, with the exception
of a single outbreak in the UK caused by C. cuniculus (Xiao, 2010;
Puleston et al., 2014; Efstratiou et al., 2017).
The 2011 Australian Drinking Water Guidelines 2011 (ADWG)
contains mostly qualitative information on treatment requirements
(https://www.nhmrc.gov.au/guidelines-publications/eh52), but will
soon move to a health-based target of 106 disability adjusted life
years (DALYs) per person per year for Cryptosporidium (O'Toole et al.,
2015). This allows for up to approximately 6% of diarrheal disease
caused by Cryptosporidium to be associated with consumption of
drinking water (O'Toole et al., 2015). To meet this target, data about
the prevalence of human-infectious Cryptosporidium species in
source waters and catchments is important for quantitative micro-
bial risk assessment (QMRA) processes. However, relatively few
large-scale longitudinal studies have been undertaken in Australia
(e.g. Ryan et al., 2005; Ng et al., 2011a; Nolan et al., 2013; Koehler
et al., 2016; Zahedi et al., 2016b) and no studies have compared
catchments in different states in Australia. The aim of the present
study therefore was to use molecular tools to more accurately
determine the prevalence, species and oocyst load of Cryptospo-
ridium in Australian water catchments across three states; New
SouthWales (NSW), Queensland (QLD) and Western Australia (WA).
2. Materials and methods
2.1. Catchment and sample collection in each state
To comply with the ADWG, water utilities employ a risk-based
multiple barrier approach with water source/catchment manage-
ment and protection, being the first barrier, and other barriers at
the treatment, storage, and distribution stages of water supply
systems. Some drinking water catchments have a relatively low
density of development, and little significant anthropogenic activ-
ity; however, this is not always the case. With the exception of
rodents, which are seldom infected with human-infectious Cryp-
tosporidium species (Feng et al., 2007; Foo et al., 2007), the pre-
dominant animals in Australian catchments are marsupials (mainly40kangaroos), rabbits, sheep and cattle (Ryan and Power, 2012).
However, the importance of these host species varies between
states and individual catchments. The most abundant hosts were
selected on a per catchment basis after consultation with water
utility staff from each state. The population size of livestock
examined in individual catchments was known and appropriate
sample sizes were estimated using Epitools (http://epitools.ausvet.
com.au/content.php?page¼home). Unfortunately, the size of
wildlife populations in these catchments is unknown, which pre-
cluded sample size analysis.
Greater Sydney's drinking water catchments cover 16,000 km2
of land and are managed by WaterNSW. About 30% of catchment
land is national park and bushland, but over 60% of the catchments
are privately owned. Two catchments were chosen in NSW
(Catchment A and Catchment B), for which cattle and sheep grazing
is the largest single land use, but horse studs, piggeries, dairies and
poultry production are also present. Eastern grey kangaroos
(Macropus giganteus) and rabbits (Oryctolagus cuniculus) are the
dominant wildlife species inhabiting these catchments. More than
one-quarter of catchment B (2600 km2) has been protected from
most human activities for over 70 years.
Seqwater is one of Australia's largest water businesses with the
most geographically spread and diverse asset base of any capital
city water authority. South-east QLD's catchments cover more than
12,000 km2 of land but only 650 km2 hectares of this land is owned
by Seqwater. Three catchment areas were analysed; Catchment A
covers an area of 67 km2 and supplies a large portion of the Sun-
shine Coast's drinking water. Catchment B is located in the Gold
Coast hinterland in South-east QLD and supplies bulk raw water to
local irrigators and Seqwater. Catchment C is situated between
Brisbane and the Sunshine Coast. Cattle and sheep are the main
livestock present in these catchments.
Water Corporation (WC) in Western Australia, is one of the
world's largest water utilities servicing an area of over 2.5 million
km2. Six catchments were analysed; Catchment A is used for agri-
culture and urban development; catchment B is located in the
South of WA; catchment C supplies approximately 20 percent of
Perth's fresh water; catchment D is located in the southwest ofWA;
catchment E located ~70 km from metropolitan Perth; and catch-
ment F is located approximately 100 km south of Perth.
2.2. Sample collection and processing
In NSW, animal faecal samples were collected by WaterNSW
staff within the WaterNSW area of operations. Samples were
collected at monthly intervals over a 30-month period (July, 2013 to
December, 2015). A total of 1521 faecal samples were collected from
Eastern grey kangaroos (Macropus giganteus) (n¼ 835), beef cattle
(n¼ 243), sheep (n¼ 217), rabbits (n¼ 217), horses (n¼ 5) and pigs
(n¼ 4) (Table 1).
In QLD, animal faecal samples were collected by Seqwater staff
over a 14-month period (September, 2014 to November, 2015). A
total of 653 faecal samples were collected from cattle (n¼ 568, of
which 216 were dairy cattle and 352 were beef cattle), sheep
(n¼ 9), horses (n¼ 38), birds (n¼ 9), pigs (n¼ 4), rabbits (n¼ 5),
flying foxes (Pteropus sp.) (n¼ 9), feral red deer (Cervus elaphus)
(n¼ 6), wild dogs (n¼ 3), a single goat, and a single wallaby (spe-
cies unknown) (Table 1).
In WA, a total of 3600 faecal samples were collected from beef
cattle (n¼ 300), sheep (n¼ 150), Western grey kangaroos (Macro-
pus fuliginosus) (n¼ 2393), rabbits (n¼ 450), birds (n¼ 7) and pigs
(n¼ 300) (Table 1).
The animal sources of the faecal samples were determined by
visually sighting the animals defecating and with the aid of a scat
and tracking manual published for Australian animals (Triggs,8
Table 1
Prevalence of Cryptosporidium in different hosts and catchments across three states of Australia; NSW, QLD and WA, as determined by Sanger sequencing.
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NC ¼ Not Collected.
a Goat sample.
b Samples collected opportunistically from wildlife (7/9 flying fox, 0/1 wallaby, 2/6 feral deer, 2/3 wild dog).
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Appendix 52004). All faecal samples were collected off the ground into indi-
vidual 75ml faecal collection pots and stored at 4 C until required,
with samples collected in NSW and QLD transported at 4 C to
Murdoch University for analysis.2.3. DNA isolation and qPCR
Genomic DNA (gDNA) was extracted from 250mg of each faecal
sample using a Power Soil DNA Kit (MO BIO, Carlsbad, California,
USA). An extraction reagent blank (no faecal sample) was used in
each extraction group. Purified gDNA was stored at 20 C prior to
molecular analyses. All samples were screened for the presence of
Cryptosporidium at the 18S rRNA locus using a quantitative PCR
(qPCR) as previously described (King et al., 2005; Yang et al., 2014)
using a Ct threshold of <35 cycles. At the 18S locus, C. macropodum,
a marsupial adapted species of Cryptosporidium, was used as a
positive control for PCR amplifications of non-marsupial-derived
samples. For samples collected from marsupials (kangaroos),
C. parvum was used as a positive control.
Quantitation was conducted using standards consisting of re-
combinant plasmids containing partial fragments of the Crypto-
sporidium 18S rRNA, calibrated by droplet digital PCR (ddPCR) as
described by Yang et al. (2014). Target copy numbers detected were
converted to numbers of oocysts based on the fact that the 18S gene
in Cryptosporidium has five copies (Le Blancq et al., 1997), and there409are four haploid sporozoites per oocyst. Therefore, every 20 copies
of 18S detected by qPCR were equivalent to one oocyst.2.4. PCR amplification at the 18S and gp60 loci by nested PCR
Samples that were positive by qPCR were amplified at the 18S
locus using nested primers which produced an approximately 825
bp product as previously described (Xiao et al., 1999). PCR
contamination controls were used, including negative controls to
detect contamination and separate laboratory areas were used for
DNA and PCR mastermix preparation and post-PCR handling.
Samples that were typed as C. hominis, C. parvum, C. cuniculus, C.
meleagridis, C. ubiquitum and C. fayeri by Sanger sequencing at the
18S locus were subtyped at the 60 kDa glycoprotein (gp60) locus
using nested PCR's as previously described (Strong et al., 2000;
Glaberman et al., 2001; Peng et al., 2003; Zhou et al., 2003;
Power et al., 2009; Li et al., 2014). At the gp60 locus, for samples
which were initially identified as C. hominis and C. parvum at the
18S locus, C. cuniculus was used as a positive control. For samples
which were previously identified as C. cuniculus at the 18S locus,
C. parvum was used as a positive control.2.5. Sanger sequence analysis
The amplified DNA from secondary PCRs were separated by gel
A. Zahedi et al. / Water Research 134 (2018) 327e340330
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tip method (Yang et al., 2013). Purified PCR products from both loci
were sequenced independently on an ABI Prism™ Dye Terminator
Cycle Sequencing kit (Applied Biosystems, Foster City, California)
according to the manufacturer's instructions, at 57 C annealing
temperature for the 18S rRNA and a range of different annealing
temperatures for different species at gp60 (56 C for C. fayeri, 58 C
for C. meleagridis and 54 C for the remaining species). Sanger se-
quences were assigned taxonomy by aligning chromatograms to
curated reference sequences from GenBank using 99% sequence
identity. Alignments were produced with Clustal W (http://www.
clustalw.genome.jp), utilised as a plugin within Geneious Pro 8.1.6
(Kearse et al., 2012) and phylogenetic analysis was conducted using
MEGA6 (after selection of the best nucleotide substitution models)
(Tamura et al., 2013) (data not shown).2.6. Next generation sequencing (NGS)
Samples that produced mixed chromatograms by Sanger
sequencing (n¼ 251) were analysed by NGS on the MiSeq (Illu-
mina) platform at the 18S locus using the 18S iF/iR primers (Morgan
et al., 1997) as previously described (Paparini et al., 2015). These
primers were selected over the longer Xiao et al. (1999) primers
used for Sanger sequencing, due to length limitation imposed by
the 250 bp paired-end sequencing technology utilised. Briefly, PCR
primers were modified to contain MiSeq adapter sequences on the
5’ end, as per standard protocols for the MiSeq platform (Illumina
Demonstrated Protocol: Metagenomic Sequencing Library Prepa-
ration). All PCR amplicons were double purified using the Agen-
court AMPure XP Bead PCR purification protocol (Beckman Coulter
Genomics, USA) and pooled in approximate equimolar ratios. To
minimize laboratory and cross-contamination all DNA handling
and PCR-setup procedures were performed within dedicated and
physically separated PCR containment hoods that are UV-sterilized
between each use. Post-PCR procedures were all performed in a
physically separate dedicated laboratory.
Sequencing was performed on an Illumina MiSeq using 500-
cycle V2 chemistry (250 paired-end reads) following the manu-
facturer's recommendations. Two no-template controls and two
DNA extraction reagent blank controls were included in the library
preparation, and distributed between samples in the PCR plate
layout. All no-template and DNA extraction reagent blank controls
produced no detectable amplification of Cryptosporidium DNA after
initial amplicon-generation PCRs or indexing PCRs. This indicated
that level of cross contamination between samples, or from the
laboratory environment, was below the detection limit of the li-
brary preparation procedure and for this reason were not
sequenced.2.7. Statistical analysis
The prevalence of Cryptosporidium in each host species was
expressed as the percentage of samples positive by qPCR, which
were also confirmed by Sanger and/or NGS analysis of the 18S rRNA
locus, with 95% confidence intervals calculated assuming a bino-
mial distribution, using the software Quantitative Parasitology 3.0
(Rozsa et al., 2000). DNA extraction efficiency was estimated for
each extraction, based on the number of the gene copies/oocysts
equivalents measured by ddPCR. Chi-square and non-parametric
analyses were performed using IBM SPSS 21.0 (statistical package
for the social sciences) for Windows (SPSS inc. Chicago, USA) to
determine if there were any associations between the prevalence
and concentration of Cryptosporidium oocysts at different sampling
times and across states.412.8. Bioinformatics analysis
Paired-end reads (73.42% of basecalls>Q30) were merged and
quality filtered with USEARCH v10 (Edgar, 2010), retaining reads
with >50 bp merged overlap, < 0.1% expected error, no mismatches
in the primer sequences, a minimum length of 200 bp, and a
minimum of 100 identical replicate copies. Primer sequences and
any distal bases were also removed from all reads. Reads were then
denoised and chimera filtered with the UNOISE3 algorithm (Edgar,
2016), to generate 107 zero-radius operational taxonomic units
(ZOTUS), that represent unique biologically correct sequences
(Edgar, 2016). Remaining high quality Cryptosporidium spp. 18S
ZOTU sequences were assigned to taxonomic groups by comparing
ZOTUs to a curated custom in-house database using BLAST 2.6.0
(Altschul et al., 1990). The reference database contained 63 reliable
18S reference sequences from 63 Cryptosporidium species and ge-
notypes extracted from GenBank (Benson et al., 2005). Taxonomy
was only assigned if there was a single unambiguous best BLAST hit
with >99% pairwise identity over >98% of the query sequence
length. This high stringency threshold was based on the minimum
pairwise percentage dissimilarity between any two Cryptospo-
ridium species/genotypes in the database to unsure unambiguous
taxonomic classifications. Of the 107 ZOTUs generated, 41 ZOTUs
were not Cryptosporidium 18S sequences when compared to Gen-
Bank using BLAST. Where possible genus-level taxonomy was
assigned when queries hit reference sequences with >99% identity
over >98% of the reads, and assigned to no other taxa at the same
level. Although non-Cryptosporidium ZOTUs were abundant (38.3%
of total ZOTUs), they represented a very small proportion of the
total reads, with only a median of 580 sequences each.
3. Results
3.1. Overall prevalence of Cryptosporidium as determined by Sanger
sequencing and NGS
The overall PCR prevalence of Cryptosporidium species in the
5774 faecal samples collected systematically from seven main host
species and opportunistically from 10 host species, in addition to
seven unknown bird samples, was 18.3% (1054/5774; 95% CI,
17.3e19.3), based on PCR positive samples that were confirmed by
Sanger or NGS sequencing.
The overall prevalence in each state based on qPCR positive
samples that have been confirmed by Sanger sequencing or NGS
was 25.9% (169/653; 95% CI, 22.6e29.4) in QLD, 17.5% (632/3600;
95% CI, 16.3e18.8) inWA and 16.6% (253/1521; 95% CI, 14.8e18.6) in
NSW. For ease of analysis and reporting, the prevalence and species
detected by Sanger and NGS are discussed separately.
3.2. Prevalence of Cryptosporidium as determined by Sanger
sequencing in various hosts and catchments
Of the 873 samples which produced clean Sanger chromato-
grams, the highest prevalence was detected in birds (68.7%), fol-
lowed by 21.5% in cattle, 16.2% in pigs, 14.3% in rabbit samples,13.5%
in kangaroos and 8% in sheep. No Cryptosporidium was detected in
the 43 horse faecal samples screened (Table 1). A high prevalence
was also detected in the small numbers of wildlife sampled
(Table 1). The overall prevalence of Cryptosporidium in each state
was 22.8%; 95% CI, 19.7e26.2 (149/653) in QLD, 14.9%; 95% CI,
13.7e16.1 (535/3600) in WA, and 12.4%; 95% CI, 10.8e14.2 (189/
1521) in NSW.
The prevalence of Cryptosporidium in cattle was not significantly
different across the three states; 18.5% in NSW, 21.7% in WA and
22.7% in QLD (29.6% in dairy cattle and 18.5% in beef cattle. The0
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Appendix 5prevalence of Cryptosporidium was highest in sheep from WA
(11.3%), compared to 11.1% in QLD and 5.5% in NSW. Kangaroos were
only sampled in NSW (8.6%) and WA (15.2%). Cryptosporidium was
not detected in the small numbers of rabbits sampled in QLD
(n¼ 5), but was more prevalent in rabbits in NSW (27.6%) than WA
(8%). Cryptosporidiumwas detected in two (out of 4) pigs in QLD and
in 16% of pigs in WA (Table 1).
3.3. Oocyst load
Oocyst numbers per gram of faeces (g1) were also determined
using qPCR (Table 2; mean, median and range for samples identi-
fied as Cryptosporidium species by Sanger sequencing and NGS).
The highest median concentration of Cryptosporidium oocysts was
identified in cattle; (31,072 oocysts/g1), followed by rabbits
(27,919 oocysts/g1), while the lowest median concentration of
oocysts was observed among samples collected opportunistically
from wildlife in QLD (9063 oocysts/g1). Overall, there was no
significant difference between the median Cryptosporidium oocysts
per gram of faeces in samples collected from sheep, kangaroos, pigs
and birds, which ranged from 10,032 to 26,756 oocysts/g1
(Table 2).
3.4. Cryptosporidium species detected in various hosts at the 18S
locus by Sanger sequencing
Clean 18S Sanger sequences were obtained from 873 positives.
Of these, a total of 14 species and two genotypes were detected;
C. macropodum (n¼ 260), C. fayeri (n¼ 150), C. parvum (n¼ 106),Table 2
Numbers of Cryptosporidium oocysts in positive samples per gram of faeces (g1) (me
catchment across three states of Australia; NSW, QLD and WA.
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e41,088)
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NA ¼ Not Available.
NC ¼ Not Collected.
ND ¼ Not Detected.
411C. cuniculus (n¼ 96), C. bovis (n¼ 60), C. hominis (n¼ 42), C. ryanae
(n¼ 41), C. ubiquitum (n¼ 36), C. scrofarum (n¼ 35), C. suis (n¼ 15),
C. muris (n¼ 15), C. galli (n¼ 8), C. meleagridis (n¼ 3), C. canis
(n¼ 2), Cryptosporidium rat genotype I (n¼ 3) and C. molnari-like
genotype (n¼ 1) (Table 3).
In cattle, of the 239 positives, a total of seven species and one
genotype were detected; C. parvum (n¼ 106), C. bovis (n¼ 60),
C. ryanae (n¼ 41), C. hominis (n¼ 16), C. muris (n¼ 8), C. ubiquitum
(n¼ 4), C. galli (n¼ 1) and rat genotype I (n¼ 3), with C. ubiquitum,
C. galli and rat genotype I only detected in beef cattle. All the sheep
were infected with C. ubiquitum (30/30) and all the rabbits were
infected with C. cuniculus (96/96). In kangaroos, C. hominis (26/
436), C. macropodum (260/436) and C. fayeri (150/436) were
detected. In pigs, C. suis (15/50) and C. scrofarum (35/50) were
detected. Three species were detected in the 11 positives from
birds, a C. molnari-like genotype in a single shag, C. galli (n¼ 7) and
C. meleagridis (n¼ 3). In wildlife, of the 11 positives typed,
C. ubiquitum was identified in feral deer (n¼ 2), C. muris in flying
foxes (n¼ 7) and C. canis from wild dogs (n¼ 2) (Table 3).
3.5. Cryptosporidium gp60 subtypes detected in various hosts by
Sanger sequencing
Of the 89 C. parvum cattle isolates subtyped at the gp60 locus, a
total of seven subtypes were identified; IIaA15G2R1 (n¼ 5),
IIaA16G2R1 (n¼ 5), IIaA17G2R1 (n¼ 27), IIaA18G3R1 (n¼ 40),
IIaA19G2R1 (n¼ 1), IIaA19G3R1 (n¼ 11), and a variant of the
IIaA13G1 subtype in five cattle, which exhibited one single nucle-
otide polymorphism from the only other previous record of thisan, median with range in parenthesis (determined by qPCR) per host species per
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Cryptosporidium species detected by Sanger sequencing in different hosts and catchments across three states of Australia; NSW, QLD and WA.
Host C. parvum
No þ/total no (%
proportionþ 95 CI)
C. hominis
No þ/total no (%
proportion þ 95 CI)
C. bovis
No þ/total no (%
proportion þ 95 CI)
C. ubiquitum
No þ/total no (%
proportion þ 95 CI)
C. ryanae
No þ/total no (%
proportion þ 95 CI)
C. suis
No þ/total no (%
proportion þ 95 CI)
C. scrofarum
No þ/total no (%
proportion þ 95 CI)
C. cuniculus
No þ/total no (%
proportion þ 95 CI)
C. macropodum
No þ/total no (%
proportion þ 95 CI)
Other
No þ/total no (%












ND ND ND ND 8/129a (6.2 %- 2.7
e11.9)
Sheep ND ND ND 1/1 (100%- 2.5
e100)
ND ND ND ND ND ND
Horses ND ND ND ND ND ND ND ND ND ND
Birds ND ND ND ND ND ND ND ND ND 6/6b (100%- 54.1
e100)
Pigs ND ND ND ND ND ND 2/2 (100%- 15.8
e100)
ND ND ND
Wildlife ND ND ND 2/11c(18.2%- 2.3
e51.8)
ND ND ND ND ND 9/11d (81.8%- 48.2
e97.7)






7/141 (5%- 2e10) 29/129 (22.5%- 15.6
e30.7)
ND 2/2 (100%- 15.8
e100)
ND ND 23/146 (15.7%- 10.3
e22.7)
NSW






N/D 1/45 (2.2%- 0.1
e11.8)
ND ND ND ND 1/45e (2.2%- 0.1
e11.8)
Sheep N/D ND ND 12/12 (100%- 73.5
e100)
ND ND ND ND ND ND
Kangaroos N/D 26/72 (36.1%- 25.1
e48.3)




Rabbits N/D ND ND ND ND ND ND 60/60 (100%- 94
e100)
ND ND























ND 11/65 (24.6%- 14.8
e36.9)
ND ND ND ND 3/65g (4.6%- 1
e12.9)
Sheep ND ND ND 17/17 (100%- 80.5
e100)
ND ND ND ND ND ND




Rabbits ND ND ND ND ND ND ND 36/36 (100%- 90.3
e100)
ND ND





Birds ND ND ND ND ND ND ND ND ND 5/5h (100%-47.8-
100)




















ND ¼ Not Detected.
a Cryptosporidium muris (n¼ 8).
b Cryptosporidium molnari (n¼ 1, Shag), Cryptosporidium galli (n¼ 5; 2 from an ibis, 1 from a goose, 1 from a boiler chicken, 1 from a swallow).
c Cryptosporidium ubiquitum from feral deer (n¼ 2).
d Cryptosporidium muris from flying fox (n¼ 7), Cryptosporidium canis from wild dog (n¼ 2).
e Cryptosporidium galli.
f Cryptosporidium fayeri.
g Cryptosporidium rat genotype I (n¼ 3).
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Appendix 5subtype (JX471005). Two C. hominis subtypes were identified;
IbA10G2 (of which 11 were identified in cattle and 23 in kangaroos)
and IdA15G1 (two in kangaroos and three in cattle). All the
C. ubiquitum typed (n¼ 28) belonged to subtype family XIIa and all
the C. meleagridis (n¼ 3) were identified as a novel subtype;
IIIeA18G2R1. Six C. cuniculus subtypes were identified; VbA18
(n¼ 12), VbA23 (n¼ 46), VbA25 (n¼ 16), VbA26 (n¼ 8), VbA28
(n¼ 2) and VbA29 (n¼ 5). Three C. fayeri subtypes were identified;
IVfA12G1T1 (n¼ 23) and two novel subtypes; IVaA11G3T1 (n¼ 16)
and IVgA10G1T1R1 (n¼ 81) (Table 6). The novel subtypes
(IIaA13G1, IIIeA18G2R1, IVaA11G3T1 and IVgA10G1T1R1) identified
in the present study have been submitted to GenBank under
accession numbers MG516789, MG516778, MG516791 and
MG516790. All other nucleotide sequences reported in this paper
are available in the GenBank database under accession numbers
MG516739 toMG516774 (18S) andMG516775 toMG516798 (gp60).3.6. Prevalence and species of Cryptosporidium identified by NGS
A total of 251 samples produced mixed Sanger chromatograms
and were re-analysed by NGS. However, of these, only 181 were
assigned to Cryptosporidium species and the remaining 70 samples
were discarded due to unassigned reads or failure to pass quality
filtering. Of these 181 samples, which produced mixed chromato-
grams by Sanger, 83 samples did not exhibit mixed infections via
NGS, i.e. only one species/genotype was detected (SupplementaryTable 4
Prevalence of mixed infection with different species of Cryptosporidium identified by NG
three states of Australia; NSW, QLD and WA.
Catchment Cattle






























NC NC 0/5 (0%- 0e52
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413Table 1). This suggests that some of the mixed chromatograms
identified by Sanger, were due to co-amplification of Cryptospo-
ridium with non-specific contaminants. Therefore, for the scope of
the present study, the prevalence of mixed infections is reported
based on only those samples which were assigned to multiple
Cryptosporidium species by NGS (n¼ 98).
Therefore, the overall prevalence of mixed infections was 1.7%
(98/5774; 95% CI, 1.4e2.1) (Table 4 and supplementary Table 1).
These mixed infections were detected in faecal samples collected
from cattle, kangaroos, rabbits, wild pigs and two feral deer. Apart
from 10% overall prevalence among samples collected opportu-
nistically from wildlife, the highest prevalence of mixed infections
was detected in kangaroos (2.8%), followed by 1.7% in cattle, 0.9% in
rabbits and 0.3% in pigs (Table 4). Overall, a total of 15 species and
four genotypes of Cryptosporidium were detected by NGS; C. bovis,
C. cuniculus, C. fayeri, C. felis, C. galli, C. hominis, C. macropodum,
C. meleagridis, C. muris, C. parvum, C. rayane, C. scrofarum, C. suis,
C. erinacei, C. ubiquitum, kangaroo genotype I, rat genotype I, rat
genotype II and rat genotype III (Table 5). The number of species
identified in individual hosts ranged from 1 to 6 species. However,
C. parvum, C. hominis, C. cuniculus, C. muris, C. fayeri, C. macropodum,
C. suis, C. galli, kangaroo genotype I and rat genotype III were the
most abundant species identified in samples with mixed infections
and therefore, were considered for prevalence and statistical
analysis in this study. A total of 39 cattle samples, of which 32 were
















No þ/total no (%
prevalence þ 95
CI)
0/15 (0%- 0e21.8) 0/2 (0%- 0e84.2) 0/3 (0%- 0e70.8) 0/1 (0%- 0e97.5)
0/16 (0%- 0e26) 0/4 (0%- 0e60.2) N/C NC
.2) 0/7 (0%- 0e41) 0/3 (0%- 0e70.8) 0/1 (0%- 0e97.5) 2a/19 (10.5%- 1.3
e33.1)
.2) 0/38 (0%- 0-9.3) 0/9 (0%- 0-33.6) 0/4 (0%- 0-60.2) 2/20 (10%- 1.2-
31.7)
1.7) NC NC NC NC
0/5 (0%- 0e52.2) NC 0/4 (0%- 0e60.2) NC
1.7) 0/5 (0%- 0-52.2) NC 0/4 (0%- 0-60.2) NC
NC 0/7 (0%- 0e41) NC NC
NC NC NC NC
NC NC NC NC
NC NC NC NC
.2 NC NC NC NC
NC NC 1/300 (0.3%- 0
e1.8)
NC
.5- NC 0/7 (0%- 0e41) 1/300 (0.3%- 0 -
1.8)
NC





Most abundant Cryptosporidium species detected by NGS in different hosts and catchments across three states of Australia; NSW, QLD and WA.
Host C. parvum
No þ/total no (%
proportionþ 95 CI)
C. hominis
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Cattle 8/18 (44.4%- 21.5
e69.2)
ND ND ND ND ND ND ND ND 10/18a (55.6%- 30.8
e78.5)
Sheep ND ND ND ND ND ND ND ND ND ND
Horses ND ND ND ND ND ND ND ND ND ND
Birds ND ND ND ND ND ND ND ND ND ND
Pigs ND ND ND ND ND ND ND ND ND ND
Wildlife ND ND ND ND ND ND ND ND ND 2/2b (100%- 15.8
e100)
Total 8/18 (44.4%- 21.5-
69.2)
ND ND ND ND ND ND ND ND 12/20 (60%- 36.1-
80.9)
NSW
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Cattle 2/2 (100%- 15.8
e100)
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ND ¼ Not Detected.
a Cryptosporidium muris (n¼ 4), Cryptosporidium galli (n¼ 5), rat genotype III (n¼ 1).
b Cryptosporidium muris (n¼ 2, feral deer).
c Cryptosporidium muris (n¼ 10).
d Cryptosporidium galli.
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Appendix 5seven from dairy cattle fromQLD), producedmixed chromatograms
by Sanger sequencing. NGS analysis identified mixed infections and
the four most abundant species and one most abundant Crypto-
sporidium genotype in individual samples were; C. parvum (n¼ 16),
C. hominis (n¼ 3), C. muris (n¼ 14), C. galli (n¼ 5) and rat genotype
III (n¼ 1). In kangaroos, C. parvum (n¼ 52), C. hominis (n¼ 48),
C. macropodum (n¼ 17), C. fayeri (n¼ 5), C. galli (n¼ 3) and kan-
garoo genotype I (n¼ 1) were identified. Re-analysis of all seven
faecal samples from wild pigs, all seven rabbit samples and two
faecal samples collected from feral deer by NGS, identified C. suis,
C. cuniculus and C. muris as the most abundant species, respectively
(Table 5).
4. Discussion
Relatively few large-scale studies of Cryptosporidium species in
animals inhabiting drinking water catchments have been con-
ducted. The present study is the largest single published study
conducted to date globally and analysed Cryptosporidium species
and subtypes in 5774 animal faecal samples from catchments
across three states of Australia; NSW, QLD and WA. As such, it
provides a unique perspective on the epidemiology of Cryptospo-
ridium in animals inhabiting water catchments across Australia. In
the present study, the overall prevalence of Cryptosporidium was
18.3% (1054/5774; 95% CI, 17.3e19.3), with a prevalence of 25.9%
(169/653, 95% CI; 22.6e29.4) in QLD, 17.6% (632/3,600, 95% CI;
16.3e18.8) in WA and 16.6% (253/1,521, 95% CI; 14.8e18.6) in NSW.
Previous studies in Australia have reported Cryptosporidium in an-
imal faecal samples from catchments across Australia at varying
prevalence; 5e25.8% in NSW (Power et al., 2004, 2005; Cox et al.,
2005; Ryan et al., 2005; Ng et al., 2011b; Zahedi et al., 2016b),
1.6e2.8% in Victoria (Cinque et al., 2008; Nolan et al., 2013; Koehler
et al., 2014a, 2016) and 6.7e16% in WA (McCarthy et al., 2008;
Ferguson, 2010). All of these, with the exception of one study
(Cox et al., 2005), have conducted genetic characterisation. The
largest study was conducted in Melbourne drinking water catch-
ments and screened 4256wildlife faecal samples between 2011 and
2015 (Koehler et al., 2016) and overall between 2009 and 2015,
analysed 6265 samples (Nolan et al., 2013; Koehler et al., 2016) and
reported a prevalence of 2.8% (56/2009) and 1.6% (69/4256),
respectively (Nolan et al., 2013; Koehler et al., 2016). The reason for
the much lower prevalence of Cryptosporidium in Melbourne
catchments is unclear, but it has been suggested that the low
prevalence could be due to animal culls (resulting in lower density
of animals), changing water levels of the reservoirs and the end of a
nine-year drought (Koehler et al., 2016).
Several studies have examined the transport of oocysts from the
site of deposition in catchments into surface waters used for pro-
ducing drinking water (Davies et al., 2004; Atwill et al., 2006b;
Ferguson et al., 2007; Curriero et al., 2011; Khaldi et al., 2011).
However, in Australia, little published information is available on
the prevalence of Cryptosporidium in source water. Analysis of
Cryptosporidium monitoring data across Australia in source water
over a period of 11e18 years by Water Research Australia
(WaterRA), revealed that detection of total (i.e. presumptive)
Cryptosporidium ranged from ~20% of samples from South Australia
and WA, to ~15% in Melbourne and Canberra, and 2e7% in NSW
(Deere et al., 2014), suggesting that significant numbers of oocysts
in faecal samples deposited in catchments are transported into
source waters due to rainfall run-off. Another study in South
Australia, reported a significant increase in oocyst concentrations
after a rainfall event (Swaffer et al., 2014). Transport of oocysts into
drinking water will be affected by climate change, as it is expected
to result in less winter rainfall but more extreme precipitation
events during summer (Sterk et al., 2016). Initial modelling of the
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Appendix 5impact of climate change on runoff of Cryptosporidium from land to
surfacewater suggests a complex relationship that will require site-
specific analysis (Sterk et al., 2016), and highlights the importance
of continued monitoring of Cryptosporidium in catchments.
In the present study, the prevalence of mixed infection assigned
to Cryptosporidium spp. in faecal samples collected from animals
inhabiting 11 catchments across three states in Australia was 1.7%
(98/5774; 95% CI, 1.4e2.1). This is the first study to apply NGS in a
large-scale study to determine the prevalence of Cryptosporidium
species in animal faecal samples with mixed Cryptosporidium in-
fections, with up to 6 species identified in a single host. Interest-
ingly C. parvum was not detected by Sanger sequencing in
kangaroos, yet C. parvum and C. hominis were among the most
abundant species detected in co-infections in cattle and kangaroos
by NGS (Table 5 and Supplementary Table 1). This has important
implications for catchment management, as animals may be
shedding human-infectious species intermittently or in lesser
abundance than a dominant species, but if analysed by Sanger
sequencing, these species may not be detected. In the present
study, NGS was used only on samples that produced mixed chro-
matograms via Sanger sequencing due to cost constraints. Future
studies should apply NGS to type all Cryptosporidium positives from
catchments.
Because NGS technologies are highly sensitive, allowing for the
detection of low abundance sequences in complex DNA mixtures,
the presence of cross-contamination between samples, or
contamination from the laboratory environment has an increased
potential to influence the taxonomic composition of samples. In
addition, sequences that occur in very low abundances are likely to
be caused by sequencing error, as errors are introduced randomly
and are not reproduced, and are likely to be unique. Therefore,
there is an intrinsic distrust of sequences or taxa that are present in
low abundances in samples, such as some of the mixed Crypto-
sporidium infections detected in the present study.
However, no amplified Cryptosporidium DNA was detected in
no-template or extraction reagent blank PCR controls after both
initial amplicon-generation PCR or the indexing PCR, indicating
that any cross contamination, or contamination from the labora-
tory, was below the detectable limit for the library preparation
process. In addition, sequences with less than 100 identical repli-
cate copies were excluded from the dataset in an attempt to miti-
gate sequencing error. Many taxa in the present study, such as
C. erinacei, C. ubiquitum, C. scrofarum, C. ryanae, C.meleagridis, and C.
bovis are only present in low abundances, and therefore their
presence cannot be attributed to cross contamination from highly
infected samples.
Analysis of the oocyst load per gram of faeces (g1) revealed that
the highest median concentration of Cryptosporidium oocysts was
shed by cattle; 31,072 oocyst/g1, followed by rabbits (27,919
oocyst/g1), sheep (26,756 oocyst/g1), pigs (21,164 oocyst/g1),
kangaroos (16,018 oocyst/g1) and birds (10,032 oocyst/g1). These
values are much higher than a previous study, which examined a
range of animal faeces in Sydney catchments and reported that the
range of oocyst shedding concentration for cattle was
<1e17,467 g1, with medians of 0.5e23 oocysts g1 for adult and
juvenile cattle respectively, for sheep, a range of 1e152,474 g1
with medians of 148 and 275 g1 for adults and juveniles respec-
tively, <1-770 g1 for pigs with a median of 0.5 g-1 and
1e39,423 g1 for kangaroos with a median of 0.5 g-1 (Davies et al.,
2003). Studies in the US reported that feedlot cattle shed 7.7 104
to 2.3 105 and 1.3 to 3.6 oocysts g1 respectively (Hoar et al.,
2000; Atwill et al., 2006a). This translates to 1.7 105 and
1.4e2.8 104 oocysts/animal per day (Hoar et al., 2000; Atwill
et al., 2006a). A limitation of these studies, is that oocyst shed-
ding is intermittent (Xiao and Herd, 1994) and recovery rates from41faecal samples and across animal types can be highly variable. For
example, recovery rates ranging from 14 to 70% for adult cattle
faeces, 0e83% for calf faeces, 4e48% for sheep faeces, 40e73% for
kangaroo faeces, and 3e24% for pig faeces have been reported
(Davies et al., 2003). A more recent study based on qPCR, reported a
range of 63e7.9 106 and a median of 3.2 104 g1 for oocysts in
sheep faeces across three states (WA, NSW and South Australia)
(Yang et al., 2014). Other studies have reported that neonatal calves
can excrete up to 30 billion oocysts or more over a 1e2 week period
(Kuczynska and Shelton, 1999) and that even apparently healthy
animals can shed high numbers of oocysts (>5 106 oocysts g1)
(Chalmers and Giles, 2010). This coupled with the very low infec-
tious dose (10e100 oocysts) of Cryptosporidium (DuPont et al.,
1995), has resulted in very significant numbers of oocysts
entering drinking water supplies resulting in outbreaks e.g. the
waterborne outbreak of cryptosporidiosis in humans in England in
2008 caused by C. cuniculus (Puleston et al., 2014).
In the present study, oocyst numbers (g1) were determined
directly by qPCR using droplet digital PCR (ddPCR) calibrated
standards, which obviates the need for recovery rate calculations
and has the advantage of providing more accurate quantitation
(Yang et al., 2014). Unfortunately, as the population size of animal
hosts are unknown in all the catchments, it is not possible to
calculate catchment loading of oocysts. This is clearly a knowledge
gap that needs to be addressed.
In the present study, a total of 17 Cryptosporidium species and
four genotypes were detected (Sanger sequencing combined with
NGS). Of these, 13 are infectious to humans; C. parvum, C. hominis
and C. meleagridis are the most common species in humans in
Australia (Ryan and Power, 2012), C. ubiquitum and C. cuniculus are
considered emerging human pathogens (Puleston et al., 2014;
Koehler et al., 2014a; Li et al., 2015), there have been numerous
reports of C. canis, C. felis, C. muris, C. suis, C. erinacei and
C. scrofarum in humans (cf. Ryan et al., 2017), two reports of C. bovis
(Khan et al., 2010; Ng et al., 2012) and one report of C. fayeri in
humans (Waldron et al., 2010). This is the first report of C. erinacei
in Australia. It was detected in cattle and kangaroo faecal samples
by NGS only, where it accounted for 2e32% of reads
(Supplementary Table 1). As with the prevalence of oocysts in
source water, very little is known about the species of Cryptospo-
ridium in source water in Australia, but a study in South Australia
identified C. parvum, C. muris, C. ubiquitum, C. ryanae, C. bovis, C.
cuniculus (subtypes Va and Vb), C. fayeri, C. canis, rat genotype and
mouse genotype II (Swaffer et al., 2014; King et al., 2015). Little is
known however about the prevalence of Cryptosporidium species in
source water in other states and future studies in this area are
needed.
In cattle, the prevalence of Cryptosporidium was high (22.3%e
26.3%) across three states and C. parvumwas the dominant species
ranging from 39.1% to 50.7% of samples positive for Cryptosporidium
in cattle in each state, followed by C. bovis (17.6%e28.1%), C. muris
(8.1%e15.6%) C. hominis (4.7e14.1%), C. ubiquitum (2.7%) and
C. ryanae (1.6%e19.7%). Cryptosporidium andersoni was not detec-
ted. Most of the cattle sampled were adult cattle and therefore the
high prevalence of C. parvum is surprising, as other studies have
suggested that C. parvum dominates in pre-weaned calves but that
C. bovis, C. ryanae and C. andersoni dominate in older cattle (Santín
et al., 2008). This highlights the importance of site-specific analysis
for accurate QMRA analysis. The C. parvum gp60 subtypes identified
(IIaA15G2R1, IIaA16G2R1, IIaA17G2R1, IIaA18G3R1, IIaA19G2R1,
IIaA19G3R1 and IIaA13G1) are commonly identified subtypes in
humans and animals worldwide (Xiao, 2010; Feng et al., 2013), with
the exception of subtype IIaA13G1, which has previously only been
detected in a single human patient from WA (Ng-Hublin et al.,
2013).6
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Appendix 5Cryptosporidium hominis was detected in cattle faecal samples
across all three states at a prevalence ranging from 4.5 to 14.1%.
Although C. hominis predominately infects humans, it has been
previously reported in cattle in Australia (Zahedi et al., 2016b),
China (Chen and Huang, 2012; Zhang et al., 2018), Kenya (Kang'ethe
et al., 2012), Korea (Park et al., 2006), Malawi (Banda et al., 2009),
New Zealand (Abeywardena et al., 2012), and Scotland (Smith et al.,
2005). However, there is no molecular evidence confirming trans-
mission of C. hominis between cattle and humans, and therefore
more studies should be conducted to fully elucidate the trans-
mission dynamics of C. hominis in cattle. In the present study, two
C. hominis subtypes were detected in cattle; IbA10G2 and IdA15G1.
Subtype IbA10G2 is a dominant subtype responsible for C. hominis-
associated outbreaks of cryptosporidiosis worldwide (Xiao, 2010).
Subtype IdA15G1 was identified in three cattle isolates from WA
and has been detected in humans from Victoria with a history of
gastrointestinal disorders (Koehler et al., 2013). It is also the
dominant subtype infecting Aboriginal people in WA (Ng-Hublin
et al., 2017).
Cryptosporidium macropodum, which is currently considered
non-zoonotic, was the dominant species in kangaroos (49.2% of
samples positive for Cryptosporidium in kangaroos), followed by
C. fayeri (27.5%). Three C. fayeri gp60 subtypes were identified;
IVfA12G1T1 and two novel subtypes; IVaA11G3T1 and
IVgA10G1T1R1. The former subtype has previously been reported
in kangaroos (Power et al., 2009), but this is the first report of
IVaA11G3T1 and IVgA10G1T1R1 in marsupials. The subtype iden-
tified in the first human patient infected with C. fayeri was
IVaA9G4T1R1 (Waldron et al., 2010) and has previously been
identified in eastern grey kangaroos from NSW catchments (Power
et al., 2009).
In addition to C. macropodum and C. fayeri, C. hominis, C. parvum,
C. galli and kangaroo genotype I were also detected in kangaroos
from NSW and WA in 13.2%, 9.2%, 0.5% and 0.2% of positives,
respectively. Unfortunately, no faecal samples from kangaroos were
collected from QLD catchments and given the identification of
C. hominis in kangaroos from NSW, future studies in catchment
areas of QLD should include kangaroos. In NSW catchments, a
previous study reported an overall prevalence of 5% for Crypto-
sporidium from 952 animal faecal samples and 3.6% (21/576) in
kangaroos (Zahedi et al., 2016b). The present study includes these
samples and extends the analysis to include a total of 1521 samples
from NSW with an overall prevalence of 16.6% (95% CI, 14.8e18.6)
and a prevalence of 14% (95% CI, 11.7e16.6) in kangaroos in NSW.
The prevalence of Cryptosporidium species in Eastern grey kangaroo
faecal samples in Sydney catchments has been analysed in several
studies. The first genetic study (2000e2002), reported a prevalence
of 6.7% (239/3557) (Power et al., 2005) and identified only
C. macropodum and C. fayeri in the populations (Power et al., 2004).
The second major study (2006e2008), identified a prevalence of
16.9% (27/160) and identified C. macropodum (n¼ 2), C. parvum
(n¼ 6), C. hominis (n¼ 18) and a C. parvum-like isolate (n¼ 1) (Ng
et al., 2011b). However, the finding of C. hominis and C. parvum in
the kangaroo faecal samples in that study could not be confirmed at
additional loci, presumably due to the low levels of oocysts in the
samples. In the present study, C. hominis was identified by Sanger
analysis and NGS in 5.2% (43/835; 3.8e6.9) of kangaroos screened
in NSW and in the previous related study by Zahedi et al. (2016b),
the median numbers of C. hominis/g1 was 4831 with a range of
26e16,890 g1 (Zahedi et al., 2016b), indicating that significant
numbers of oocysts were present in some samples. Another recent
study also analysed these kangaroo-derived C. hominis isolates
using both Sanger and NGS (Zahedi et al., 2017). In that study, un-
like C. parvum isolates, in which additional within-host gp60 sub-
type diversity was identified by NGS, only one C. hominis subtype417was identified by both Sanger and NGS in the kangaroo-derived
DNA samples, suggesting a single, recent introduction of
C. hominis into kangaroos (Zahedi et al., 2017). The C. hominis in the
kangaroos may have come from spill-back from humans in the
catchments, which may have also have spilled-over to infect cattle
in the catchments. The lack of identification of C. hominis in kan-
garoos in NSW catchments prior to 2011 tends to support this.
However, only a small fraction of samples were typed in those
studies and it is not possible to determine if even the same kan-
garoo populations were analysed in the previous studies and
therefore it is impossible to draw any real inferences. Collection site
coordinates of C. hominis positive kangaroo and cattle samples in
NSW indicated that there was a geographical overlap between
areas from which six cattle and nine kangaroo C. hominis positives
(including both subtypes IbA10G2 and IdA15G1) were collected (S-
34.61278, E150.58498). Cryptosporidium galli (a common bird
parasite) and kangaroo genotype I, previously only reported in
western grey kangaroos inWA (Yang et al., 2011) were also detected
in kangaroos, but neither are considered zoonotic.
Despite being the third most common Cryptosporidium species
detected in humans in Australia (Ryan and Power, 2012),
C. meleagridis was only detected in three bird isolates from WA,
however very low numbers of faecal samples were collected from
birds from WA (n¼ 7) and QLD (n¼ 9) and no samples were
collected from NSW. The C. meleagridis gp60 subtype detected was
IIIeA18G2R1, which has not been previously reported.
Cryptosporidium cuniculus was not detected in the five samples
that were collected from QLD, but was detected at an overall
prevalence of 27.6% (60/217) in rabbits in NSW and 9.6% (43/450;
95% CI, 7e12.7%) in rabbits in WA. This species has been previously
identified in rabbits, humans and a kangaroo in Australia (Nolan
et al., 2010, 2013; KF279538; Koehler et al., 2014a). It has also
been linked to a number of sporadic human cases across the UK
(Chalmers et al., 2011; Elwin et al., 2012), Nigeria (Molloy et al.,
2010) and France (ANOFEL, 2010) and was implicated in a water-
borne outbreak of cryptosporidiosis in humans in England in 2008
(Chalmers et al., 2009; Puleston et al., 2014). Two distinct gp60
subtype families, designated Va and Vb have been identified in
C. cuniculus (Chalmers et al., 2009). In the present study, all six
subtypes belonged to the Vb subtype family (VbA18, VbA23, VbA25,
VbA26, VbA28 and VbA29). Most cases described in humans relate
to Va and the first waterborne outbreak was typed as VaA22
(Robinson et al., 2008; Chalmers et al., 2009), but a VbA25 variant
and VbA27 have been reported in human patients in Australia
(KF279538; Koehler et al., 2014b).
Cryptosporidium ubiquitum was the only species detected in
sheep by Sanger sequencing (5.5%, 11.1% and 11.3% prevalence
across NSW, QLD and WA respectively). It was also detected 33.3%
of feral deer faecal samples in QLD. Cryptosporidium ubiquitum has
not been identified in Australia in the limited typing of Australian
human Cryptosporidium isolates that has been conducted to date
(Ryan and Power, 2012), however it has been identified in surface
waters in Australia (Monis et al., unpublished). Subtyping identified
all C. ubiquitum positives as subtype XIIa, which has been found in
humans and therefore XIIa is a potentially zoonotic subtype (Li
et al., 2014).
In North America, bothwildlife and domestic animals contribute
to contamination of Cryptosporidium spp. in drinking water catch-
ments, with prevalence ranging from 6 to 20.5% (Feng et al., 2007;
Starkey et al., 2007; Ziegler et al., 2007a, b; Jellison et al., 2009;
Szonyi et al., 2010). In those studies, the majority of Cryptospo-
ridium spp. detected in wildlife species were host adapted (Feng
et al., 2007; Ziegler et al., 2007a; Jellison et al., 2009), while some
species such as C. hominis-like, C. parvum, C. ubiquitum and
C. meleagridis occasionally detected in some hosts such as eastern
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Appendix 5gray squirrels, eastern chipmunks, beavers, woodchucks, raccoons,
red-backed voles, deer, geese, and deer mice (Feng et al., 2007;
Ziegler et al., 2007a; Jellison et al., 2009). In the present study,
the majority of samples collected from wildlife were from kanga-
roos and rabbits and the most significant difference between the
findings of the present study and studies conducted in North
America, is the identification of C. hominis and C. parvum in wildlife
(kangaroo) populations. In North American catchments, C. parvum,
C. bovis, C. ryanae and C. andersoni are the most commonly reported
Cryptosporidium in cattle faeces (Starkey et al., 2007; Szonyi et al.,
2010). With the exception of C. andersoni, these species were also
detected in cattle faeces in the present study, along with C. hominis.
Further studies are required to understand the source and human
health significance of C. hominis in both wildlife and livestock in
drinking water catchments.
5. Conclusions
 The present study has provided an extensive analysis of Cryp-
tosporidium species and subtypes from 5774 faecal samples
collected from various host species in 11 water catchments
across three states of Australia (QLD, NSW and WA).
 The overall prevalence of Cryptosporidium was 18.3% and of the
17 Cryptosporidium species and 4 genotypes identified, 13 spe-
cies are of public health significance.
 The significant findings were the detection of a C. hominis in
cattle and kangaroos and the high prevalence of C. parvum in
cattle. In addition, two novel C. fayeri subtypes (IVaA11G3T1 and
IVgA10G1T1R1), one novel C. meleagridis subtype (IIIeA18G2R1)
were identified and C. erinacei was reported for the first time in
Australia
 The identification of zoonotic Cryptosporidium species in both
livestock and wildlife has implications for management of
drinking water sources.
 Continued identification of the sources/carriers of human
pathogenic strains as well as accurate assessments of the pop-
ulation size of various hosts in catchments is therefore essential
for accurate risk assessment and optimal catchment
management.
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Editor: Zhen (Jason) HeWastewater recycling is an increasingly popular option inworldwide to reduce pressure onwater supplies due to
population growth and climate change. Cryptosporidium spp. are among the most common parasites found in
wastewater and understanding the prevalence of human-infectious species is essential for accurate quantitative
microbial risk assessment (QMRA) and cost-effective management of wastewater. The present study conducted
next generation sequencing (NGS) to determine the prevalence and diversity of Cryptosporidium species in 730
raw influent samples from 25 Australian wastewater treatment plants (WWTPs) across three states: New
South Wales (NSW), Queensland (QLD) and Western Australia (WA), between 2014 and 2015. All samples
were screened for the presence of Cryptosporidium at the 18S rRNA (18S) locus using quantitative PCR (qPCR),
oocyst numbers were determined directly from the qPCR data using DNA standards calibrated by droplet digital
PCR, and positives were characterized using NGS of 18S amplicons. Positives were also screened using C. parvum
and C. hominis specific qPCRs. The overall Cryptosporidium prevalencewas 11.4% (83/730): 14.3% (3/21) in NSW;
10.8% (51/470) in QLD; and 12.1% (29/239) inWA. A total of 17 Cryptosporidium species and six genotypes were
detected by NGS. In NSW, C. hominis and Cryptosporidium rat genotype III were the most prevalent species (9.5%
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Appendix 6respectively), while in WA, C. meleagridis was the most prevalent species (6.3%). The oocyst load/Litre ranged
from 70 to 18,055 oocysts/L (overall mean of 3426 oocysts/L: 4746 oocysts/L in NSW; 3578 oocysts/L in QLD;
and 3292 oocysts/L inWA). NGS-based profiling demonstrated that Cryptosporidium is prevalent in the raw influ-
ent across Australia and revealed a large diversity of Cryptosporidium species and genotypes, which indicates the
potential contribution of livestock, wildlife and birds to wastewater contamination.
© 2018 Elsevier B.V. All rights reserved.1. Introduction
Australia is the driest of the world's inhabited continents, with the
lowest percentage of rainfall as run-off and the lowest amount of
water in rivers (Anonymous, 2004). Drinking water resources are
under considerable strain as a result ofmajor shifts in long-term climate
change, and climate predictions for all Australian States and Territories
suggest increasing temperatures, a decline in average rainfall, but in-
creasing severity and frequency of storm events (Garnaut Review,
2008). Consequently, there is increasing pressure for more efficient
use of water resources, both in urban and rural environments (Toze,
2006a). Recycling wastewater will help address these challenges and
is a prominent option among the various alternative sources of water
in both developing and developed countries (Miller, 2006; Mekala and
Davidson, 2016). However, infection with pathogenic microorganisms
is a major risk factor (Rodriguez-Manzano et al., 2012) and therefore
water destined for reuse must be fit for purpose (Toze, 2006b).
The waterborne parasite Cryptosporidium represents an important
public health concern for water utilities, as it is a major cause of diar-
rhoea and there is neither a vaccine nor an effective treatment (Ryan
et al., 2016; Zahedi et al., 2016a). Cryptosporidium is particularly suited
to waterborne transmission as the oocyst stage is highly resistant to
chlorine disinfection and can penetrate and survive routine water and
wastewater treatment systems (King and Monis, 2007; King et al.,
2017; Ryan et al., 2017a). The parasite has been responsible for numer-
ous large-scale waterborne outbreaks worldwide (Efstratiou et al.,
2017) and is highly prevalent in wastewater (Amorós et al., 2016; Ma
et al., 2016).
Cryptosporidium species are currently monitored in wastewater
using standard detection methodologies (i.e. fluorescence microscopy
using EPA method 1623 - USEPA, 2012), however, this method cannot
discriminate between different Cryptosporidium species. Of the 37
recognised Cryptosporidium species, C. hominis and C. parvum are the
dominant species that infect humans (Ryan et al., 2016; Zahedi et al.,
2017a; Čondlová et al., 2018; Kváč et al., 2018). As not all species of
Cryptosporidium are infectious to humans (Ryan et al., 2016), under-
standing the diversity of Cryptosporidium in wastewater is crucial for
more accurate quantitative microbial risk assessment (QMRA), for
proper management of wastewater and its recycling. Due to the com-
plex composition, abundance, and distribution patterns of Cryptosporid-
ium species present in wastewater samples, molecular techniques such
as conventional PCR and Sanger sequencing-based genotypingmethods
are unable to resolve complex DNA mixtures due to mixed sequencing
chromatograms and are also unable to detect low abundance species
or variants of Cryptosporidium (which typically appear as a “bumpy
baseline” in Sanger chromatograms) (Murray et al., 2015; Paparini
et al., 2015; Grinberg and Widmer, 2016).
Next-generation sequencing (NGS) technologies have allowed the
comprehensive characterization and deep coverage of microbial com-
munity structure and diversity in environmental samples such as soil,
water, the atmosphere and other environments (Cruaud et al., 2014).
NGS is also more sensitive for the detection of less abundant species
within microbial communities (Salipante et al., 2013). Recently, NGS
approaches have been described that examine the composition and di-
versity of microbial communities (Shanks et al., 2013; Ma et al., 2015;
Newton et al., 2015; Xu et al., 2017), adenovirus (Ogorzaly et al.,422015), norovirus (Prevost et al., 2015), astrovirus (Brinkman et al.,
2013) and protists (Maritz et al., 2017) in sewage. However, to the
best of the authors' knowledge, to date no large scale longitudinal stud-
ies have been undertaken to investigate the composition and diversity
of Cryptosporidium species in wastewater using high-throughput
amplicon NGS. As the costs of NGS continue to decrease and the bioin-
formatics analysis of data continues to improve, NGS screening of
wastewater samples has become more feasible (Muir et al., 2016).
Therefore, the aim of the present study was to use NGS, for the first
time on a large scale, to more accurately determine the prevalence and
composition of Cryptosporidium species in Australian WWTPs across
three states: New SouthWales (NSW), Queensland (QLD) andWestern
Australia (WA).
2. Materials and methods
2.1. Study sites and sample collection
In NSW, WWTP samples (250 mL raw influent) were collected on a
monthly interval over five months (April 2015 to August 2015). A total
of 21WWTP sampleswere collected from fourwastewater plantswithin
the WaterNSW area of operations (greater Sydney) (Table 1). In QLD, a
total of 470 WWTP samples (250 mL raw influent) were collected on
fortnightly intervals from WWTP sites (n = 19) across south east
Queensland (Table 1) over a year (January 2014 to January 2015). In
WA, a total of 239WWTP samples (250mL raw influent) were collected
from two treatment plants on weekly intervals from December 2014 to
December 2015 (Table 1). All raw influent WWTP samples were col-
lected into individual 250 mL collection pots and stored at 4 °C until re-
quired and samples collected in NSWandQLDwere shipped toMurdoch
University for analysis.
2.2. Sample processing and DNA isolation
All 250 mL WWTP samples were transferred to 50 mL centrifuge
tubes, and evenly weighed tubes (n = 5) were prepared from the
same samples. These samples were centrifuged at 10,000 ×g for 20 min
and pellets from the same samples were mixed together again. DNA
was extracted fromaseptically separated 250mg aliquots of each sample
(pellet), using a Power Soil DNA Kit (MO BIO, Carlsbad, California, USA)
(Walden et al., 2017). An extraction blank (noWWTP sample) and a pos-
itive extraction control (a Cryptosporidium positive faecal sample from a
kangaroo), was included in each extraction batch, as a process control for
extraction efficiency. Purified DNAwas stored at−20 °C prior to molec-
ular analyses.
2.3. qPCR and oocyst enumeration
AllWWTP sample extractswere screened for the presence of Crypto-
sporidium at the 18S rRNA (18S) locus using a quantitative PCR (qPCR)
as previously described (King et al., 2005; Yang et al., 2014). A spike
analysis of the 18S qPCR assay (addition of 0.5 μL of positive control
DNA into test samples) was conducted on randomly selected negative
samples from each group of DNA extractions, to determine if negative
results were due to PCR inhibition by comparing the cycle threshold
(Ct) values of the spike and the positive control (both with same2
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Appendix 6concentration of DNA). In addition, Cryptosporidium oocyst concentra-
tions in each sample (oocyst numbers per litre) were determined di-
rectly from the qPCR data using DNA standards calibrated by droplet
digital PCR (ddPCR) (QX100™ droplet digital PCR system, Bio-Rad),
which has the advantage of providing more accurate quantitation
(Yang et al., 2014). Briefly, target copy numbers of the 18S gene de-
tected in individual samples were converted to estimates of oocyst
numbers based on the fact that the 18S gene in Cryptosporidium has
five copies per haploid sporozoite (Le Blancq et al., 1997; Abrahamsen
et al., 2004), and there are four haploid sporozoites per oocyst. There-
fore, every 20 copies of 18Sdetected by qPCRwere equivalent to oneoo-
cyst. To estimate oocyst density per litre, oocyst numbers detected per
250mg aliquots of each sample (pellet) were extrapolated to the corre-
sponding total pellet weight extracted from each 250 mL wastewater
sample, and then multiplied by four.
2.4. Next generation sequencing
Samples that were positive by qPCR were analysed by NGS on the
MiSeq (Illumina) platform at the 18S locus using the 18S iF/iR primers
(Morgan et al., 1997) that were modified to contain MiSeq adapter se-
quences on the 5′ and 3′ end as previously described (Paparini et al.,
2015). The library was prepared as per standard protocols for the
MiSeq platform (Illumina Demonstrated Protocol: 16S Metagenomic
Sequencing Library Preparation) with the following modifications: all
PCR amplicons (uniquely indexed per sample) were double purified
using the Agencourt AMPure XP Bead PCR purification protocol
(Beckman Coulter Genomics, USA) and pooled in approximate equimo-
lar ratios (based on gel electrophoresis). Sequencing was performed on
an Illumina MiSeq using 500-cycle V2 chemistry (250 bp paired-end
reads) following the manufacturer's recommendations. Two no-
template controls and two DNA extraction reagent blank controls
were included in the library preparation and distributed between sam-
ples in the PCR plate layout. All no-template and extraction reagent
blank controls produced no detectable amplification of Cryptosporidium
DNA throughout the library preparation. This indicated that level of
cross contamination between samples, or from the laboratory environ-
ment, was below the detection limit of the library preparation proce-
dure and for this reason were not sequenced. We have also previously
sequenced extraction blanks and no-template controls from other NGS
studies in our laboratory, and after quality filtering, b10 reads were de-
tected in those samples.
2.5. Species-specific PCR for detection and enumeration of C. hominis and C.
parvum
All WWTP samples positive for Cryptosporidium spp. by qPCR at the
18S locus were also screened and enumerated independently using
primers and species-specific minor groove binder (MGB) probes to a
unique Cryptosporidium specific gene (Clec) that codes for a novel
mucin-like glycoprotein that contains a C-type lectin domain to confirm
the presence/absence of C. hominis and C. parvum as described by Yang
et al. (2013).
2.6. Statistical analysis
The overall prevalence of Cryptosporidium in samples collected from
each WWTP was expressed as the percentage of samples positive by
combined qPCR and NGS, with 95% confidence intervals calculated as-
suming a binomial distribution, using the software Quantitative Parasi-
tology 3.0 (Rózsa et al., 2000). DNA extraction efficiency was estimated
for each extraction, based on the number of the gene copies/oocyst
equivalents measured by ddPCR. Odds ratios (OR) and their 95% confi-
dence intervals were used tomeasure the strength of association of sea-
son (risk factor) with the occurrence of the Cryptosporidium species in
WWTP samples. Chi-square and non-parametric analyses were423performed using IBM SPSS 21.0 (statistical package for the social sci-
ences) for Windows (SPSS Inc. Chicago, USA) to determine if there
were any associations between the prevalence and concentration of
Cryptosporidium oocysts at different sampling seasons and across states.
2.7. Bioinformatics analysis
IlluminaMiSeq sequencing resulted in 1,068,270,250 bp paired-end
reads with 78% of the basecalls NQ30. Paired-end reads were merged
and quality filtered with USEARCH v9.2 (Edgar, 2010), retaining reads
with N50 bp merged overlap, b0.1% expected error, no mismatches in
the primer sequences, a minimum length of 200 bp, and a minimum
of 100 identical replicate copies as previously described (Zahedi et al.,
2017b). Primer sequences and any distal bases were also removed
from all reads. Reads were then denoised and chimera filtered with
the UNOISE3 algorithm (Edgar, 2016) to generate 169 zero-radius oper-
ational taxonomic units (ZOTUs) that represent unique biologically cor-
rect sequences (Edgar, 2016). Cryptosporidium 18S ZOTU sequences
were assigned taxonomy by comparing ZOTUs to a curated custom da-
tabase containing 63 reliable 18S reference sequences from 35 Crypto-
sporidium species and 28 genotypes extracted from GenBank using the
Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990). Tax-
onomy was only assigned if there was a single unambiguous BLAST hit
with N99% pairwise identity over N98% of the query ZOTU sequence.
Of the 169 ZOTUs generated, 62 did notmatch any known Cryptosporid-
ium species or genotypes. These non-specific ZOTUs were compared to
GenBank using BLAST, and where possible, taxonomy was assigned
when queries hit reference sequences with N99% identity over N98% of
the query reads and matched to no other taxa at the same level. Many
of these non-specific ZOTUs were assigned to uncultured eukaryotes
or benign waterborne fungi, algae and dinoflagellates (Supplementary
Table 1). Although abundant at the ZOTU level, these non-specific se-
quences represented a very small proportion of the total reads per sam-
ple (mean 0.71%).
3. Results
3.1. Overall prevalence of Cryptosporidium in WWTP samples
In the present study, a total of 730 WWTP samples from 25WWTPs
across three states in Australia (NSW, QLD and WA) were screened
using qPCR, and the composition of Cryptosporidium species in positive
samples was determined by NGS. Results were tabulated as the preva-
lence of the most abundant single species (determined by NGS), de-
tected per sample (Table 2) and the prevalence of all Cryptosporidium
species detected across all samples regardless of their abundance
(Table 3). Overall, Cryptosporidium was detected in 11.4% (83/730;
95% CI, 9.2–13.9) of WWTP samples collected across three states.
(Table 4 and Supplementary Table 1). This comprises a prevalence of
14.3% (3/21; 95% CI, 3–36.3) in NSW, 10.8% (51/470; 95% CI, 8.2–14)
in QLD and 12.1% (29/239; 95% CI, 8.3–17) in WA. However, there was
no significant difference between the prevalence in different states (p
N 0.05). In general, across the three states, samples collected in summer
were 1.9 times more likely to have Cryptosporidium than samples col-
lected during winter months (Odds ratio = 1.9; 95% CI, 1.2–3.4), but
there was no statistical difference between samples collected in spring,
winter and autumn (p N 0.05). For NSW, sampleswere only collected for
autumn and winter.
In QLD, the prevalence of Cryptosporidium peaked at 17.5% (18/103;
95% CI, 10.7–26.2) during summer months (averaged over two partial
summers; 2014 and 2015), when the samples were 2.3 times more
likely to have Cryptosporidium than samples collected during winter
months (averaged over winter 2014 and 2015) (Odds ratio = 2.3; 95%
CI, 1.2–5.2). There was no significant difference between the prevalence
in spring, autumn and winter (p N 0.05). Unlike QLD, WA had the
highest prevalence of Cryptosporidium in WWTP samples collected
Table 1
Wastewater treatment plants (WWTPs) included in the present study.




Nature of trade waste Any storm
water intrusion
Animal presence/activity around the
plant
QLD
Plant A Trickle filter Rural Domestic/some commercial 9000 Not received NA Yes Yes (cattle in neighbouring
properties)
Plant B Lagoon Rural Domestic/some commercial 500 Not received NA Yes Yes (cattle in neighbouring
field/wildlife, kangaroo/koalas)
Plant C Extended activated sludge Rural Domestic/some commercial 1000 Not received NA Yes Yes (bats)
Plant D Activated sludge Rural Principally domestic 36,000 Small portion is trade waste Industrial trade waste Yes No
Plant E Activated sludge Urban Principally domestic 45,000 Significant portion is trade waste Chemical trade waste/tannery
waste
Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
Plant F Activated sludge Rural Principally domestic 1000 Small portion is trade waste Restaurant waste Yes WWTP in rural area with cattle
grazing adjacent but no linkage to
plant inflow.
Plant G Activated sludge Rural Principally domestic 105,000 Small portion is trade waste Industrial trade waste Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
Plant H Activated sludge Rural Principally domestic 12,500 Insignificant portion is trade
waste
Rendering plant that pre-treats
waste before sending waste to
WWTP
Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
Plant I Activated sludge Rural Principally domestic 2400 Insignificant portion is trade
waste
Industrial waste Yes WWTP in rural area with cattle
grazing adjacent but no linkage to
plant inflow.
Plant J Activated sludge Urban Principally domestic 118,000 Significant portion is trade waste Restaurant waste Yes No
Plant K Activated sludge Urban Principally domestic 60,000 Small portion is trade waste Seafood waste Yes No
Plant L Activated sludge Rural Principally domestic 126,000 Significant portion is trade waste Industrial trade waste Yes No
Plant M Activated sludge Rural Decommissioned (August
2014)
Decommissioned Decommissioned NA Yes N/A
Plant N Activated sludge Rural Principally domestic 22,000 Small portion is trade waste Industrial trade waste Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.












possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
Plant P Activated sludge Rural Principally domestic 43,000 Significant portion is trade waste Food manufacturing waste Yes No
Plant Q Activated sludge Rural Principally domestic 47,000 Small portion is trade waste Restaurant waste Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
Plant R Activated sludge Urban Principally domestic 5000 Small portion is trade waste Restaurant waste Yes No
Plant S Activated sludge Rural Principally domestic 26,000 Small portion is trade waste Restaurant waste Yes WWTP adjoined to scrub area with
possible animal activity, i.e.
kangaroos etc. but no linkage to
plant inflow.
NSW
Plant A Oxidation ditch (Pasveer),
sludge lagoons




Yes Yes (native wildlife (wombats,
kangaroos and birds))
Plant B IDEA tank, oxidation ditch
(Pasveer) (not in operation),
sludge drying/lagoons




Yes Yes (Native wildlife (wombats,
kangaroos and birds))
Plant C IDEA tank, sludge
drying/lagoons.




Yes Yes (native wildlife (wombats,
kangaroos and birds))
Plant D IDAL aeration, oxidation ditch
(Pasveer), sludge drying/lagoons




Yes Yes (native wildlife (wombats,
kangaroos and birds))
WA
Plant A Activated sludge Urban Principally domestic (but
also receives industrial waste
through the sewer network)
75,000 Received Septage and grease trap waste,
abattoir and farm waste
(through third party tankers)
Yes Limited (foxes, feral cats, birds and
snakes)
Plant B Pond system Urban Domestic 5000 Not received NA Yes Cattle, kangaroos and birds (turtles
snakes and birds live in the ponds)
NA = Not Available.
IDEA = Intermittently Decanted Extended Aeration.













Prevalence of themost abundant Cryptosporidium species detected by NGS of individual wastewater treatment plant (WWTP) samples across three states of Australia; NSW, QLD andWA (based on a single species that was themost abundant species






















































ND ND ND ND ND
Plant B ND ND ND ND ND ND ND ND ND ND ND 2a/20
(10%, 1.2–31.7)




ND ND ND ND
Plant D 1/41 (2.4%, 0.1–12.9) ND ND ND ND ND ND ND 1/41 (2.4%, 0.1–12.9) ND ND ND






ND ND ND ND ND















ND ND ND ND ND
Plant H 1/41
(2.4%- 0.1–12.9)




ND ND ND ND ND
Plant I ND ND ND ND ND ND 1/41
(2.4%, 0.1–12.9)
ND ND ND ND ND
Plant J ND ND 1/41 (2.4%, 0.1–12.9) ND ND ND ND ND ND ND 3/41
(7.3%, 1.5–19.9)
ND
Plant K ND ND ND ND ND ND 5/41
(12.2%, 4.1–26.2)
ND ND ND ND ND
Plant L ND ND ND ND ND ND ND ND ND ND ND ND
Plant M ND ND ND 1/7
(14.3%, 0.4–57.9)
ND ND ND ND ND ND ND ND
Plant N ND ND ND ND ND ND ND ND 1/4
(25%, 0.6–80.6)
ND ND ND
Plant O ND ND ND ND ND ND 1/4
(25%, 0.6–80.6)
ND ND ND ND ND
Plant P ND ND ND ND ND ND 1/4
(25%, 0.6–80.6)
ND ND ND ND ND
Plant Q ND ND ND ND ND ND 1/4
(25%, 0.6–80.6)
ND ND ND ND ND
Plant R ND ND ND ND ND ND ND ND ND ND ND ND
Plant S ND ND ND ND ND ND ND ND ND ND ND ND

















Plant A ND ND ND ND ND ND ND ND ND ND ND ND
Plant B 1/5 (20%, 0.5–71.6) ND ND ND ND ND ND ND ND ND ND ND
Plant C ND 1/5 (20%, 0.5–71.6) ND ND ND ND ND ND ND ND ND ND
Plant D ND 1/6 (16.7%, 0.4–64.1) ND ND ND ND ND ND ND ND ND ND










Plant B ND ND ND ND ND 6/93
(6.5%, 2.4–13.5)


















ND = not detected.
a Rat genotype I (n = 1), rat genotype II (n = 1).
b Rat genotype I (n = 2), rat genotype II (n = 2), rat genotype III (n = 1), kangaroo genotype I (n = 1).













Prevalence of all Cryptosporidium species/genotypes detected by NGS in wastewater treatment plant (WWTP) samples across three states of Australia; NSW, QLD andWA (regardless of
abundance).
Cryptosporidium spp. No+/total no (% proportion + 95% CI)
NSW QLD WA
C. hominis 2/21 (9.5%; 95% CI, 1.2–30.4) 2/470 (0.4%; 95% CI, 0.1–1.5) ND
C. parvum 1/21 (4.8%; 95% CI, 0.1–23.8) 21/470 (4.5%; 95% CI, 2.8–6.7) 3/239 (1.3%; 95% CI, 0.3–3.6)
C. avium ND 2/470 (0.4%; 95% CI, 0.1–1.5) ND
C. bovis ND 5/470 (1.1%; 95% CI, 0.3–2.5) ND
C. canis ND 1/470 (0.2%; 95% CI, 0–1.2) ND
C. cuniculus ND 1/470 (0.2%; 95% CI, 0–1.2) ND
C. erinacei 1/21 (4.8%; 95% CI, 0.1–23.8) 14/470 (3.0%; 95% CI, 1.6–4.9) 3/239 (1.3%; 95% CI, 0.3–3.6)
C. fayeri ND 1/470 (0.2%; 95% CI, 0–1.2) ND
C. felis ND 4/470 (0.8%; 95% CI, 0.2–2.2) 5/239 (2.1%; 95% CI, 0.7–4.8)
C. galli 1/21 (4.8%; 95% CI, 0.1–23.8) 36/470 (7.7%; 95% CI, 5.4–10.4) ND
C. macropodum ND 3/470 (0.6%; 95% CI, 0.1–1.9) 1/239 (0.4%; 95% CI, 0–2.3)
C. meleagridis ND ND 14/239 (5.9%; 95% CI, 3.2–9.6)
C. muris 1/21 (4.8%; 95% CI, 0.1–23.8) 27/470 (5.7%; 95% CI, 3.8–8.2) 1/239 (0.4%; 95% CI, 0–2.3)
C. ryanae ND 3/470 (0.6%; 95% CI, 0.1–1.9) ND
C. scrofarum ND 3/470 (0.6%; 95% CI, 0.1–1.9) 2/239 (0.8%; 95% CI, 0.1–3)
C. suis 1/21 (4.8%; 95% CI, 0.1–23.8) 11/470 (2.3%; 95% CI, 1.2–4.1) 1/239 (0.4%; 95% CI, 0–2.3)
C. ubiquitum ND 2/470 (0.4%; 95% CI, 0.1–1.5) ND
Bat genotype VI ND 1/470 (0.2%; 95% CI, 0–1.2) ND
Kangaroo genotype I ND 1/470 (0.2%; 95% CI, 0–1.2) 4/239 (1.7%; 95% CI, 0.5–4.2)
Rat genotype I ND 9/470 (1.9%; 95% CI, 0.91–3.6) 2/239 (0.8%; 95% CI, 0.1–3)
Rat genotype II ND 5/470 (1.1%; 95% CI, 0.3–2.5) 2/239 (0.8%; 95% CI, 0.1–3)
Rat genotype III 2/21 (9.5%; 95% CI, 1.2–30.4) 4/470 (0.8%; 95% CI, 0.2–2.2) 2/239 (0.8%; 95% CI, 0.1–3)
Rat genotype IV ND 2/470 (0.4%; 95% CI, 0.1–1.5) ND
ND = not detected.
The bold data indicates the most two common species of Cryptosporidium reported in humans in Australia, accounting for N95% of human infections.
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Appendix 6during spring (16.8%; 95% CI, 8.3–28.5), while there was no signifi-
cant difference between the prevalence in summer, autumn and
winter (p N 0.05). Although the prevalence of different species
peaked at different times (Supplementary Table 1), in WA (Plant
A), there was a winter peak in both C. parvum and rate genotype 1
and a spring peak for C. felis, and in plant B, there was a summer
peak for C. suis (Supplementary Table 1).
3.2. Prevalence of all Cryptosporidium species/genotypes as determined by
NGS (regardless of abundance)
A total of 17 Cryptosporidium species and six genotypes were de-
tected by NGS (Table 3, and Supplementary Table 1). Cryptosporidium
hominis and rat genotype III were the most prevalent species detected
in wastewater samples collected from NSW (9.5% each, 2/21; 95% CI,
1.2–30.4). In addition to C. hominis and rat genotype III, C. parvumwas
detected in one NSW sample only (4.8%, 1/21; 95% CI; 0.1–23.8) and
C. erinacei, C. galli, C. muris and C. suis were also detected in the same
sample in low abundance (Table 3 and Supplementary Table 1). In
QLD, of the 51 WWTP samples positive for Cryptosporidium, NGS
detected more than one Cryptosporidium species/genotype in 42 sam-
ples, ranging from two to eight species in individual samples, whereas
in nine samples, only one Cryptosporidium species/genotype was
identified. In general, the prevalence of different Cryptosporidium spe-
cies/genotypes detected by NGS in WWTP samples across QLD ranged
from 0.2% to 7.7% (Table 3). Cryptosporidium galli (7.7%), C. muris
(5.7%) and C. parvum (4.5%) were the three most prevalent (and abun-
dant) species detected in WWTP samples from QLD, followed by C.
erinacei (3.0%), C. suis (2.3%) and rat genotype I (1.9%) (Table 3), and
were significantly more prevalent than all other species detected in
samples fromQLD (p b 0.05) (Table 3). Unlike QLD, themajority of sam-
ples positive for Cryptosporidium in WA (22/29) contained only one
species/genotype of Cryptosporidium (75.9%; 95% CI, 56.5–89.7), and
only seven sampleswere identifiedwithmixed Cryptosporidium species
present (24.1%; 95% CI, 10.3–43.5). Cryptosporidiummeleagridiswas de-
tected in 5.9% (15/239; 95% CI, 3.2–9.6) of wastewater samples col-
lected from WA, and was significantly more prevalent than any other
species detected (p b 0.05). However, there was no significant427difference between the prevalence of other Cryptosporidium species de-
tected in WA samples (p N 0.05). Cryptosporidium C. parvum (1.3%), C.
erinacei (1.3%), C. scrofarum (0.8%) and C. muris (0.4%) were detected
at a low prevalence only in samples with mixed Cryptosporidium spe-
cies/genotypes in WA (Table 3 and Supplementary Table 1).
3.3. Abundance and diversity of all Cryptosporidium reads determined by
NGS
Overall, the highest number of reads (sequences) across the 83
WWTP samples positive for Cryptosporidium was assigned to C. galli
(22.8% of all sequences analysed). This was followed by C.meleagridis
(15.7%), C. muris (11.9%), C. felis (8.7%), C. parvum (6.8%), kangaroo
genotype I (JF316651) (4.9%), C. macropodum (4.5%), rat genotype I
(3.9%), rat genotype II (2.9%), C. hominis (2.5%), C. erinacei (2.5%),
rat genotype III (2.1%), C. suis (1.7%), C. bovis (0.8%), C. scrofarum
(0.5%), C. canis (0.4%), C. fayeri (0.3%), C. cuniculus (0.2%), C. avium
(0.2%), C. ubiquitum (0.1%), C. ryanae (0.1%), rat genotype IV (0.1%)
and bat genotype VI (0.1%) (Supplementary Table 1 and Fig. 1).
There were also a small proportion of NGS sequences (6.1%), across
11 samples, that were not assigned to any Cryptosporidium species
or genotypes (Supplementary Table 1 and Fig. 1). In general, at the
individual sample level across the three states, the number of species
identified in individual wastewater samples ranged from one to
eight species.
3.4. Additional confirmation of presence/absence and enumeration of
C. hominis and C. parvum in WWTP samples using a species-specific qPCR
Of 83 WWTP samples positive for Cryptosporidium spp. NGS de-
tected C. parvum and C. hominis in 25 and four samples, respectively, in-
cluding two samples that contained both species (QLD-E76 and QLD-
G115) (Table 3, Table 5 and Supplementary Table 1). A C. parvum spe-
cies-specific qPCR assay confirmed the presence of C. parvum in 20/25
samples, but failed to amplify the remaining five samples, which were
previously identified by NGS to contain C. parvum sequences in low
abundance, ranging from 113 to 535 reads (Table 5). The occurrence
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42specific qPCR, with no C. hominis amplification in a single sample which
was previously confirmed by NGS to contain C. hominis in low abun-
dance (QLD-E76) (Table 5 and Supplementary Table 1). The concentra-
tion of C. hominis and C. parvum oocysts per litre in these samples
ranged from 386 to 3294 and from 14 to 6314, respectively (Table 5).
The absence of C. hominis and C. parvum in the remaining samples (n
= 56) was confirmed by the C. hominis and C. parvum species-specific
qPCR assays (Table 5).
3.5. Enumeration of Cryptosporidium oocysts in wastewater samples using
qPCR
Cryptosporidium oocyst concentration per litre was estimated using
qPCR standards calibrated by ddPCR at the 18S locus (Table 4). Overall,
the oocyst load per litre in samples collected across the three states
ranged from 70 to 18,055 oocysts/L and the mean was 3426 oocysts/L
(Table 4). The mean Cryptosporidium oocyst concentration in samples
collected from WWTPs in NSW was the highest among the states
(4746 oocysts/L). However, due to the low number of samples collected
from NSW (n=21), compared to 470 from QLD and 239 fromWA, sta-
tistical analysis of oocyst load was only conducted for QLD and WA to
avoid potential bias in the analysis.
The mean number of oocysts per litre in samples collected from the
twoWWTPs inWA over four seasons was 3292 oocysts/L (ranging from
327 to 16,812), while themean Cryptosporidium oocyst concentration in
these samples peaked during spring 2015 at 6326 oocysts/L (ranging
from 2267 to 16,812). This corresponded with a peak of prevalence at
this time (spring 2015) (16.8%; 95% CI, 8.3–28.5) (Table 4).
Compared to WA, the overall mean Cryptosporidium oocyst concen-
tration in WWTP samples from QLD was relatively higher (3578 oo-
cysts/L, ranging from 70 to 18,055). Seasonal mean concentrations
(averaged over the two same seasons in 2014 and 2015)were 1953 oo-
cysts/L in spring, 2323 oocysts/L in winter, 2583 oocysts/L in autumn
and 5966 oocysts/L in summer. This also corresponded with a peak
prevalence of 17.5% (95% CI, 10.7–26.2) during summer (averaged
over summer 2014, 2015 and 2016) (Table 4).
4. Discussion
The present study has demonstrated the utility of NGS in detecting
mixtures of Cryptosporidium species and genotypes in sewage and has
shown that they are frequently present but variable and diverse in
space, time and composition. The overall prevalence of Cryptosporidium
inWWTP samples across Australiawas 11.4% (83/730). Previous studies
have reported prevalence ranging from 6.4% to 100% (Xiao et al., 2001;
Ward et al., 2002; Zhou et al., 2003;Hanninen et al., 2005; CantusioNeto
et al., 2006; Hashimoto et al., 2006; Hirata and Hashimoto, 2006;
Ottoson et al., 2006; Robertson et al., 2006; Castro-Hermida et al.,
2008; Feng et al., 2009; Dungeni and Momba, 2010; Liu et al., 2011;
Ajonina et al., 2012; Ben Ayed et al., 2012; Li et al., 2012;
Gallas-Lindemann et al., 2013, 2016; Hachich et al., 2013; Spanakos
et al., 2015; Amorós et al., 2016; Hatam-Nahavandi et al., 2016; Ulloa-
Stanojlović et al., 2016; ; Huang et al., 2017; Imre et al., 2017; Ramo
et al., 2017; Santos and Daniel, 2017). However, to the best of the au-
thors' knowledge, in Australia little published information is available
on the prevalence and composition of Cryptosporidium species inwaste-
water (King et al., 2015, 2017).
In the present study, a total of 17 Cryptosporidium species and six ge-
notypes were detected by NGS. This is higher than the diversity re-
ported in previous studies due to the ability of NGS to detect mixtures
of sequences in low abundance. Wastewater treatment networks how-
ever, rarely contain only domestic wastewater; they often also contain
wastewater from industrial sources and can be influenced by environ-
mental water sources, such as stormwater or groundwater (Pandey
et al., 2014). In addition, wild animals may directly contribute to con-
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Fig. 1. Percent composition of 18S sequences from Cryptosporidium species detected in wastewater treatment plant samples from NSW, QLD and WA.
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Appendix 6present atwastewater treatment plants. Therefore, the presence of a va-
riety of Cryptosporidium species from livestock, wildlife and birds in
sewage samples may be attributed to other sources such as stormwater
or industrial waste from animal processing.
In the present study, of 83WWTP samples positive for Cryptosporid-
ium spp., NGS detected C. hominis and C. parvum in only 27 samples
(32.5%; 95% CI, 22.6–43.7), of which two samples contained both spe-
cies. A C. hominis and C. parvum species-specific qPCR provided further
support for the lack of C. hominis and C. parvum in the majority of sam-
ples, although it failed to detect C. hominis and C. parvum in one and five
samples, respectively, whichweremainly sampleswith low numbers of
C. parvum/C. hominis reads (109–535 reads) by NGS. The qPCR assay has
been tested extensively on human faecal samples and has been shown
to have an analytical sensitivity of 1 oocyst/μL of DNA extract (Yang
et al., 2013). This is the first time we have applied the qPCR to WWTP
samples and no inhibition was observed.
In NSW, the dominant species detected were C. hominis and rat ge-
notype III, whereas in QLD, C. galli, C. muris and C. parvum were the
three most prevalent species, while in WA, C. meleagridis was the
most prevalent species. Of these, C. parvum and C. hominis are the
most common species reported in humans in Australia, accounting for
N95% of human infections, with C. meleagridis the third most common
species reported and usually accounting for 1–2% of notifications
(Ryan and Power, 2012; Ng-Hublin et al., 2017). There have been nu-
merous reports of C. muris in humans in other countries (cf. Ryan
et al., 2017b). Other Cryptosporidium species with zoonotic potential,
whichwere detected at a low prevalence inWWTP samples in the pres-
ent study included C. bovis, C. canis, C. cuniculus, C. erinacei, C. felis,
C. scrofarum, C. suis and C. ubiquitum. Nevertheless, caution is required
when extrapolating any molecular data from WWTP samples to deter-
mine host sources of wastewater contamination by Cryptosporidium,
as there are many potential input sources other than humans into
wastewater networks. Unlike faecal material, there is no direct rela-
tionship between Cryptosporidium oocysts fromwastewater samples
and any potential host species, and an understanding of existing
host-parasite interactions, parasite epidemiology and sources of fae-
cal inputs into the wastewater network is required (Castro-Hermida
et al., 2008).
A number of studies across the world have reported C. hominis (the
predominant species in humans) among themost prevalent species de-
tected in wastewater; Australia (King et al., 2015), Brazil and Peru429(Ulloa-Stanojlović et al., 2016), China (Feng et al., 2009; Li et al., 2012;
Huang et al., 2017), Japan (Hashimoto et al., 2006; Hirata and
Hashimoto, 2006), Switzerland and Germany (Ward et al., 2002), the
USA (Xiao et al., 2001; Zhou et al., 2003) and Tunisia (Ben Ayed et al.,
2012). In addition to anthroponotic sources of C. hominis, several studies
in Australia have previously identified C. hominis in Australian cattle and
wildlife including bandicoots (Isoodon obesulus), brushtail possums
(Trichosurus vulpecula), eastern grey kangaroos (Macropus giganteus)
and brush-tailed rock-wallabies (Petrogale penicillata) (Hill et al.,
2008; Ng et al., 2011; Dowle et al., 2013; Vermeulen et al., 2015;
Zahedi et al., 2016b; Zahedi et al., 2018). To date there is no conclusive
molecular or epidemiological evidence linking contamination of waste-
water by animals with the occurrence of C. hominis in raw wastewater
or in human populations in Australia and further research is required
in this area. In the present study, C. hominis was detected in NSW in
plants C and D which received mainly septic tank waste and accounted
for 93.0% and 77.3% of all Cryptosporidium species detected in plants C
and D respectively, suggesting humans were the source. In NSW,
C. hominiswas detected in plants E and G. Plant E received a significant
portion of trade waste and the C. hominis detected accounted for only
4.4% of all Cryptosporidium species identified, while plant G received
mostly human waste and the C. hominis detected accounted for 26.6%
all Cryptosporidium species identified.
In Europe, several studies have reported that C. parvum is the domi-
nant species in wastewater (Hanninen et al., 2005; Spanakos et al.,
2015; Imre et al., 2017; Ramo et al., 2017), while some studies in
China, Iran, Tunisia and the USA have reported that livestock associated
species such as C. andersoni and C. xiaoi dominate (Xiao et al., 2001; Liu
et al., 2011; Ben Ayed et al., 2012; Hatam-Nahavandi et al., 2016). In the
present study, C. andersoni and C. xiaoi were not detected in WWTPs
across three states in Australia, however C. parvumwas the third most
prevalent species identified in QLD samples andwas detected in a single
sample and three samples from NSW and WA, respectively. Cryptospo-
ridium parvum has been identified widely in both calves and humans
in Australia (Ryan and Power, 2012) with reported prevalences for C.
parvum in humans in Australia ranging from ~24% in Victoria (Jex
et al., 2007; Koehler et al., 2013) to 17–19.8% in WA (Morgan et al.,
1998; Ng et al., 2010) and 46.8% in NSW (Waldron et al., 2009). There
are no published reports on the prevalence of C. parvum in the human
population in QLD, which is a knowledge gap that needs to be
addressed.
Table 5
C. hominis and C. parvum detected by NGS and species specific qPCR in individual wastewater treatment plant (WWTP) samples positive for Cryptosporidium spp. across three states of
Australia; NSW, QLD and WA.
State Plant Sample NGS C. hominis and C. parvum oocysts numbers determined by
species specific qPCR (MGB probes)
No of reads
assigned to C. hominis
No of reads
assigned to C. parvum
C. hominis oocysts/L C. parvum oocysts/L
QLD Plant A QLD-A7 0 0 ND ND
QLD-A24 0 0 ND ND
Plant B QLD-B2 0 0 ND ND
QLD-B3 0 109 ND 61
Plant C QLD-C2 0 779 ND 470
QLD-C3 0 246 ND 117
QLD-C19 0 910 ND 482
QLD-C25 0 133 ND 50a
Plant D QLD-D104 0 1181 ND 448
QLD-D140 0 0 ND ND
Plant E QLD-E18 0 562 ND 82a
QLD-E34 0 0 ND ND
QLD-E76 109 918 76a 361
QLD-E195 0 0 ND ND
QLD-E222 0 0 ND ND
QLD-E258 0 0 ND ND
QLD-E303 0 0 ND ND
QLD-E357 0 0 ND ND
QLD-E375 0 265 ND 47
QLD-E393 0 0 ND ND
Plant F QLD-F1 0 0 ND ND
QLD-F33 0 140 ND 2834
QLD-F84 0 126 ND 51
QLD-F130 0 189 ND 32
QLD-F157 0 0 ND ND
QLD-F319 0 0 ND ND
QLD-F382 0 140 ND 38a
Plant G QLD-G53 0 113 ND 292a
QLD-G115 2382 4336 386 812
QLD-G304 0 20,571 ND 954
QLD-G331 0 0 ND ND
QLD-G340 0 0 ND ND
Plant H QLD-H8 0 18,529 ND 6314
QLD-H179 0 1638 ND 922
QLD-H197 0 4674 ND 1528
QLD-H386 0 0 ND ND
Plant I QLD-I41 0 1873 ND 476
Plant J QLD-J15 0 0 ND ND
QLD-J47 0 0 ND ND
QLD-J354 0 0 ND ND
QLD-J363 0 0 ND ND
Plant K QLD-K71 0 0 ND ND
QLD-K119 0 0 ND ND
QLD-K281 0 0 ND ND
QLD-K380 0 0 ND ND
QLD-K389 0 0 ND ND
Plant M QLD-M60 0 0 ND ND
Plant N QLD-N35 0 0 ND ND
Plant O QLD-O54 0 991 ND 14
Plant P QLD-P63 0 0 ND ND
Plant Q QLD-Q11 0 0 ND ND
NSW Plant B NSW-B2 0 20,347 ND 1380
Plant C NSW-C20 9227 0 2998 ND
Plant D NSW-D21 3082 0 3294 ND
WA Plant A WA-A5 0 0 ND ND
WA-A8 0 0 ND ND
WA-A13 0 0 ND ND
WA-A16 0 0 ND ND
WA-A24 0 0 ND ND
WA-A37 0 0 ND ND
WA-A40 0 0 ND ND
WA-A55 0 0 ND ND
WA-A65 0 884 ND 92
WA-A66 0 2563 ND 214
WA-A68 0 535 ND 51a
WA-A78 0 0 ND ND
WA-A79 0 0 ND ND
WA-A80 0 0 ND ND
WA-A81 0 0 ND ND
WA-A82 0 0 ND ND
WA-A88 0 0 ND ND




State Plant Sample NGS C. hominis and C. parvum oocysts numbers determined by
species specific qPCR (MGB probes)
No of reads
assigned to C. hominis
No of reads
assigned to C. parvum
C. hominis oocysts/L C. parvum oocysts/L
WA-A91 0 0 ND ND
Plant B WA-B2 0 0 ND ND
WA-B4 0 0 ND ND
WA-B12 0 0 ND ND
WA-B13 0 0 ND ND
WA-B14 0 0 ND ND
WA-B19 0 0 ND ND
WA-B28 0 0 ND ND
WA-B30 0 0 ND ND
WA-B41 0 0 ND ND
WA-B42 0 0 ND ND
WA-B45 0 0 ND ND
ND = not detected.
WWTP samples in which NGS detected C. parvum and/or C. hominis are in bold.
a For these samples, the C. hominis and C. parvum species-specific qPCR assay failed and oocyst/L is reported based on 18S qPCR and the percentage of NGS reads attributed to C. hominis
and C. parvum.
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protected, with minimal animal access, the predominance of C. parvum
in wastewater in QLD may indicate that human sewage was the source
of C. parvumor that it came from a combination of anthroponotic contri-
butions and industry waste from abattoirs. In many of the QLD plants, a
significant proportionwas “tradewaste” some ofwhichmay have come
from abattoirs, however it was not possible to obtain further informa-
tion on the sources of the trade waste. In WA, C. parvum was detected
in plant A, which received both human and abattoir waste. In NSW,
the single WWTP (Plant B) that was positive for C. parvum received
waste predominately from septic tanks, suggesting an anthroponotic
source. It is also important to remember that previous studies that re-
ported Australian prevalence data for Cryptosporidium were from clini-
cal samples, which in many cases were dominated by samples from
the major metropolitan areas. Based on the population sizes for at
least some of the WWTPs in the present study, most of the “urban
sites” aremore likely to be regional centres, somay have a different pat-
tern of Cryptosporidium prevalence and species composition compared
with major urban centres.
Cryptosporidium meleagridis is a common parasite of humans in
Australia (Ryan and Power, 2012) and also infects a wide range of
birds (Zahedi et al., 2016a), with many overlapping C. meleagridis sub-
types found in both birds and humans; suggesting both anthroponotic
and zoonotic transmission (Silverlas et al., 2012). This is evidenced by
the fact that C.meleagridis is commonly reported in wastewater world-
wide (Hashimoto et al., 2006; Hirata and Hashimoto, 2006; Feng et al.,
2009; Li et al., 2012; Huang et al., 2017). In the present study, C.
meleagridiswas the most prevalent species detected in WWTP samples
collected from WA and in many cases was the only species detected
(Supplementary Table 1). However, it was not detected in NSW or
QLD. Although a variety of bird species are commonly seen at WWTPs
in Australia, particularly around lagoons and clarifiers (secondary and
tertiary treatment), the raw sewage entries to most WWTPs are cov-
ered, and not exposed and accessible to birds and animals. Some of
the C.meleagridis detected inWWTPs inWA could have been originated
from humans, however, further investigation revealed that the raw in-
fluent samples were taken directly from the distribution chamber lo-
cated just before the primary ponds, which was only covered with a
layer of mesh, providing easy access to bird contamination. Alterna-
tively, industrial sources of wastewater from poultry farms could also
be a major contributor. The predominance of the bird-specific C. galli
in WWTP samples from QLD also confirms the potential role birds
may play in contamination of wastewater by Cryptosporidium, but cur-
rently data on the contribution of poultry farms to WWTP in both WA
and QLD is lacking and is an important knowledge gap. To date, there431has only been one report of C. galli in wastewater (Ramo et al., 2017),
however, C. baileyi, another avian Cryptosporidium species, has been re-
ported in several studies from China (Feng et al., 2009; Li et al., 2012;
Huang et al., 2017). It is possible that the high levels of C. meleagridis
and C. galli detected in WA and QLD respectively, were due to contam-
ination in our laboratory. However, this is unlikely as neither species
were included as controls on the same Illumina MiSeq run and quality
filtering removed all reads b100. The high number of C. meleagridis
reads in WA (107 to 58,246 reads/sample) and C. galli reads in QLD
(129 to 32,164 reads/sample) supports their validity. In addition, if it
was due to gross contamination, then both species would be randomly
distributed across all samples, with mixtures of both species in some
samples.
Two emerging human-pathogenic Cryptosporidium species, includ-
ing C. ubiquitum (n = 2) and C. cuniculus (n = 1), were also found in
wastewater samples from QLD at a lower frequency and abundance
than other major species. Cryptosporidium cuniculus is a common para-
site of rabbits and has been reported in source water in South Australia
(Swaffer et al., 2018) and linked to several sporadic human cases in
Australia (Nolan et al., 2010, 2013; Sari et al., 2013 unpublished -
KF279538; Koehler et al., 2014), the UK (Chalmers et al., 2011; Elwin
et al., 2012), Nigeria (Molloy et al., 2010) and France (ANOFEL, 2010).
To date there are no published reports of C. cuniculus detected in
WWTP samples in Australia, however, it has been previously reported
from WWTPs in Brazil, Peru and China (Li et al., 2012; Ulloa-
Stanojlović et al., 2016). Mainly infecting small ruminants, C. ubiquitum
has been identified in a broad range of hosts including humans and
wildlife (in particular rodents) with a wide geographic distribution
across the world (Zahedi et al., 2016a). It has also been frequently re-
ported from source water, stormwater runoff, stream sediment and
wastewater across the world (Xiao et al., 2000; Nolan et al., 2013; Li
et al., 2014). In Australia, C. ubiquitum has not been detected in the stud-
ies conducted to type Cryptosporidium isolates from humans (Ryan and
Power, 2012); however, it has been identified in source water in
Australia (Swaffer et al., 2018). More recently, the identification of sim-
ilar C. ubiquitum subtypes in humans and in wastewater samples from
China, Tunisia and the USA strengthens the hypothesis that sheep and
wild rodents are a source of C. ubiquitum transmission to humans
through contamination of untreated drinking water (Zhou et al., 2003;
Liu et al., 2011; Ben Ayed et al., 2012; Li et al., 2014; Huang et al., 2017).
In the present study C. muris, a predominantly a rodent species of
Cryptosporidium, was sporadically identified in wastewater samples
fromNSWandWA andwas the secondmost prevalent species detected
in QLD. There have been numerous reports of C. muris in humans and
wastewater (Xiao et al., 2001; Ward et al., 2002; Zhou et al., 2003;
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2014; Spanakos et al., 2015; Huang et al., 2017), suggesting both human
contribution as well as faecal contamination by rodents in wastewater
distribution systems. However, as the frequency of detection of C.
muris in humans is low (1–3%) (Wang et al., 2012), rodents are the
more likely source. The identification of other rodent Cryptosporidium
genotypes (rat genotypes I–IV) across all states in the present study,
also supports this hypothesis.
Factors that influence oocyst density in wastewater are the inci-
dence of cryptosporidiosis in the community (i.e. number of infected
humans and animals in the community served by the WWTP), the in-
tensity of infection (oocyst shedding), the size of the community (pop-
ulation), seasonality and dilution by other waste entering the WWTP
(Domenech et al., 2017; King et al., 2017). In the present study, oocyst
numbers per litre of sewage across the three states were estimated
and ranged from 70 to 18,055 oocysts/L (mean = 3426 oocysts/L).
This is similar to a previous study of WWTPs across South Australia
and Victoria, with oocyst densities ranging from 3 to 21,335 oocysts/L
with a mean density of 2355 oocysts/L (King et al., 2017). It is difficult,
however, to compare across different studies using different methodol-
ogies. Worldwide, mean densities of between 10 and N700 oocysts/L
have been commonly reported (Ajonina et al., 2012; Tonani et al.,
2013; Nasser, 2016; Xiao et al., 2018) with a mean of 60,000 oocysts/L
reported in one study (Cantusio Neto et al., 2006). The somewhat
higher number of oocysts detected in the present study compared to
other studies may be due to the fact that the oocyst concentrations
were determined directly from total DNA extracted from WWTP sam-
ples by qPCR (using ddPCR calibrated standards), which may have
overestimated the oocyst concentration, as DNA from lysed (and there-
fore no longer viable) oocysts would also have been detected. Previous
studies have purified oocysts from WWTP samples and counted intact
oocysts using USEPA method 1623, however, recovery efficiencies
from wastewater samples can be highly variable, ranging from 5.5 ±
1.3% to as high as 85% (Nasser, 2016). The DNA extraction efficiency in
the present study is unknown.
Estimation of Cryptosporidium risk from wastewater requires an
evaluation of the efficiency of oocyst removal and inactivation along
the treatment process and the reduction in the levels of oocysts (and
their infectivity) in final treated effluent compared with oocyst counts
in raw sewage (Xiao et al., 2018). Guideline values have traditionally
set log10 removal targets based on end-use application (King et al.,
2017), but these guidelines still do not incorporate the potential for in-
activation of oocysts throughout the treatment process. A limitation of
the present study is that samples were only taken from influent raw
wastewater, and oocyst numberswere not investigated across the treat-
ment train including the final effluent. Another limitation is that the vi-
ability/infectivity of oocysts detected in WWTP samples was not
analysed. A recent study developed an integrated assay to determine
oocyst density and infectivity from a single-sample concentrate (King
et al., 2017), which will allow for improved QMRA analysis, as only
analysing total oocyst numbers in raw sewage could result in an overes-
timation or underestimation of the Cryptosporidium risk in treated
water. Finally, in the present study, the weather on sampling days
(and preceding days) was not taken into account in the study design
and future studies should include this data to better understand the ef-
fects of storm water intrusion for all the plants studied.
Conclusions: The current study has demonstrated that Cryptospo-
ridium is prevalent in the raw influent ofwastewater treatment facilities
across Australia. NGS was central to unravelling the large diversity of
Cryptosporidium species and genotypes in these samples and revealed
the potential contribution of livestock, wildlife and birds (in addition
to humans), to wastewater contamination. While human waste is a
major contributor to WWTPs, the data from the present study suggests
that abattoirs and poultry processing plants etc., could also be major
contributors to wastewater treatment facilities. NGS analysis of the ver-
tebrate species contributing to the wastewater will also help with43determining the origin of the Cryptosporidium species detected in
wastewater samples, and clearly further research is required to better
understand the sources of Cryptosporidium in Australian wastewater.
Comparisons between the results of the present study with previous
studies which used Sanger sequencing are difficult, but as NGS becomes
more widely used as the method of choice for typing pathogens in
wastewater in the future, comparisonswill becomemuchmore relevant
and meaningful across studies.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.scitotenv.2018.07.024.
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First report of Cryptosporidium parvum
in a dromedary camel calf from Western Australia
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Abstract 
Cryptosporidium is an important enteric parasite that can contribute large numbers of infectious oocysts to drinking water
catchments. As a result of its resistance to disinfectants including chlorine, it has been responsible for numerous waterborne 
outbreaks of gastroenteritis. Wildlife and livestock play an important role in the transmission of Cryptosporidium in the envi-
ronment. Studies conducted outside Australia have indicated that camels may also play a role in the transmission of zoonotic
species of Cryptosporidium. Despite Australia being home to the world’s largest camel herd, nothing is known about the preva-
lence and species of Cryptosporidium infecting camels in this country. In the present study, C. parvum was identified by PCR
amplification and sequencing of a formalin-fixed intestinal tissue specimen from a one-week old dromedary camel (Camelus
dromedarius). Subtyping analysis at the glycoprotein 60 (gp60) locus identified C. parvum subtype IIaA17G2R1, which is a
common zoonotic subtype reported in humans and animals worldwide. Histopathological findings also confirmed the presence
of large numbers of variably-sized (1–3 μm in diameter) circular basophilic protozoa – consistent with Cryptosporidium
spp.– adherent to the mucosal surface and occasionally free within the lumen. Further analysis of the prevalence and species
of Cryptosporidium in camel populations across Australia are essential to better understand their potential for contamination
of drinking water catchments.
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Introduction
Cryptosporidium spp. are ubiquitous enteric parasites with 
a wide range of vertebrate hosts including humans (Hunter
et al. 2007; Xiao 2010; Ryan et al. 2014). Transmission is via
direct faecal-oral contact and via contamination of food and
water with numerous waterborne outbreaks reported globally
(Baldursson and Karanis 2011; Efstratiou et al. 2017). Cryp-
tosporidium is particularly suited to waterborne transmission
as the environmental stage, the oocysts, are shed in large quan-
tities, have a low infectious dose (1–10 oocysts) and are highly
resistant to disinfectants including chlorine treatment of com-
munity water supplies (Baldursson and Karanis 2011; Efstra-
tiou et al. 2017). To date, 34 valid Cryptosporidium species
have been described, of which more than 20 species have been
reported in humans, with C. hominis and C. parvum responsi-
ble for the majority of human infections (Jezkova et al. 2016;
Zahedi et al., 2017).
Wildlife and livestock can contribute large numbers of
Cryptosporidium oocysts to the environment, which may be
transported to surface water and contaminate drinking water
sources (Ryan et al. 2014; Zahedi et al. 2016). Therefore,
wild and domestic animals play an important role in the epi-
demiology and transmission dynamics of zoonotic Cryp-
tosporidium species (Appelbee et al. 2005; Ziegler et al. 2007;
Ryan et al. 2014). However, very little is known about the
range of species and genotypes of Cryptosporidium in
camelids, particularly domesticated dromedary (Camelus
dromedaries) and bactrian (Camelus bactrianus) camels, and
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studies that have investigated Cryptosporidium in camelids 
to date have identified C. andersoni, C. muris, C. parvum and
C. ubiquitum in bactrian camels, llamas (Lama glama) and 
alpacas (Vicugna pacos) (Starkey et al. 2007; Wang et al.
2008; Gómez-Couso et al. 2012; Wang et al. 2012; Liu et al.
2014; Robertson et al. 2014). Reports of cryptosporidiosis in
dromedary camels have all been based on microscopy and no
molecular data is available (Razavi et al. 2009; Nazifi et al.
2010; Sazmand et al. 2011; Yakhchali and Moradi 2012). 
Both dromedary and bactrian camels have a global popu-
lation of over 27 million (FAO 2014), with the majority of
camels in Australia being dromedary camels (Edwards et al.
2008). Dromedary camels were imported into Australia in the
19th century for transport and explorations, and are well
adapted to arid and semi-arid areas of Australia including
Western Australia, the Northern Territory, western Queensland
and northern South Australia. With no natural predators, their
populations have flourished rapidly resulting in the Australian
government introducing a management (culling) program in
2009 (Brown 2004; Edwards et al. 2004, 2008). Currently, the
feral dromedary camel population in Australia is the world’s
largest camel herd, estimated at 300,000 (Tan et al. 2016),
however in-depth information about diseases in these camels
is scarce (Brown 2004) and to date, no molecular data is avail-
able for Cryptosporidium spp. infecting camels in Australia.
The present study is the first report of a Cryptosporidium
species from a dromedary camel calf referred to the Animal
Hospital at Murdoch University, Western Australia.
Materials and Methods
Clinical record
A fresh carcass of a one-week old 45 kg female dromedary
camel calf in lean body condition was submitted to the Mur-
doch University Pathology Department for post-mortem ex-
amination. The calf was born from a feral dromedary camel
that had been brought into a farm two weeks prior with other
dromedary camels. No abnormalities were seen for the first
five days after birth, and the calf was treated for endo- and ec-
toparasites on day five as part of the standard treatment be-
fore the new camels were introduced to the rest of the herd. On
day six, the calf went lame, and the following morning the calf
was found in lateral recumbency, poorly responsive, with di-
arrhoea, and was flaccid and dehydrated by the afternoon, and
therefore was referred to the Animal Hospital at Murdoch Uni-
versity, Perth, Western Australia. After a thorough examination
by a veterinarian, the animal was euthanised due to a poor
prognosis. A post-mortem examination was immediately per-
formed and revealed the entire mucosal surface of the intes-
tinal tract to be necrotic with half a dozen mucosal ulcers
within the mid-jejunum. Sections of multiple organs, includ-
ing the intestinal tract, were placed in a 10% buffered forma-
lin solution for histopathology.
Histopathology
Sections of intestinal tissue were fixed in formalin for 24 h then
routinely processed for histopathological diagnosis. 2 µm-thick
sections were cut and manually stained with a Giemsa stain for
microscopic assessment. For the staining, microscope slides
containing cut intestinal tissue sections were acidified with 10%
acetic acid for 15 s. The slides were then placed in a solution of
0.75 g Giemsa powder, 65 ml methanol and 65 ml glycerol,
which was diluted 1:10 with water, and heated to 50°C for 
1 min. The jar containing the slides was then microwaved on 
a low setting for 30 seconds. The slides were then rinsed with
distilled water and cover-slipped. Two veterinary pathologists
performed the microscopic assessment, including a diplomat of
the American College of Veterinary Pathologists (A.L.W.).
DNA isolation
Following five cycles of freeze-thaw, genomic DNA (gDNA)
was extracted from ≤ 25 mg sections of the formalin-fixed 
intestinal tissue using a QIAamp DNA FFPE Tissue Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions (Paraffin removal steps were excluded). An ex-
traction blank negative control (no faecal sample) was in-
cluded. Purified DNA was stored in –20°C before being
processed by PCR. DNA extraction and post-DNA extraction
procedures were performed in separate laboratories.
PCR amplification of the 18S rRNA gene
Extracted DNA was amplified at the 18S locus using primers
which produced a 611 bp product as previously described
(Silva et al. 2013) with minor modifications; the annealing
temperature was increased to 57°C for 30 s and the number of
cycles was increased from 39 to 45 cycles for both primary
and secondary reactions. Each 25 µl PCR mixture contained
1 µl of gDNA, 1x KAPA Taq buffer (KAPA Biosystems,
South Africa), 3.75 mM MgCl
2
, 400 µM of each dNTP, 0.4
µM of forward and reverse primers and 1 U/reaction KAPA
Taq DNA polymerase (KAPA Biosystems, South Africa). PCR
contamination controls used included no-template controls.
PCR amplification of the actin gene
An ~818 bp fragment was amplified at the actin locus as pre-
viously described (Ng et al. 2006), with the following modi-
fications; denaturation time was increased from 30 s to 45 s,
annealing time from 20 s to 30 s and extension time from 40
s to 1 min. Both positive and no-template PCR controls were
included in the reaction to validate the PCR.
PCR amplification of the gp60 gene
As C. parvum was identified at both 18S and actin loci, sub-
typing was conducted using a nested PCR at the 60 kDa gly-
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coprotein (gp60) locus as previously described (Zhou et al.
2003).
Sequence analysis
The amplified DNA from secondary PCR products were sep-
arated by gel electrophoresis and were purified for sequencing
using an in-house filter tip method (Yang et al. 2013). Purified
PCR products were sequenced independently using an ABI
Prism™ Dye Terminator Cycle Sequencing kit (Applied
Biosystems, Foster City, California, USA) according to the
manufacturer’s instructions, with annealing temperatures of
57°C, 58°C and 54°C for the 18S rRNA, actin and gp60 loci,
respectively. Sanger sequencing chromatogram files were im-
ported into Geneious Pro 8.1.6 (Kearse et al. 2012), edited,
analysed and aligned with reference sequences from GenBank
using Clustal W (http://www.clustalw.genome.jp).
Results
Histopathological findings
Six sections of small intestine were evaluated. Villi were oc-
casionally fused, with blunted tips. There were large numbers
of variably-sized (1-3 μm in diameter) circular basophilic pro-
tozoa adherent to the mucosal surface and also occasionally
free within the lumen (Fig 1). The lamina propria was ex-
panded by moderate to large numbers of neutrophils, lym-
phocytes, plasma cells and eosinophils, and scattered
throughout the sections within the superficial lamina propria
were necrotic cells with hypereosinophilic cytoplasm and py-
knotic or karyorrhectic nuclei. Blood vessels were congested.
Based on these pathological findings, severe, multifocal to co-
alescing lymphoplasmacytic, neutrophilic and eosinophilic en-
teritis with multifocal necrosis and intralesional protozoa (con-
sistent with Cryptosporidium spp.) was reported.
Cryptosporidium species detected in a camel calf
Based on the sequence analysis at the 18S and actin loci, 
C. parvum was identified in this camel calf. At the actin locus,
the isolate exhibited a single nucleotide polymorphism (SNP)
from a reference C. parvum isolate (AF382337) across 787 bp
of the sequence, while across 591 bp at the 18S locus, two
SNPs were present when compared to the reference C. parvum
isolate (AY204230).
Subtyping analysis across 548 bp of gp60 sequence iden-
tified C. parvum subtype IIaA17G2R1, with three SNPs from
a reference isolate (JF727798) from a human patient in New
South Wales, Australia. Nucleotide sequences reported in this
paper are available in the GenBank database under accession
numbers MG738816, MG738817 and MG738818.
Discussion
Neonatal calf diarrhea is a major issue of camel production in-
dustry and can be attributed to nutritional issues as well as a
large spectrum of pathogenic agents including bacteria, viruses
and parasites (Al-Ruwaili et al. 2012; Muktar et al. 2015). In the
present study, histopathological damage due to the observed in-
fection with Cryptosporidium spp., was most likely responsi-
ble for the diarrhoea, recumbency and dehydration noted
clinically. However, contributing factors and pathogens cannot
be ruled out. Further tests are required to confirm the presence
and pathogenicity of other infectious agents.
To the best of authors’ knowledge, this is the first case of
cryptosporidiosis reported from dromedary camels in Aus-
tralia, for which molecular characterisation was conducted.
Fig. 1 Small intestine, Giemsa stain, x1000 magnification, depicting various Cryptosporidium developmental stages attached to the brush 
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Cryptosporidium parvum is the most commonly reported
zoonotic species of Cryptosporidium infecting humans and is
also the most common species detected in cattle (Bos taurus)
in Australia (Ryan et al. 2014). While there are no previous re-
ports of this species from camelids in Australia, studies have
reported C. parvum in alpacas (Vicugna pacos) from the USA
and Peru (Starkey et al. 2007; Gómez-Couso et al. 2012) and
in camels (C. dromedarius) from Iran (based on morphology
only) (Razavi et al. 2009).
In the present study, the C. parvum subtype IIaA17G2R1
was identified, which is a common zoonotic subtype reported
in both humans and animals worldwide (Xiao et al. 2007;
Broglia et al. 2008; Wielinga et al. 2008; Mi et al. 2014; Cer-
tad et al. 2015) and has been reported widely in both cattle and
humans in Australia (Nolan et al. 2009; Ng et al. 2011; Wal-
dron et al. 2011). Although most feral camels live in remote
arid and semi-arid areas of central and western Australia
(Saalfeld and Edwards 2010), they still have access to drink-
able water sources (Pople and McLeod 2010), which may
also be used by humans.
Recent periods of drought in Australia have resulted in feral
camels entering remote communities in search of water and ex-
tensively damaging water infrastructure such as bathrooms,
bores, taps and tanks, with the potential to contaminate remote
communities’ drinking water sources. Similarly, during
droughts, areas close to remote waterholes, rock-holes, soaks
and springs become refuges for camels, where they can easily
contaminate these water sources. A study by Brim-Box et al.
(2010) reported that faecal contamination of a waterhole used
as drinking water for people travelling through the Petermann
and Katiti Aboriginal Land trusts in the Uluru-Kata Tjuta Na-
tional Park, Northern Territory, was most likely caused by
feral camels that were recorded and monitored at the site, es-
pecially during periods of low rainfall. Therefore, camel pop-
ulations in Australia may contribute to the zoonotic transmis-
sion of C. parvum via contamination of the environment, in
particular water sources for remote communities. These find-
ings indicate the need for further characterisation of the preva-
lence, intensity of infection and species of Cryptosporidium in
camel populations across Australia.
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A B S T R A C T
Cryptosporidiosis is a protozoan parasitic disease which affects human and animals worldwide. In adult im-
munocompetent individuals, cryptosporidiosis usually results in acute and self-limited diarrhoea; however, it
can cause life threatening diarrhoea in children and immunocompromised individuals. In the present study, we
compared the prevalence of Cryptosporidium species and gp60 subtypes amongst paediatric oncology patients
with diarrhoea (n = 160) from King Hussein Medical Centre for Cancer in Jordan, and non-oncology paediatric
patients with diarrhoea (n = 137) from Al-Mafraq paediatric hospital. Microscopy results using modified acid
fast staining identified a significantly (p ≤0.05) higher prevalence of Cryptosporidium in paediatric oncology
patients with diarrhoea (14.4% - 23/160), compared to non-oncology paediatric patients with diarrhoea only
(5.1% - 7/137). With the exception of one sample, all microscopy-positive samples (n = 29) and an additional 3/
30 microscopy-negative controls were typed to species and subtype level at the 18S and gp60 loci, respectively.
All Cryptosporidium positives were typed as C. parvum. Of the 22 typed Cryptosporidium positives from the
paediatric oncology patients, 21 were subtyped as IIaA17G2R1 and one as IIaA16G2R1 C. parvum subtypes. The
7 typed positives from the paediatric patients from Al-Mafraq hospital were subtyped as IIaA17G2R1 (n = 5)
and IIaA16G2R1 (n = 2). The 3 additional positives from the 30 microscopy negative control samples were
subtyped as IIaA17G2R1. The high prevalence of the IIaA17G2R1 subtype, particularly amongst oncology pa-
tients, suggests that an outbreak of cryptosporidiosis may have been occurring in oncology patients during the
collection period (April to December, 2016). New therapies for cryptosporidiosis in immunocompromised pa-
tients are urgently required.
1. Introduction
Cryptosporidium species are intracellular protozoan parasites that
infect a wide range of hosts including humans, domestic and wild an-
imals (Ryan et al., 2014; Zahedi et al., 2016). World-wide, human
cryptosporidiosis is mainly caused by two species of Cryptosporidium (C.
hominis and C. parvum); although numerous species of Cryptosporidium
have been reported in humans, including C. meleagridis, C. felis, C. canis,
C. cuniculus, C. ubiquitum, C. viatorum, C. suis, C. scrofarom, C. viatorum,
C. tyzerri, C. xiaoi, C. fayeri, C. muris, and C. andersoni (Xiao, 2010; Ryan
et al., 2016).
Cryptosporidium infection can result in acute diarrhoea, nausea,
vomiting and weight loss, which is usually self-limiting (Ryan et al.,
2016). In infants, cryptosporidiosis can be more serious and can lead to
malnutrition, growth retardation and impairment in cognitive function
(Shrivastava et al., 2017). Similarly, patients with some type of im-
munocompromised condition have an increased probability of
acquiring cryptosporidiosis, which can manifest as severe protracted
diarrhoea, chronic malabsorption, failure to thrive, malnutrition and
increased mortality (Assefa et al., 2009; Idris et al., 2010; Domenech
et al., 2011; Kurniawan et al., 2013; Marcos and Gotuzzo, 2013;
Valenzuela et al., 2014; Nsagha et al., 2016).
Immunosuppression and diarrhoea are well-recognised side-effects
of cancer treatment, yet relatively few studies have been conducted
examining the prevalence of Cryptosporidium in cancer patients (Botero
et al., 2003; Tamer et al., 2008; Al-Qobati et al., 2012; Hassanein et al.,
2012; Sulżyc-Bielicka et al., 2012; García-Elorriaga et al., 2013). In
Jordan, the molecular epidemiology of cryptosporidiosis is poorly un-
derstood and to date, only two genotyping studies have been conducted
(Hijjawi et al., 2010; Hijjawi et al., 2016). The aim of the present study
was to investigate the prevalence of Cryptosporidium species and sub-
types in paediatric oncology patients with diarrhoea and paediatric
patients with diarrhoea only, to better understand the epidemiology
and management of cryptosporidiosis in these patients.
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2. Materials and methods
2.1. Cryptosporidium isolates
A total of 297 fresh diarrheic stool specimens were collected from
two groups of children (aged 1–5 years old) from April until December,
2016; including paediatric oncology patients with diarrhoea at the King
Hussein Medical Centre for Cancer (n = 160) and paediatric patients
with diarrhoea only at the Al-Mafraq paediatric hospital (n = 137). The
samples from King Hussein Medical Centre for Cancer were collected
from children undergoing chemotherapy for different types of cancer
(mainly leukemia) and who resided in different parts of Jordan but
regularly visited the centre for treatment. The children who were re-
ferred to the Al-Mafraq paediatric hospital, were mainly from Al-
Mafraq city and nearby villages. In addition, a further 30 samples were
collected from the same two hospitals (18 samples from the King
Hussein Medical Centre for Cancer and 12 from Al-Mafraq hospital),
from children with diarrhoea, but which were negative by microscopy
for Cryptosporidium oocysts, in order to serve as a negative control to
compare the sensitivity of microscopy and PCR.
Ethical approval to conduct the study was obtained from the King
Hussein Medical Centre for Cancer and Al-Mafraq paediatric hospital
and issued by the Institutional Review Board at Hashemite University
(Ethics permit number 150/1313/18). A signed consent form was ob-
tained from parents or guardians of each child, who voluntarily parti-
cipated after a clear explanation of the research objectives.
Demographic data regarding age, gender, residency, medical history
and duration of symptoms were obtained via questionnaire from the
guardian of each child (Ethics permit number 150/1313/18).
2.2. Microscopy, DNA extraction and typing
Microscopy was performed on all faecal samples using a routine
modified acid fast staining procedure. Briefly, a smear was prepared
using 1 to 2 drops of the collected stool specimen, fixed with absolute
methanol for 30 s, stained with carbol fuchsin for 3 min, rinsed briefly
with tap water before being stained with methylene blue. The stained
dried slides were labelled and examined at 100× oil immersion lens
under a light microscope (Olympus CH40/RF200, Japan) for the
presence of Cryptosporidium oocysts.
For subsequent DNA extraction, 1 to 2 g of the individually collected
fresh stool specimen from each child were fixed in 2.5% potassium
dichromate and left at room temperature for 2–6 months. Before DNA
extraction, the stool samples were washed three times in 10% PBS
buffer and centrifuged at 2000 ×g for 2–3 min in order to remove the
potassium dichromate. Total DNA was extracted using a QIAmp DNA
Stool Kit (Qiagen, Germany), following the recommendation of the
supplier after 5 cycles of freezing and thawing. The extracted DNA was
stored at −80 °C until further molecular characterization. All samples
which were positive for Cryptosporidium by microscopy (n = 30) and
the 30 samples that were Cryptosporidium negative by microscopy (ne-
gative controls) were initially screened at the 18S locus and identified
to species level using nested PCR amplification and Sanger sequencing
as previously described (Xiao et al., 1999). Samples were then subtyped
at the glycoprotein 60 (gp60) locus using a nested PCR to amplify a
~400 bp product using the primers AL3531 (5′-ATAGTCTCCGCTGTA-
TTC-3′) and AL3533 (5-GAGATATATCTTGGTGCG-3) for the primary
PCR, and AL3532 (5′-TCCGCTGTATTCTCAGCC-3′) and LX0029 (5′-C-
GAACCACATTACAAATGAAGT-3′) for the secondary PCR (Sulaiman
et al., 2005).
2.3. Statistical analysis
The prevalence of Cryptosporidium in faecal samples collected from
each group was expressed as the percentage of samples positive by
microscopy, with 95% confidence intervals calculated assuming a bi-
nomial distribution, using the software Quantitative Parasitology 3.0
(Rózsa et al., 2000). Fisher's exact test was performed using SPSS 22 for
Windows (SPSS Inc. Chicago, USA), to determine if there was a statis-
tical difference in the prevalence of Cryptosporidium in paediatric on-
cology patients with diarrhoea and paediatric patients with diarrhoea
only.
3. Results
3.1. Prevalence by microscopy and demographic data
Microscopic screening using modified acid fast staining of the 297
Table 1
Demographic data, Cryptosporidium species and subtypes for the 23 microscopy-positive faecal samples, which were collected from April until December 2016 from paediatric oncology
patients attending the King Hussein cancer centre.
Locality Collection date (day/month) Age (in years) Sex Clinical symptoms Type of cancer Species (18S) gp60 subtype
Amman 4/4 5 M Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Zarqa 11/4 3 M Diarrhoea/mucus Leukemia C. parvum IIaA17G2R1
Irbid 11/4 2 F Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Al-Mafraq 24/4 5 M Diarrhoea/watery NA C. parvum IIaA17G2R1
Amman 2/5 5 M Diarrhoea/watery Neuroblastoma C. parvum IIaA17G2R1
Amman 16/5 2 F Diarrhoea/mucus Lymphoma C. parvum IIaA17G2R1
Amman 30/5 5 M Diarrhoea/mucus Leukemia C. parvum IIaA17G2R1
Amman 30/5 1 F Soft stool Brain cancer C. parvum IIaA16G2R1
Amman 6/6 2 F Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Zarqa 20/6 3 M Diarrhoea/mucus Bone cancer C. parvum IIaA17G2R1
Zarqa 4/7 4 F Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Zarqa 18/7 4 F Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Zarqa 1/8 3 F Diarrhoea/mucus NA C. parvum IIaA17G2R1
Amman 15/8 2 M Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Jarash 15/8 1.5 M Diarrhoea/watery NA C. parvum IIaA17G2R1
Jarash 29/8 2 M Diarrhoea/mucus Leukemia No amplification –
Amman 5/9 1 M Soft stool NA C. parvum IIaA17G2R1
Zarqa 5/9 1 F Diarrhoea/watery NA C. parvum IIaA17G2R1
Amman 12/9 5 M Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Asalt 26/9 5 F Soft stool Lymphoma C. parvum IIaA17G2R1
Zarqa 3/10 4 M Diarrhoea/watery Leukemia C. parvum IIaA17G2R1
Zarqa 17/10 2 M Soft stool NA C. parvum IIaA17G2R1
Amman 17/10 1 M Diarrhoea/mucus Leukemia C. parvum IIaA17G2R1
NA: not available.
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stool specimens from the recruited children in the present study iden-
tified a prevalence of 14.4% (23/160) – 95% CI 9.3–20.8, in paediatric
oncology patients with diarrhoea and 5.1% (7/137) – 95% CI, 2.1–10.2
for non-oncology paediatric patients with diarrhoea. This difference
was significant (p < 0.05). The overall prevalence of Cryptosporidium
across the two groups was 10.1% (30/297) 95% CI 6.9–14.1.
The majority of Cryptosporidium-positive paediatric oncology pa-
tients (82.6% - 19/23) were experiencing diarrhoea, whereas the re-
maining 4 had soft stools (Table 1). Of the paediatric patients from Al-
Mafraq hospital, 57.1% (4/7) had diarrhoea, while the remaining 3 had
soft stools (Table 2). Leukemia was the most common type of cancer
experienced by the patients that were positive for Cryptosporidium
(n = 12), followed by lymphoma (n = 2). Data on the type of cancer
was unavailable for 6 patients (Table 1).
3.2. Cryptosporidium species and gp60 subtypes
Sequences were obtained for 29/30 positives from the two groups.
In addition, screening of the additional 30 faecal samples from pae-
diatric patients from both hospitals, which were negative for
Cryptosporidium by microscopy, identified another 3 positives. A total of
32 samples typed. All were identified as C. parvum. Of the 22 typed
Cryptosporidium positives from the paediatric oncology patients, from
King Hussein Medical Centre for Cancer, 21 were typed as IIaA17G2R1
and one as IIaA16G2R1 (Table 1). The 7 typed positives from the
paediatric patients from Al-Mafraq hospital were typed as IIaA17G2R1
(n = 5) and IIaA16G2R1 (n = 2). The 3 additional positives from the
30 microscopy negative control samples were typed as IIaA17G2R1
(Supplementary Table 1). There was no heterogeneity within individual
subtypes. Representative gp60 sequences from C. parvum subtypes
IIaA17G2R1 and IIaA16G2R1 were submitted to GenBank under ac-
cession numbers MF770731 – MF770734.
4. Discussion
The present study compared the prevalence of Cryptosporidium
species and gp60 subtypes amongst paediatric oncology and non-on-
cology patients with diarrhoea. As expected, the prevalence of
Cryptosporidium was significantly higher amongst paediatric oncology
patients with diarrhoea (14.4%), compared to non-oncology paediatric
patients with diarrhoea (5.1%), with 2.8 times more cryptosporidiosis
cases amongst the former. This result is similar to a previous study in
Egypt, which detected Cryptosporidium in 24% of children with acute
lymphoblastic leukemia (ALL) on maintenance chemotherapy, com-
pared to 3% in control patients with diarrhoea (Hassanein et al., 2012).
In addition to being a cause of diarrhoea in oncology patients, Cryp-
tosporidium has been associated with colon cancer (Sulżyc-Bielicka
et al., 2012) and has been shown to induce low-to-high grade intestinal
dysplasia in immunocompromised mice (Abdou et al., 2013).
Previous studies in Jordan (for which the immune status is un-
known) have reported prevalences ranging from 1.5–37.7% in humans
and 3.9–18.7% in production animals using both microscopy and mo-
lecular tools (Youssef et al., 2000; Nimri, 2003; Mahgoub et al., 2004;
Hijjawi et al., 2010; Hijjawi et al., 2016(. These differences likely reflect
differences in detection methods, sample size, area of collection and
microscopist skill etc.
During the present study, only one species, C. parvum and two gp60
subtypes (IIaA16G2R1, IIaA16G2R1), were detected in all the typed
isolates. This was an unexpected finding as in two previous genotyping
studies in Jordan, up to 4 Cryptosporidium species (C. parvum, C. ho-
minis, C. meleagridis, and C. canis) and six subtype families (IIa, IIc, IId,
1b, 1d and IIIa) were detected in human isolates (Hijjawi et al., 2010;
Hijjawi et al., 2016). In the previous two studies, C. parvum and C.
hominis were the dominant species and were detected in almost equal
frequencies (Hijjawi et al., 2010; Hijjawi et al., 2016). The lack of
identification of the C. parvum IId subtype and also C. hominis is sur-
prising, as previous studies have shown that both are common in hu-
mans in Middle Eastern countries including Jordan, although most
studies have reported that C. parvum is the dominant Cryptosporidium
species (Sulaiman et al., 2005; Meamar et al., 2007; Al-Brikan et al.,
2008; Pirestani et al., 2008; Hijjawi et al., 2010; Iqbal et al., 2011;
Nazemalhosseini-Mojarad et al., 2011; Taghipour et al., 2011; Alyousefi
et al., 2013; Sharbatkhori et al., 2015), which may explain the lack of
detection of C. hominis. The IIa subtype family has been previously
detected in Jordan children, however, this is the first report of the
IIaA17G2R1 and IIaA16G2R1 subtypes in humans in Jordan. The
IIaA16G2R1 subtype has also been previously reported from one cattle
isolate from Jordan (Hijjawi et al., 2016).
The dominant subtype, IIaA17G2R1, was detected in 91.3% (95%
CI, 72–98.9) of paediatric oncology patients with diarrhoea and 71.4%
(95% CI, 29–96.3) of paediatric patients with diarrhoea only. The high
prevalence of this subtype, particularly amongst oncology patients,
suggests that an outbreak may have been occurring in oncology patients
at the King Hussein Medical Centre for Cancer and Al-Mafraq hospital
during the collection period (summer 2016). This may also explain the
lack of detection of the C. parvum IId subtype and C. hominis. However,
Multi-Locus Sequence Typing (MLST) is required to confirm this.
Alternatively, the low heterogeneity observed at the subtype level, may
reflect intensive and stable transmission of C. parvum in this region. For
example, a study of several human populations in Tunisia reported that
the C. hominis subtype IaA26G1R1, was the most dominant subtype
(50%), suggesting stable anthroponotic cryptosporidiosis transmission
(Essid et al., 2017). IIaA17G2R1 is a relatively common subtype that
has been reported in livestock (Alves et al., 2006; Xiao et al., 2007; Mi
et al., 2014; Kaupke and Rzeżutka, 2015) and has also been responsible
for an outbreak of cryptosporidiosis in a youth summer camp in North
Carolina in 2009 (CDC, 2011). In the latter study, IIaA17G2R1 was
identified in faecal samples from livestock and humans at the camp,
indicating that zoonotic transmission may have occurred. In the present
study, the source of the Cryptosporidium infection is unknown but may
have been due to the consumption of contaminated food or water. In
order to identify the risk factors involved in the acquisition of Cryp-
tosporidium infections in children and immunocompromised individuals
in Jordan, a well-designed case control study, with detailed collection
of data on water and food sources, animal and human contact and
immune status is required. As only one molecular study has been con-
ducted on species and subtypes of Cryptosporidium in livestock in Jordan
(Hijjawi et al., 2016), further studies on larger numbers of animal and
human samples, as well as water samples are essential to determine the
transmission dynamics of cryptosporidiosis in Jordanian children.
A limitation of the present study is that while a compromised im-
mune system can be assumed for the paediatric oncology patients, the
immune status of non-oncology paediatric patients with diarrhoea is
unknown, as this is not part of routine monitoring for children in
Table 2
Demographic data, Cryptosporidium species and subtypes for the 7 microscopy-positive
faecal samples from non-oncology paediatric patients with diarrhoea attending the Al-










4 6/4 F Soft stool C. parvum IIaA17G2R1
3 20/4 F Diarrhoea/
mucus
C. parvum IIaA17G2R1
3 11/5 M Diarrhoea/
watery
C. parvum IIaA16G2R1
1 15/6 M Diarrhoea/
watery
C. parvum IIaA16G2R1
5 29/6 M Soft stool C. parvum IIaA17G2R1
4 6/7 F Diarrhoea/
watery
C. parvum IIaA17G2R1
3 24/8 M Soft stool C. parvum IIaA17G2R1
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Jordan hospitalised for diarrhoea. In addition, in the present study, the
prevalence of Cryptosporidium species and subtypes in these children
was accessed using microscopy only and therefore the true prevalence
is likely underestimated. For example, one previous which compared
microscopy and molecular analysis on Jordanian human patients
identified a prevalence of 1.8% by microscopy and> 19% by quanti-
tative PCR (qPCR) confirming the superior sensitivity of PCR (Hijjawi
et al., 2010). The finding of an additional 3 positives in the present
study in the 30 microscopy negative samples, further supports this.
In conclusion, a high prevalence of cryptosporidiosis was detected
amongst paediatric oncology patients. Routine screening for
Cryptosporidium should be conducted for all oncology patients under-
going chemotherapy, preferably by PCR. The detection of cryptospor-
idiosis in these patients however presents specific challenges for the
treatment, as the only FDA approved drug, nitazoxanide, is ineffective
in immunocompromised individuals (Amadi et al., 2009). A previous
study reported the eradication of Cryptosporidium in four children with
acute lymphoblastic leukemia using paromomycin or azithromycin
(Trad et al., 2003), and therefore these therapies should be considered
for paediatric oncology patients. There is no vaccine for cryptospor-
idiosis and given the parasite's high infectivity, robustness, and re-
sistance to disinfection (Ryan et al., 2016), improved therapeutics
particularly for immunocompromised individuals are urgently required.
The advent of whole genome sequencing has identified several pro-
mising drug targets including inosine-5′-monophosphate dehy-
drogenase (IMPDH) (essential for purine salvage) and acyl-coenzyme A
synthetases (LC-ACS) which are essential in fatty acid metabolism
(Ryan and Hijjawi, 2015), which holds promise for the future.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.meegid.2017.08.033.
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A B S T R A C T
The morphological, biological, and molecular characterisation of a new Cryptosporidium species from the guinea
pig (Cavia porcellus) are described, and the species name Cryptosporidium homai n. sp. is proposed. Histological
analysis conducted on a post-mortem sample from a guinea pig euthanised due to respiratory distress, identified
developmental stages of C. homai n. sp. (trophozoites and meronts) along the intestinal epithelium. Molecular
analysis at 18S rRNA (18S), actin and hsp70 loci was then conducted on faeces from an additional 7 guinea pigs
positive for C. homai n. sp. At the 18S, actin and hsp70 loci, C. homai n. sp. exhibited genetic distances ranging
from 3.1% to 14.3%, 14.4% to 24.5%, and 6.6% to 20.9% from other Cryptosporidium spp., respectively. At the
18S locus, C. homai n. sp. shared 99.1% similarity with a previously described Cryptosporidium genotype in
guinea pigs from Brazil and it is likely that they are the same species, however this cannot be confirmed as actin
and hsp70 sequences from the Brazilian guinea pig genotype are not available. Phylogenetic analysis of con-
catenated 18S, actin and hsp70 sequences showed that C. homai n. sp. exhibited 9.1% to 17.3% genetic distance
from all other Cryptosporidium spp. This clearly supports the validity of C. homai n. sp. as a separate species.
1. Introduction
Cryptosporidum spp. are protozoan parasites responsible for gastro-
enteritis in a wide range of vertebrates including humans, domestic and
wild animals and are a common cause of waterborne outbreaks
worldwide (Zahedi et al., 2016; Ryan et al., 2016; Efstratiou et al.,
2017). The parasite is transmitted via the faecal-oral route with both
zoonotic and anthroponotic transmission cycles (Ryan et al., 2014).
Currently relatively little is known about the molecular characteristics,
host specificity, pathogenicity and zoonotic importance of Cryptospor-
idium spp. in wild and domestic rodents (Appelbee et al., 2005; Ziegler
et al., 2007a,b; Ryan et al., 2014; Kváč et al., 2016; Li et al., 2016). To
date, of the 33 recognised Cryptosporidium spp. (cf. Ryan et al., 2016;
Jezkova et al., 2016), 11 species including C. proliferans, C. meleagridids,
C. tyzerri, C. andersoni, C. ubiquitum, C. wrairi, C. parvum, C. suis, C.
meleagridis, C. muris and C. rubeyi and over 20 genotypes of unknown
species status have been reported in rodents with a prevalence ranging
from 1% to 63% (Table 1) (Qi et al., 2015; Song et al., 2015; Stenger
et al., 2015; Zahedi et al., 2016; Li et al., 2016).
The guinea pig (Cavia porcellus) is one of eight species in the genus
Cavia (Rodentia: Caviidae), and is endemic to South America. Based on
available archaeological and molecular data, it has been living in the
region since the Miocene-Pliocene boundary, and it has been suggested
that C. porcellus was initially derived from Cavia tschudii, when the
Amerindia peoples of Peru started to domesticate guinea pigs
4500–7000 years ago. Eventually, the utility of the domesticated form
of guinea pig as a food source or pet and laboratory animal, has resulted
in its worldwide distribution including Australia (Dunnum and Salazar-
Bravo, 2009).
Currently, C. wrairi is the only valid Cryptosporidium spp. described
in guinea pigs (Cavia porcellus), with strong host specificity and no re-
ports of human infection (Vetterling et al., 1971; Chrisp et al., 1990;
Spano et al., 1997; Lv et al., 2009; Gressler et al., 2010; Smith et al.,
2010). Previous experimental infections indicated that C. wrairi was
infective to mice, lambs and calves, causing a sparse infection in ru-
minants, however as genotyping was not conducted, this cannot be
confirmed (Angus et al., 1985; Chrisp et al., 1992).
The present study examined the morphological, biological and
http://dx.doi.org/10.1016/j.vetpar.2017.08.014
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molecular characteristics of a Cryptosporidium sp. detected in the gas-
trointestinal tract and faeces of guinea pigs. Based on the collective data
from the present study, the Cryptosporidium spp. detected in these
guinea pigs is genetically and biologically distinct from all species of
Cryptosporidium described previously, and we propose the species name
Cryptosporidium homai n. sp. For clarity, we herein refer to this novel
species by its proposed name.
2. Materials and methods
2.1. Source of sample and sample processing
A guinea pig, which was part of a group of experimental animals
held at the University of Western Australia Animal Care Services, Perth,
Australia, presented with audible respiratory distress (rattled breathing
sounds, difficulty in breathing and chin coated in saliva) and as a result
was euthanised. Post-mortem examination was performed and intestinal
and lung sections were sent to a specialist veterinary laboratory for
further histopathological examination, and during routine handling,
individual faecal sample were collected and stored at 4 °C until re-
quired. Further to the initial histopathology and molecular analysis,
additional faecal samples (n = 28) were collected either from in-
dividual animals or pooled from animals kept in the same enclosure for
further molecular analysis (Table 2).
2.2. Histopathology
Sections of intestinal tissue were fixed in 10 mg/100 ml phosphate
buffered formalin for at least 24 h, dehydrated in an ethanol-xylene
series and embedded in paraffin wax. Two micrometer tissue sections
Table 2
List of faecal samples collected for this study, from guinea pigs, held at the University of
Western Australia Animal Care Services, Perth, Australia.
Sample ID Date Type of sample
Z1 12/12/2016 Faeces – Pooled
Z2 12/12/2016 Faeces – Individual
Z3 12/12/2016 Faeces – Individual
Z4 12/12/2016 Faeces – Pooled
Z5 12/12/2016 Faeces – Pooled
Z6 12/12/2016 Faeces – Pooled
Z7 12/12/2016 Faeces – Pooled
Z8 12/12/2016 Faeces – Pooled
Z9 12/12/2016 Faeces – Pooled
Z10 12/12/2016 Faeces – Pooled
Z11 12/12/2016 Faeces – Pooled
Z12 12/12/2016 Faeces – Pooled
Z13 12/12/2016 Faeces – Pooled
Z14 12/12/2016 Faeces – Individual
Z15 12/12/2016 Faeces – Pooled
Z16 12/12/2016 Faeces – Pooled
Z17 12/12/2016 Faeces – Pooled
Z18 12/12/2016 Faeces – Individual
Z19 12/12/2016 Faeces – Pooled
Z20 12/12/2016 Faeces – Pooled
Z21 12/12/2016 Faeces – Pooled
Z22 12/12/2016 Faeces – Pooled
Z23 12/12/2016 Faeces – Pooled
Z24 12/12/2016 Faeces – Pooled
Z25 12/12/2016 Faeces – Pooled
Z26 12/12/2016 Faeces – Pooled
Z27 12/12/2016 Faeces – Pooled
Z28 12/12/2016 Faeces – Individual
E89 01/11/2016 Faeces – Individual
Fig. 1. (A–D) Giemsa-stained section of intestinal epithelium
showing moderate to heavy epicellular infection by
Cryptosporidium, associated with minimal host inflammatory
response (isolate E89). Trophozoites (T) and meronts (Me)
generally measured less than five micrometres as is typical for
Cryptosporidium. There was a predominance of merogony
with both type I (MeI) and type II meronts (MeII) present.
Scale bar: 5 μm.
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were dewaxed in xylene, rehydrated in an ethanol series and stained by
haematoxylin & eosin (H & E) or Giemsa. Giemsa stock solutions were
made up with 0.75 g Giemsa powder, 65 ml methanol and 65 ml gly-
cerol, and diluted 1:10 with tap water immediately prior to use. Giemsa
stained tissue sections were acidified with 10% acetic acid for 15 s, and
placed in freshly diluted Giemsa stain, preheated in a microwave
(Kambrook model 686LE, 1150W) on medium for 30 s, followed by
microwaving on low for 30 s. Slides were rinsed in tap water followed
by absolute ethanol, before permanent mounting in DPX (Dako).
2.3. DNA isolation
Following five cycles of freeze-thaw, genomic DNA was extracted
from 250 mg of each faecal sample (n = 29), using a Power Soil Kit
(MO BIO, Carlsbad, California, USA) in accordance to the manu-
facturer’s instructions. An extraction blank (no faecal sample) was used
in each extraction group. Purified DNA was stored in −20 °C prior to
molecular analyses. DNA extraction and post-DNA extraction proce-
dures were performed in separate dedicated laboratories.
2.4. PCR amplification
A nested PCR approach was used to amplify an approximately
825 bp 18S rRNA fragment using the primers SSU-F2 (5′-
TTCTAGAGCTAATACATGCG-3′) and SSU-R2 (5′-CCCATT
TCCTTCGAAACAGGA-3′) for the primary PCR and SSU-F3 (5′-
GGAAGGGTTGTATTTATTAGATAAAG-3′) and SSU-R4 (5′-
AAGGAGTAAGGAACAACCTCCA-3′) for the nested PCR (Xiao et al.,
1999). Each 25 μl PCR mixture contained 1 μl of genomic DNA, 1× Go
Taq PCR buffer (KAPA Biosystems, South Africa), 3.75 mM MgCl2,
400 μM of each dNTPs, 0.4 μM of forward and reverse primers and 1 U
Kapa DNA polymerase (Kapa Biosystems, South Africa). The PCR cy-
cling conditions consisted of an initial denaturation step at 94 °C for
3 min followed by 40 cycles of 94 °C for 45 s, 58 °C for 90 s, and 72 °C
for 1 min, followed by a final extension step at 72 °C for 7 min. An
approx. ∼818 bp fragment of the actin gene was amplified as pre-
viously described (Ng et al., 2006), with the following modifications;
denaturation time was increased from 30 s to 45 s, annealing time from
20 s to 30 s and extension time from 40 s to 1 min. PCR amplification of
an approximately 325 bp fragment of the hsp70 gene was performed
using a nested PCR as previously described (Hong et al., 2014).
No-template and extraction reagent blank controls were included in
every PCR run. Positive control DNA (C. macropodum) was also added to
every run to validate the PCRs. PCR setup and DNA handling procedure
were performed in separate physically contained PCR-hoods, and post-
PCR procedures were performed in a separate laboratory.
2.5. Sequence and phylogenetic analysis
Nested PCR products were electrophoresed through 1% agarose
gels, and DNA fragments of the expected size (bp) for the 18S, actin and
hsp70 assays were excised from the gels and purified for Sanger se-
quencing using an in-house filter tip method (Yang et al., 2013). Pur-
ified PCR products from all three assays, were sequenced independently
in both directions using an ABI Prism™ Dye Terminator Cycle Sequen-
cing kit (Applied Biosystems, Foster City, California, USA) according to
the manufacturer’s instructions at 58 °C, 58 °C and 56 °C annealing
temperature for the 18S rRNA, actin and hsp70 loci, respectively.
Fig. 2. Evolutionary phylogenetic relationship between C. homai n. sp. and Cryptosporidium species described to date as inferred by maximum likelihood (ML) analysis of 18S rRNA locus.
Percentage support (> 50%) from 1000 pseudoreplicates from ML analyses is indicated at the left of the supported node. Scale bars indicate the number of substitutions per nucleotide
position.
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Sanger sequencing chromatogram files were imported into Geneious
Pro 8.1.6 (Kearse et al., 2012), and the nucleotide sequences of each
gene was curated, analysed and aligned with reference sequences from
GenBank using Clustal W (http://www.clustalw.genome.jp). The most
suitable nucleotide substitution model was assessed in MEGA7 (Kumar
et al., 2015). Distance, Parsimony and Maximum Likelihood (ML) trees
were constructed using MEGA version 7 (Kumar et al., 2015). Bootstrap
support for branching was based on 1000 replications. Sequences have
been deposited in GenBank under the accession numbers
MF499131–MF499151.
3. Results
3.1. Prevalence and histological analysis
In the present study, C. homai n. sp. was detected in 24.1% (7/
29–95% CI: 10.3%–43.5%) of faecal samples collected from guinea pig
enclosures by PCR and sequencing at 3 loci. Histological analysis of the
small intestine of one guinea pig (isolate E89), indicated moderate to
heavy epicellular infection of the intestinal epithelium by
Cryptosporidium, associated with a minimal host inflammatory re-
sponse. Trophozoites and meronts generally measured<5 μm, as is
typical for Cryptosporidium. There was a predominance of merogony
with both type I and type II meronts present (Fig. 1). The lamina pro-
pria was expanded by mild to moderate predominantly lymphocytic-
plasmocytic inflammatory infiltrate with the occasional neutrophils,
eosinophils and necrotic cells. An average of 1–2 and up to 3 mitotic
figures were observed per intestinal crypt in 40–50% of crypts per high
power field (40× objective). Mildly tortuous intestinal glands or crypts
and the prominence of mitotic figures are suggestive of intestinal epi-
thelial hyperplasia.
3.2. Sequence and phylogenetic analysis C. homai n. sp. at the 18S, actin
and hsp70 loci
Phylogenetic relationships were inferred by Distance, Parsimony
Fig. 3. Phylogenetic relationships between C. homai n. sp. and other Cryptosporidium species inferred by ML analysis of actin gene. Percentage support (> 50%) from 1000 pseudor-
eplicates from ML analyses is indicated at the left of the supported node. Scale bars indicate the number of substitutions per nucleotide position.
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and Maximum Likelihood (ML) analyses at 18S, actin and hsp70 loci,
based on 825, 818 and 325 bp of nucleotide sequences, respectively,
and produced trees with mostly similar topologies with some exceptions
(Figs. 2–4). An ML tree was also inferred from concatenated 18S, actin
and hsp70 sequences (Fig. 5).
At the 18S locus, all C. homai n. sp. (n = 7, which included 6 faecal
samples and the intestinal sample, E89) were identical and grouped in a
separate clade, sharing 99.1% identity with a novel genotype of
Cryptosporidium spp. reported in guinea pigs (C. procellus) from Brazil (7
and 6 SNPs difference over 676 bp of submissions DQ885337 and
DQ885338, respectively) (Huber et al., 2007). C. homai n. sp exhibited
3.1% genetic distance from the closest species, C. felis, 3.6% genetic
distance from C. wrairi, and 3.2% (C. suis) to 15.4% (C. scophthalmi)
genetic distance from all other Cryptosporidium spp.
At the actin locus, C. homai n. sp. again grouped separately and
exhibited 14.4% genetic distance from the closest species, C. varanii,
18.4% genetic distance from C. wrairi and genetic distances ranging
from 15.7% (C. suis) to 24.5% (C. scophthalmi) from all other
Cryptosporidium spp.
Phylogenetic analysis of the hsp70 gene, also confirmed the genetic
distinctness of C. homai n. sp., where it exhibited 6.6% genetic distance
from the closest species, C. suis, 7% genetic distance from C. wrairi, and
7.1% (C. varanii) to 20.9% (C. serpentis) genetic distance from all other
Cryptosporidium spp.
An ML tree inferred from concatenated 18S, actin and hsp70 se-
quences grouped C. homai n. sp. with C. varanii and C. macropodum,
with 9.1% and 10% genetic distance respectively. Based on phyloge-
netic analysis using concatenated sequences, C. homai n. sp. exhibited
10.8% genetic distance from C. wrairi, the only valid Cryptosporidium sp.
described in guinea pigs, and exhibited between 17.3% (C. proliferans)
and 9.7% (C. suis) genetic distance from all other Cryptosporidium spp.
3.3. Taxonomic summary and species description
Order: Cryptogregarida (Cavalier-Smith, 2014).
Family: Cryptosporidiidae
Species name: C. homai n. sp.
Type host: Guinea pigs (Cavia porcellus)
Other natural hosts: Unknown
Type locality: Perth, Western Australia
Site of infection: Intestine
Prepatent period: Unknown
Patent period: Unknown
Material deposited: partial sequences of 18S, actin and hsp70 genes
were submitted to GenBank under accession numbers
MF499131–MF499151.
Etymology: This species is named C. homai n. sp. in honor of my late
aunt, Ms. Homa Hoorfar.
4. Discussion
In the present study, post-mortem analysis of a guinea pig eu-
thanised due to respiratory distress, identified an intestinal infection
with a Cryptosporidium species, which on the basis of molecular analysis
is a new species, named C. homai n. sp. The new species was detected in
24.1% of faecal samples from guinea pigs held at an experimental
Fig. 4. Phylogenetic relationships between C. homai n. sp. and other Cryptosporidium species inferred by ML analysis of partial hsp70 gene sequences. Percentage support (> 50%) from
1000 pseudoreplicates from ML analyses is indicated at the left of the supported node. Scale bars indicate the number of substitutions per nucleotide position.
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animal facility. The exact prevalence is difficult to determine as pooled
faecal samples were obtained from enclosures, however the high pre-
valence is likely due to the close proximity of animals to each other,
which would facilitate transmission. Very little is known about
Cryptosporidum in guinea pigs. Surveys of pet guinea pigs in Italy
(n = 80) and Ecuador (n = 40) failed to detect Cryptosporidium
(d’Ovidio et al., 2015; Vasco et al., 2016). Another study in Brazillian
guinea pigs (Cavia aperea aperea), detected Cryptosporidium in 3 of 5
faecal samples by microscopy, and Cryptosporidium was also detected in
one guinea pig on a farm in the UK, but no genotyping was conducted in
either study (Gressler et al., 2010; Smith et al., 2010). Other studies
have identified C. wrairi in guinea pigs (Lv et al., 2009; Feng et al.,
2011), and until recently this was the only Cryptosporidium spp. iden-
tified in guinea pigs.
A previous study identified a novel Cryptosporidium genotype in
guinea pigs (C. procellus) obtained from an indoor public market, in Rio
de Janeiro, Brazil (Huber et al., 2007), which shared 99.1% similarity
with C. homai n. sp. at the 18S locus (7 and 6 SNPs difference over
676 bp of submissions DQ885337 and DQ885338, respectively). Phy-
logenetic analysis grouped them in a clade together with high bootstrap
support, suggesting that they are likely the same species. Unfortunately,
sequences at the actin and hsp70 loci were unavailable for this genotype
to confirm this.
Trophozoites and meronts of C. homai n. sp. measured<5 μm, but
oocysts were not observed. However, it is widely accepted that mor-
phology is not a useful criterion for delimiting Cryptosporidium spp.
(Fall et al., 2003). Phylogenetic analysis at the 18S, actin and hsp70 loci
confirmed the genetic distinctness of C. homai n. sp. which exhibited
genetic distances ranging from 3.1% to 15.4%, 14.4% to 24.5%, and
6.6% to 20.9% from all other Cryptosporidium spp., respectively. Phy-
logenetic analysis of concatenated 18S, actin and hsp70 sequences also
exhibited 9.1–17.3% genetic distances between C. homai n. sp. and
other Cryptosporidium spp. This clearly supports the species status of C.
homai n. sp., as these differences are greater than between many cur-
rently accepted species. For example, the genetic distance at the 18S
and actin loci between C. hominis and C. cuniculus is 0.4% and 1.6%,
respectively (Kvác et al., 2014), and the genetic distance between C.
muris and C. andersoni at the 18S, actin, hsp70 loci is 0.7%, 3.5% and
2.2%, respectively (Holubová et al., 2016).
In the present study, C. homai n. sp. did not group with C. wrairi (the
only currently valid species in guinea pigs) and exhibited 3.6%, 18.4%
and 7.0% genetic distance from this species at 18S, actin and hsp70 loci,
respectively and is clearly a separate species from C. wrairi. The phy-
logenetic relationship of C. homai n. sp. to other Cryptosporidium spp. is
however still ambiguous; at the 18S locus, it was most closely related to
C. felis, while at the actin locus, it was closest to C. varanii (14.4% ge-
netic distance), at the hsp70 locus, it grouped most closely with C. suis
(6.6%), and a concatenated analysis of all 3 loci, grouped it most closely
with C. varanii (9.1%). Analysis at additional loci or whole genome
analysis will shed more light on the evolutionary relationships between
C. homai n. sp. and other Cryptosporidium spp.
The pathogenic potential of C. homai n. sp. is unknown.
Histopathological analysis indicated minimal host inflammatory re-
sponses, with the lamina propria expanded by mild predominantly
lymphocytic-plasmocytic inflammatory infiltrate with the occasional
neutrophils, eosinophils and necrotic cells. Intestinal mucosal cells are
usually replaced from germinal cells in the crypts, as the older epithelial
cells are sloughed at the tips of villi. The occasional mitotic figure is
Fig. 5. Phylogenetic relationships between C. homai n. sp. and other Cryptosporidium species inferred ML analysis of concatenated sequences constructed from partial DNA sequences of
18S, actin and hsp70 loci. Percentage support (> 50%) from 1000 pseudoreplicates from ML analyses is indicated at the left of the supported node. Scale bars indicate the number of
substitutions per nucleotide position.
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expected in the normal healthy animal as renewal of cells. But large
numbers indicate a response to the infection. Histopathological analysis
of the infected guinea pig in the present study revealed large numbers
of mitotic figures which suggest increased replacement of intestinal
cells from hyperplasia. More structured studies are required to clearly
define the clinical signs (if any) caused by C. homai n. sp.
The host range of C. homai n. sp. and its zoonotic potential are also
currently unknown, but it has not been previously reported in any other
host, suggesting that it may be host specific, however, further analysis
is required to determine this.
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Abstract A molecular epidemiological survey of
Cryptosporidium from water buffalo (Bubalus bubalis) in
the Northern Territory in Australia was conducted. Fecal sam-
ples were collected from adult farmed (n=50) and wild buf-
falo (n=50) and screened using an 18S quantitative PCR
(qPCR). Positives were typed by sequence analysis of 18S
nes ted PCR products . The qPCR prevalence of
Cryptosporidium species in farmed and wild buffalo was 30
and 12 %, respectively. Sequence analysis identified two spe-
cies: C. parvum and C. bovis, with C. parvum accounting for
~80 % of positives typed from the farmed buffalo fecal sam-
ples compared to 50 % for wild buffalo. Subtyping at the
60 kDa glycoprotein (gp60) locus identified C. parvum sub-
types IIdA19G1 (n=4) and IIdA15G1 (n=1) in the farmed
buffalo and IIaA18G3R1 (n=2) in the wild buffalo. The pres-
ence of C. parvum, which commonly infects humans, sug-
gests that water buffaloes may contribute to contamination
of r ivers and waterways with human infect ious
Cryptosporidium oocysts, and further research on the epide-
miology of Cryptosporidium in buffalo populations in
Australia is required.
Keywords Cryptosporidium . Buffalo . 18S .C. parvum .C.
bovis . gp60
Introduction
Cryptosporidium is an important protozoan parasite that infects
a wide range of animals including humans (Xiao 2010). The
parasite is fecal orally transmitted via water, food, or direct
contact (Burnet et al. 2014). Clinical symptoms in immuno-
competent individuals can include self-limiting watery diar-
rhea, abdominal pain, nausea, and vomiting but in immuno-
compromised individuals, infections can result in chronic or
protracted diarrhea (Chalmers and Davies 2010). The environ-
mental stage of the parasite (oocyst) is resistant to inactivation
by commonly used drinking water disinfectants (Baldursson
and Karanis 2011; Burnet et al. 2014). As a result of this,
contamination of water supplies is a major mode of transmis-
sion, andCryptosporidiumwas the etiological agent in 60.3%
(120) of the waterborne protozoan parasitic outbreaks reported
worldwide between 2004 and 2010 (Baldursson and Karanis
2011). Of the twenty-nine recognized Cryptosporidium spe-
cies (Ryan and Hijjawi 2015; Zahedi et al. 2015), C. parvum
and C. hominis have been responsible for the majority of in-
fections in humans (Xiao 2010).
Livestock animals have been implicated as a source of
human cryptosporidiosis based on molecular epidemiological
studies conducted in various countries (Xiao 2010; Santín
2013; Abeywardena et al. 2014; Abeywardena et al. 2015).
However, relatively little is known about the range of species
and genotypes of Cryptosporidium in other members of the
family Bovidae, including water buffalo (Bubalus bubalis),
but to date, C. parvum, C. ryanae, C. bovis, C. ubiquitum, a
BC. suis-like^ genotype, and C. ryanae variants have been
reported (Gómez-Couso et al. 2005; Cacciò et al. 2007; Feng et
al. 2012; Venu et al. 2012; Abeywardena et al. 2013a; Abu Samra
et al. 2013; Amer et al. 2013; Helmy et al. 2013; Inpankaew et al.
2014; Mahfouz et al. 2014; Ma et al. 2015; Abeywardena et al.
2015; Aquino et al. 2015; Helmy et al. 2015).
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Water buffalo are one of the important livestock ani-
mals in many regions of the developing world. The
world’s water buffalo population was estimated as 195
million in 2011, being mostly distributed in Asia, some
Mediterranean regions and Latin American countries
(Robertson et al. 2014). Water buffalo were brought to
Australia between 1824 and 1886 from South-East Asia
to provide working animals and meat for the remote
northern settlements (Letts 1964). When the early settle-
ments were abandoned, the buffaloes were released, where
they became feral populations. Currently, both farmed and
feral buffalo herds exist in Australia, with the majority of
feral buffaloes in the Northern Territory (in Arnhem Land)
with a minimum estimated population of wild buffalo of
approximately 98,000 buffalo across 92,000 km2 of coun-
try (Saalfeld 2014).
To date, only one study of Cryptosporidium in farmed wa-
ter buffalo in Victoria, Australia, has been conducted
(Abeywardena et al. 2013a), and nothing is known about the
prevalence and species of Cryptosporidium infecting water
buffalo in Northern Australia. Therefore, the aim of the pres-
ent study was to use molecular tools to better understand the
public health risks of Cryptosporidium sp. in both wild and
farmed buffalo herds to drinking water supplies in the
Northern Territory (NT) of Australia.
Materials and methods
Sample collection and processing
Buffalo fecal samples were collected in August 2015 from
(1) wild buffalo (n= 50) located near the Maude Creek cat-
tle station, 30-km south of Katherine, NT (the herd was
originally sourced from the Phelp River, South-Eastern
Arnhem Land) and (2) farmed buffalo (n = 50) from the
Northern Territory Government, Department of Primary
Industry and Fisheries (DPIF) buffalo farm (Beatrice Hill
Farm), near the Adelaide River, NT by Tropical Water
Solution staff. Samples were collected from freshly depos-
ited fecal samples into individual 75-ml fecal collection
pots using a scrapper to expose and scoop from the center
of the scat pile. All samples were stored at 4 °C, shipped to
Murdoch University, and stored at 4 °C until analyzed. All
fecal samples were collected from adult animals; the wild
buffalo were between 2–5 years of age, and the farmed
buffalo were between 3 and 4 years of age. Approval for
faecal collection was obtained from the Northern Territory
Buffalo Industry Council and individual property owners
directly by phone. As the samples were collected directly
from the ground and not per rectum, specific animal ethics
approval was not required.
DNA isolation
Genomic DNAwas extracted from 250 mg of each fecal sam-
ple using a Power Soil DNA Kit (MolBio, Carlsbad,
California). A negative control (no fecal sample) was used
in each extraction group.
PCR amplification of the 18S rRNA gene
All samples were screened for the presence of
Cryptosporidium at the 18S rRNA locus using a quantitative
PCR (qPCR) previously described (King et al. 2005; Yang
et al. 2014). Each 10-μl PCR mixture contained 1× Go Taq
PCR buffer (KAPABiosystems), 3.75mMMgCl2, 400μMof
each dNTPs, 0.5-μM 18SiF primer, 0.5-μM 18SiR primer,
0.2-μM probe, and 1U/reaction Kapa DNA polymerase
(MolBio, Carlsbad, California). The PCR cycling conditions
consisted of one pre-melt cycle at 95 °C for 6 min and then
50 cycles of 94 °C for 20 s and 60 °C for 90 s.
Samples that were positive by qPCR were amplified at the
18S locus using primers which produced a 611-bp product as
previously described (Silva et al. 2013) with minor modifica-
tions; the annealing temperature used in the present study was
57 °C for 30 s, and the number of cycles was increased from
39 to 47 cycles for both primary and secondary reactions. PCR
contamination controls were used including negative controls
and separation of preparation and amplification areas.
PCR amplification of the gp60 gene
Samples that were typed as C. parvum at the 18S locus were
subtyped at the 60 kDa glycoprotein (gp60) locus using a
nested PCR as previously described (Zhou et al. 2003).
Sequence analysis
The amplified DNA from secondary PCR products was sepa-
rated by gel electrophoresis and purified for sequencing using
an in-house filter tip method (Yang et al. 2013). Purified PCR
products from both loci were sequenced independently using
an ABI Prism™ Dye Terminator Cycle Sequencing kit
(Applied Biosystems, Foster City, California) according to
the manufacturer’s instructions at 57 and 54 °C annealing
temperature for the 18S rRNA and gp60 loci, respectively.
Sanger sequencing chromatogram files were imported in
Geneious Pro 8.1.6 (Kearse et al. 2012), edited, analyzed,
and aligned with reference sequences from GenBank using
Clustal W (http://www.clustalw.genome.jp).
Statistical analysis
Statistical analyses (Fisher’s exact test) were performed using




determine if there was a statistical difference in the prevalence
of Cryptosporidium in farmed versus wild buffalo.
Results
Prevalence of Cryptosporidium in farmed and wild buffalo
The qPCR prevalence of Cryptosporidium species in the
farmed buffalo was 30 % (15/50) (95 % CI, 17.9–44.6) and
was 12 % (6/50) (95 % CI, 4.5–24.3) in the wild buffalo. This
difference was significant (P=0.048, P<0.05).
Cryptosporidium species detected in farmed and wild
buffalo
Sequence analysis at the 18S locus was only successful for six
of the fifteen farmed buffalo positives and four of the six wild
buffalo samples. Two Cryptosporidium species, C. parvum
and C. bovis, were identified in both types of the samples. In
the farmed buffalo samples, five were C. parvum and one was
C. bovis, whereas for the wild buffalo, two were identified as
C. parvum and two were C. bovis.
Sequences at the gp60 locus were obtained for five of the
farmed buffalo C. parvum positives, and C. parvum subtypes
IIdA19G1 (n=4) and IIdA15G1 (n=1) were identified. In the
wild buffalo, gp60 sequences were obtained for both
C. parvum positives, and both were identified as IIaA18G3R1.
Discussion
The present study described the prevalence and molecular
characterization of Cryptosporidium species in the farmed
and wild buffalo from the Northern Territory in Australia.
The prevalence of Cryptosporidium species in the farmed
and wild buffalo fecal samples was 30.0 and 12.0 % respec-
tively. A previous study of Cryptosporidium in farmed water
buffalo in Victoria reported a prevalence of 13.0 % (62/476)
(Abeywardena et al. 2013a). Other studies have reported prev-
alences in buffalo ranging from 5.7 to 62.1 % (Amer et al.
2013; Inpankaew et al. 2014; Abeywardena et al. 2014;
Aquino et al. 2015; Ma et al. 2015).
Cryptosporidium parvum is the most commonly reported
zoonotic species of Cryptosporidium infecting humans and
was the most common species detected in farmed buffalo
(~80 % of positives typed) and in wild buffalo accounted for
50 % of the positives typed. This species has been detected
previously in buffaloes in many countries including Spain,
Italy, Australia, Egypt, India, and Thailand (Amer et al.
2013; Cacciò et al. 2007; Gómez-Couso et al. 2005; Maurya
et al. 2013; Abeywardena et al. 2013a; Inpankaew et al. 2014;
Mahfouz et al. 2014; Aquino et al. 2015). Previous studies
have reported that C. parvum was the predominant species
in young buffaloes (Cacciò et al. 2007; Maurya et al. 2013;
Inpankaew et al. 2014), and in the previous study in Australia,
C. parvum was only detected in buffalo <6 months of age
(Abeywardena et al. 2013a). In the present study, however,
all buffalo samples were adults (2–5 years), indicating that
this species can also commonly infect adult buffaloes.
Cryptosporidium bovis was detected in ~20 and 50 % of
the farmed and wild buffalo isolates-typed, respectively. This
species has previously been reported in buffalo in Egypt
(Helmy et al. 2013), South Africa (Abu Samra et al. 2013),
Australia (Abeywardena et al. 2013a), and China (Ma et al.
2015). In the previous study in Australia, C. ryanae variants
(reported as genotypes 1 and 2) and a C. suis-like genotype
(reported as genotype 3) were also reported in buffaloes
(Abeywardena et al. 2013a). Cryptosporidium bovis is pre-
dominantly a parasite of livestock and has only been reported
in humans on a few occasions (Khan et al. 2010; Ng et al.
2012).
The C. parvum subtype IIaA18G3R1 was identified in the
two wild buffalo samples. IIaA18G3R1 is a common subtype
and has been reportedwidely in both cattle and humansworld-
wide including Australia (Plutzer and Karanis 2009; Ryan and
Power 2012). The C. parvum subtypes IIdA19G1 and
IIdA15G1 were identified in the farmed buffalo in the present
study. Both are considered zonootic subtypes (Wang et al.
2014). The C. parvum IId subtype family has been reported
mainly from sheep and goats but has also been reported in
humans and cattle (Plutzer and Karanis 2009; Xiao 2010;
Wang et al. 2014). TheC. parvum IIdA15G1 subtype has been
detected in livestock and humans (Plutzer and Karanis 2009;
Xiao 2010; Wang et al. 2014), including a human in Australia
(Ng et al. 2010). The IIdA19G1 subtype is less common but
has been reported in humans and animals (Xiao 2010;Wang et
al. 2014). In China, IId is the predominant C. parvum subtype
(Wang et al. 2014), and both of these IId subtypes are com-
monly found in bovine animals in China including yaks
(Wang et al. 2014; Qi et al. 2015). However, this subtype is
not common in dairy cattle in Australia (Ng et al. 2012;
Abeywardena et al. 2013b). Previous analysis has indicated
that C. parvum IId subtypes were probably dispersed from
Western Asia to other geographical regions (Wang et al.
2014). As water buffalo in Australia came from Asia (Letts
1964), it is likely that the IId subtype family was introduced
into Australia with the introduction of buffalo. In the previous
study in Australia (Abeywardena et al. 2013a), gp60
subtyping was not conducted.
Conclusion
The preliminary data from the present study indicates that




transmission of C. parvum via contamination of water, as buf-
faloes usually wallow in rivers, streams, and other water
sources (Abeywardena et al. 2014). These findings indicate
the need (1) for further characterization of the prevalence,
intensity of infection, and species of Cryptosporidium in buf-
falo populations across Australia and (2) to determine the
levels of oocysts in rivers and waterways flowing from buffalo
farms and wild buffalo locations, particularly those that flow
into water reservoirs used for drinking water.
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